ANNUAL REPORT

FY 2020 — Annual report

FY 2020PDF · 160 pages7.8 MB
2020 Annual Report
Delivering today,
building for a
stronger tomorrow

-- 1 of 160 --

1
Dear shareholders,
2020 Annual Report
As the COVID-19 pandemic worsened in March 2020,
3M’s respirator plant in Valley, Nebraska issued a
call for help: it needed two dozen 3M engineers and
technicians to work on additional manufacturing lines
that were already running around the clock. By the
next morning, over a hundred 3Mers from across the
Midwest had volunteered — at a moment’s notice — to
pack up, temporarily relocate and sacrifice time away
from family to make a difference.
It is inspiring, but it is not surprising. This is 3M.
This is who we are and what we do.
I have been with this company for more than three
decades. 2020 was a year like no other, and I’ve never
been prouder of how 3Mers everywhere stepped up to
help the world during a unique moment in history. Our
response throughout COVID-19 has been guided by
our purpose, and shaped by three priorities: protecting
our employees, fighting the pandemic from every angle
and delivering for our customers and shareholders. Last
year, we made more respirators than ever before, while
continuing to innovate for customers, invest for the
future and advance our values.
As a result, 3M is well-positioned to lead through
the global recovery and capitalize on market and
technological trends that favor our market-leading
businesses. That too is an example of who we are and
what we do.
Ultimately, we have more work to do to build an even
stronger, more competitive enterprise. My commitment
is for all of 3M to stay relentlessly focused on delivering
extraordinary value for all stakeholders who have
placed their trust in us — including premium returns
for you, our shareholders.
Mike Roman
3M Chairman of the Board and Chief Executive Officer
Delivering in 2020,
building for a stronger
tomorrow
This letter refers to non-GAAP measures such as free cash flow and net debt that are not otherwise referenced in the accompanying charts/tables. See the Financial
Condition and Liquidity section of Item 7 of 3M’s 2020 Annual Report on Form 10-K for further details.

-- 2 of 160 --

2
Good operational performance
in an uncertain environment
With respect to 2020 financial results, the impact
of COVID-19 and the global economic slowdowns
varied across 3M. Some areas of our portfolio —
such as personal safety — experienced higher
demand, while others — such as health care
elective procedures — faced substantial declines.
Broadly speaking, we saw many of our end-markets
sequentially improve as we moved through the
second half of the year and as economies began
to reopen, though of course significant economic
uncertainty remains as we start 2021.
Companywide, organic growth was -1.7%, along with
earnings of $9.25 per share, or $8.74 on an adjusted
basis. Our team delivered another year of robust free
cash flow, up 23% to $6.6 billion, with a conversion rate
of 123% — demonstrating our ability to perform across
economic cycles. We posted a good return on invested
capital of 18%, along with operating margins of 22%, and
adjusted operating margins of nearly 21%. Finally, we
returned $3.8 billion to shareholders through dividends
and share repurchases, and 2020 marked our 62nd
consecutive year of dividend increases.
Protecting lives in the global
pandemic
Beyond financial results, 2020 was a year in which
3M stepped up where we were needed the most. Our
company has a unique and critical responsibility in
pandemic preparedness and response, and it starts with
an uncompromising commitment to the safety of our
employees. When the virus broke out, we moved quickly
to remote work where possible, while instituting more
robust safety protocols in our factories and other facilities.
For 3Mers personally affected, we implemented pandemic
support policies to help protect their pay and benefits and
allow them to take care of themselves and their families.
At the same time, we worked to protect the public,
including and especially the nurses, doctors and first
responders on the front lines. 3M is a longtime leader in
personal safety, with a range of science-based solutions
for respiratory, face, hearing and fall protection. These
include our N95 respirators, which 3M pioneered 50
years ago, and which we have continuously refined and
improved ever since. The bulk of our N95 respirators are
manufactured in the United States at plants in Nebraska
and South Dakota; we also have manufacturing facilities
in Asia Pacific, Europe and Latin America. Following SARS
in the early 2000s, we decided to prepare for future crises
by investing in significant respirator surge capacity at our
plants. Those investments have enabled us to respond to
emergencies such as H1N1, the Japanese tsunami and
wildfires. When the world needs us, 3M is there.
3M is committed to being
best-in-class in ESG
3M is investing $1 billion over the next
20 years to become carbon neutral by
2050, reduce water use, and improve
water quality.
3M is helping shape the future of work by
expanding access to science, manufacturing
and skilled-trades careers inside and outside
3M for underrepresented groups.
3M believes that good corporate governance
practices serve the long-term interests of
all stakeholders, strengthen the Board and
management, and further enhance the public
trust 3M has earned. 3M is one of the World’s
Most Ethical Companies as rated by Ethisphere.

-- 3 of 160 --

3
Thus, when COVID-19 emerged in January, we were
able to quickly activate our surge capacity and double
our production of respirators to support the urgent
public health response. We have since made additional
investments, and forged partnerships with other
companies and governments around the world, to
continuously bring on additional capacity. In total, 3M
produced and delivered 2 billion respirators globally
in 2020, with approximately half in the United States.
Today, we are producing respirators at a rate of 2.5
billion per year, a 4-fold increase versus 2019.
Investing for the future
As we fought COVID-19 on so many fronts, we never
lost focus on taking strategic actions to position
ourselves for long-term growth, productivity and value
creation. Innovation differentiates 3M, and last year
we invested $3.4 billion in the combination of research
and development and capital expenditures, enabling
us to both invent and manufacture unique solutions
for customers. We found ways to innovate faster and
differently, while driving strong results in our priority
growth platforms like indoor air quality, biopharma
filtration and automotive electrification. For example,
last year we introduced cutting-edge products to
improve electric car batteries, one element of our
work to support more sustainable vehicle designs.
For the full year, our priority growth platforms grew
7%, outperforming the markets they serve.
3M also continued to advance the new, streamlined
global operating model that we implemented at
the beginning of 2020, a significant step in our
transformation. Our new model has enabled us to
respond to the pandemic with agility and resilience —
from expansion of respirator production to our ability to
maintain business continuity, strong customer service
and the integrity of our supply chain. To further optimize
our model and streamline our organization, we initiated
a series of actions across the company that will reduce
annual operating costs by $250 to $300 million.
2020 Annual Report
Our team has also collaborated with law enforcement
and retailers to combat price-gouging, counterfeiting
and other fraudulent activity. We published our
respirator prices, filed nearly two dozen lawsuits and
removed thousands of deceptive websites and social
media posts. We’ve helped identify more than 10 million
counterfeit respirators, protecting healthcare workers
from bad actors.
In addition to respirators, 3M has led the fight against
COVID-19 in other important ways. Our biopharma
filtration solutions have helped speed development and
manufacture of critical vaccines and therapeutics. We
introduced new daily face coverings, and quickly adapted
our cleaning and disinfecting product lines to serve
new customers. We also made investments to support
vulnerable populations, and helped young students learn
remotely through science-at-home programs.
At the center of our COVID-19 response has been our
people: from the 50,000 3Mers in our factories and
distribution centers, to the retirees who came back to
staff our fraud hotline, to those who answered the call in
Valley, Nebraska. People across 3M have stepped up to
make a difference, and I cannot thank our entire team
enough for their extraordinary contributions in 2020.
Disciplined capital allocation across the entire company
— coupled with strong cash flow — also helped us
reduce net debt by over $4 billion in the year. As a result,
we exited 2020 with a stronger balance sheet and capital
structure, and well-positioned for the future.

-- 4 of 160 --

4
3M is also partnering with our communities to improve
society. In 2020 we took steps to advance our values,
including our commitments to diversity, equity
and inclusion. We launched an ambitious plan to
strengthen economic opportunities and education
for people of color, and we are holding ourselves
accountable to new goals to support underrepresented
groups at 3M, building on recent progress. In February
2021 we released our first annual Diversity, Equity and
Inclusion report with details on our goals and metrics,
further increasing transparency in this important area.
Similarly, we are strengthening our commitment to
sustainability, another core value for 3M. Over the
last two decades we’ve reduced our greenhouse gas
emissions significantly, and 3M products help our
customers avoid millions of tons of emissions every
year, including innovations that make cars, homes and
electronics more energy efficient. At the same time, we
are increasing our efforts to make our operations more
sustainable, including anticipated investments of $1
billion over the next 20 years to accelerate our ability to
achieve carbon neutrality by 2050, further reduce water
usage, and improve water quality.
Positioned for growth and emerging
market trends
COVID-19 is rapidly changing the global economy and
the way people live, work and communicate. Years’
worth of changes are unfolding in a matter of months,
creating opportunities to unleash 3M science and drive
sustainable, long-term growth.
With people at home more, for example, there is
growing need for products to maintain and improve
households, increasing demand for our indoor
air quality and do-it-yourself solutions. The rapid
movement to a digital-first world opens more
opportunities for our innovations that improve the
performance of data centers and semiconductor
manufacturing. An increased focus in other areas,
such as personal safety and health care, is also
highly attractive for 3M. To capitalize on these
market trends, we are increasing the prioritization
of investments where demand is strong, while
digitizing our operations and accelerating our
use of data and analytics in everything we do.
Committed to science, society,
sustainability
As we move forward, we will continue to step up our
leadership in science, society and sustainability. The
pandemic has emphasized the importance of science
in solving the world’s toughest challenges. For 3M,
science drives us forward. We leverage and combine
our technologies in unique ways across all of our
businesses, which helps make 3M greater than the
sum of our parts. We are positioned to do even more
to deliver differentiated solutions for our customers
into the future.
Applying science
to improve lives

-- 5 of 160 --

5
At 3M, achieving our environmental goals means
we will bend the curve in a way that goes beyond
what’s expected, and accelerates improvements our
world needs. For example, we plan to aggressively
cut our carbon emissions: 50% by 2030, 80% by
2040, and be fully carbon neutral by 2050. We also
expect to achieve a 10% reduction in water use by
the end of next year, and a 25% reduction overall by
2030 — saving 2.5 billion gallons of water annually.
Our investments to improve water quality will allow us
to put in place advanced technology by 2023 at our
sites that use the most water, and have that technology
fully operationalized by 2024, as we quickly move to
return water to the environment better than what we
took into our plants.
This is 3M. This is who we are and this is what we do.
Most successful endeavors � whether an organization
or a social movement � are fueled by one big idea.
For 3M, it is applying science to improve lives, and we
are finding new and better ways to do that every day.
I am confident in the future for 3M, and in our ability to
continue doing what we do best: use science to make
the world a safer, healthier and better place.
Thank you for your continued confidence in 3M.
Mike Roman
3M Chairman of the Board and Chief Executive Officer
2020 Annual Report
*Earnings per share-diluted, adjusted for special items (non-GAAP measure). See the Overview section of Item 7 of 3M’s 2020 Annual Report on Form 10-K for
further details.
Well-positioned to
lead through the global
recovery and capitalize
on market and
technological trends
$35
$30
$25
$20
$15
$10
$5
$0
Sales (billions)
$32.8
2018
$32.1
2019
$32.2
2020
$12
$10
$8
$6
$4
$2
$0
$8.89/$9.91* 	$7.81/$8.88* 	$9.25/$8.74*
2018 	2019 	2020
Earnings per share-diluted
$6.00
$5.50
$5.00
$4.50
$4.00
$3.50
$3.00
$2.50
$2.00
$1.50
$1.00
$0.50
$0.00
$5.44
2018
$5.76 	$5.88
2019 	2020
Cash dividends paid per share

-- 6 of 160 --

6
2020 financial results
Organic local currency sales growth by
business group (year-on-year)
Total sales by business group**
GAAP earnings
per share
+18.4% year-on-year
$9.25
$3.4B
$1.9B
$32.2B 	22.3% 	-0.3%	21.3% 	+2.1%
$0.4B
$1.5B
-1.7%	$8.74 	18.2% 	123%
Dividends 	Share
Repurchases
Organic local
currency sales growth
year-on-year
Adjusted earnings
per share*
-1.5% year-on-year
Return on
invested capital*
Free cash
flow conversion*
Investment in
research and
development
Net sales 	GAAP operating
income margins
Impact of currency
on worldwide sales
Adjusted operating
income margins*
Impact of acquisitions,
net of divestitures,
on worldwide sales
+0.1% year-on-year 	+310 basis points
year-on-year
year-on-year	flat year-on-year 	year-on-year
Investment
in capital
expenditures
100% of new products
in development contain
a Sustainability Value
Commitment
Safety &
Industrial
+3.5% 	-7.1%
Transportation &
Electronics
6
+1.0%
Health Care
+4.1%
Consumer
*2020 operating cash flow of $8.1 billion. Full financial data and non-GAAP reconciliations of free cash flow conversion and return on invested capital (refer to the
Financial Condition and Liquidity section) and certain amounts adjusted for special items (refer to the Overview section) are included in Item 7 of 3M’s 2020 Annual
Report on Form 10-K.
**3M business segment reporting measures include dual credit for certain sales. See 3M’s 2020 Annual Report on Form 10-K for further details.
Safety & Industrial
Consumer
Heath Care
Transportation & Electronics
$5.3B
(17%)
$11.8B
(37%)
$8.8B
(27%)
$8.3B
(26%)

-- 7 of 160 --

7
Safety & Industrial
Accelerating safety and industry performance by
serving the industrial, electrical and safety markets.
2020 Annual Report
Transportation & Electronics
Moving transportation and a connected world forward
by serving automotive and electronic OEM customers.
2020 sales by business
10%
12%
17%
18%
43%
Advanced Materials
Automotive & Aerospace
Commercial Solutions
Electronics
Transportation Safety
2020 sales by business
3%
	8%
9%
10%
10%
22%
38%
Abrasives
Automotive Aftermarket
Closure & Masking Systems
Electrical Markets
Industrial Adhesives & Tapes
Personal Safety
Roofing Granules
Market-leading
businesses
($M) 	2020
Sales 	$8,827
Sales growth 	-8.0%
Organic local currency sales growth 	-7.1%
Operating margins 	21.8%
2020 performance
($M) 	2020
Sales 	$11,767
Sales growth 	+2.2%
Organic local currency sales growth 	+3.5%
Operating margins 	26.0%
2020 performance

-- 8 of 160 --

88
Serving our customers through
four business groups
At 3M, we apply science to improve lives and help solve
the world’s toughest challenges. Our company has deep
competitive advantages: unique technology platforms,
advanced manufacturing, global capabilities and leading
brands. We leverage these capabilities across all of our
Health Care
Leveraging science and technology to improve the
delivery of health care and patient outcomes.
Consumer
Innovating to improve homes, work and life by serving
global consumers.
2020 sales by business
2%	4%
10%
13%
14%
57%
Drug Delivery
	Food Safety
Health Information Systems
Medical Solutions
Oral Care
Separation & Purification
3%
	7%
20%
23%
47%
Consumer Health Care
Home Care
Home Improvement
Stationery & Office
Other Consumer
2020 sales by business
businesses which make 3M stronger and better enables
us to invent, build and sell products across our vast global
network. Powered by insights from customers and global
trends, we create differentiated solutions and products
that we bring to market through four business groups:
Safety & Industrial, Transportation & Electronics, Health
Care, and Consumer.
Learn more about 3M Business Groups at go.3M.com/BGs.
($M) 	2020
Sales 	$8,345
Sales growth 	+12.3%
Organic local currency sales growth 	+1.0%
Operating margins 	21.9%
2020 performance
($M) 	2020
Sales 	$5,336
Sales growth 	+3.6%
Organic local currency sales growth 	+4.1%
Operating margins 	23.4%
2020 performance

-- 9 of 160 --

9
2020 Annual Report
Commitment to sustainability
At 3M what we believe is simple: We are people
committed to helping other people. We seek to
observe, understand and solve. Every day we help
tackle problems, big and small, in pursuit of our
vision to improve every life.
Our customers, employees, investors and other
stakeholders are asking for bigger commitments and
stronger actions. We have set clear goals and ambitious,
long-term strategies to direct our efforts to areas in
which we can make a significant impact. Building on
our global capabilities and diverse technologies, we
established our Strategic Sustainability Framework
to focus on three priority areas.
To learn more, please visit www.3M.com/Sustainability.
Improving lives
through innovation
and action
Design solutions that do more with less material,
advancing a global circular economy.
Science for Circular
3M™ Natural Pozzolans SCM (supplementary cementitious material)
used in the making of concrete, helps reduce CO2 emissions as a partial
replacement of cement in concrete.1 It’s estimated that each ton of SCM
used to displace cement reduces CO2 emissions by 0.75 tons.2
3M™ Envision™ Print Wrap Films and Overlaminates offer dimensional
stability and versatility in applications, whether on vehicles or interior, exterior
wall applications. These non-PVC films are made in part from bio-based
material, manufactured with less solvent, and GREENGUARD™ Gold certified
for low chemical emissions, contributing to healthier indoor air quality.
Scotch® Box Lock™ Packaging Tape sticks instantly to any box,
including harder-to-stick-to 100% recycled boxes. Its extreme grip
ensures boxes stay securely sealed, even during rough handling and
is made with solvent-free adhesive.
Goals
Expanded in 2021
Reduce global water use by an additional 10%, indexed to sales by 2022,
20% by 2025, and 25% by 2030.3,4
Announced in 2021
Return higher quality water to the environment after use in 3M manufacturing
operations. In our largest water-using locations, we expect to install state-of-art
water purification technology by the end of 2023 and fully operational by 2024.3
Announced previously
Engage 100% of water-stressed/scarce communities where 3M manufactures,
on community-wide approaches to water management by 2025.
Drive supply chain sustainability through targeted raw material traceability
and supplier performance assurance by 2025.
Reduce manufacturing waste by an additional 10%, indexed to sales by 2025.
Achieve zero landfill status at more than 30% of manufacturing sites by 2025.
Require every new product that enters 3M’s new product commercialization
process to have a Sustainability Value Commitment, demonstrating how it
drives impact for the greater good.

-- 10 of 160 --

10
Science for Climate
Innovate to decarbonize industry, accelerate
global climate change solutions and improve our
environmental footprint.
Science for Community
Create a more positive world through science and
inspire people to join us.
3M™ Dual Brightness Enhancement Film is a family of reflective
polarizers used to recycle light and bring a brighter view to all viewers
in front of a device, and can increase the energy efficiency in a device,
whether it’s plugged in or running on battery power.
3M™ Wind Blade Protection Tape can help protect the leading edge
of wind turbine blades against weathering and harsh environments,
ultimately enhancing reliability, extending life and improving the
performance of wind turbines.
Filtrete™ Room Air Purifiers can help capture 99.97% of airborne
particles5 such as dust and lint, mold spores, bacteria, and pet dander
with a Filtrete™ True HEPA filter. Even better, Filtrete™ Room Air
Purifier models with ENERGY STAR® certification are 40% more
energy-efficient than standard models.
Personal protective equipment (PPE) by 3M is engineered with
leading-edge technology, product innovations and groundbreaking
research so everyone can perform their best when conditions such
as environmental hazards, natural disasters, infectious diseases and
workplace activities impact personal safety.
3MSM Health Care Academy and 3M’s Personal Safety Division provide
education on proper use of health and safety products for infection
prevention, personal safety and overall health through our commitment to
provide training to five million people globally on worker and patient safety.7
3M™ M*Modal CDI Engage™ One™ reduces the administrative burden
on physicians and empowers the entire care team to drive better clinical
outcomes through advanced artificial intelligence tools. The paperless
platform creates a complete and accurate patient story, while allowing
physicians to spend more time on patient care and relationship-building.
Goals
Expanded in 2021
Reduce Scope 1 and 2 market-based GHG emissions at least 50%
by 2030, 80% by 2040 and achieve carbon neutrality in our operations
by 2050.3,6
Announced previously
Improve energy efficiency, indexed to net sales, by 30% by 2025.
Increase renewable energy to 50% of total electricity use by 2025
and to 100% by 2050.
Help our customers reduce their GHGs by 250 million tons of CO2
equivalent emissions through the use of 3M products by 2025.
Goals
Announced previously
Invest cash and products for education, community and environmental
programs by 2025.
Double the pipeline of diverse talent in management to build a diverse
workforce by 2025.
100% participation in employee development program to advance
individual and organizational capabilities by 2025.
Donate 300,000 skills-based work hours across the globe by 2025.
Provide training to five million people globally on worker and patient
safety by 2025.
(1) CO2 emissions from cement’s calcining step
(2) Based on 3M screening-level life cycle estimates
(3) 2019 will be the baseline measure year for these new commitments
(4) Expanded commitment from 10% between 2015 and 2025
(5) From the air passing through the filter media. Initial efficiency value
(6) Expanded 3M’s 2025 goal to stay below 50% of our 2002 baseline, meaning 3M’s 2030
Scope 1 and 2 emissions will now be reduced more than 85% from 2002 levels
(7) Includes the number of training experiences delivered by our Health Care Group and Personal Safety Division

-- 11 of 160 --

11
$32,765
7,207
5,349
9.09
8.89
$32,136
6,174
4,570
7.92
7.81
2018	2019
50.9
21.5
5.6
22.0
16.3
53.4
21.5
5.9
19.2
14.2
3,193
5.44
190.54
36,500
13,411
1,577
1,488
1,821
93,516
588.5
602.0
3,316
5.76
176.42
44,659
17,518
1,699
1,593
1,911
96,163
577.0
585.1
2020 Annual Report
Financial summary
(Dollars in millions, except per share amounts)
Operating Results
Net sales
Operating income
Net income attributable to 3M
Per share – basic
Per share – diluted
$32,184
7,161
5,384
9.32
9.25
2020
Financial Ratios
Percent of sales
Cost of sales
Selling, general and administrative expense, net of gain
on sale of businesses
Research, development and related expenses
Operating income
Net income attributable to 3M
%	%	%	51.6
20.3
5.8
22.3
16.7
Additional Information
Cash dividends paid
Per share
Stock price at year-end
Total assets
Long-term debt (excluding current portion)
Capital expenditures
Depreciation and amortization
Research, development and related expenses
Number of employees at year-end
Average shares outstanding – basic (in millions)
Average shares outstanding – diluted (in millions)
3,388
5.88
174.79
47,344
17,989
1,501
1,911
1,878
94,987
577.6
582.2

-- 12 of 160 --

low
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
☒☒ 	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020
Commission file number 1-3285
3M COMPANY
State of Incorporation: 	Delaware 	I.R.S. Employer Identification No. 	41-0417775
Principal executive offices: 	3M Center, St. Paul, Minnesota 55144
Telephone number: 	(651) 733-1110
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, Par Value $.01 Per Share 	MMM 	New York Stock Exchange, Inc.
MMM 	Chicago Stock Exchange, Inc.
0.375% Notes due 2022 	MMM22A 	New York Stock Exchange, Inc.
0.950% Notes due 2023 	MMM23 	New York Stock Exchange, Inc.
1.500% Notes due 2026 	MMM26 	New York Stock Exchange, Inc
1.750% Notes due 2030 	MMM30 	New York Stock Exchange, Inc.
1.500% Notes due 2031 	MMM31 	New York Stock Exchange, Inc.
Note: The common stock of the registrant is also traded on the SWX Swiss Exchange.
Securities registered pursuant to section 12(g) of the Act: 	None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes 	☒ 	No 	☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes 	☐ 	No 	☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes 	☒ 	No 	☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes 	☒ 	No 	☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐ 	Non-accelerated filer 	☐ 	Smaller reporting company 	☐ 	Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. 	☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under
Section 404(b) of the Sarbanes Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes 	☒ 	No 	☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes 	☐ 	No 	☒
The aggregate market value of voting stock held by nonaffiliates of the registrant, computed by reference to the closing price and shares outstanding, was approximately $101.7 billion as of
January 31, 2021 (approximately $89.9 billion as of June 30, 2020, the last business day of the registrant’s most recently completed second quarter).
Shares of common stock outstanding at January 31, 2021: 579.1 	million
DOCUMENTS INCORPORATED BY REFERENCE
Parts of the Company’s definitive proxy statement (to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal year-end of
December 31, 2020) for its annual meeting to be held on May 11, 2021, are incorporated by reference in this Form 10-K in response to Part III, Items 10,
11, 12, 13 and 14.
1

-- 13 of 160 --

3M COMPANY
FORM 10-K
For the Year Ended December 31, 2020
Pursuant to Part IV, Item 16, a summary of Form 10-K content follows, including hyperlinked cross-references (in the EDGAR filing). This allows
users to easily locate the corresponding items in Form 10-K, where the disclosure is fully presented. The summary does not include certain Part III
information that will be incorporated by reference from the proxy statement, which will be filed after this Form 10-K filing.
Beginning
Page
PART I
ITEM 1 4
ITEM 1A 10
ITEM 1B 14
ITEM 2 15
ITEM 3 15
ITEM 4 15
PART II
ITEM 5
Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosures
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities 16
ITEM 6 17
ITEM 7 18
18
29
34
39
40
43
44
52
ITEM 7A 52
ITEM 8 54
54
54
54
55
57
58
Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations
MD&A is designed to provide a reader of 3M’s financial statements with a narrative from the perspective of
management. 3M’s MD&A is presented in eight sections:
Overview
Results of Operations
Performance by Business Segment
Performance by Geographic Area
Critical Accounting Estimates
New Accounting Pronouncements
Financial Condition and Liquidity
Financial Instruments
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Index to Financial Statements
Management’s Responsibility for Financial Reporting
Management’s Report on Internal Control Over Financial Reporting
Report of Independent Registered Public Accounting Firm
Consolidated Statement of Income for the years ended December 31, 2020, 2019 and 2018
Consolidated Statement of Comprehensive Income for the years ended December 31, 2020, 2019 and 2018
Consolidated Balance Sheet at December 31, 2020 and 2019 59
2

-- 14 of 160 --

Beginning
Page
ITEM 8
60
61
62
62
70
71
74
76
80
81
82
83
83
87
88
91
100
108
111
129
130
133
138
ITEM 9 139
ITEM 9A 139
ITEM 9B 139
PART III
ITEM 10 140
ITEM 11 140
ITEM 12 141
ITEM 13 141
ITEM 14 141
PART IV
ITEM 15 142
ITEM 16
Financial Statements and Supplementary Data (continued)
Consolidated Statement of Changes in Equity for the years ended December 31, 2020, 2019 and 2018
Consolidated Statement of Cash Flows for the years ended December 31, 2020, 2019 and 2018
Notes to Consolidated Financial Statements
Note 1. Significant Accounting Policies
Note 2. Revenue
Note 3. Acquisitions and Divestitures
Note 4. Goodwill and Intangible Assets
Note 5. Restructuring Actions
Note 6. Supplemental Income Statement Information
Note 7. Supplemental Balance Sheet Information
Note 8. Supplemental Equity and Comprehensive Income Information
Note 9. Supplemental Cash Flow Information
Note 10. Income Taxes
Note 11. Marketable Securities and Held-to-Maturity Debt Securities
Note 12. Long-Term Debt and Short-Term Borrowings
Note 13. Pension and Postretirement Benefit Plans
Note 14. Derivatives
Note 15. Fair Value Measurements
Note 16. Commitments and Contingencies
Note 17. Leases
Note 18. Stock-Based Compensation
Note 19. Business Segments and Geographic Information
Note 20. Quarterly Data (Unaudited)
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information
Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accounting Fees and Services
Exhibits, Financial Statement Schedules
Form 10-K Summary 144
3

-- 15 of 160 --

3M COMPANY
ANNUAL REPORT ON FORM 10-K
For the Year Ended December 31, 2020
PART I
Item 1. Business.
3M Company was incorporated in 1929 under the laws of the State of Delaware to continue operations begun in 1902. The Company’s ticker
symbol is MMM. As used herein, the term “3M” or “Company” includes 3M Company and its subsidiaries unless the context indicates otherwise.
In this document, for any references to Note 1 through Note 20, refer to the Notes to Consolidated Financial Statements in Item 8.
Available Information
The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers, including the
Company, that file electronically with the SEC. The public can obtain any documents that the Company files with the SEC at http://www.sec.gov.
The Company files annual reports, quarterly reports, proxy statements and other documents with the Securities and Exchange Commission (SEC)
under the Securities Exchange Act of 1934 (Exchange Act).
3M also makes available free of charge through its website (http://investors.3M.com) the Company’s Annual Report on Form 10-K, Quarterly
Reports on Form 10-Q, Current Reports on Form 8-K, and, if applicable, amendments to those reports filed or furnished pursuant to the Exchange
Act as soon as reasonably practicable after the Company electronically files such material with, or furnishes it to, the SEC.
General
3M is a diversified technology company with a global presence in the following businesses: Safety and Industrial; Transportation and Electronics;
Health Care; and Consumer. 3M is among the leading manufacturers of products for many of the markets it serves. Most 3M products involve
expertise in product development, manufacturing and marketing, and are subject to competition from products manufactured and sold by other
technologically oriented companies.
Business Segments
3M manages its operations in four business segments. The reportable segments are Safety and Industrial, Transportation and Electronics, Health
Care, and Consumer. 3M’s four business segments bring together common or related 3M technologies, enhancing the development of innovative
products and services and providing for efficient sharing of business resources. Financial information and other disclosures relating to 3M’s
business segments and operations in major geographic areas are provided in the Notes to Consolidated Financial Statements.
As described in Note 19, effective in the first quarter of 2020, the Company changed its business segment reporting in its continuing effort to
improve the alignment of businesses around markets and customers. Additionally, the Company consolidated the way it presents geographic area
net sales by providing an aggregate Americas geographic region (combining former United States and Latin America and Canada areas). Also,
effective in the second quarter of 2020, the measure of segment operating performance used by 3M’s chief operating decision maker changed and,
as a result, the Company’s disclosed measure of segment profit/loss has been updated. Information provided herein reflects the impact of these
changes for all periods presented.
4

-- 16 of 160 --

Transportation and
Business Segment 	Safety and Industrial 	Electronics 	Health Care 	Consumer
Underlying
divisions/businesses
Refer to Note 2 for
disaggregated
revenue information
• Abrasives
• Automotive aftermarket
• Closure and masking systems
• Communication markets (divested
in 2018)
• Electrical markets
• Industrial adhesives and tapes
• Personal safety
• Roofing granules
• Other safety and industrial
• Advanced materials
• Automotive and aerospace
• Commercial solutions
• Display materials and systems
• Electronics materials solutions
• Transportation and safety
• Other transportation and
electronics
• Drug delivery (divested in 2020)
• Food safety
• Health information systems
• Medical solutions
• Oral care solutions
• Separation and purification
sciences
• Other health care
• Consumer health care
• Home care
• Home improvement
• Stationery and office
• Other consumer
Representative
revenue-generating
activities, products
or services
• Industrial abrasives and finishing
for metalworking applications
• Autobody repair solutions
• Closure systems for personal
hygiene products, masking, and
packaging materials
• Electrical products and materials
for construction and maintenance,
power distribution and electrical
original equipment manufacturers
(OEMs)
• Structural adhesives and tapes
• Respiratory, hearing, eye and fall
protection solutions
• Natural and color-coated mineral
granules for shingles
• Advanced ceramic solutions
• Attachment tapes, films, sound and
temperature management for
transportation vehicles
• Premium large format graphic
films for advertising and fleet
signage
• Light management films and
electronics assembly solutions
• Packaging and interconnection
solutions
• Reflective signage for highway,
and vehicle safety
• Food safety indicator solutions
• Health care procedure coding and
reimbursement software
• Skin, wound care, and infection
prevention products and solutions
• Dentistry and orthodontia solutions
• Filtration and purification systems
• Consumer bandages, braces,
supports and consumer respirators
• Cleaning products for the home
• Retail abrasives, paint accessories,
car care DIY products, picture
hanging and consumer air quality
solutions
• Stationery products
Some seasonality impacts this
business segment related to back-to-
school, generally in the third quarter
of each year
Example
brands/offerings
• 3M™ Cubitron™ II abrasives
• Scotch-Brite™ Abrasives
Scotch & Temflex Vinyl Tapes,
Scotchkote Coatings, Dynatel
locators, Scotchcast resins
• Collision repair and paint spray
products
• Reclosable fasteners; tapes and
label materials for durable goods
• Electrical infrastructure products;
medium voltage cable accessories
and insulation tapes
• 3M ™ VHB™ Bonding tapes;
Scotch® masking, packaging and
filament tapes
• Disposable respirators and fall
protection products
• Scotchgard™ Protector for
shingles
• 3M™ Nextel™ Ceramic fibers and
textiles
• Thinsulate™ Acoustic Insulation
products and automotive
components
• 3M™ Novec™ Engineered Fluids
• 3M™ Scotchlite™ graphic films,
3M™ Scotchcal™ and 3M™
Controltac™ Commercial graphics
• Electronic display enhancement
films and optically clear adhesives
• Electronic interconnect products
• 3M™ Diamond Grade™ DG3
reflective sheeting for transportation
safety
• 3M™ Petrifilm™ and 3M™
Allergen Testing
• 3M ™ 360 Encompass™ medical
coding systems
• 3M ™ Tegaderm™ wound
dressings, V.A.C.® Therapy
Systems and disposable respirators
in the health care channel
•3M™ Filtek™ and 3M™ RelyX™
dental filing materials and cements;
3M™ Clarity™ aligners
• Biopharma and other filtration
systems, bags, capsules and
components
• ACE™ , FUTURO™ and
Nexcare™ personal health care
products
• Scotch-Brite™ cleaning supplies,
sponges, brushes, and scouring pads;
Scotchgard™ products
• Scotch® tapes and other products,
Filtrete™ filters and Command™
adhesive products
• Post-it® products
Representative
market trends or
opportunities
• Connected safety
• Structural bonding
• Surface finishing
• Respiratory protection
• Building components
• Automation and robotics
• Grid modernization
• Automotive electrification
• Sustainable packaging
• Automotive electrification
• Semiconductor fabrication and
assembly
• Datacenter thermal management
• Advanced wound care
• Population health clinical care
improvement platform
• Increased food safety
• Biopharma industry expansion
• Custom orthodontics
• Air quality
• Connected filters and other
products
5

-- 17 of 160 --

Distribution
3M products are sold through numerous distribution channels, including directly to users and through numerous e-commerce and traditional
wholesalers, retailers, jobbers, distributors and dealers in a wide variety of trades in many countries around the world. Management believes the
confidence of wholesalers, retailers, jobbers, distributors and dealers in 3M and its products — a confidence developed through long association
with skilled marketing and sales representatives — has contributed significantly to 3M’s position in the marketplace and to its growth.
Resources
Human Capital
On December 31, 2020, the Company employed approximately 95,000 people (full-time equivalents), with approximately 40,000 employed in the
United States and 55,000 employed internationally. The ability to recruit, retain, develop, protect, and fairly compensate its global workforce are
enablers of 3M’s success. This includes four general categories of focus: Health and Safety; Development; Diversity, Equity and Inclusion; and
Compensation and Benefits.
Health and Safety
3M is committed to the safety, health, and well-being of its employees. The Company continuously evaluates opportunities to raise safety and
health standards, visiting sites to identify and manage environmental health and safety risks; evaluating compliance with regulatory requirements
and 3M policy; and maintaining a global security operation for the protection of facilities and people on 3M sites. 3M also promotes a culture of
health and well-being through disease prevention programs, on-site clinical services, employee assistance programs, and comprehensive health
care benefits.
Development
Developing employees contributes to growing 3M’s business. 3M maintains talent and succession planning processes, including regular review by
the Company’s chief executive officer (CEO) and reporting up through the Board of Directors. The Company has a suite of high-potential
leadership development programs which brings a consistent approach to leadership development. 3M also has development programs for managers
and supervisors and provides learning opportunities for all employees. With the Company’s global online employee learning platform, employees
are able to access unique, just-in-time development resources in over 15 languages to support their career aspirations and advance their skills.
Diversity, Equity and Inclusion
A diverse, global workforce and inclusive culture that provides fair and equitable opportunities helps 3M remain competitive, advance its
innovation culture, and serve customers. 3M focuses on attracting and advancing top talent and has publicly committed to advance global diversity
in management across all dimensions, with additional specific goals to continue advancing pay equity and to increase the Company’s diversity
with underrepresented groups. 3M supports these values with an internal CEO Inclusion Council, a forum led by senior management to advance
diversity, equity, and inclusion initiatives. The Company also plans to invest $50 million over 2020 to 2025 to address racial opportunity gaps
through workforce development initiatives in the communities in which its employees live and 3M business operates.
Compensation and Benefits
In addition to a professional work environment that promotes innovation and rewards performance, 3M’s total compensation for employees
includes a variety of components that support sustainable employment and the ability to build a strong financial future, including competitive
market-based pay and comprehensive benefits. In addition to earning a base salary, eligible employees are compensated for their contributions to
the Company’s goals with both short-term cash incentives and long-term equity-based incentives. Through its global pay philosophy, principles
and consistent implementation, 3M is committed to providing fair and equitable pay for employees. Eligible full-time employees in the United
States also have access to medical, dental, and vision plans; savings and retirement plans; a 3M employee stock purchase plan; and other
resources. Some of these benefits can also be available to regular part-time employees who work at least 20 hours a week. Programs and benefits
differ internationally for a variety of reasons,
6

-- 18 of 160 --

such as local legal requirements, market practices, and negotiations with works councils, trade unions, and other employee representative bodies.
Raw Materials
In 2020, the coronavirus (COVID-19) pandemic caused fluctuations in supply markets. Generally, as demand for certain COVID-related products
surged, 3M saw a corresponding tightening in supply and some degree of price inflation in associated markets. Within the supply chain of less
essential products, 3M experienced raw material price deflation as economies slowed and certain producers scaled back or idled operations.
Conversely, as markets re-opened and demand increased, the Company experienced raw material price inflation with some level of stabilization
late in the year.
The Company continued to deploy productivity projects to minimize the impact of raw material inflation and market supply challenges, including
input management, reformulations, and multi-sourcing activities. Overall, on a consolidated basis, 3M experienced net raw material price deflation
in 2020. To date, the Company is receiving sufficient quantities of all raw materials to meet its reasonably foreseeable production requirements. It
is difficult to predict future shortages of raw materials or the impact any such shortages would have. 3M has avoided disruption to its
manufacturing operations through careful management of existing raw material inventories, strategic relationships with key suppliers, and
development as well as qualification of additional supply sources. 3M manages spend category price risks through negotiated supply contracts and
price protection agreements. In addition, 3M evaluates suppliers’ conformance with environmental and social compliance requirements.
Patents, Trademarks and Licenses
The Company’s products are sold around the world under various trademarks. The Company also owns, or holds licenses to use, numerous U.S.
and foreign patents. The Company’s research and development activities generate a steady stream of inventions that are covered by new patents or
trade secrets. Patents applicable to specific products extend for varying periods according to the date of patent application filing or patent grant and
the legal term of patents in the various countries where patent protection is obtained. The actual protection afforded by a patent, which can vary
from country to country, depends upon the type of patent, the scope of its coverage and the availability of legal remedies in the country.
The Company believes that its trademarks, patents, and trade secrets provide an important competitive advantage in many of its businesses. In
general, no single patent or group of related patents is in itself essential to the Company as a whole or to any of the Company’s business segments.
Government Regulation and Environmental Law Compliance
The Company’s business operations are subject to various governmental regulations in the U.S. and internationally, including, among others, those
related to product liability, antitrust, intellectual property, environmental, tax, the U.S. Foreign Corrupt Practices Act and other anti-bribery laws,
U.S. trade sanctions, regulations of the U.S. Food and Drug Administration (FDA) and similar foreign agencies, U.S. federal healthcare program-
related laws and regulations, such as the False Claims Act, anti-kickback laws and the Sunshine Act.
3M’s manufacturing operations are affected by national, state and local environmental laws and regulations around the world. The Company
places consistent emphasis on environmental responsibility. 3M has made, and plans to continue making, necessary expenditures for compliance
with applicable laws and regulations. 3M is also involved in remediation actions relating to environmental matters from past operations at certain
sites (refer to “Environmental Matters and Litigation” in Note 16, Commitments and Contingencies).
Environmental expenditures relating to existing conditions caused by past operations that do not contribute to current or future revenues are
expensed. Reserves for liabilities for anticipated remediation costs are recorded on an undiscounted basis when they are probable and reasonably
estimable, generally no later than the completion of feasibility studies, the Company’s commitment to a plan of action, or approval by regulatory
agencies. Environmental expenditures for capital projects that contribute to current or future operations generally are capitalized and depreciated
over their estimated useful lives.
In 2020, 3M expended approximately $55 million on capital projects for environmental purposes as defined below. Capital projects for
environmental purposes include waste reduction and pollution control programs such as, water usage reduction and water quality
7

-- 19 of 160 --

improvement equipment, scrubbers, containment structures, solvent recovery units and thermal oxidizers. Capital expenditures for similar projects
are presently expected to approach approximately $400 million for 2021 and 2022 in aggregate.
Although an estimate of certain nearer-term capital expenditures is provided above, 3M cannot predict with certainty whether future costs of
compliance with government regulations (including environmental regulations) will have a material effect on its capital expenditures, earnings or
competitive position.
Information about our Executive Officers
Following is a list of the executive officers of 3M, and their age, present position, the year elected to their present position and other positions they
have held during the past five years. No family relationships exist among any of the executive officers named, nor is
8

-- 20 of 160 --

there any undisclosed arrangement or understanding pursuant to which any person was selected as an officer. This information is presented in the
table below as of the date of the 10-K filing (February 4, 2021).
Year
Elected
to Present
Name 	Age 	Present Position 	Position 	Other Positions Held during 2016 - 2020
Michael F. Roman 	61 	Chairman of the Board, President
and Chief Executive Officer
2019 	Chief Executive Officer, 2018-2019
Chief Operating Officer and Executive Vice President, 2017-2018
Executive Vice President, Industrial Business Group, 2014-2017
John P. Banovetz 	53 	Senior Vice President, Innovation
and Stewardship and Chief
Technology Officer
2020 	Senior Vice President of Research and Development and Chief Technology Officer, 2017-
2019
Managing Director, DACH Region, 2016-2017
Ivan K. Fong 	59 	Senior Vice President, General
Counsel and Secretary
2019 	Senior Vice President, Legal Affairs & General Counsel, 2012-2019
Eric D. Hammes 	46 	Executive Vice President,
Enterprise Operations
2019 	Senior Vice President, Manufacturing & Supply Chain, 2019
Senior Vice President, Business Transformation & Information Technology, 2017-2019
Vice President, Corporate Controller and Chief Accounting Officer, 2014-2017
Ashish K. Khandpur 	53 	Executive Vice President,
Transportation & Electronics
Business Group
2019 	Executive Vice President, Electronics & Energy Business Group, 2017-2019
Senior Vice President, Research and Development, and Chief Technology Officer, 2014-
2017
Veena M. Lakkundi 	52 	Senior Vice President, Strategy &
Business Development
2020 	Vice President and General Manager, Industrial Adhesives and Tapes Division, 2019-2020
Vice President and Chief Ethics & Compliance Officer, Ethics & Compliance, Legal
Affairs, 2019
Vice President, Chief Compliance Officer, Compliance and Business Conduct, Legal
Affairs, 2017-2019
Business Director, Manufacturing Solutions, Industrial Adhesives and Tapes Division,
2015-2017
Jeffrey R. Lavers 	57 	Executive Vice President,
Consumer Business Group
2020 	Vice President and General Manager, Automotive and Aerospace Solutions Division, 2019-
2020
Vice President and General Manager, Construction and Home Improvement Division, 2015-
2019
Kristen M. Ludgate 	58 	Senior Vice President, Human
Resources
2018 	Senior Vice President, Corporate Communications and Enterprise Services, 2018
Vice President, Global Human Resources Business Operations, Human Resources, 2017-
2018
Vice President, Associate General Counsel & Chief Compliance Officer, Compliance and
Business Conduct, 2015-2017
Monish Patolawala 	51 	Senior Vice President and Chief
Financial Officer
2020 	Chief Financial Officer, Health Care and Vice President, Operational Transformation,
General Electric, 2019-2020
Chief Financial Officer, Health Care, General Electric, 2015-2019
Mojdeh Poul 	58 	Executive Vice President, Health
Care Business Group
2019 	Executive Vice President, Safety and Graphics Business Group, 2018-2019
President and General Manager, 3M Canada, 2016-2018
Vice President and General Manager, Infection Prevention Division, 2014-2016
Denise R. Rutherford 	58 	Senior Vice President, Corporate
Affairs
2019 	Vice President, Research & Development and Commercialization, Industrial Business
Group, 2017- 2019
Managing Director, 3M Japan, 2016-2017
Vice President, Greater China Area and Managing Director, 3M China, 2015-2016
Michael G. Vale 	54 	Executive Vice President, Safety &
Industrial Business Group
2019 	Executive Vice President, Health Care Business Group, 2016-2019
Executive Vice President, Consumer Business Group, 2012-2016
Cautionary Note Concerning Factors That May Affect Future Results
This Annual Report on Form 10-K, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item
7, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
9

-- 21 of 160 --

1995. The Company may also make forward-looking statements in other reports filed with the Securities and Exchange Commission, in materials
delivered to shareholders and in press releases. In addition, the Company’s representatives may from time to time make oral forward-looking
statements.
Forward-looking statements relate to future events and typically address the Company’s expected future business and financial performance.
Words such as “plan,” “expect,” “aim,” “believe,” “project,” “target,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could,” “forecast” and
other words and terms of similar meaning, typically identify such forward-looking statements. In particular, these include, among others,
statements relating to:
• 	worldwide economic, political, regulatory, international trade, capital markets and other external conditions, such as interest rates,
financial conditions of our suppliers and customers, trade restrictions such as tariffs in addition to retaliatory counter measures, and natural
and other disasters or climate change affecting the operations of the Company or our suppliers and customers,
• 	risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19),
• 	liabilities related to certain fluorochemicals and the outcome of contingencies,
• 	the Company’s strategy for growth, future revenues, earnings, cash flow, uses of cash and other measures of financial performance, and
market position,
• 	competitive conditions and customer preferences,
• 	foreign currency exchange rates and fluctuations in those rates,
• 	new business opportunities, product development, and future performance or results of current or anticipated products,
• 	fluctuations in the costs and availability of purchased components, compounds, raw materials and energy,
• 	Information technology systems including ERP system roll-out and implementations,
• 	Security breaches and other disruptions to information technology infrastructure,
• 	the scope, nature or impact of acquisition, strategic alliance and divestiture activities,
• 	operational execution, including inability to generate productivity improvements as estimated,
• 	future levels of indebtedness, common stock repurchases and capital spending,
• 	future availability of and access to credit markets,
• 	pension and postretirement obligation assumptions and future contributions,
• 	asset impairments,
• 	tax liabilities and effects of changes in tax rates, laws or regulations, and
• 	legal and regulatory proceedings, legal compliance risks (including 3rd 	party risks) with regards to environmental, product liability and
other laws and regulations in the United States and other countries in which we operate.
The Company assumes no obligation to update or revise any forward-looking statements.
Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and
uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking
statements depending on a variety of factors. Important information as to these factors can be found in this document, including, among others,
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the headings of “Overview,” “Financial
Condition and Liquidity,” and annually in “Critical Accounting Estimates.” Discussion of these factors is incorporated by reference from
Part I, Item 1A, “Risk Factors,” of this document, and should be considered an integral part of Part II, Item 7, “Management’s Discussion and
Analysis of Financial Condition and Results of Operations.” For additional information concerning factors that may cause actual results to vary
materially from those stated in the forward-looking statements, see our reports on Form 10-K, 10-Q and 8-K filed with the SEC from time to time.
Item 1A. Risk Factors
Provided below is a cautionary discussion of what we believe to be the most important risk factors applicable to the Company. Discussion of these
factors is incorporated by reference into and considered an integral part of Part I, Item 2, “Management’s Discussion and Analysis of Financial
Conditions and Results of Operations.”
Risks Related to the Global Economy and Public Health Crises
* The Company’s results are impacted by the effects of, and changes in, worldwide economic, political, regulatory, international trade and other
external conditions.
10

-- 22 of 160 --

The Company operates in more than 70 countries and derives approximately 60 percent of its revenues from outside the United States, and,
accordingly, the Company’s business is subject to global competition and geopolitical risks that are beyond its control, such as disruptions in
financial markets, economic downturns, government actions impacting international trade agreements, imposing trade restrictions such as tariffs,
and retaliatory counter measures, government deficit reduction and other austerity measures in specific countries or regions, or in the various
industries in which the Company operates; social, political or labor conditions in specific countries or regions; or adverse changes in the
availability and cost of capital, interest rates, or exchange control, ability to expatriate earnings and other regulations in the jurisdictions in which
the Company operates. Climate change, as well as related environmental and social regulations, may negatively impact the Company or its
customers and suppliers, in terms of availability and cost of natural resources, sources and supply of energy, product demand and manufacturing,
and the health and well-being of individuals and communities in which we operate.
* The Company is subject to risks related to public health crises such as the global pandemic associated with 	the coronavirus (COVID-19).
3M, as a global company, is impacted by public health crises such as the global pandemic associated with COVID-19. The outbreak has
significantly increased economic and demand uncertainty. In addition, public and private sector policies and initiatives to reduce the transmission
of COVID-19, such as the imposition of travel restrictions and the adoption of remote working, have impacted 3M’s operations. In these
challenging and dynamic circumstances, 3M continues to work to protect its employees and the public, maintain business continuity and sustain its
operations, including ensuring the safety and protection of approximately 50,000 people who work in our plants and distribution centers across the
world, many of whom support the manufacturing and delivery of products that are critical in response to the global pandemic. COVID-19 has
impacted 3M’s supply chains relative to global demand for products like respirators, surgical masks and commercial cleaning solutions. Even with
3M’s accelerated production at its global facilities combined with capacity from other manufacturers, the industry-wide challenge is that global
demand for N95 and other respirators continues to exceed the industries’ ability to deliver. Within individual regions and countries around the
world, 3M is working with governments, distributors and others to prioritize supplies to the most critical customer and public health needs. 3M’s
manufacturing, supply chain and distribution protocols have, for example, been impacted by the need to prioritize rated orders issued by the
Federal Emergency Management Agency pursuant to the U.S. Defense Production Act. In addition, trade barriers, export restrictions and other
similar measures imposed by national governments also negatively impact the supplies of personal protection equipment including those made by
3M going into the most needed areas. COVID-19 has also affected the ability of suppliers and vendors to provide products and services to 3M.
Some of these COVID-related factors have increased demand for certain 3M products, while others have decreased demand from certain end
markets or could make it more difficult for 3M to serve customers. 3M has received reports of price gouging, counterfeiting and other illegal or
fraudulent activities involving its N95 respirators, has taken legal action in several states and continues to work with state, federal and international
law enforcement to protect the public and 3M against those who seek to exploit 3M’s brand and reputation and defraud others. Furthermore,
COVID-19 has impacted and may further impact the broader economies of affected countries, including negatively impacting economic growth,
the proper functioning of financial and capital markets, foreign currency exchange rates, and interest rates. For example, COVID-19 has led to
disruption and volatility in the global capital markets, which increases the cost of capital and could adversely impact access to capital. As
economies start to reopen in certain parts of the world, workplace safety, for the Company and others, will increasingly become a focus of
concern. As part of the return to work process at the Company, the Company could face additional privacy and data security risks related to the
collection of data regarding employees and contractors with respect to COVID-19 testing, temperature checks, and contact tracing. Due to the
speed and scope with which the COVID situation is developing and evolving and the uncertainty of its duration and the timing of recovery, 3M is
not able at this time to predict the extent to which the COVID-19 pandemic may have a material effect on its consolidated results of operations or
financial condition.
* Foreign currency exchange rates and fluctuations in those rates may affect the Company’s ability to realize projected growth rates in its sales
and earnings.
Because the Company’s financial statements are denominated in U.S. dollars and approximately 60 percent of the Company’s revenues are derived
from outside the United States, the Company’s results of operations and its ability to realize projected growth rates in sales and earnings could be
adversely affected if the U.S. dollar strengthens significantly against foreign currencies.
Risks Related to Legal and Regulatory Proceedings
* 	The Company faces liabilities related to certain fluorochemicals, which could adversely impact our results.
11

-- 23 of 160 --

As previously reported, the Company has been voluntarily cooperating with various local, state, federal (primarily the U.S. Environmental
Protection Agency (EPA)), and international agencies in their review of the environmental and health effects of a broad group of perfluoroalkyl
and polyfluoroalkyl substances produced by the Company, collectively known as “PFAS.” The PFAS group contains several categories and
classes of durable chemicals and materials with properties that include oil, water, temperature, chemical and fire resistance, as well as electrical
insulating properties. The strength of the carbon-fluorine bond also means that these compounds do not easily degrade. These characteristics have
made PFAS critical to the manufacture of electronic devices such as cell phones, tablets and semi-conductors. They are also used to help prevent
infections in products like surgical gowns and drapes. Commercial aircraft and low-emissions vehicles also rely on PFAS technology. PFAS
compounds are manufactured by various companies, including 3M, and are used in everyday products. As science and technology evolve and
advance, and in response to evolving knowledge and the understanding that PFAS compounds had the potential to build up over time, 3M
announced in 2000 that we would voluntarily phase out production of perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) globally
as a precautionary measure. We phased out of materials used to produce certain repellants and surfactant products, with most of these activities in
the U.S. completed by the end of 2002. Phased out products included Aqueous Film Forming Foam (AFFF) and coatings for food packaging, for
example. 3M currently is defending lawsuits concerning various PFAS-related products and chemistries, and is subject to unasserted and asserted
claims and governmental regulatory proceedings and inquiries related to the production and use of PFAS in a variety of jurisdictions, as discussed
in Note 16, “Commitments and Contingencies,” within the Notes to Consolidated Financial Statements. An adverse outcome in any one or more of
these matters could be material to our financial results. For example, we recorded a pre-tax charge of $897 million, inclusive of legal fees and
other related obligations, in the first quarter of 2018 with respect to the settlement of a matter brought by the State of Minnesota involving the
presence of PFAS in the groundwater, surface water, fish or other aquatic life, and sediments in the state. Governmental inquiries or lawsuits
involving PFAS could lead to our incurring liability for damages or other costs, civil or criminal proceedings, the imposition of fines and penalties,
or other remedies, as well as restrictions on or added costs for our business operations going forward, including in the form of restrictions on
discharges at our manufacturing facilities or otherwise.
* The Company’s future results may be affected by various asserted and unasserted legal and regulatory proceedings and legal compliance risks,
including those involving product liability, antitrust, intellectual property, environmental, tax, the U.S. Foreign Corrupt Practices Act and other
anti-bribery laws, U.S. trade sanctions compliance, regulations of the U.S. Food and Drug Administration (FDA) and similar foreign agencies,
U.S. federal healthcare program-related laws and regulations including the False Claims Act, anti-kickback laws, the Sunshine Act, or other
matters. 	Legal compliance risks also include third-party risks where the Company’s suppliers, vendors or channel partners have business
practices that are inconsistent with 3M’s Supplier Responsibility Code, 3M performance requirements or with legal requirements.
The outcome of these legal proceedings may differ from the Company’s expectations because the outcomes of litigation, including regulatory
matters, are often difficult to reliably predict. Although the Company maintains general liability insurance, the amount of liability that may result
from certain of these risks may not always be covered by, or could exceed, the applicable insurance coverage. Various factors or developments can
lead the Company to change current estimates of liabilities and related insurance receivables where applicable, or make such estimates for matters
previously not susceptible of reasonable estimates, such as a significant judicial ruling or judgment, a significant settlement, significant regulatory
developments or changes in applicable law. A future adverse ruling, settlement or unfavorable development could result in future charges that
could have a material adverse effect on the Company’s results of operations or cash flows in any particular period. In addition, negative publicity
related to product liability, environmental, health and safety or other matters referenced above involving the Company may negatively impact the
Company’s reputation. For a more detailed discussion of the legal proceedings involving the Company and the associated accounting estimates,
see the discussion in Note 16, “Commitments and Contingencies,” within the Notes to Consolidated Financial Statements.
Risks Related to Our Products and Customer Preferences
* The Company’s results are affected by competitive conditions and customer preferences.
Demand for the Company’s products, which impacts revenue and profit margins, is affected by (i) the development and timing of the introduction
of competitive products; (ii) the Company’s response to downward pricing to stay competitive; (iii) changes in customer order patterns, such as
changes in the levels of inventory maintained by customers and the timing of customer purchases which may be affected by announced price
changes, changes in the Company’s incentive programs, or the customer’s ability to achieve incentive goals; (iv) changes in customers’
preferences for our products, including the success of products offered by our competitors, and changes in customer designs for their products that
can affect the demand for some of the Company’s products; and (v) changes in the
12

-- 24 of 160 --

business environment related to disruptive technologies, such as artificial intelligence, block-chain, expanded analytics and other enhanced
learnings from increasing volume of available data.
* The Company’s growth objectives are largely dependent on the timing and market acceptance of its new product offerings, including its ability
to continually renew its pipeline of new products and to bring those products to market.
This ability is subject to difficulties or delays in product development, such as the inability to identify viable new products, obtain adequate
intellectual property protection, or gain market acceptance of new products. There are no guarantees that new products will prove to be
commercially successful.
* The Company’s future results are subject to vulnerability with respect to materials and fluctuations in the costs and availability of purchased
components, compounds, raw materials and energy, due to shortages, increased demand, supply interruptions, manufacturing site disruptions,
natural disasters and other disruptive factors.
The Company depends on various components, compounds, raw materials, and energy (including oil and natural gas and their derivatives)
supplied by others for the manufacturing of its products. Supplier relationships have been and could be interrupted in the future due to supplier
material shortage, climate impacts, natural and other disasters and other disruptive events, or be terminated. Any sustained interruption in the
Company’s receipt of adequate supplies or disruption to key manufacturing sites’ operations could have a material adverse effect on the Company.
In addition, while the Company has a process to minimize volatility in component and material pricing, no assurance can be given that the
Company will be able to successfully manage price fluctuations or that future price fluctuations or shortages will not have a material adverse effect
on the Company.
Risks Related to Our Business
* The Company employs information technology systems to support its business, including ongoing phased implementation of an enterprise
resource planning (ERP) system as part of business transformation on a worldwide basis over the next several years. Security breaches and other
disruptions to the Company’s information technology infrastructure could interfere with the Company’s operations, compromise information
belonging to the Company or its customers, suppliers, and employees, exposing the Company to liability which could adversely impact the
Company’s business and reputation.
In the ordinary course of business, the Company relies on centralized and local information technology networks and systems, some of which are
provided, hosted or managed by vendors and other third parties, to process, transmit and store electronic information, and to manage or support a
variety of businesses. Additionally, the Company collects and stores certain data, including proprietary business information, and has access to
confidential or personal information in certain of our businesses that is subject to privacy and security laws, regulations and customer-imposed
controls. Despite our cybersecurity and business continuity measures (including employee and third-party training, monitoring of networks and
systems, patching, maintenance, and backup of systems and data), the Company’s information technology networks and infrastructure are still
potentially vulnerable to the security risks of our vendors and third-party service providers, security breaches, damage, disruptions or shutdowns
due to attacks by threat actors including nation-state actors, computer viruses, hardware, software, and system vulnerabilities, ransomware, service
or cloud provider disruptions or security breaches, employee error or malfeasance, power outages, telecommunication or utility failures, systems
failures, natural disasters or other catastrophic events. The Company’s increased adoption of remote working, which was driven by the pandemic,
may also introduce additional threats to our information technology networks and infrastructure. Despite our cybersecurity measures, it is possible
for security vulnerabilities to remain undetected for an extended time period, up to and including several years. While we have experienced, and
expect to continue to experience, threats and disruptions to the Company’s information technology infrastructure, none of them to date has had a
material impact to the Company. Any such threats or disruptions could result in legal claims or proceedings, liability or penalties under privacy
laws, interference with the Company’s operations, and damage to the Company’s reputation, which could adversely affect the Company’s
business. Although the Company maintains insurance coverage for various cybersecurity and business continuity risks, there can be no guarantee
that all costs or losses incurred will be fully insured.
* Acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business
strategies, and possible organizational restructuring could affect future results.
The Company monitors its business portfolio and organizational structure and has made and may continue to make acquisitions, strategic alliances,
divestitures and changes to its organizational structure. With respect to acquisitions, including, for example, the recently completed acquisition of
Acelity, Inc. and its KCI subsidiaries (a leading global medical technology company), future results will be affected by the Company’s ability to
integrate acquired businesses quickly and obtain the anticipated synergies. The Company
13

-- 25 of 160 --

realigned from five to four business segments, effective in April of 2019, to better serve its global customers and markets. Successful execution of
the realignment and the associated adjustments of our portfolio and business operating model, as well as other organizational changes, will be
important to the Company’s future results.
* The Company’s future results may be affected by its operational execution, including scenarios where the Company generates fewer productivity
improvements than estimated.
The Company’s financial results depend on the successful execution of its business operating plans. The Company utilizes various tools, such as
Lean Six Sigma, and engages in ongoing global business transformation. Business transformation is defined as changes in processes and
internal/external service delivery across 3M to move to more efficient business models to improve operational efficiency and productivity, while
allowing 3M to serve customers with greater speed and efficiency. This is enabled by the ongoing multi-year phased implementation of an ERP
system. There can be no assurance that all of the projected productivity improvements will be realized. In addition, the ability to adapt to business
model and other changes and agility to respond to customer needs and service expectations are important, which, if not done successfully, could
negatively impact the Company’s ability to win new business and enhance revenue and 3M’s brand. Operational challenges, including those
related to customer service, pace of change and productivity improvements, could have a material adverse effect on the Company’s business,
financial conditions and results of operations.
Risks Related to Financial and Capital Markets and Tax Matters
* The Company's defined benefit pension and postretirement plans are subject to financial market risks that could adversely impact our results.
The performance of financial markets and discount rates impact the Company's funding obligations under its defined benefit plans. Significant
changes in market interest rates, decreases in the fair value of plan assets and investment losses on plan assets, and legislative or regulatory
changes relating to defined benefit plan funding may increase the Company's funding obligations and adversely impact its results of operations and
cash flows.
* Change in the Company’s credit ratings could increase cost of funding.
The Company’s credit ratings are important to 3M’s cost of capital. The major rating agencies routinely evaluate the Company’s credit profile and
assign debt ratings to 3M. This evaluation is based on a number of factors, which include financial strength, business and financial risk, as well as
transparency with rating agencies and timeliness of financial reporting. 3M currently has an A1 credit rating with a negative outlook from
Moody’s Investors Service and an A+ credit rating with a negative outlook from Standard & Poor’s. The Company’s credit ratings have served to
lower 3M’s borrowing costs and facilitate access to a variety of lenders. The addition of further leverage to the Company’s capital structure could
impact 3M’s credit ratings in the future. Failure to maintain strong investment grade ratings would adversely affect the Company’s cost of funding
and could adversely affect liquidity and access to capital markets.
* Changes in tax rates, laws or regulations could adversely impact our financial results.
The Company’s business is subject to tax-related external conditions, such as tax rates, tax laws and regulations, changing political environments
in the U.S. and foreign jurisdictions that impact tax examination, assessment and enforcement approaches. In addition, changes in tax laws
including further regulatory developments arising from U.S. tax reform legislation and/or regulations around the world could result in a tax
expense or benefit recorded to the Company’s Consolidated Statement of Earnings. In connection with the Base Erosion and Profit Shifting
(BEPS) Integrated Framework provided by Organization for Economic Cooperation and Development (OECD), determination of multi-
jurisdictional taxation rights and the rate of tax applicable to certain types of income may be subject to potential change. Due to uncertainty of the
regulation changes and other tax-related factors stated above, it is currently not possible to assess the ultimate impact of these actions on our
financial statements.
Item 1B. Unresolved Staff Comments.
None.
14

-- 26 of 160 --

Item 2. Properties.
In the U.S., 3M’s general offices, corporate research laboratories, and certain division laboratories are located in St. Paul, Minnesota. The
Company operates 64 manufacturing facilities in 29 states. Internationally, the Company operates 97 manufacturing and converting facilities in 35
countries.
3M owns the majority of its physical properties. 3M’s physical facilities are highly suitable for the purposes for which they were designed.
Because 3M is a global enterprise characterized by substantial intersegment cooperation, properties are often used by multiple business segments.
Item 3. Legal Proceedings.
Discussion of legal matters is incorporated by reference from Part II, Item 8, Note 16, “Commitments and Contingencies,” of this document, and
should be considered an integral part of Part I, Item 3, “Legal Proceedings.”
Item 4. Mine Safety Disclosures.
Pursuant to Section 1503 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Act”), the Company is required to disclose, in
connection with the mines it operates, information concerning mine safety violations or other regulatory matters in its periodic reports filed with
the SEC. For the year 2020, the information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Act is
included in Exhibit 95 to this annual report.
15

-- 27 of 160 --

PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Equity compensation plans’ information is incorporated by reference from Part III, Item 12, “Security Ownership of Certain Beneficial Owners
and Management and Related Stockholder Matters,” of this document, and should be considered an integral part of Item 5. At January 31, 2021,
there were 68,372 shareholders of record. 3M’s stock ticker symbol is MMM and is listed on the New York Stock Exchange, Inc. (NYSE), the
Chicago Stock Exchange, Inc., and the SWX Swiss Exchange. Cash dividends declared and paid totaled $1.47 and $1.44 per share for each quarter
in 2020 and 2019, respectively. 3M typically declares and pays dividends in the same quarter.
Issuer Purchases of Equity Securities
Repurchases of 3M common stock are made to support the Company’s stock-based employee compensation plans and for other corporate
purposes. In November 2018, 3M’s Board of Directors replaced the Company’s February 2016 repurchase program with a new repurchase
program. This new program authorizes the repurchase of up to $10 billion of 3M’s outstanding common stock, with no pre-established end date.
Issuer Purchases of Equity Securities
(registered pursuant to Section 12 of the Exchange Act)
Maximum
Approximate
Dollar Value of
Total Number of 	Shares that May
Shares Purchased 	Yet Be Purchased
Total Number of 	Average Price 	as Part of Publicly 	under the Plans
Shares Purchased 	Paid per 	Announced Plans 	or Programs
Period 	(1) 	Share 	or Programs (2) 	(Millions)
January 1-31, 2020 	567,358 	$ 	175.01 	567,162 	$ 	7,973
February 1-29, 2020 	752,388 	$ 	157.29 	750,262 	$ 	7,855
March 1-31, 2020 	723,676 	$ 	140.55 	723,676 	$ 	7,753
Total January 1-March 31, 2020 	2,043,422 	$ 	156.28 	2,041,100 	$ 	7,753
April 1-30, 2020 	86 	$ 	133.13 	— 	$ 	7,753
May 1-31, 2020 	— 	$ 	— 	— 	$ 	7,753
June 1-30, 2020 	— 	$ 	— 	— 	$ 	7,753
Total April 1-June 30, 2020 	86 	$ 	114.18 	— 	$ 	7,753
July 1-31, 2020 	— 	$ 	— 	— 	$ 	7,753
August 1-31, 2020 	— 	$ 	— 	— 	$ 	7,753
September 1-30, 2020 	779 	$ 	172.38 	— 	$ 	7,753
Total July 1-September 30, 2020 	779 	$ 	172.38 	— 	$ 	7,753
October 1-31, 2020 	— 	$ 	— 	— 	$ 	7,753
November 1-30, 2020 	680 	$ 	173.64 	— 	$ 	7,753
December 1-31, 2020 	— 	$ 	— 	— 	$ 	7,753
Total October 1-December 31, 2020 	680 	$ 	173.64 	— 	$ 	7,753
Total January 1-December 31, 2020 	2,044,967 	$ 	156.29 	2,041,100 	$ 	7,753
(1) 	The total number of shares purchased includes: (i) shares purchased under the Board’s authorizations described above, and (ii) shares
purchased in connection with the exercise of stock options.
(2) 	The total number of shares purchased as part of publicly announced plans or programs includes shares purchased under the Board’s
authorizations described above.
16

-- 28 of 160 --

Item 6. Selected Financial Data.
(Dollars in millions, except per share amounts) 	2020 	2019* 	2018** 	2017 	2016
Years ended December 31:
Net sales 	$ 	32,184 	$ 	32,136 	$ 	32,765 	$ 	31,657 	$ 	30,109
Net income attributable to 3M 	5,384 	4,570 	5,349 	4,858 	5,050
Per share of 3M common stock:
Net income attributable to 3M — basic 	9.32 	7.92 	9.09 	8.13 	8.35
Net income attributable to 3M — diluted 	9.25 	7.81 	8.89 	7.93 	8.16
Cash dividends declared and paid per 3M common share 	5.88 	5.76 	5.44 	4.70 	4.44
At December 31:
Total assets 	$ 	47,344 	$ 	44,659 	$ 	36,500 	$ 	37,987 	$ 	32,906
Long-term debt (excluding portion due within one year) and long-term
lease obligations 	18,082 	17,629 	13,486 	12,156 	10,723
* The Company adopted ASU No. 2016-02 and related standards (collectively, Accounting Standards Codification (ASC) 842, Leases), as
described in Note 1, on January 1, 2019 using the modified retrospective method of adoption. The adoption resulted in the recording of right of use
assets and associated lease liabilities of $0.8 billion each as of January 1, 2019, $0.5 billion of which relates to long-term operating lease
obligations.
** The Company adopted ASU No. 2014-09 and related standards (collectively, ASC 606, Revenue from Contracts with Customers), as described
in Note 2, on January 1, 2018 using the modified retrospective method of adoption, the impact of which was not material to the Company’s
consolidated results of operations and financial condition. Prior periods have not been restated.
17

-- 29 of 160 --

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a reader of 3M’s
financial statements with a narrative from the perspective of management. 3M’s MD&A is presented in eight sections:
● 	Overview
● 	Results of Operations
● 	Performance by Business Segment
● 	Performance by Geographic Area
● 	Critical Accounting Estimates
● 	New Accounting Pronouncements
● 	Financial Condition and Liquidity
● 	Financial Instruments
Forward-looking statements in Item 7 may involve risks and uncertainties that could cause results to differ materially from those projected (refer to
the section entitled “Cautionary Note Concerning Factors That May Affect Future Results” in Item 1 and the risk factors provided in Item 1A for
discussion of these risks and uncertainties).
Additional information about results for year end 2018 and certain year-on-year comparisons between 2019 and 2018 can be found in
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in the Company’s Annual Report on Form
10-K for the year ended December 31, 2019.
OVERVIEW
3M is a diversified global manufacturer, technology innovator and marketer of a wide variety of products and services. As more fully described in
both the Performance by Business Segment section in MD&A and in Note 19, effective in the first quarter of 2020, the Company changed its
business segment reporting in its continuing effort to improve the alignment of businesses around markets and customers. Additionally, the
Company consolidated the way it presents geographic area net sales by providing an aggregate Americas geographic region (combining former
United States and Latin America and Canada areas). Also, effective in the second quarter of 2020, the measure of segment operating performance
used by 3M’s chief operating decision maker changed and, as a result, the Company’s disclosed measure of segment profit/loss has been updated.
Business segment information presented herein reflects the impact of these changes for all periods presented.
3M manages its operations in four operating business segments: Safety and Industrial; Transportation and Electronics; Health Care; and
Consumer. From a geographic perspective, any references to EMEA refer to Europe, Middle East and Africa on a combined basis.
Consideration of COVID-19:
3M is impacted by the global pandemic and related effects associated with the coronavirus (COVID-19). The Company updated its risk factors
with respect to COVID-19, which can be found in Item 1A “Risk Factors” in this document.
Public and private sector policies and initiatives to reduce the transmission of COVID-19, such as the imposition of travel restrictions and the
adoption of remote working, have impacted 3M’s operations. 3M continues to work to protect its employees and the public, maintain business
continuity and sustain its operations, including ensuring the safety and protection of people who work in its plants and distribution centers across
the world, many of whom support the manufacturing and delivery of products that are critical in response to the global pandemic. COVID-19 has
impacted 3M’s supply chains relative to global demand for products like respirators, surgical masks and commercial cleaning solutions. As this
situation continues, 3M also closely monitors and responds to potential impacts to the Company’s broader supply chain associated with other
products. COVID-19 has also affected the ability of suppliers and vendors to provide products and services to 3M. Furthermore, COVID-19 has
impacted the broader economies of affected countries, including negatively impacting economic growth.The Company has taken steps to help
employees lead safe and productive lives during the outbreak including remote working; escalated procedures in factories related to personal
safety, cleaning and medical screening measures; and pandemic leave policies. 3M closely monitors how the spread of COVID-19 is affecting
employees and business operations and has preparedness plans to help protect the safety of employees around the world while safely continuing
business. While nearly all of our manufacturing locations and distribution centers are fully or partially operational, the Company
18

-- 30 of 160 --

implemented plant and/or line shutdowns during 2020 related to certain markets due to weaker customer demand or government mandates. Some
of the above factors have increased the demand for 3M products, while others have decreased demand or made it more difficult for 3M to serve
customers. Serving 3M customers is a priority and teams continue to communicate with individual customers about potential disruptions.
3M’s total sales increased 0.1% for the full year 2020 when compared to 2019. Organic local-currency sales decreased 1.7% for the full year 2020
when compared to 2019. Given the diversity of 3M’s businesses, the impact of COVID-19 varied across the Company throughout 2020. 3M
experienced strong sales growth in personal safety, as well as in other areas such as home improvement, general cleaning, semiconductor, data
center, and biopharma filtration. COVID-related respirator sales are estimated to have impacted year-on-year organic local-currency sales growth
by approximately 3 percent for the year ending December 31, 2020. At the same time, weakness in several end markets, while improving,
contributed in part to sales declines in a number of 3M’s businesses with the biggest year-on-year total sales decreases in oral care (down 19
percent), advanced materials (down 17 percent), automotive and aerospace (down 16 percent), commercial solutions (down 14 percent), stationery
and office (down 11 percent), closure and masking (down 11 percent), automotive aftermarket (down 10 percent), and businesses aligned to
general industrial applications such as abrasives (down 15 percent) and industrial adhesives and tapes (down 5 percent).
3M’s operating income margins increased 3.1 percentage points year-on-year for the year ending December 31, 2020. Factoring out the impact on
operating income of special items as described in the 	Certain amounts adjusted for special items - (non-GAAP measures) 	section below, operating
income margins increased 0.1 points to 21.3 percent for the year ending December 31, 2020 when compared to 2019. Various COVID-19
implications contributed in part to these results.
Overall, the impact of the COVID-19 pandemic on 3M’s consolidated results of operations was primarily driven by factors related to changes in
demand for products and disruption in global supply chains as described above. While it is not feasible to identify or quantify all the other direct
and indirect implications on 3M’s results of operations, below are factors that 3M believes have also affected its 2020 results:
Factors contributing to charges:
● 	Period expenses of unabsorbed manufacturing costs and increased expected credit losses on customer receivables.
● 	Restructuring actions addressing structural enterprise costs and operations in certain end markets as a result of the COVID-19 pandemic
and related economic impact resulting in a second quarter 2020 charge of $58 million (as further discussed in Note 5).
● 	Committed financial support to various COVID-relief and medical research initiatives.
● 	Charge of $22 million related to equity securities as discussed in the “Assets and Liabilities that are Measured at Fair Value on a
Nonrecurring Basis” section of Note 15 that use the measurement alternative described therein in addition to an immaterial pre-tax charge
related to impairment of certain indefinite lived tradenames in the first quarter of 2020. 3M continues to regularly consider if COVID-19
and other related market implications could indicate it is more likely than not the carrying amount of various applicable assets may be
impaired and assess whether certain investments without readily determinable fair values may have been impacted.
Factors providing benefits or other impacts:
● 	Decreased discretionary spending in areas such as travel, professional services, and advertising/merchandising as well as cost reduction
efforts, hiring freezes, and maintaining only essential contract workers. 3M continues to monitor discretionary spending and deploy cost
control efforts as the situation continues.
● 	Government-sponsored COVID-response stimulus and relief initiatives, including certain employment retention benefits under the
Coronavirus Aid, Relief and Economic Security (CARES) Act in the United States.
● 	Lower self-insured medical visit/instance expense during 2020.
● 	Instituted accelerated vacation usage policies which benefited the second quarter of 2020 year-on-year, but provided a penalty in
comparison to prior year in the second half of 2020.
As previously disclosed, in light of circumstances, 3M took actions to ensure sources of cash may remain strong, including the March 2020
issuance of $1.75 billion of registered notes, suspension of share repurchases, and the decrease of its 2020 capital spending to approximately $1.5
billion. While capital spending decreased, it included additional expansion of respirator production capacity. 3M continues to have access to its
commercial paper program and undrawn committed credit facility. Refer to the Financial Condition and Liquidity section below for more
information on the Company’s liquidity position.
19

-- 31 of 160 --

The Company also continues to evaluate the extent to which it may avail itself of various government-sponsored COVID-response stimulus, relief,
and production initiatives around the world, such as under the Defense Production Act (DPA) and CARES Act in the United States. During 2020
and into January 2021, 3M reached certain agreements with governments in the U.S. and other countries involving just over $250 million of asset
funding to expand capacity to supply N-95 respirators.
Due to the speed with which the COVID-19 situation is developing and evolving and the uncertainty of its duration and the timing of recovery, 3M
is not able at this time to predict the extent to which the COVID-19 pandemic may have a material effect on its consolidated results of operations
or financial condition.
Earnings per share (EPS) attributable to 3M common shareholders – diluted:
The following table provides the increase (decrease) in diluted earnings per share for 2020 compared to the same period last year, in addition to
2019 compared to 2018. As applicable, certain items in the table reflect specific income tax rates associated therewith.
Year ended December 31,
(Earnings per diluted share) 	2020 	2019
Same period last year 	$ 	7.81 	$ 	8.89
Significant litigation-related charges/benefits 	1.01 	1.28
TCJA measurement period adjustment 	— 	0.29
Loss on deconsolidation of Venezuelan subsidiary 	0.28 	—
Gain/loss on sale of businesses 	(0.22) 	(0.73)
Divestiture-related restructuring actions 	— 	0.18
Same period last year, excluding special items 	$ 	8.88 	$ 	9.91
Increase/(decrease) in earnings per share - diluted, due to:
Organic growth/productivity and other 	(0.06) 	(0.60)
Non divestiture-related restructuring actions 	0.12 	(0.41)
Acquisitions/divestitures 	(0.10) 	(0.24)
Foreign exchange impacts 	(0.11) 	—
Income tax rate 	(0.03) 	—
Shares of common stock outstanding 	0.04 	0.22
Current period, excluding special items 	$ 	8.74 	$ 	8.88
Significant litigation-related charges/benefits 	0.07 	(1.01)
Loss on deconsolidation of Venezuelan subsidiary 	— 	(0.28)
Gain/loss on sale of businesses 	0.52 	0.22
Divestiture-related restructuring actions 	(0.08) 	—
Current period 	$ 	9.25 	$ 	7.81
Year 2020 EPS:
For year ended December 31, 2020, net income attributable to 3M was $5.384 billion, or $9.25 per diluted share basis, compared to $4.570 billion,
or $7.81 per diluted share, for year ended December 31, 2019, an increase of 18.4 percent on a per diluted share basis.
The Company refers to various “adjusted” amounts or measures on an “adjusted basis”. These exclude special items. These non-GAAP measures
are further described and reconciled to the most directly comparable GAAP financial measures in the 	Certain amounts adjusted for special items
- (non-GAAP measures) 	section below.
On an adjusted basis, net income attributable to 3M was $5.088 billion, or $8.74 per diluted share for 2020 compared to $5.193 billion, or $8.88
per diluted share in December 31, 2019, a decrease of 1.5 percent on a per diluted share basis.
Additional discussion related to the components of the year-on-year change in earnings per diluted share follows:
Organic growth/productivity and other:
● 	Lower organic volume growth in 2020 as a result of significant COVID-19 related impacts, in addition to COVID-related net factors
described in the preceding Overview—Consideration of COVID-19 section, decreased earnings per diluted share year-on-year. 3M also
experienced year-over-year increased costs as a result of the regular review of its respirator mask
20

-- 32 of 160 --

liabilities and certain follow-on accelerated depreciation following some of the restructuring described below. Partially offsetting this net
decrease in earnings per share were year-on-year net gains related to certain property sales (in 2020 within Safety and Industrial and in
2019 within Corporate and Unallocated) in addition to benefits recognized in 2020 related to the restructuring and other actions taken in
2019 (and the adjustments thereto in 2020) along with continued cost management and productivity efforts.
● 	On a combined basis, higher defined benefit pension and postretirement service cost increased expense year-on-year.
● 	Interest expense (net of interest income) increased in 2020, as a result of higher U.S. average debt balances and lower year-on-year
interest income driven by lower average interest rates on cash balances. 2020 interest expense also included an early debt extinguishment
charge in conjunction with the repayment of notes in December 2020.
Non divestiture-related restructuring actions:
● 	3M recorded non divestiture-related restructuring pre-tax charges aggregating $195 million in 2020. These included charges in the second
quarter of 2020 to address certain COVID-related impacts and in the fourth quarter as 3M initiated actions to further enhance its
operational and marketing capabilities. In 2019, charges included $282 million as the Company committed to actions in light of slower
than expected 2019 sales and associated with realigning its organizational structure and operating model. See Note 5 for additional
details.
● 	The year-on-year impact of the non divestiture-related restructuring actions taken in 2020 and 2019 increased earnings per diluted share
by 12 cents.
Acquisitions/divestitures:
● 	Acquisition impacts, which are measured for the first twelve months post-transaction, relate to the acquisitions of M*Modal (first quarter
2019), and Acelity (fourth quarter 2019). These items collectively decreased earnings per diluted share by 7 year-on-year for 2020. The
net impacts related to these acquisitions included income from operations, more than offset by transaction and integration costs.
Financing costs related to these acquisitions is also included.
● 	Divestiture impacts include the lost operating income from divested businesses, which decreased earnings per diluted share by 3 cents
year-on-year for 2020. This was primarily related to the divestiture of the Company’s drug delivery business.
Foreign exchange impacts:
● 	Foreign currency impacts (net of hedging) decreased pre-tax earnings year-on-year by approximately $81 million in 2020, which
decreased earnings per diluted share by 11 cents, excluding the impact of foreign currency changes on tax rates.
Income tax rate:
● 	Certain items above reflect specific income tax rates associated therewith. Overall, the effective tax rate for 2020 was 19.6 percent, a
decrease of 0.2 percentage points versus 2019. On an adjusted basis (as discussed below), the effective tax rate increased 0.1 percentage
points year-on-year for 2020.
● 	Factors that decreased the effective tax rate for 2020 included geographical income mix and adjustments to uncertain tax positions. These
decreases were partially offset by decreased benefit from stock options. 	Refer to Note 10 for additional details.
Shares of common stock outstanding:
● 	Lower shares outstanding increased earnings per share year-on-year by 4 cents per diluted share for 2020. Weighted-average diluted
shares outstanding in 2020 declined 0.5 percent year-on-year, which benefited earnings per share. The decrease in the outstanding
weighted-average diluted shares relates to the Company’s purchase of $368 million of its own stock, prior to suspension of share
repurchases under its board-approved stock repurchase program in late March 2020 with other repurchase activity limited to 3M’s stock
compensation plans.
Year 2019 EPS:
Organic growth/productivity and other:
● 	Negative organic local-currency sales growth as a result of softness in certain end markets and channel inventory adjustments, along with
actions taken by 3M in response to lower sales volumes and high inventory levels, which resulted in lower manufacturing and inventory
absorption, reduced earnings per diluted share. Partially offsetting these impacts were benefits from restructuring actions taken in the
second quarter of 2019.
21

-- 33 of 160 --

● 	Defined benefit pension and postretirement service cost expense decreased expense year-on-year, which benefited earnings per diluted
share.
● 	Lower income related to non-service cost components of pension and postretirement expense, increased expense year-on-year.
● 	Interest expense (net of interest income) increased in 2019, as a result of higher U.S. average debt balances, partially offset by the
increase in interest income driven by higher balances in cash, cash equivalents and marketable securities during the year resulting from
the proceeds from debt issuances in advance of the October 2019 Acelity acquisition.
Non divestiture-related restructuring actions:
● 	During the second quarter of 2019, in light of slower than expected 2019 sales, and additionally in the fourth quarter to realign 	3M’s
organizational structure and operating model, management approved and committed to undertake certain restructuring actions. In
aggregate, the Company recorded a full year 2019 combined pre-tax charge of $282 million, or 41 cents per diluted share. See Note 5 for
additional details.
Acquisitions/divestitures:
● 	Acquisition impacts, which are measured for the first twelve months post-transaction, relate to the acquisitions of M*Modal (first quarter
2019), and Acelity (fourth quarter 2019). These items collectively decreased earnings per diluted share by 19 cents year-on-year for 2019.
The net impacts related to these acquisitions included income from operations, more than offset by transaction and integration costs.
Interest expense related to financing costs of these acquisitions is also included. Expenses related to the October 2019 acquisition of
Acelity also include financing costs and the tax effect of repatriating funds in advance of the close of the acquisition.
● 	Divestiture impacts collectively decreased earnings per diluted share by 5 cents year-on-year for 2019. They include remaining stranded
costs and lost operating income related to the 2018 divestiture of the Communication Markets Division, which decreased earnings per
diluted share by 4 cents year-on-year, and lost operating income from other divested businesses (primarily the Company’s gas and flame
detection business), which decreased earnings per diluted share by 1 cent year-on-year.
Foreign exchange impacts:
● 	Foreign currency impacts (net of hedging) were essentially flat year-on-year, excluding the impact of foreign currency changes on tax
rates.
Income tax rate:
● 	Certain items above reflect specific income tax rates associated therewith. Overall, the effective tax rate for 2019 was 19.8 percent, a
decrease of 3.6 percentage points versus 2018. On an adjusted basis (as discussed below), the effective tax rate increased 0.2 percentage
points year-on-year for 2019.
● 	Factors that decreased the effective tax rate on a GAAP basis for 2019 included prior year measurement period adjustments related to
2017 Tax Cuts and Jobs Act (TCJA), prior year resolution of the NRD lawsuit (as described in Note 16) and geographical income mix.
These decreases were partially offset by the deconsolidation of the Venezuelan subsidiary, adjustments to uncertain tax positions, and
significant litigation-related charges. Refer to Note 10 for additional details.
Shares of common stock outstanding:
● 	Lower shares outstanding increased earnings per share year-on-year by 22 cents per diluted share for 2019. Weighted-average diluted
shares outstanding in 2019 declined 2.8 percent year-on-year which benefited earnings per share. The decrease in the outstanding
weighted-average diluted shares relates to the Company’s purchase of $1.4 billion of its own stock in 2019.
22

-- 34 of 160 --

Certain amounts adjusted for special items - (non-GAAP measures):
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides non-GAAP measures that adjust for the
impacts of special items. For the periods presented, special items include the items described below. Beginning in 2020, the Company includes
gain/loss on sale of businesses and divestiture-related restructuring actions as special items due to their potential distortion of underlying operating
results. Information provided herein reflects the impact of this change for all periods presented. Operating income (measure of segment operating
performance), income before taxes, net income, earnings per share, and the effective tax rate are all measures for which 3M provides the reported
GAAP measure and a measure adjusted for special items. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP
measures. The Company considers these non-GAAP measures in evaluating and managing the Company’s operations. The Company believes that
discussion of results adjusted for these items is meaningful to investors as it provides a useful analysis of ongoing underlying operating trends. The
determination of these items may not be comparable to similarly titled measures used by other companies. Special items include:
Significant litigation-related charges/benefits:
● 	In 2020, 3M recorded a net pre-tax charge of $17 million ($13 million after tax) related to PFAS (certain perfluorinated compounds)
matters. The charge was more than offset by a reduction in tax expense of $52 million related to resolution of tax treatment with
authorities regarding the previously disclosed 2018 agreement reached with the State of Minnesota that resolved the Natural Resources
Damages lawsuit. These items, in aggregate, resulted in a $39 million after tax benefit.
● 	In 2019, the Company recorded significant litigation-related charges of $762 million ($590 million after tax) related to PFAS matters and
coal mine dust respirator mask lawsuits of which $214 million ($166 million after tax) occurred in the fourth quarter. The aggregate 2019
pre-tax charge was reflected in cost of sales ($328 million) and selling, general and administrative expense ($434 million). These charges
are further discussed in Note 16.
● 	In 2018, the Company recorded significant litigation-related charges of $897 million ($770 million after tax) for PFAS matters related to
the previously disclosed agreement reached with the State of Minnesota that resolved the Natural Resource Damages lawsuit. Essentially
all of the aggregate 2018 pre-tax charge was reflected in selling, general and administrative expense.
Gain/loss on sale of businesses:
● 	In the first quarter of 2020, 3M recorded a pre-tax gain of $2 million ($1 million loss after tax) related to the sale of its advanced ballistic-
protection business and recognition of certain contingent consideration. In the second quarter of 2020, 3M recorded a pre-tax gain of
$387 million ($304 million after tax) related to the sale of its drug delivery business. Refer to Note 3 for further details.
● 	In the first quarter of 2019, 3M recorded a gain related to the sale of certain oral care technology comprising a business in addition to
reflecting an earnout on a previous divestiture, which together resulted in a net gain of $8 million ($7 million after tax). In the second
quarter of 2019, as a result of a “held for sale” tax benefit related to the legal entities associated with the pending divestiture of the
Company’s gas and flame detection business, 3M recorded an after-tax gain of $43 million. In the third quarter of 2019, 3M recorded a
gain related to the divestiture of the Company’s gas and flame detection business and an immaterial impact as a result of measuring a
disposal group at the lower of its carrying amount or fair value less cost to sell, which in aggregate resulted in a pre-tax gain of $106
million ($79 million after tax).
● 	In the first quarter of 2018, 3M recorded a gain related to the sale of certain personal safety product offerings primarily focused on noise,
environmental, and heat stress monitoring, the sale of its polymer additives compounding business, and a gain on final closing
adjustments from a prior divestiture which, in aggregate, resulted in a net pre-tax gain of $24 million ($19 million after tax). In the
second quarter of 2018, 3M recorded a pre-tax gain of $12 million ($10 million after tax) related to the sale of its abrasive glass products
business. In the fourth quarter of 2018, 3M recorded a gain of $2 million related to an earnout from a previous divestiture. Additionally,
in 2018, 3M completed the sale of substantially all of its Communication Markets Division and reflected a pre-tax gain of $509 million
($410 million after tax).
Divestiture-related restructuring actions:
● 	In the second quarter 2020, following the divestiture of substantially all of the drug delivery business (see Note 3) management approved
and committed to undertake certain restructuring actions addressing corporate functional costs and manufacturing footprint across 3M in
relation to the magnitude of amounts previously allocated/burdened to the divested business. As a result, 3M recorded a second quarter
2020 pre-tax charge of $55 million ($46 million after tax) and made a subsequent immaterial adjustment thereto. Refer to Note 5 for
further details.
23

-- 35 of 160 --

● 	During 2018, management approved and committed to undertake certain restructuring actions as further described in Note 5, related to
addressing corporate functional costs following the Communication Markets Division divestiture resulting in a 2018 pre-tax charge of
$127 million ($110 million after tax), net of adjustments for reductions in cost estimates of $10 million.
Loss on deconsolidation of Venezuelan subsidiary:
● 	In the second quarter of 2019, 3M recorded a pre-tax charge of $162 million related to the deconsolidation of the Company’s Venezuelan
subsidiary as further discussed in Note 1.
Measurement period accounting for TCJA:
● 	3M recorded a net tax expense of $176 million in 2018 as a measurement period adjustment to the enactment of the 2017 Tax Cuts and
Jobs Act (TCJA). See Note 10 for additional information.
(Dollars in millions, except per share
amounts)
Operating
Income
Operating
Income
Margin
Income
Before
Taxes
Provision
for
Income
Taxes
Effective
Tax Rate
Net Income
Attributable
to 3M
Earnings
Per
Diluted
Share
Earnings
per
diluted
share
percent
change
Year ended December 31, 2018 GAAP 	$ 	7,207 	22.0 %$ 	7,000 	$ 	1,637 	23.4 %$ 	5,349 	$ 	8.89
Adjustments for special items:
Significant litigation-related
charges/benefits 	897 	897 	127 	770 	1.28
Gain/loss on sale of businesses 	(547) 	(547) 	(107) 	(440) 	(0.73)
Divestiture-related restructuring
actions 	127 	127 	17 	110 	0.18
Measurement period accounting for
TCJA 	— 	— 	(176) 	176 	0.29
Year ended December 31, 2018 adjusted
amounts (non-GAAP measures) 	$ 	7,684 	23.5 %$ 	7,477 	$ 	1,498 	20.0 %$ 	5,965 	$ 	9.91
Year ended December 31, 2019 GAAP 	$ 	6,174 	19.2 %$ 	5,712 	$ 	1,130 	19.8 %$ 	4,570 	$ 	7.81 	(12.1)%
Adjustments for special items:
Significant litigation-related
charges/benefits 	762 	762 	172 	590 	1.01
Gain/loss on sale of businesses 	(114) 	(114) 	15 	(129) 	(0.22)
Loss on deconsolidation of
Venezuelan subsidiary 	— 	162 	— 	162 	0.28
Year ended December 31, 2019 adjusted
amounts (non-GAAP measures) 	$ 	6,822 	21.2 %$ 	6,522 	$ 	1,317 	20.2 %$ 	5,193 	$ 	8.88 	(10.4)%
Year ended December 31, 2020 GAAP 	$ 	7,161 	22.3 %$ 	6,711 	$ 	1,318 	19.6 %$ 	5,384 	$ 	9.25 	18.4 %
Adjustments for special items:
Significant litigation-related
charges/benefits 	17 	17 	56 	(39) 	(0.07)
Gain/loss on sale of businesses 	(389) 	(389) 	(86) 	(303) 	(0.52)
Divestiture-related restructuring
actions 	55 	55 	9 	46 	0.08
Year ended December 31, 2020 adjusted
amounts (non-GAAP measures) 	$ 	6,844 	21.3 %$ 	6,394 	$ 	1,297 	20.3 %$ 	5,088 	$ 	8.74 	(1.5)%
24

-- 36 of 160 --

Year 2020 sales and operating income by business segment:
The following tables contain sales and operating income results by business segment for the years ended December 31, 2020 and 2019. Refer to
the section entitled “Performance by Business Segment” later in MD&A for additional discussion concerning 2020 verses 2019 results, including
Corporate and Unallocated. Refer to Note 19 for additional information on business segments, including Elimination of Dual Credit.
2020 vs 2019
2020 	2019 	% change
Net 	% of 	Oper. 	Net 	% of 	Oper. 	Net 	Oper.
(Dollars in millions) 	Sales 	Total 	Income 	Sales 	Total 	Income 	Sales 	Income
Business Segments
Safety and Industrial 	$ 11,767 	36.6 % 	$ 3,054 	$ 	11,514 	35.8 % $ 	2,510 	2.2 % 	21.7 %
Transportation and Electronics 	8,827 	27.4 	1,927 	9,591 	29.8 	2,221 	(8.0) 	(13.3)
Health Care 	8,345 	25.9 	1,828 	7,431 	23.1 	1,858 	12.3 	(1.6)
Consumer 	5,336 	16.6 	1,249 	5,151 	16.0 	1,124 	3.6 	11.2
Corporate and Unallocated 	(1) 	— 	(363) 	110 	0.3 	(1,130) 	— 	—
Elimination of Dual Credit 	(2,090) 	(6.5) 	(534) 	(1,661) 	(5.0) 	(409) 	— 	—
Total Company 	$ 32,184 	100.0 % 	$ 7,161 	$ 	32,136 	100.0 % $ 	6,174 	0.1 % 	16.0 %
Year ended December 31, 2020
Worldwide Sales Change 	Organic local- 	Total sales
By Business Segment 	currency sales 	Acquisitions 	Divestitures 	Translation 	change
Safety and Industrial 	3.5 % 	—% 	(0.6)% 	(0.7) % 	2.2 %
Transportation and Electronics 	(7.1) 	— 	(1.1) 	0.2 	(8.0)
Health Care 	1.0 	15.5 	(4.1) 	(0.1) 	12.3
Consumer 	4.1 	— 	— 	(0.5) 	3.6
Total Company 	(1.7)% 	3.5 % 	(1.4)% 	(0.3)% 	0.1 %
25

-- 37 of 160 --

Year 2020 sales results by geographic area/business segment:
Percent change information compares the year ended December 31, 2020 with the same period last year, unless otherwise indicated. Additional
discussion of business segment results is provided in the Performance by Business Segment section.
Year ended December 31, 2020
Europe,
Asia 	Middle East 	Other
Americas 	Pacific 	& Africa 	Unallocated 	Worldwide
Net sales (millions) 	$ 	16,525 	$ 	9,569 	$ 	6,109 	$ 	(19) 	$ 	32,184
% of worldwide sales 	51.3 % 	29.7 % 	19.0 % 	— 	100.0 %
Components of net sales change:
Volume — organic 	(1.2)% 	(2.9)% 	(4.0)% 	— 	(2.3)%
Price 	1.0 	(0.5) 	1.2 	— 	0.6
Organic local-currency sales 	(0.2) 	(3.4) 	(2.8) 	— 	(1.7)
Acquisitions 	5.5 	0.7 	2.8 	— 	3.5
Divestitures 	(1.5) 	(0.2) 	(2.9) 	— 	(1.4)
Translation 	(1.3) 	0.6 	1.0 	— 	(0.3)
Total sales change 	2.5 % 	(2.3)% 	(1.9)% 	— 	0.1 %
Total sales change:
Safety and Industrial 	2.8 % 	(1.4)% 	4.7 % 	— 	2.2 %
Transportation and Electronics 	(15.4)% 	(2.4)% 	(12.9)% 	— 	(8.0)%
Health Care 	20.5 % 	(0.8)% 	3.8 % 	— 	12.3 %
Consumer 	5.2 % 	(1.3)% 	1.5 % 	— 	3.6 %
Organic local-currency sales change:
Safety and Industrial 	5.0 % 	(1.5)% 	5.6 % 	— 	3.5 %
Transportation and Electronics 	(11.4)% 	(2.8)% 	(13.8)% 	— 	(7.1)%
Health Care 	3.9 % 	(6.0)% 	0.2 % 	— 	1.0 %
Consumer 	6.3 % 	(2.2)% 	0.1 % 	— 	4.1 %
Additional information beyond what is included in the preceding table is as follows:
● 	In the Americas geographic area, U.S. total sales increased 6 percent and organic-local currency sales increased 1 percent. Total sales in
Mexico decreased 14 percent while organic local-currency sales decreased 12 percent. In Canada, total sales decreased 1 percent as
organic local-currency sales decreases of 4 percent were partially offset by acquisition-related sales growth. In Brazil, total sales
decreased 17 percent while organic local-currency sales increased 7 percent, as organic sales growth was more than offset by foreign
currency translation impacts.
● 	In the Asia Pacific geographic area, China total sales increased 4 percent and organic local-currency sales increased 3 percent. In Japan,
total sales decreased 3 percent and organic local currency sales decreased 7 percent.
Foreign currency translation decreased year-on-year sales by 0.3 percent, while selling prices increased by 0.6 percent year-on-year for 2020, with
price growth in EMEA and Americas, while Asia Pacific decreased.
26

-- 38 of 160 --

Year 2019 sales results by geographic area/business segment:
Percent change information compares the full year 2019 with the full year 2018, unless otherwise indicated. Additional discussion of business
segment results is provided in the Performance by Business Segment section.
Year ended December 31, 2019
Europe,
Asia 	Middle East 	Other
Americas 	Pacific 	& Africa 	Unallocated 	Worldwide
Net sales (millions) 	$ 	16,124 	$ 	9,796 	$ 	6,226 	$ 	(10) 	$ 	32,136
% of worldwide sales 	50.1 % 	30.5 % 	19.4 % 	— 	100.0 %
Components of net sales change:
Volume — organic 	(1.5)% 	(2.8)% 	(2.2)% 	— 	(2.1)%
Price 	0.8 	(0.1) 	1.3 	— 	0.6
Organic local-currency sales 	(0.7) 	(2.9) 	(0.9) 	— 	(1.5)
Acquisitions 	3.5 	0.3 	1.0 	— 	2.0
Divestitures 	(0.6) 	(0.2) 	(1.9) 	— 	(0.7)
Translation 	(0.6) 	(1.7) 	(4.6) 	— 	(1.7)
Total sales change 	1.6 % 	(4.5)% 	(6.4)% 	— 	(1.9)%
Total sales change:
Safety and Industrial 	(5.3)% 	(7.6)% 	(11.0)% 	— 	(7.2)%
Transportation and Electronics 	(3.8)% 	(5.3)% 	(6.6)% 	— 	(5.1)%
Health Care 	15.5 % 	2.5 % 	0.6 % 	— 	8.9 %
Consumer 	2.2 % 	(2.8)% 	(4.6)% 	— 	0.5 %
Organic local-currency sales change:
Safety and Industrial 	(3.3)% 	(4.7)% 	(2.4)% 	— 	(3.4)%
Transportation and Electronics 	(3.3)% 	(4.1)% 	(2.2)% 	— 	(3.6)%
Health Care 	1.1 % 	3.1 % 	1.4 % 	— 	1.5 %
Consumer 	2.6 % 	(1.1)% 	0.4 % 	— 	1.7 %
Additional information beyond what is included in the preceding table is as follows:
● 	In the Americas geographic area, U.S. total sales increased 2 percent and organic-local currency decreased 1 percent. Total sales
remained flat in Mexico, as organic local-currency sales increases of 1 percent were partially offset by lost sales from divested businesses
and foreign currency translation impacts. In Canada, total sales and organic local currency increased 3 percent. In Brazil, total sales
decreased 4 percent, as organic local-currency sales growth of 3 percent was more than offset by foreign currency translation impacts.
● 	In the Asia Pacific geographic area, China total sales decreased 7 percent and organic local-currency sales decreased 4 percent. In Japan,
total sales decreased 2 percent and organic local currency sales decreased 3 percent.
Foreign currency translation decreased year-on-year sales by 1.7 percent, while selling prices increased by 0.6 percent year-on-year for 2019, with
price growth in EMEA and Americas, while Asia Pacific was flat.
Managing currency risks:
The stronger U.S. dollar had a negative impact on sales in full year 2020 compared to the same period last year. Net of the Company’s hedging
strategy, foreign currency negatively impacted earnings for full year 2020 compared to the same period last year. 3M utilizes a number of tools to
hedge currency risk related to earnings. 3M uses natural hedges such as pricing, productivity, hard currency and hard currency-indexed billings,
and localizing source of supply. 3M also uses financial hedges to mitigate currency risk. In the case of more liquid currencies, 3M hedges a portion
of its aggregate exposure, using a 12, 24 or 36 month horizon, depending on the currency in question. For less liquid currencies, financial hedging
is frequently more expensive with more limitations on tenor. Thus, this risk is largely managed via local operational actions using natural hedging
tools as discussed above. In either case, 3M’s hedging approach is
27

-- 39 of 160 --

designed to mitigate a portion of foreign currency risk and reduce volatility, ultimately allowing time for 3M’s businesses to respond to changes in
the marketplace.
Financial condition:
3M generated $8.1 billion of operating cash flow in 2020, an increase of $1.0 billion when compared to 2019. This increase was primarily due to
cost saving actions taken in response to COVID-19 and lower year-on-year significant litigation-related charges and the timing of associated
payments. This followed an operating cash flow increase of $631 million when comparing 2019 to 2018. Refer to the section entitled “Financial
Condition and Liquidity” later in MD&A for a discussion of items impacting cash flows.
In November 2018, 3M’s Board of Directors replaced the Company’s February 2016 repurchase program with a new repurchase program. This
new program authorizes the repurchase of up to $10 billion of 3M’s outstanding common stock, with no pre-established end date. In 2020, the
Company purchased $0.4 billion of its own stock, compared to purchases of $1.4 billion in 2019. As of December 31, 2020, approximately $7.8
billion remained available under the authorization. In the first quarter of 2020, the Company suspended repurchases under its board-approved
share repurchase program with other repurchase activity limited to 3M’s stock compensation plans. The Company plans to resume share purchases
in 2021. In February 2021, 3M’s Board of Directors declared a first-quarter 2021 dividend of $1.48 per share, an increase of 1 percent. This
marked the 63rd consecutive year of dividend increases for 3M.
Raw materials:
In 2020, the coronavirus (COVID-19) pandemic caused fluctuations in supply markets. Generally, as demand for certain COVID-related products
surged, 3M saw a corresponding tightening in supply and some degree of price inflation in associated markets. Within the supply chain of less
essential products, 3M experienced raw material price deflation as economies slowed and certain producers scaled back or idled operations.
Conversely, as markets re-opened and demand increased, the Company experienced raw material price inflation with some level of stabilization
late in the year.
In response, the Company continued to deploy productivity projects to minimize the impact of raw material inflation and market supply
challenges, including input management, reformulations, and multi-sourcing activities. Overall, on a consolidated basis, 3M experienced net raw
material deflation in 2020. To date, the Company is receiving sufficient quantities of all raw materials to meet its reasonably foreseeable
production requirements. It is difficult to predict future shortages of raw materials or the impact any such shortages would have. 3M has avoided
disruption to its manufacturing operations through careful management of existing raw material inventories, strategic relationships with key
suppliers, and development as well as qualification of additional supply sources. 3M manages spend category price risks through negotiated supply
contracts and price protection agreements. In addition, 3M evaluates suppliers’ conformance with environmental and social compliance
requirements.
Pension and postretirement defined benefit/contribution plans:
On a worldwide basis, 3M’s pension and postretirement plans were 87 percent funded at year-end 2020. The primary U.S. qualified pension plan,
which is approximately 67 percent of the worldwide pension obligation, was 91 percent funded and the international pension plans were 93 percent
funded. The U.S. non-qualified pension plan is not funded due to tax considerations and other factors. Asset returns in 2020 for the primary U.S.
qualified pension plan were 13.6%, as 3M strategically invests in both growth assets and fixed income matching assets to manage its funded status.
For the primary U.S. qualified pension plan, the expected long-term rate of return on an annualized basis for 2021 is 6.50%. The primary U.S.
qualified pension plan year-end 2020 discount rate was 2.55%, down 0.70 percentage points from the year-end 2019 discount rate of 3.25%. The
decrease in U.S. discount rates resulted in an increased valuation of the projected benefit obligation (PBO). The primary U.S. qualified pension
plan’s funded status decreased 1 percentage point in 2020 due to the higher PBO resulting from the discount rate decrease and partially offset by
higher return on assets. Additional detail and discussion of international plan asset returns and discount rates is provided in Note 13 (Pension and
Postretirement Benefit Plans).
3M expects to contribute approximately $100 million to $200 million of cash to its global defined benefit pension and postretirement plans in
2021. The Company does not have a required minimum cash pension contribution obligation for its U.S. plans in 2021. 3M expects global defined
benefit pension and postretirement expense in 2021 to decrease by approximately $40 million pre-tax when
28

-- 40 of 160 --

compared to 2020. Refer to “Critical Accounting Estimates” within MD&A and Note 13 (Pension and Postretirement Benefit Plans) for additional
information concerning 3M’s pension and post-retirement plans.
RESULTS OF OPERATIONS
Net Sales:
Refer to the preceding “Overview” section and the “Performance by Business Segment” section later in MD&A for additional discussion of sales
change.
Operating Expenses:
(Percent of net sales) 	2020 	2019 	2020 versus 2019
Cost of sales 	51.6 % 	53.4 % 	(1.8)%
Selling, general and administrative expenses (SG&A) 	21.5 	21.9 	(0.4)
Research, development and related expenses (R&D) 	5.8 	5.9 	(0.1)
Gain on sale of businesses 	(1.2) 	(0.4) 	(0.8)
Operating income margin 	22.3 % 	19.2 % 	3.1 %
Operating income margins increased year over year for 2020. The increase from 2019 to 2020 was primarily driven by lower significant litigation-
related charges and higher gains on divestitures (net of divestiture-related restructuring actions) year-on-year. These items are further described in
the Certain amounts adjusted for special items - (non-GAAP measures) section above. A number of factors impact the various income statement
line items. Expanded discussion of each of the income statement line items follows in the various sections below.
In 2020 the Company’s operating expenses were impacted by factors described in the preceding Overview – Consideration of COVID-19 section
above.
In 2020 and 2019, 3M approved and committed to certain restructuring actions that impacted cost of sales, SG&A, and R&D (see Note 5 for
additional details). In addition to actions related to divestitures (as discussed earlier in the Certain amounts adjusted for special items - (non-GAAP
measures) section), for 2020 these included charges to address certain COVID-related impacts and actions to further enhance its operational and
marketing capabilities. In 2019, charges included actions in light of slower than expected 2019 sales and associated with realigning its
organizational structure and operating model.
Pension and postretirement service cost expense is recorded in cost of sales, SG&A, and R&D. In total, 3M’s defined benefit pension and
postretirement service cost expense increased $31 million in 2020. Refer to Note 13 (Pension and Postretirement Plans) for the service cost
components of net periodic benefit costs.
The Company is investing in an initiative called business transformation, with these investments impacting cost of sales, SG&A, and R&D.
Business transformation encompasses the ongoing multi-year phased implementation of an enterprise resource planning (ERP) system on a
worldwide basis, as well as changes in processes and internal/external service delivery across 3M.
Cost of Sales:
Cost of sales includes manufacturing, engineering and freight costs.
Cost of sales, measured as a percent of sales, decreased during 2020 when compared to 2019. Decreases were related to lower significant
litigation-related charges taken in 2020, which were partially offset by 2020 COVID-related net impacts, including period expenses of unabsorbed
manufacturing costs, in addition to higher restructuring action charges taken in 2020 along with certain related follow-on accelerated depreciation.
In addition, selling prices increased year-on-year by 0.6 percent for full year 2020, and lower raw material costs reduced cost of sales as a
percentage of sales.
29

-- 41 of 160 --

Selling, General and Administrative Expenses:
SG&A in dollars decreased slightly in 2020 when compared to 2019. The decrease was driven by cost saving actions taken in response to COVID-
19, in addition to benefits from prior year restructuring (and adjustments thereto in 2020). Additional factors that decreased SG&A in 2020 also
include lower year-on-year impact related to significant litigation-related charges. In terms of SG&A as a percent of sales, partially offsetting these
decreases was the overall effect of the COVID-19 pandemic on sales that resulted in higher costs as a percent of sales. SG&A was also impacted
by increased spending year-on-year related to Acelity, which was acquired in the fourth quarter of 2019.
Research, Development and Related Expenses:
R&D in dollars decreased slightly in 2020 when compared to 2019 and remained relatively consistent as a percent of sales at 5.8% in 2020
compared to 5.9% in 2019. 3M continued to invest in its key initiatives, including R&D aimed at disruptive innovation programs with the potential
to create entirely new markets and disrupt existing markets. Incremental R&D spending in 2020 included activities related to the Acelity business
acquired in the fourth quarter of 2019. 3M also experienced lower year-on-year restructuring activities impacting R&D.
Gain on Sale of Businesses:
During the first quarter of 2020, the Company recorded a pre-tax gain of $2 million ($1 million loss after tax) related to the sale of its advanced
ballistic-protection business and recognition of certain contingent consideration. During the second quarter of 2020, the Company recorded a pre-
tax gain of $387 million ($304 after tax) related to the sale of substantially all of its drug delivery business.
During the first quarter of 2019, the Company sold certain oral care technology comprising a business and reflected an earnout on a previous
divestiture resulting in a pre-tax gain of $8 million ($7 million gain after tax). In the third quarter of 2019, 3M recorded a gain related to the
divestiture of the Company’s gas and flame detection business and an immaterial impact as a result of measuring a disposal group at the lower of
its carrying amount or fair value less cost to sell, which in aggregate resulted in a pre-tax gain of $106 million ($79 million after tax). Refer to
Note 3 for additional details on divestitures.
Operating Income Margin:
3M uses operating income as one of its primary business segment performance measurement tools. Refer to the table below for a reconciliation of
operating income margins for 2020 and 2019.
Year ended December 31,
(Percent of net sales) 	2020 	2019
Same period last year 	19.2 % 	22.0 	%
Significant litigation-related charges/benefits 	2.4 	2.7
Gain/loss on sale of businesses 	(0.4) 	(1.6)
Divestiture-related restructuring actions 	— 	0.4
Same period last year, excluding special items 	21.2 % 	23.5 	%
Increase/(decrease) in operating income margin, due to:
Organic volume/productivity and other 	(0.1) 	(1.7)
Non divestiture-related restructuring actions 	0.2 	(0.8)
Acquisitions/divestitures 	(0.5) 	(0.6)
Selling price and raw material impact 	0.7 	0.4
Foreign exchange impacts 	(0.2) 	0.4
Current period, excluding special items 	21.3 % 	21.2 	%
Significant litigation-related charges/benefits 	— 	(2.4)
Gain/loss on sale of businesses 	1.2 	0.4
Divestiture-related restructuring actions 	(0.2) 	—
Current period 	22.3 % 	19.2 	%
30

-- 42 of 160 --

Year 2020 operating income:
Operating income margins increased 3.1 percentage points in 2020 when compared to 2019. Factoring out the impact on operating income of
special items as described in the 	Certain amounts adjusted for special items – (non-GAAP measures) 	section above, operating margins increased
0.1 percentage points to 21.3 percent in 2020 when compared to 2019.
Additional discussion related to the components of the year-on-year change in operating income margins follows:
Organic volume/productivity and other:
● 	Lower organic volume growth in 2020 as a result of significant COVID-19 related impacts, in addition to COVID-related net factors
described in the preceding Overview—Consideration of COVID-19 section, decreased operating income margins year-on-year. 3M also
experienced year-over-year increased costs as a result of the regular review of its respirator mask liabilities and certain follow-on
accelerated depreciation following some of the restructuring described below. Partially offsetting this net decrease were year-on-year net
gains related to certain property sales (in 2020 with Safety and Industrial and in 2019 within Corporate and Unallocated) in addition to
benefits recognized in 2020 related to the restructuring and other actions taken in 2019 (and the adjustments thereto in 2020) along with
continued cost management and productivity efforts.
● 	Operating income margins decreased year-on-year due to higher defined benefit pension and postretirement service cost expense.
Non divestiture-related restructuring actions:
● 	3M recorded non divestiture-related restructuring charges that impacted operating income aggregating $195 million in 2020. These
included charges in the second quarter of 2020 to address certain COVID-related impacts and in the fourth quarter as 3M initiated actions
to further enhance its operational and marketing capabilities. In 2019, charges included $246 million impacting operating income (and
$36 million impacting other expense (income)) as the Company committed to actions in light of slower than expected 2019 sales and
associated with realigning its organizational structure and operating model. See Note 5 for additional details.
● 	The year-on-year impact of the non divestiture-related restructuring charges taken in 2020 and 2019 increased operating income margins.
Acquisitions/divestitures:
● 	Acquisition-related impacts relate to the ongoing integration of M*Modal and Acelity, which decreased operating income margins year-
on-year.
● 	Divestiture impacts, which includes lost operating income from divested businesses, increased operating income margins year-on-year.
Selling price and raw material impact:
● 	Higher selling prices in addition to lower raw material cost impacts benefited operating income margins year-on-year for 2020.
Foreign exchange impacts:
● 	Foreign currency effects (net of hedge gains) decreased operating income margins year-on-year.
Significant litigation-related charges:
● 	Operating income margins for 2020 and 2019 included the $17 million and $762 million impact, respectively, of significant litigation-
related charges (as discussed earlier in the 	Certain amounts adjusted for special items - (non-GAAP measures) 	section).
Gain/loss on sale of businesses:
● 	2020 and 2019 included gains of $389 million and $114 million, respectively, on sale of businesses. See the 	Certain amounts adjusted for
special items - (non-GAAP measures) 	section for more information.
31

-- 43 of 160 --

Divestiture-related restructuring actions:
● 	Operating income margins for full year 2020 included the $55 million second quarter impact as a result of certain restructuring actions
following the divestiture of substantially all of the drug delivery business addressing corporate functional costs and manufacturing
footprint across 3M in relation to the magnitude of amounts previously allocated/burdened to the divested business. Refer to Note 5 for
further details. This item was also discussed earlier in the 	Certain amounts adjusted for special items - (non-GAAP measures) 	section.
Year 2019 operating income:
Operating income margins decreased 2.8 percentage points for the full year 2019 when compared to full year 2018. Factoring out the impact on
operating income of special items as described in the 	Certain amounts adjusted for special items – (non-GAAP measures) 	section above, operating
margins decreased 2.3 percentage points to 21.2 percent in 2019 when compared to 2018.
Organic volume/productivity and other:
● 	Negative organic local sales volume growth as a result of softness in certain end markets and channel inventory adjustments, along with
actions taken by 3M in response to lower sales volumes and high inventory levels, which resulted in lower manufacturing and inventory
absorption, reduced operating margins. Partially offsetting these impacts were benefits from restructuring actions taken in the second
quarter of 2019.
● 	Operating income margins increased year-on-year due to lower defined benefit pension and postretirement service cost expense.
Non divestiture-related restructuring actions:
● 	During the second quarter of 2019, in light of slower than expected 2019 sales, and additionally in the fourth quarter to realign 3M’s
organizational structure and operating model, management approved and committed to undertake certain restructuring actions. The
resulting charges included $246 million impacting operating income (and $36 million impacting other expense (income)). See Note 5 for
additional details.
Acquisitions/divestitures:
● 	Acquisition-related impacts relate to the on-going integration of M*Modal and Acelity, which decreased operating income margins year-
on-year.
● 	Divestiture impacts include the lost operating income from divested businesses, which increased operating income margins year-on-year
and primarily relate to the divestiture of the Communication Markets Division.
● 	Remaining stranded costs from the 2018 divestiture of the Communication Markets Division also reduced operating margins year-on-
year.
Selling price and raw material impact:
● 	Higher selling prices, partially offset by raw material cost increases, benefited operating income margins year-on-year for 2019.
Foreign exchange impacts:
● 	Foreign currency effects (net of hedge gains) increased operating income margins year-on-year.
Significant litigation-related charges:
● 	Operating income margins for 2018 and 2019 included the $897 million and $762 million impact, respectively, of significant litigation-
related charges (as discussed earlier in the 	Certain amounts adjusted special items - (non-GAAP measures) 	section.
Other Expense (Income), Net:
See Note 6 for a detailed breakout of this line item.
The decrease in other expense (income) during 2020 was primarily due to the 2019 impact of deconsolidation of the Company’s Venezuelan
subsidiary. Refer to Note 1 for additional details.
32

-- 44 of 160 --

Interest expense (net of interest income) increased during 2020 and 2019. The increase in 2020 was due to higher U.S. average debt balances and
lower year-on-year interest income driven by lower average interest rates on cash balances. 2020 interest expense also included an early debt
extinguishment charge in conjunction with the repayment of notes in December 2020. The increase in 2019 was driven by higher U.S. average
debt balances, partially offset by the year-on-year increase in interest income driven by higher balances in cash, cash equivalents and marketable
securities during the year resulting from the proceeds from debt issuances in advance of the October 2019 Acelity acquisition.
In addition, other expense (income) was impacted by lower year-on-year pension and postretirement net periodic benefit non-service benefits for
2020 and 2019, respectively. The lower year-on-year benefit in 2020 was primarily due to the increased expense from lower December 31, 2019
discount rates. The decreases in 2019 was primarily due to the charge associated with the voluntary retirement program taken in the second quarter
of 2019 in addition to the pension settlement charges in the fourth quarter of 2019 related to employee retirements. Refer to Note 13 for additional
details.
Provision for Income Taxes:
(Percent of pre-tax income) 	2020 	2019
Effective tax rate 	19.6 % 	19.8 %
The effective tax rate for 2020 was 19.6 percent, a decrease of 0.2 percentage points when compared to 2019. The effective tax rate for 2019 was
19.8 percent, compared to 23.4 percent in 2018, a decrease of 3.6 percentage points. Factors that impacted the tax rates between years are further
discussed in the Overview section above and in Note 10.
3M currently estimates its effective tax rate for 2021 will be approximately 20 to 21 percent.
The tax rate can vary from quarter to quarter due to discrete items, such as the settlement of income tax audits, changes in tax laws, and employee
share-based payment accounting; as well as recurring factors, such as the geographic mix of income before taxes.
Refer to Note 10 for further discussion of income taxes.
Income from Unconsolidated Subsidiaries, Net of Taxes:
(Millions) 	2020 	2019
Income (loss) from unconsolidated subsidiaries, net of taxes 	$ 	(5) 	$ 	—
Income (loss) from unconsolidated subsidiaries, net of taxes, is primarily attributable to the Company’s ownership interest in Kindeva using the
equity method of accounting following 3M’s divestiture of the drug delivery business in 2020. See Note 3 for further discussion.
Net Income Attributable to Noncontrolling Interest:
(Millions) 	2020 	2019
Net income (loss) attributable to noncontrolling interest 	$ 	4 	$ 	12
Net income (loss) attributable to noncontrolling interest represents the elimination of the income or loss attributable to non-3M ownership interests
in 3M consolidated entities. The primary noncontrolling interest relates to 3M India Limited, of which 3M’s effective ownership is 75 percent.
Currency Effects:
3M estimates that year-on-year currency effects, including hedging impacts, decreased pre-tax income by $81 million in 2020 and increased pre-
tax income by $1 million in 2019. This estimate includes the effect of translating profits from local currencies into U.S. dollars; the impact of
currency fluctuations on the transfer of goods between 3M operations in the United States and abroad; and transaction gains and losses, including
derivative instruments designed to reduce foreign currency exchange rate risks. 3M estimates that year-on-year foreign currency transaction
effects, including hedging impacts, decreased pre-tax income by approximately $21 million in 2020 and increased pre-tax income by
approximately $201 million in 2019. These estimates include transaction gains and
33

-- 45 of 160 --

losses, including derivative instruments designed to reduce foreign currency exchange rate risks. Refer to Note 14 in the Consolidated Financial
Statements for additional information concerning 3M’s hedging activities.
PERFORMANCE BY BUSINESS SEGMENT
Item 1, Business Segments, provides an overview of 3M’s business segments. In addition, disclosures relating to 3M’s business segments are
provided in Note 19. Effective in the first quarter of 2020, the Company changed its business segment reporting in its continuing effort to improve
the alignment of businesses around markets. Also, effective in the second quarter of 2020, the measure of segment operating performance used by
3M’s chief operating decision maker (CODM) changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment
operating income) has been updated for all periods presented. The change to business segment operating income aligns with the update to how the
CODM assesses performance and allocates resources for the Company’s business segments.
As discussed in Note 19, 3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M
operating income and income before taxes. Business segment operating income includes dual credit for certain related operating income (as
described below in “Elimination of Dual Credit”). Business segment operating income excludes certain expenses and income that are not allocated
to business segments (as described below in “Corporate and Unallocated”). Additionally, the following special items are excluded from business
segment operating income and, instead, are included within Corporate and Unallocated: significant litigation-related charges/benefits, gain/loss on
sale of businesses, and divestiture-related restructuring actions.
Information provided herein reflects the impact of these changes for all periods presented. 3M manages its operations in four business segments.
The reportable segments are Safety and Industrial; Transportation and Electronics; Health Care; and Consumer.
Corporate and Unallocated:
In addition to these four business segments, 3M assigns certain costs to “Corporate and Unallocated,” which is presented separately in the
preceding business segments table and in Note 19. Corporate and Unallocated includes a variety of miscellaneous items, such as corporate
investment gains and losses, certain derivative gains and losses, certain insurance-related gains and losses, certain litigation and environmental
expenses, corporate restructuring charges and certain under- or over-absorbed costs (e.g. pension, stock-based compensation) that the Company
determines not to allocate directly to its business segments. Additionally, Corporate and Unallocated operating income includes special items such
as significant litigation-related charges/benefits, gain/loss on sale of businesses, and divestiture-related restructuring costs. Corporate and
Unallocated also includes sales, costs, and income from contract manufacturing, transition services and other arrangements with the acquirer of the
Communication Markets Division following its 2018 divestiture through 2019 and the acquirer of the former drug delivery business following its
2020 divestiture. Because this category includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis.
Corporate and Unallocated net operating loss decreased by $767 million in 2020 when compared to 2019.
Special Items
Refer to the Certain amounts adjusted for special items - (non-GAAP measures) section and Note 5 for additional details on the impact of
significant litigation-related charges/benefits, gain/loss on sale of businesses, and divestiture-related restructuring actions that are reflected in
Corporate and Unallocated.
Other Corporate Expense - Net
Other corporate operating expenses increased in 2020. The increases were due to year-over-year increased net costs as a result of the regular
review of 3M’s respirator mask liabilities, lower year-on-year gains from certain property sales reflected in Corporate and Unallocated, in addition
to transition service and other arrangement costs, net of income, post-divestiture of the Company’s former drug delivery business in 2020, and
increased legal expenses. These increases were partially offset by lower year-on-year non divestiture-related restructuring costs reflected in
Corporate and Unallocated.
34

-- 46 of 160 --

Operating Business Segments:
Information related to 3M’s business segments is presented in the tables that follow. Organic local-currency sales include both organic volume
impacts plus selling price impacts. Acquisition impacts, if any, are measured separately for the first twelve months post-transaction. The
divestiture impacts, if any, foreign currency translation impacts and total sales change are also provided for each business segment. Any references
to EMEA relate to Europe, Middle East and Africa on a combined basis.
The following discusses total year results for 2020 compared to 2019 and 2019 compared to 2018, for each business segment. Refer to the
preceding “Sales and operating income by geographic area” section for organic local-currency sales growth by business segment within major
geographic areas.
Safety and Industrial Business (36.6% of consolidated sales):
2020 	2019
Sales (millions) 	$ 	11,767 	$ 	11,514
Sales change analysis:
Organic local-currency 	3.5 % 	(3.4)%
Divestitures 	(0.6) 	(1.7)
Translation 	(0.7) 	(2.1)
Total sales change 	2.2 % 	(7.2)%
Business segment operating income (millions) 	$ 	3,054 	$ 	2,510
Percent change 	21.7 % 	(12.2)%
Percent of sales 	26.0 % 	21.8 %
Year 2020 results:
Sales in Safety and Industrial totaled $11.8 billion, an increase of 2.2 percent compared to the same period last year. Organic local-currency sales
increased 3.5 percent, divestitures decreased sales by 0.6 percent, and foreign currency translation decreased sales by 0.7 percent.
On an organic local-currency sales basis:
● 	Sales increased in personal safety and roofing granules, while industrial adhesives and tapes, electrical markets, closure and masking
systems, automotive aftermarket, and abrasives sales declined year-on-year.
● 	Strong growth related to unprecedented demand for respirators as a result of the COVID-19 pandemic was partially offset by softness that
impacted sales growth across most of the Company’s general industrial-related portfolio.
Divestitures:
● 	2018 divestitures that impacted 2019 results relate to the sale of certain personal safety product offerings primarily focused on noise,
environmental, and heat stress monitoring (first quarter 2018), and it’s abrasives glass products business (second quarter of 2018).
● 	Also in 2018, 3M completed the sale of substantially all of its Communication Markets Division.
● 	In August 2019, 3M completed the sale of its gas and flame detection business.
Business segment operating income:
● 	Business segment operating income margins increased 4.2 percentage points, primarily related to strong productivity, continued cost
discipline and benefits from certain property sale, 2019 restructuring and other actions.
35

-- 47 of 160 --

Year 2019 results:
Sales in Safety and Industrial totaled $11.5 billion, down 7.2 percent in U.S. dollars, compared to full year 2018. Organic local-currency sales
decreased 3.4 percent, divestitures decreased sales by 1.7 percent, and foreign currency translation decreased sales by 2.1 percent.
On an organic local-currency sales basis:
● 	Sales increased in roofing granules and personal safety, while electrical markets, industrial adhesives and tapes, abrasives, automotive
aftermarket, and closure and masking systems declined year-on-year.
Divestitures:
● 	In February 2018, 3M closed on the sale of certain personal safety product offerings primarily focused on noise, environmental, and heat
stress monitoring.
● 	In May 2018, 3M divested an abrasives glass products business.
● 	In 2018, 3M completed the sale of substantially all of its Communication Markets Division.
● 	In August 2019, 3M completed the sale of its gas and flame detection business.
Business segment operating income:
● 	Operating income margins decreased 1.2 percentage points, primarily related to sales declines, particularly in Asia Pacific and the U.S, in
addition to inventory reductions and restructuring impacts.
Transportation and Electronics Business (27.4% of consolidated sales):
2020 	2019
Sales (millions) 	$ 	8,827 	$ 	9,591
Sales change analysis:
Organic local-currency 	(7.1)% 	(3.6)%
Divestitures 	(1.1) 	—
Translation 	0.2 	(1.5)
Total sales change 	(8.0)% 	(5.1)%
Business segment operating income (millions) 	$ 	1,927 	$ 	2,221
Percent change 	(13.3)% 	(16.0)%
Percent of sales 	21.8 % 	23.2 %
Year 2020 results:
Sales in Transportation and Electronics totaled $8.8 billion, down 8.0 percent in U.S. dollars. Organic local-currency sales decreased 7.1 percent,
divestitures decreased sales by 1.1 percent, and foreign currency translation increased sales by 0.2 percent.
On an organic local-currency sales basis:
● 	Sales declined in transportation safety, advanced materials, commercial solutions, and automotive and aerospace. Automotive and
aerospace was primarily impacted by the decline in global car and light truck builds. Commercial solutions and transportation safety were
impacted by soft-end markets such as hospitality, advertising and highway infrastructure due to social distancing and work-from-home
protocols as a result of COVID-19.
● 	Sales increased in 3M’s electronics-related businesses. Electronics-related growth was led by demand for semiconductor, data center, and
factory automation end-markets, and was partially offset by softness in the consumer electronics end-market.
Divestitures:
● 	In January 2020, 3M completed the sale of its advanced ballistic-protection business. Refer to Note 3 for details.
36

-- 48 of 160 --

Business segment operating income:
● 	Business segment operating income margins decreased 1.4 percentage points, primarily related to lower sales and reduced productivity in
key end-markets due to COVID-19 related impacts, partially offset by continued cost discipline and benefits from last year’s restructuring
actions.
Year 2019 results:
Sales in Transportation and Electronics totaled $9.6 billion, down 5.1 percent in U.S. dollars. Organic local-currency sales decreased 3.6 percent,
and foreign currency translation decreased sales by 1.5 percent.
On an organic local-currency sales basis:
● 	Sales increased in advanced materials and transportation safety, while commercial solutions and automotive and aerospace solutions
declined.
● 	Automotive and aerospace was impacted by the decline in global car and light truck builds along with channel inventory reductions
within its Automotive OEM business, particularly in China.
● 	Sales decreased 6 percent in 3M’s electronics-related businesses, with decreases in both display materials and systems and electronics
materials solutions. Electronics-related growth was impacted by soft consumer electronics and factory automation end markets in
addition to channel inventory adjustments.
● 	Sales decreased 4 percent in Asia Pacific, where 3M’s electronics business is concentrated.
Business segment operating income:
● 	Operating income margins decreased 3.0 percentage points, primarily impacted by continued sales declines, particularly in Asia Pacific
and the U.S, in addition to inventory reductions. Operating income margins were also impacted by the restructuring charges initiated in
2019.
Health Care Business (25.9% of consolidated sales):
2020 	2019
Sales (millions) 	$ 	8,345 	$ 	7,431
Sales change analysis:
Organic local-currency 	1.0 % 	1.5 %
Acquisitions 	15.5 	9.4
Divestitures 	(4.1) 	—
Translation 	(0.1) 	(2.0)
Total sales change 	12.3 % 	8.9 %
Business segment operating income (millions) 	$ 	1,828 	$ 	1,858
Percent change 	(1.6)% 	(3.1)%
Percent of sales 	21.9 % 	25.0 %
Year 2020 results:
Sales in Health Care totaled $8.3 billion, up 12.3 percent in U.S. dollars. Organic local-currency sales increased 1.0 percent, acquisitions increased
sales by 15.5 percent, divestitures decreased sales by 4.1 percent, and foreign currency translation decreased sales by 0.1 percent.
On an organic local-currency sales basis:
● 	Sales increased in medical solutions, separation and purification sciences, and food safety, while sales decreased in health information
systems and oral care.
● 	Increases in healthcare volumes benefited both medical solutions and oral care after significant disruptions in the second quarter, with
strong pandemic-related demand for disposable respirators resulting in increased sales for medical solutions, while oral care sales
decreased year-on-year. In addition, health information systems decreased due to hospitals remaining cautious relative to their
information technology investments.
37

-- 49 of 160 --

Acquisitions:
● 	In February 2019, 3M acquired M*Modal, a leading healthcare technology provider of cloud-based, conversational artificial intelligence-
powered systems that help physicians efficiently capture and improve the patient narrative.
● 	In October 2019, 3M completed the acquisition of Acelity Inc. and its KCI subsidiaries, a leading global medical technology company
focused on advanced wound care and specialty surgical applications.
Divestitures:
● 	In the first quarter of 2019, the Company sold certain oral care technology comprising a business.
● 	In May 2020, 3M completed the sale of substantially all of its drug delivery business.
Business segment operating income:
● 	Operating income margins decreased 3.1 percentage points year-on-year, driven by impacts related to the Acelity acquisition in addition
to significant sales declines in oral care during the second quarter of 2020, partially offset by continued cost discipline and benefits from
2019 restructuring and other costs.
Year 2019 results:
Sales in Health Care totaled $7.4 billion, up 8.9 percent in U.S. dollars. Organic local-currency sales increased 1.5 percent, acquisitions increased
sales 9.4 percent, and foreign currency translation decreased sales by 2.0 percent.
On an organic local-currency sales basis:
● 	Sales increased in health information systems, food safety, and medical solutions, while separation and purification sciences decreased,
and oral care was flat.
● 	Drug delivery declined year-on-year, as continued softness in the business negatively impacted overall Health Care organic growth.
Acquisitions:
● 	In February 2019, 3M acquired M*Modal, a leading healthcare technology provider of cloud-based, conversational artificial intelligence-
powered systems that help physicians efficiently capture and improve the patient narrative.
● 	In October 2019, 3M completed the acquisition of Acelity Inc. and its KCI subsidiaries, a leading global medical technology company
focused on advanced wound care and specialty surgical applications.
Divestitures:
● 	In the first quarter of 2018, 3M completed the sale of its polymer additives compounding business.
● 	In the first quarter of 2019, the Company sold certain oral care technology comprising a business.
Business segment operating income:
● 	Operating income margins decreased 3.1 percentage points year-on-year.
38

-- 50 of 160 --

Consumer Business (16.6% of consolidated sales):
2020 	2019
Sales (millions) 	$ 	5,336 	$ 	5,151
Sales change analysis:
Organic local-currency 	4.1 % 	1.7 %
Translation 	(0.5) 	(1.2)
Total sales change 	3.6 % 	0.5 %
Business segment operating income (millions) 	$ 	1,249 	$ 	1,124
Percent change 	11.2 % 	3.7 %
Percent of sales 	23.4 % 	21.8 %
Year 2020 results:
Sales in Consumer totaled $5.3 billion, an increase of 3.6 percent in U.S. dollars. Organic local-currency sales increased 4.1 percent and foreign
currency translation decreased sales by 0.5 percent.
On an organic local-currency sales basis:
● 	Sales grew in home improvement and home care, while consumer health care and stationery and office declined.
● 	Stationery and office declined year-on-year as a result of many business offices and schools remaining partially or fully closed due to the
pandemic.
● 	Sales showed continued strength in the Company’s CommandTM, FiltreteTM, Scotch BlueTM, Scotch BriteTM, and MeguiarsTM 	brands.
Business segment operating income:
● 	Operating income margins increased 1.6 percentage points year-on-year as a result of strong organic sales growth and continued cost
discipline.
Year 2019 results:
Sales in Consumer totaled $5.2 billion, an increase of 0.5 percent in U.S. dollars. Organic local-currency sales increased 1.7 percent and foreign
currency translation decreased sales by 1.2 percent.
On an organic local-currency sales basis:
● 	Sales grew in home improvement, while home care and stationery and office were flat. Consumer health care decreased year on year.
● 	Geographically, the U.S. showed particular strength in the Company’s FiltreteTM 	and CommandTM 	brands, while Asia Pacific was
impacted by lower consumer demand for respiratory solutions.
Business segment operating income:
● 	Operating income margins increased 0.7 percentage points year-on-year. Increases in operating income margins were primarily due to
benefits from portfolio and footprint actions taken, partially offset by the restructuring charges initiated in 2019.
PERFORMANCE BY GEOGRAPHIC AREA
While 3M manages its businesses globally and believes its business segment results are the most relevant measure of performance, the Company
also utilizes geographic area data as a secondary performance measure. Export sales are generally reported within the geographic area where the
final sales to 3M customers are made. A portion of the products or components sold by 3M’s operations to its customers are exported by these
customers to different geographic areas. As customers move their operations from one geographic area to another, 3M’s results will follow. Thus,
net sales in a particular geographic area are not indicative of end-user consumption in that geographic area. Financial information related to 3M
operations in various geographic areas is provided in Note 2 and Note 19.
39

-- 51 of 160 --

Refer to the “Overview” section for a summary of net sales by geographic area and business segment.
Geographic Area Supplemental Information
Property, Plant and
Equipment - net
Employees as of December 31, 	Capital Spending 	as of December 31,
(Millions, except Employees) 	2020 	2019 	2018 	2020 	2019 	2018 	2020 	2019
Americas 	56,042 	56,027 	53,661 	$ 	943 	$ 1,218 	$ 	1,044 	$ 	5,752 	$ 	5,873
Asia Pacific 	18,271 	18,724 	18,971 	235 	241 	238 	1,662 	1,637
Europe, Middle East and Africa 	20,674 	21,412 	20,884 	323 	240 	295 	2,007 	1,823
Total Company 	94,987 	96,163 	93,516 	$ 1,501 	$ 1,699 	$ 	1,577 	$ 	9,421 	$ 	9,333
Employment:
Employment decreased by approximately 1,200 positions in 2020 and increased by approximately 2,600 positions in 2019. The above table
includes the impact of acquisitions (which involved approximately 5,500 positions in 2019), net of divestitures and other actions.
Capital Spending/Net Property, Plant and Equipment:
Investments in property, plant and equipment enable growth across many diverse markets, helping to meet product demand and increasing
manufacturing efficiency. In 2020, 63 percent of 3M’s capital spending was within the Americas, followed by Europe, Middle East and Africa,
and Asia Pacific. 3M is increasing its investment in manufacturing and sourcing capability in order to more closely align its product capability
with its sales in major geographic areas in order to best serve its customers throughout the world with proprietary, automated, efficient, safe and
sustainable processes. Capital spending is discussed in more detail later in MD&A in the section entitled “Cash Flows from Investing Activities.”
CRITICAL ACCOUNTING ESTIMATES
Information regarding significant accounting policies is included in Note 1 of the consolidated financial statements. As stated in Note 1, the
preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities,
revenue and expenses, and related disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and on
various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
The Company believes its most critical accounting estimates relate to legal proceedings, pension and postretirement obligations, goodwill and
certain long-lived assets, and uncertainty in income tax positions. Senior management has discussed the development, selection and disclosure of
its critical accounting estimates with the Audit Committee of 3M’s Board of Directors.
Legal Proceedings:
Assessments of lawsuits and claims can involve a series of complex judgments about future events and can rely heavily on estimates and
assumptions. The Company accrues an estimated liability for legal proceeding claims that are both probable and estimable in accordance with
Accounting Standard Codification (ASC) 450, Contingencies. Please refer to the section entitled “Process for Disclosure and Recording of
Liabilities Related to Legal Proceedings” (contained in “Legal Proceedings” in Note 16) for additional information about such estimates.
Pension and Postretirement Obligations:
The Company makes certain estimates and judgements in relation to its defined benefit pension and postretirement obligations.
The benefit obligation represents the present value of the benefits that employees are entitled to in the future for services already rendered as of the
measurement date. The Company measures the present value of these future benefits by projecting benefit payment cash flows for each future
period and discounting these cash flows back to the December 31 measurement date, using the yields of a
40

-- 52 of 160 --

portfolio of high quality, fixed-income debt instruments that would produce cash flows sufficient in timing and amount to settle projected future
benefits. Service cost and interest cost are measured separately using the spot yield curve approach applied to each corresponding obligation.
Service costs are determined based on duration-specific spot rates applied to the service cost cash flows. The interest cost calculation is determined
by applying duration-specific spot rates to the year-by-year projected benefit payments. The spot yield curve approach does not affect the
measurement of the total benefit obligations as the change in service and interest costs offset in the actuarial gains and losses recorded in other
comprehensive income.
Using this methodology, the Company determined discount rates for its plans as follow:
U.S. Qualified
Pension
International
Pension (weighted
average)
U.S.
Postretirement
Medical
December 31, 2020 Liability:
Benefit obligation 	2.55 % 	1.38 % 	2.35 %
2021 Net Periodic Benefit Cost Components:
Service cost 	2.84 % 	1.23 % 	2.71 %
Interest cost 	1.93 % 	1.13 % 	1.68 %
Another significant element in determining the Company’s pension expense is the expected return on plan assets. The expected return on plan
assets for the primary U.S. qualified pension plan is based on strategic asset allocation of the plan, long-term capital market return expectations,
and expected performance from active investment management. For the primary U.S. qualified pension plan, the expected long-term rate of return
on an annualized basis for 2021 is 6.50%, a decrease from 6.75% in 2020. Return on assets assumptions for international pension and other post-
retirement benefit plans are calculated on a plan-by-plan basis using plan asset allocations and expected long-term rate of return assumptions. The
weighted average expected return for the international pension plans is 4.36% for 2021 compared to 4.70% for 2020. Refer to Note 13 for
information on how the 2020 rates were determined.
3M follows ASC 820, 	Fair Value Measurements and Disclosures 	in determining the fair value of plan assets within the Company’s pension and
postretirement benefit plans. While the Company believes the valuation methods used to determine the fair value of plan assets are appropriate and
consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial
instruments could result in a different estimate of fair value at the reporting date. See Note 13 for additional discussion of actuarial assumptions
used in determining defined benefit pension and postretirement health care liabilities and expenses.
For the year ended December 31, 2020, the Company recognized consolidated defined benefit pre-tax pension and postretirement service cost
expense of $456 million and a benefit of $50 million related to all non-service pension and postretirement net benefit costs (after settlements,
curtailments, special termination benefits and other) for a total consolidated defined benefit pre-tax pension and postretirement expense of $406
million, up from $357 million in 2019.
In 2021, defined benefit pension and postretirement service cost expense is anticipated to total approximately $497 million while non-service
pension and postretirement net benefit costs is anticipated to be a benefit of approximately $130 million, for a total consolidated defined benefit
pre-tax pension and postretirement expense of $367 million, a decrease of approximately $40 million compared to 2020.
The table below summarizes the impact on 2021 pension expense for the U.S. and international pension plans of a 0.25 percentage point
increase/decrease in the expected long-term rate of return on plan assets and discount rate assumptions used to measure plan liabilities and 2020
net periodic benefit cost. The table assumes all other factors are held constant, including the slope of the discount rate yield curves.
Increase (Decrease) in Net Periodic Benefit Cost
Discount Rate 	Expected Return on Assets
(Millions) 	-0.25% 	+0.25% 	-0.25% 	+0.25%
U.S. pension plans 	$ 	34 	$ 	(34) 	$ 	39 	$ 	(39)
International pension plans 	27 	(28) 	21 	(17)
41

-- 53 of 160 --

Goodwill and Certain Long-Lived Assets:
The Company makes certain estimates and judgments in relation to goodwill and certain long-lived assets. Those include considerations made in
the valuation of certain acquired identifiable definite-lived and indefinite-lived assets as a result of business combinations as well as considerations
in the recoverability and impairment assessments of long-lived assets and goodwill.
Acquisition of certain identifiable definite-lived and indefinite-lived assets
In conjunction with an acquisition of a business, the Company records identifiable definite-lived and indefinite-lived intangible assets acquired at
their respective fair values as of the date of acquisition. The corresponding fair value estimates for these assets acquired include projected future
cash flows, associated discount rates used to calculate present value, asset life cycles, royalty rates, and customer retention rates. The fair value
calculated for indefinite-lived intangible assets such as certain tradenames, in addition to intangible assets that are definite-lived such as patents,
customer relationships, tradenames and other technology-based assets may change during the finalization of the purchase price allocation, due to
the significant estimates used in determining their fair value. As a result, the Company may make adjustments to the provisional amounts recorded
for certain items as part of the purchase price allocation subsequent to the acquisition, not to exceed one year after the acquisition date, until the
purchase accounting allocation is finalized.
Assessments of long-lived assets and goodwill
As of December 31, 2020, net property, plant and equipment totaled $9.4 billion and net identifiable intangible assets totaled $5.8 billion, of which
$0.7 billion related to indefinite-lived tradenames. In addition, 3M goodwill totaled approximately $13.8 billion as of December 31, 2020. Long-
lived assets with a definite life are tested for impairment whenever events or circumstances indicate that the carrying amount of an asset (asset
group) may not be recoverable. An impairment loss is recognized when the carrying amount exceeds the estimated undiscounted cash flows from
the asset’s or asset group’s ongoing use and eventual disposition. If an impairment is identified, the amount of the impairment loss recorded is
calculated by the excess of the asset’s carrying value over its fair value. Fair value is generally determined using a discounted cash flow analysis.
Intangible assets with an indefinite life, namely certain tradenames, are not amortized. Indefinite-lived intangible assets are tested for impairment
annually and are tested for impairment between annual tests if an event occurs or circumstances change that would indicate that the carrying
amount may be impaired. An impairment loss would be recognized when the fair value is less than the carrying value of the indefinite-lived
intangible asset. Goodwill is tested for impairment annually in the fourth quarter of each year, as further discussed below, and is tested between
annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. If future non-cash asset
impairment charges are taken, 3M would expect that only a portion of the long-lived assets or goodwill would be impaired.
Management makes estimates and assumptions in preparing the consolidated financial statements for which actual results will emerge over long
periods of time. This includes the recoverability of long-lived assets employed in the business, including assets of acquired businesses. These
estimates and assumptions are closely monitored by management and periodically adjusted as circumstances warrant. For instance, expected asset
lives may be shortened or an impairment recorded based on a change in the expected use of the asset or performance of the related asset group.
Factors which could result in future impairment charges include, among others, changes in worldwide economic conditions, changes in
competitive conditions and customer preferences, and fluctuations in foreign currency exchange rates. These risk factors are discussed in Item 1A,
“Risk Factors,” of this document. In addition, changes in the weighted average cost of capital could also impact impairment testing results.
As of December 31, 2020, the $0.7 billion of indefinite-lived tradenames primarily relates to Capital Safety (acquired in 2015), whose tradenames
($520 million at acquisition date) have been in existence for over 60 years (refer to Note 4 for more detail). The primary valuation technique used
in estimating the fair value of indefinite lived intangible assets (tradenames) is a discounted cash flow approach. Specifically, a relief of royalty
rate is applied to estimated sales, with the resulting amounts then discounted using an appropriate market/technology discount rate. The relief of
royalty rate is the estimated royalty rate a market participant would pay to acquire the right to market/produce the product. In the first quarter of
2020, 3M reflected an immaterial charge related to impairment of certain indefinite-lived assets in 2020. Based on annual impairment testing in the
third quarter of 2020, no additional impairment was indicated.
3M goodwill totaled approximately $13.8 billion as of December 31, 2020. 3M’s annual goodwill impairment testing is performed in the fourth
quarter of each year. Impairment testing for goodwill is done at a reporting unit level, with all goodwill assigned to a reporting unit. Reporting
units are one level below the business segment level, but are required to be combined when reporting units
42

-- 54 of 160 --

within the same segment have similar economic characteristics. At 3M, reporting units correspond to a division. 3M did not combine any of its
reporting units for impairment testing. An impairment loss would be recognized when the carrying amount of the reporting unit’s net assets
exceeds the estimated fair value of the reporting unit, and the loss would equal that difference. The estimated fair value of a reporting unit is
determined using earnings for the reporting unit multiplied by a price/earnings ratio for comparable industry groups, or by using a discounted cash
flow analysis. 3M typically uses the price/earnings ratio approach for stable and growing businesses that have a long history and track record of
generating positive operating income and cash flows. 3M uses the discounted cash flow approach for start-up, loss position and declining
businesses, in addition to using for businesses where the price/earnings ratio valuation method indicates additional review is warranted. 3M also
uses discounted cash flow as an additional tool for businesses that may be growing at a slower rate than planned due to economic or other
conditions. Where applicable, 3M uses a weighted-average discounted cash flow analysis for certain divisions, using projected cash flows that
were weighted based on different sales growth and terminal value assumptions, among other factors. The weighting was based on management’s
estimates of the likelihood of each scenario occurring.
As described in Note 19, effective in the first quarter of 2020, the Company changed its business segment reporting. For any product changes that
resulted in reporting unit changes, the Company applied the relative fair value method to determine the impact on goodwill of the associated
reporting units, the results of which were immaterial. In conjunction with the change in segment reporting, 3M completed an assessment indicating
no goodwill impairment existed as a result of this new segment structure. The discussion that follows relates to the separate fourth quarter 2020
annual impairment test and is in the context of the reporting unit structure that existed at that time.
Based on the annual test in the fourth quarter of 2020, no goodwill impairment was indicated for any of the reporting units. As of October 1, 2020,
3M had 22 primary reporting units, with ten reporting units accounting for approximately 93 percent of the goodwill. These ten reporting units
were comprised of the following divisions: Advanced Materials, Display Materials and Systems, Electronics Materials Solutions, Health
Information Systems, Industrial Adhesives and Tapes, Medical Solutions, Oral Care Solutions, Personal Safety, Separation and Purification
Sciences, and Transportation Safety.
3M is a highly integrated enterprise, where businesses share technology and leverage common fundamental strengths and capabilities, thus many
of 3M’s businesses could not easily be sold on a stand-alone basis. 3M’s focus on research and development has resulted in a portion of 3M’s
value being comprised of internally developed businesses that have no goodwill associated with them.
3M will continue to monitor its reporting units and asset groups in 2021 for any triggering events or other indicators of impairment.
Uncertainty in Income Tax Positions:
The extent of 3M’s operations involves dealing with uncertainties and judgments in the application of complex tax regulations in a multitude of
jurisdictions. The final taxes paid are dependent upon many factors, including negotiations with taxing authorities in various jurisdictions and
resolution of disputes arising from federal, state, and international tax audits. The Company recognizes potential liabilities and records tax
liabilities for anticipated tax audit issues in the United States and other tax jurisdictions based on its estimate of whether, and the extent to which,
additional taxes will be due. The Company follows guidance provided by ASC 740, Income Taxes, a subset of which relates to uncertainty in
income taxes, to record these liabilities (refer to Note 10 for additional information). The Company adjusts these reserves in light of changing facts
and circumstances; however, due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is
materially different from the Company’s current estimate of the tax liabilities. If the Company’s estimate of tax liabilities proves to be less than the
ultimate assessment, an additional charge to expense would result. If payment of these amounts ultimately proves to be less than the recorded
amounts, the reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are
no longer necessary.
NEW ACCOUNTING PRONOUNCEMENTS
Information regarding new accounting pronouncements is included in Note 1 to the Consolidated Financial Statements.
43

-- 55 of 160 --

FINANCIAL CONDITION AND LIQUIDITY
The strength and stability of 3M’s business model and strong free cash flow capability, together with proven capital markets access, provides
financial flexibility and enables the Company to invest through business cycles. Investing in 3M’s business to drive organic growth and deliver
strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures,
and commercialization capability. Organic investments will be supplemented by complementary acquisitions. The Company also continues to
actively manage its portfolio to maximize value for shareholders. Given uncertainty arising from COVID-19, the Company suspended repurchases
under its board-approved share repurchase program effective March 2020 with other repurchase activity limited to 3M’s stock compensation plans.
3M will continue to return cash to shareholders through dividends and plans to resume share repurchases in 2021. 3M maintains strong liquidity
and further added to its liquidity position through the issuance of $1.75 billion in registered notes in March 2020. To fund cash needs in the United
States, the Company relies on ongoing cash flow from U.S. operations, access to capital markets and repatriation of the earnings of its foreign
affiliates that are not considered to be permanently reinvested. For those international earnings still considered to be reinvested indefinitely, the
Company currently has no plans or intentions to repatriate these funds for U.S. operations. See Note 10 for further information on earnings
considered to be reinvested indefinitely.
3M’s primary short-term liquidity needs are met through cash on hand and U.S. commercial paper issuances. 3M believes it will have continuous
access to the commercial paper market. 3M’s commercial paper program permits the Company to have a maximum of $5 billion outstanding with
a maximum maturity of 397 days from date of issuance. At December 31, 2020, there was no commercial paper issued and outstanding.
Total Debt:
The strength of 3M’s credit profile and significant ongoing cash flows provide 3M proven access to capital markets. Additionally, the Company’s
debt maturity profile is staggered to help ensure refinancing needs in any given year are reasonable in proportion to the total portfolio. 3M
currently has an A1 credit rating with a negative outlook from Moody’s Investors Service and an A+ credit rating with negative outlook from
Standard and Poor’s.
The Company’s total debt was $1.5 billion lower at December 31, 2020 when compared to December 31, 2019. Decreases in debt are further
described in Note 12 and include the repayment of aggregate $445 million principal amount of Third Lien Notes subject to in-substance
defeasance, 650 million euros and $500 million aggregate principal amount of floating-rate medium-term notes that matured, the December 2020
repayment of $1 billion aggregate principal amount of notes related to make-whole-call offers, lower commercial paper balance, and the
repayment of the 80 billion Japanese yen and 150 million euro credit facilities. These decreases were partially offset by the March 2020 issuance
of $1.75 billion of registered notes. For discussion of repayments of and proceeds from debt refer to the following “Cash Flows from Financing
Activities” section.
In July 2017, the United Kingdom’s Financial Conduct Authority announced that it would no longer require banks to submit rates for the London
InterBank Offered Rate (“LIBOR”) after 2021. In November 2020, the ICE Benchmark Administration (IBA), LIBOR’s administrator, proposed
extending the publication of USD LIBOR through June 2023. The Company has reviewed its debt securities, bank facilities, and derivative
instruments and continues to evaluate commercial contracts that may utilize LIBOR as the reference rate. 3M will continue its assessment and
monitor regulatory developments during the transition period.
Effective February 10, 2020, the Company updated its “well-known seasoned issuer” (WKSI) shelf registration statement, which registers an
indeterminate amount of debt or equity securities for future issuance and sale. This replaced 3M’s previous shelf registration dated February 24,
2017. In May 2016, in connection with the WKSI shelf, 3M entered into an amended and restated distribution agreement relating to the future
issuance and sale (from time to time) of the Company’s medium-term notes program (Series F), up to the aggregate principal amount of $18
billion, which was an increase from the previous aggregate principal amount up to $9 billion of the same Series.
As of December 31, 2020, the total amount of debt issued as part of the medium-term notes program (Series F), inclusive of debt issued in
February 2019 and prior years is approximately $17.6 billion (utilizing the foreign exchange rates applicable at the time of issuance for the euro
denominated debt). Additionally, the August 2019 and March 2020 debt was issued under the WKSI shelf registration, but not as part of the
medium-term notes program (Series F). Information with respect to long-term debt issuances and maturities for the periods presented is included
in Note 12.
44

-- 56 of 160 --

The Company has a $3.0 billion five-year revolving credit facility expiring in November 2024. The revolving credit agreement includes a
provision under which 3M may request an increase of up to $1.0 billion (at lender’s discretion), bringing the total facility up to $4.0 billion. In
addition, 3M entered into a $1.25 billion 364-day credit facility, which was renewed in November 2020 with an expiration date of November
2021. The 364-day credit agreement includes a provision under which 3M may convert any advances outstanding on the maturity date into term
loans with a maturity date one year later. These credit facilities were undrawn at December 31, 2020. Under both the $3.0 billion and $1.25 billion
credit agreements, the Company is required to maintain its EBITDA to Interest Ratio as of the end of each fiscal quarter at not less than 3.0 to 1.
This is calculated (as defined in the agreement) as the ratio of consolidated total EBITDA for the four consecutive quarters then ended to total
interest expense on all funded debt for the same period. At December 31, 2020, this ratio was approximately 17 to 1. Debt covenants do not restrict
the payment of dividends.
Apart from the committed credit facilities described above, in September 2019, 3M entered into a credit facility initially expiring in July 2020 that
was further extended to August 2021 in the amount of 80 billion Japanese yen. In November 2019, 3M entered into a credit facility expiring in
November 2020 in the amount of 150 million euros. During the third quarter of 2020, the Company paid the outstanding balances and closed these
credit facilities. The Company also had $273 million in stand-alone letters of credit and bank guarantees issued and outstanding at December 31,
2020. These instruments are utilized in connection with normal business activities.
Cash, Cash Equivalents and Marketable Securities:
At December 31, 2020, 3M had $5.1 billion of cash, cash equivalents and marketable securities, of which approximately $2.8 billion was held by
the Company’s foreign subsidiaries and approximately $2.3 billion was held by the United States. These balances are invested in bank instruments
and other high-quality fixed income securities. At December 31, 2019, 3M had $2.5 billion of cash, cash equivalents and marketable securities, of
which approximately $2.4 billion was held by the Company’s foreign subsidiaries and approximately $100 million was held by the United States.
The increase from December 31, 2019 primarily resulted from strong cash flow from operations, reduced capital expenditures, and lower share
repurchases.
Net Debt (non-GAAP measure):
Net debt is not defined under U.S. GAAP and may not be computed the same as similarly titled measures used by other companies. The Company
defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M believes net debt is
meaningful to investors as 3M considers net debt and its components to be important indicators of liquidity and financial position. The following
table provides net debt as of December 31, 2020 and 2019.
December 31, 	2020 versus
(Millions) 	2020 	2019 	2019
Total debt 	$ 	18,795 	$ 	20,313 	$ 	(1,518)
Less: Cash, cash equivalents and marketable securities 	5,068 	2,494 	2,574
Net debt (non-GAAP measure) 	$ 	13,727 	$ 	17,819 	$ 	(4,092)
Refer to the preceding “Total Debt” and “Cash, Cash Equivalents and Marketable Securities” sections for additional details.
Balance Sheet:
3M’s strong balance sheet and liquidity provide the Company with significant flexibility to fund its numerous opportunities going forward. The
Company will continue to invest in its operations to drive growth, including continual review of acquisition opportunities.
The Company uses working capital measures that place emphasis and focus on certain working capital assets, such as accounts receivable and
inventory activity.
45

-- 57 of 160 --

Working Capital (non-GAAP measure):
December 31, 	2020 versus
(Millions) 	2020 	2019 	2019
Current assets 	$ 	14,982 	$ 	12,971 	$ 	2,011
Less: Current liabilities 	7,948 	9,222 	(1,274)
Working capital (non-GAAP measure) 	$ 	7,034 	$ 	3,749 	$ 	3,285
Various assets and liabilities, including cash and short-term debt, can fluctuate significantly from month to month depending on short-term
liquidity needs. Working capital is not defined under U.S. generally accepted accounting principles and may not be computed the same as similarly
titled measures used by other companies. The Company defines working capital as current assets minus current liabilities. 3M believes working
capital is meaningful to investors as a measure of operational efficiency and short-term financial health.
Working capital increased $3.3 billion compared with December 31, 2019. Balance changes in current assets increased working capital by $2.0
billion, driven by increases in cash and cash equivalents and inventory, partially offset by decreases in accounts receivable. Balance changes in
current liabilities increased working capital by $1.3 billion, primarily due to decreases in short-term borrowing and the current portion of long-
term debt.
Accounts receivable decreased $86 million from December 31, 2019, primarily due to ongoing collection management and increased expected
credit losses on customer receivables related to COVID-19 uncertainty. Inventory increased $105 million from December 31, 2019 primarily as a
result of foreign currency impacts. These increases were partially offset by inventory decreases as a result of the divestiture of the drug delivery
business.
Return on Invested Capital (non-GAAP measure:
Return on Invested Capital (ROIC) is not defined under U.S. generally accepted accounting principles. Therefore, ROIC should not be considered
a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other
companies. The Company defines ROIC as adjusted net income (net income including non-controlling interest plus after-tax interest expense)
divided by average invested capital (equity plus debt). The Company believes ROIC is meaningful to investors as it focuses on shareholder value
creation. The calculation is provided in the below table.
46

-- 58 of 160 --

In 2020, ROIC of 18.2 percent was higher than 2019. The increase was driven by the lower year-over-year impact of significant litigation-related
charges in addition to the non-repeating charge from the 2019 deconsolidation of the Company’s Venezuela subsidiary. 2019 ROIC was also
negatively impacted by the increase in cash and cash equivalents in anticipation of the funding of the acquisition of Acelity.
Years ended December 31
(Millions) 	2020 	2019
Return on Invested Capital (non-GAAP measure)
Net income including non-controlling interest 	$ 	5,388 	$ 	4,582
Interest expense (after-tax) (1) 	425 	359
Adjusted net income (Return) 	$ 	5,813 	$ 	4,941
Average shareholders' equity (including non-controlling interest) (2) 	$ 	11,500 	$ 	10,198
Average short-term and long-term debt (3) 	20,413 	17,982
Average invested capital 	$ 	31,913 	$ 	28,180
Return on invested capital (non-GAAP measure) 	18.2 % 	17.5 %
(1) Effective income tax rate used for interest expense 	19.6 % 	19.8 %
(2) Calculation of average equity (includes non-controlling interest)
Ending total equity as of:
March 31 	$ 	10,209 	$ 	9,757
June 30 	10,915 	10,142
September 30 	11,943 	10,764
December 31 	12,931 	10,126
Average total equity 	$ 	11,500 	$ 	10,198
(3) Calculation of average debt
Ending short-term and long-term debt as of:
March 31 	$ 	22,495 	$ 	16,370
June 30 	20,762 	15,806
September 30 	19,598 	19,439
December 31 	18,795 	20,313
Average short-term and long-term debt 	$ 	20,413 	$ 	17,982
Cash Flows:
Cash flows from operating, investing and financing activities are provided in the tables that follow. Individual amounts in the Consolidated
Statement of Cash Flows exclude the effects of acquisitions, divestitures and exchange rate impacts on cash and cash equivalents, which are
presented separately in the cash flows. Thus, the amounts presented in the following operating, investing and financing activities tables reflect
changes in balances from period to period adjusted for these effects.
47

-- 59 of 160 --

Cash Flows from Operating Activities:
Years Ended December 31
(Millions) 	2020 	2019
Net income including noncontrolling interest 	$ 	5,388 	$ 	4,582
Depreciation and amortization 	1,911 	1,593
Company pension and postretirement contributions 	(156) 	(210)
Company pension and postretirement expense 	406 	357
Stock-based compensation expense 	262 	278
Gain on sale of businesses 	(389) 	(111)
Income taxes (deferred and accrued income taxes) 	(33) 	(68)
Loss on deconsolidation of Venezuelan subsidiary 	— 	162
Accounts receivable 	165 	345
Inventories 	(91) 	370
Accounts payable 	252 	(117)
Other — net 	398 	(111)
Net cash provided by operating activities 	$ 	8,113 	$ 	7,070
Cash flows from operating activities can fluctuate significantly from period to period, as pension funding decisions, tax timing differences and
other items can significantly impact cash flows.
In 2020, cash flows provided by operating activities increased $1.0 billion compared to the same period last year, with this increase primarily due
to cost saving actions taken in response to COVID-19 and lower year-on-year significant litigation-related charges and the timing of associated
payments. The combination of accounts receivable, inventories and accounts payable improved operating cash flow by $326 million in 2020,
compared to an operating cash flow improvement of $598 million in 2019. Additional discussion on working capital changes is provided earlier in
the “Financial Condition and Liquidity” section.
Cash Flows from Investing Activities:
Years ended December 31
(Millions) 	2020 	2019
Purchases of property, plant and equipment (PP&E) 	$ 	(1,501) 	$ 	(1,699)
Proceeds from sale of PP&E and other assets 	128 	123
Acquisitions, net of cash acquired 	(25) 	(4,984)
Purchases and proceeds from maturities and sale of marketable securities and investments, net 	232 	(192)
Proceeds from sale of businesses, net of cash sold 	576 	236
Other — net 	10 	72
Net cash provided by (used in) investing activities 	$ 	(580) 	$ 	(6,444)
Investments in property, plant and equipment enable growth across many diverse markets, helping to meet product demand and increasing
manufacturing efficiency. In 2020, 3M reduced overall spending in light of uncertainty regarding COVID-19, but continued to invest in expanding
the Company’s ability to increase production of respiratory products to meet worldwide demand. The Company expects 2021 capital spending to
be approximately $1.8 billion to $2.0 billion as 3M continues to invest in growth, productivity and sustainability.
3M records capital-related government grants earned as reductions to the cost of property, plant and equipment; and associated unpaid liabilities
and grant proceeds receivable are considered non-cash changes in such balances for purposes of preparation of statement of cash flows.
3M invests in renewal and maintenance programs, which pertain to cost reduction, cycle time, maintaining and renewing current capacity,
eliminating pollution, and compliance. Costs related to maintenance, ordinary repairs, and certain other items are expensed. 3M also invests in
growth, which adds to capacity, driven by new products, both through expansion of current facilities and new facilities. Finally, 3M also invests in
other initiatives, such as information technology (IT), laboratory facilities, and a continued focus on investments in sustainability.
48

-- 60 of 160 --

Refer to Note 3 for information on acquisitions and divestitures. The Company is actively considering additional acquisitions, investments and
strategic alliances, and from time to time may also divest certain businesses. Acquisitions, net of cash acquired, in 2020 primarily relate to the
payment made for contingent consideration in regards to the Acelity acquisition. Proceeds from sale of businesses in 2020 primarily relate to the
sales of the Company’s advanced ballistic-protection business and its drug delivery business. Acquisitions, net of cash acquired, in 2019 primarily
include the purchase of M*Modal and Acelity Inc. Proceeds from sale of businesses in 2019 primarily relate to the sale of certain oral care
technology comprising a business and the gas and flame detection business.
Purchases of marketable securities and investments and proceeds from maturities and sale of marketable securities and investments are primarily
attributable to certificates of deposit/time deposits, commercial paper, and other securities, which are classified as available-for-sale. In 2020 these
included the maturity of the held-to-maturity debt security that was purchased to satisfy the redemption of the Third Lien Notes (which matured in
May 2020). Refer to Note 11 for more details about 3M’s diversified marketable securities portfolio. Purchases of investments include additional
survivor benefit insurance, plus investments in equity securities.
Cash Flows from Financing Activities:
Years ended December 31
(Millions) 	2020 	2019
Change in short-term debt — net 	$ 	(143) 	$ 	(316)
Repayment of debt (maturities greater than 90 days) 	(3,482) 	(2,716)
Proceeds from debt (maturities greater than 90 days) 	1,750 	6,281
Total cash change in debt 	$ 	(1,875) 	$ 	3,249
Purchases of treasury stock 	(368) 	(1,407)
Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 	429 	547
Dividends paid to stockholders 	(3,388) 	(3,316)
Other — net 	(98) 	(197)
Net cash used in financing activities 	$ 	(5,300) 	$ 	(1,124)
2020 Debt Activity:
Total debt was approximately $18.8 billion at December 31, 2020 and $20.3 billion at December 31, 2019. Repayment of debt primarily consists
of the aggregate $445 million principal amount of Third Lien Notes and the 650 million euros and $500 million aggregate principal amount of
floating-rate medium-term notes that matured in May 2020 and August 2020, respectively. During the third quarter of 2020, the Company paid the
outstanding balances on their Japanese yen and euro credit facilities. In addition, $1.0 billion aggregate principal amount of notes maturing in
September 2021 were repaid in December 2020 via make-whole-call offers. Increases in debt were related to the March 2020 issuance of $1.75
billion in registered notes. There was no outstanding commercial paper at December 31, 2020, as compared to $150 million at December 31, 2019.
Net commercial paper issuances in addition to repayments and borrowings by international subsidiaries are largely reflected in “Change in short-
term debt – net” in the preceding table. 3M’s primary short-term liquidity needs are met through cash on hand and U.S. commercial paper
issuances. Refer to Note 12 for more detail regarding debt.
2019 Debt Activity:
Total debt was approximately $5.7 billion higher at December 31, 2019 when compared to December 31, 2018. Increases in debt related to the
first quarter and third quarter 2019 issuances of $2.25 billion of medium-term notes and $3.25 billion of other registered notes, respectively, 69
billion Japanese yen (approximately $632 million at December 31, 2019 exchange rates) outstanding from the 80 billion Japanese yen credit
facility established in September 2019, 150 million euros (approximately $168 million at December 31, 2019 exchange rates) outstanding credit
facility established in November 2019, and $0.5 billion of debt assumed and not yet repaid as a result of the Company’s acquisition of Acelity Inc.
Repayment of debt primarily consists of the June 2019 repayment of $625 million aggregate principal amount of fixed-rate medium-term notes
that had matured, in addition to debt assumed and subsequently repaid as a result of the Company’s acquisitions of M*Modal and Acelity Inc. as
discussed in Note 3. Outstanding commercial paper decreased $285 million from December 31, 2018 to December 31, 2019. Refer to Note 12 for
more detail regarding debt.
49

-- 61 of 160 --

Repurchases of Common Stock:
Repurchases of common stock are made to support the Company’s stock-based employee compensation plans and for other corporate purposes. In
November 2018, 3M’s Board of Directors replaced the Company’s February 2016 repurchase program with a new repurchase program. This new
program authorizes the repurchase of up to $10 billion of 3M’s outstanding common stock, with no pre-established end date. In 2020, the
Company purchased $0.4 billion of its own stock, compared to purchases of $1.4 billion in 2019. As of December 31, 2020, approximately $7.8
billion remained available under the authorization. In the first quarter of 2020, the Company suspended repurchases under its board-approved
share repurchase program with other repurchase activity limited to 3M’s stock compensation plans. The Company plans to resume share purchases
in 2021. For more information, refer to the table titled “Issuer Purchases of Equity Securities” in Part II, Item 5. The Company does not utilize
derivative instruments linked to the Company’s stock.
Dividends Paid to Shareholders:
Cash dividends paid to shareholders totaled $3.388 billion ($5.88 per share) in 2020, $3.316 billion ($5.76 per share) in 2019, and $3.193 billion
($5.44 per share) in 2018. 3M has paid dividends since 1916. In February 2021, 3M’s Board of Directors declared a first-quarter 2021 dividend of
$1.48 per share, an increase of 1 percent. This is equivalent to an annual dividend of $5.92 per share and marked the 63rd consecutive year of
dividend increases.
Other cash flows from financing activities may include various other items, such as cash paid associated with certain derivative instruments,
distributions to or sales of noncontrolling interests, changes in cash overdraft balances, and principal payments for finance leases.
Free Cash Flow (non-GAAP measure:
Free cash flow and free cash flow conversion are not defined under U.S. generally accepted accounting principles (GAAP). Therefore, they should
not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled
measures used by other companies. The Company defines free cash flow as net cash provided by operating activities less purchases of property,
plant and equipment. It should not be inferred that the entire free cash flow amount is available for discretionary expenditures. The Company
defines free cash flow conversion as free cash flow divided by net income attributable to 3M. The Company believes free cash flow and free cash
flow conversion are meaningful to investors as they are useful measures of performance and the Company uses these measures as an indication of
the strength of the company and its ability to generate cash. The first quarter of each year is typically 3M’s seasonal low for free cash flow and free
cash flow conversion. Below find a recap of free cash flow and free cash flow conversion.
Refer to the preceding “Cash Flows from Operating Activities” and “Cash Flows from Investing Activities” sections for discussion of items that
impacted the operating cash flow and purchases of PP&E components of the calculation of free cash flow. Refer to the preceding “Results of
Operations” section for discussion of items that impacted the net income attributable to 3M component of the calculation of free cash flow
conversion.
50

-- 62 of 160 --

Free cash flow conversion grew to 123% in 2020 compared to 118% in 2019 as increases in free cash flow out-paced increases in net income
attributable to 3M.
Years ended December 31
(Millions) 	2020 	2019
Major GAAP Cash Flow Categories
Net cash provided by (used in) operating activities 	$ 	8,113 	$ 	7,070
Net cash provided by (used in) investing activities 	(580) 	(6,444)
Net cash provided by (used in) financing activities 	(5,300) 	(1,124)
Free Cash Flow (non-GAAP measure)
Net cash provided by (used in) operating activities 	$ 	8,113 	$ 	7,070
Purchases of property, plant and equipment 	(1,501) 	(1,699)
Free cash flow 	$ 	6,612 	$ 	5,371
Net income attributable to 3M 	$ 	5,384 	$ 	4,570
Free cash flow conversion 	123 % 	118 %
Off-Balance Sheet Arrangements and Contractual Obligations:
As of December 31, 2020, the Company has not utilized special purpose entities to facilitate off-balance sheet financing arrangements. Refer to the
section entitled “Warranties/Guarantees” in Note 16 for discussion of accrued product warranty liabilities and guarantees.
In addition to guarantees, 3M, in the normal course of business, periodically enters into agreements that require the Company to indemnify either
major customers or suppliers for specific risks, such as claims for injury or property damage arising out of the use of 3M products or the
negligence of 3M personnel, or claims alleging that 3M products infringe third-party patents or other intellectual property. While 3M’s maximum
exposure under these indemnification provisions cannot be estimated, these indemnifications are not expected to have a material impact on the
Company’s consolidated results of operations or financial condition.
Contractual Obligations
A summary of the Company’s significant contractual obligations as of December 31, 2020, follows:
Payments due by year
After
(Millions) 	Total 	2021 	2022 	2023 	2024 	2025 	2025
Total debt (Note 12) 	$ 	18,795 	$ 	806 	$ 	1,659 	$ 	1,878 	$ 	1,100 	$ 	1,790 	$ 	11,562
Interest on long-term debt 	6,540 	501 	475 	449 	416 	389 	4,310
Operating leases (Note 17) 	930 	273 	201 	141 	93 	60 	162
Finance leases (Note 17) 	123 	20 	18 	18 	16 	10 	41
Tax Cuts and Jobs Act (TCJA) transition tax (Note 10) 	653 	69 	69 	129 	172 	214 	—
Unconditional purchase obligations and other 	1,735 	1,027 	330 	218 	97 	48 	15
Total contractual cash obligations 	$ 	28,776 	$ 	2,696 	$ 	2,752 	$ 	2,833 	$ 	1,894 	$ 	2,511 	$ 	16,090
As a result of put provisions associated with certain debt instruments, long-term debt payments due in 2021 include floating rate notes totaling $53
million (classified as current portion of long-term debt).
In conjunction with the 2017 Tax Cuts and Jobs Act (TCJA), the Company has a transition tax liability that is payable over 8 years beginning in
2018. See Note 10 for additional details.
Unconditional purchase obligations are defined as agreements to purchase goods or services that are enforceable and legally binding on the
Company. Included in the unconditional purchase obligations category above are certain obligations related to take or pay contracts, capital
commitments, service agreements and utilities. These estimates include both unconditional purchase obligations with
51

-- 63 of 160 --

terms in excess of one year and normal ongoing purchase obligations with terms of less than one year. Many of these commitments relate to take
or pay contracts, in which 3M guarantees payment to ensure availability of products or services that are sold to customers. The Company expects
to receive consideration (products or services) for these unconditional purchase obligations. Contractual capital commitments are included in the
preceding table, but these commitments represent a small part of the Company’s expected capital spending. The purchase obligation amounts do
not represent the entire anticipated purchases in the future but represent only those items for which the Company is contractually obligated. The
majority of 3M’s products and services are purchased as needed, with no unconditional commitment. For this reason, these amounts will not
provide a reliable indicator of the Company’s expected future cash outflows on a stand-alone basis.
Other obligations, included in the preceding table within the caption entitled “Unconditional purchase obligations and other” include the current
portion of the liability for uncertain tax positions under ASC 740, which is expected to be paid out in cash in the next 12 months, when applicable.
The Company is not able to reasonably estimate the timing of the long-term payments, or the amount by which the liability will increase or
decrease over time; therefore, the long-term portion of the total net tax liability of $933 million is excluded from the preceding table. In addition,
the transition tax prescribed under the Tax Cuts and Jobs Act (TCJA) is separately included in the table above. Refer to Note 10 for further details.
Additionally, included within the caption entitled “Unconditional purchase obligations and other” are operating lease commitments that have not
yet commenced, which as of December 31, 2020, totaled approximately $18 million. These commitments pertain to 3M’s right of use buildings.
As discussed in Note 13, the Company does not have a required minimum cash pension contribution obligation for its U.S. plans in 2021 and
Company contributions to its U.S. and international pension plans are expected to be largely discretionary in future years; therefore, amounts
related to these plans are not included in the preceding table.
FINANCIAL INSTRUMENTS
The Company enters into foreign exchange forward contracts, options and swaps to hedge against the effect of exchange rate fluctuations on cash
flows denominated in foreign currencies and to offset, in part, the impacts of changes in value of various non-functional currency denominated
items including certain intercompany financing balances. The Company manages interest rate risks using a mix of fixed and floating rate debt. To
help manage borrowing costs, the Company may enter into interest rate swaps. Under these arrangements, the Company agrees to exchange, at
specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.
The Company manages commodity price risks through negotiated supply contracts and price protection agreements.
Refer to Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, for further discussion of foreign exchange rates risk, interest
rates risk, commodity prices risk and value at risk analysis.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
In the context of Item 7A, 3M is exposed to market risk due to the risk of loss arising from adverse changes in foreign currency exchange rates,
interest rates and commodity prices. Changes in those factors could impact the Company’s results of operations and financial condition. Senior
management provides oversight for risk management and derivative activities, determines certain of the Company’s financial risk policies and
objectives, and provides guidelines for derivative instrument utilization. Senior management also establishes certain associated procedures relative
to control and valuation, risk analysis, counterparty credit approval, and ongoing monitoring and reporting.
The Company is exposed to credit loss in the event of nonperformance by counterparties in interest rate swaps, currency swaps, and forward and
option contracts. However, the Company’s risk is limited to the fair value of the instruments. The Company actively monitors its exposure to
credit risk through the use of credit approvals and credit limits, and by selecting major international banks and financial institutions as
counterparties. The Company does not anticipate nonperformance by any of these counterparties.
Foreign Exchange Rates Risk:
Foreign currency exchange rates and fluctuations in those rates may affect the Company’s net investment in foreign subsidiaries and may cause
fluctuations in cash flows related to foreign denominated transactions. 3M is also exposed to the translation of foreign currency earnings to the
U.S. dollar. The Company enters into foreign exchange forward and option contracts to hedge against the
52

-- 64 of 160 --

effect of exchange rate fluctuations on cash flows denominated in foreign currencies. These transactions are designated as cash flow hedges. 3M
may dedesignate these cash flow hedge relationships in advance of the occurrence of the forecasted transaction. The maximum length of time over
which 3M hedges its exposure to the variability in future cash flows of the forecasted transactions is 36 months. In addition, 3M enters into foreign
currency contracts that are not designated in hedging relationships to offset, in part, the impacts of changes in value of various non-functional
currency denominated items including certain intercompany financing balances. As circumstances warrant, the Company also uses foreign
currency forward contracts and foreign currency denominated debt as hedging instruments to hedge portions of the Company’s net investments in
foreign operations. The dollar equivalent gross notional amount of the Company’s foreign exchange forward and option contracts designated as
either cash flow hedges or net investment hedges was $2.3 billion at December 31, 2020. The dollar equivalent gross notional amount of the
Company’s foreign exchange forward and option contracts not designated as hedging instruments was $3.2 billion at December 31, 2020. In
addition, as of December 31, 2020, the Company had 3.5 billion Euros in principal amount of foreign currency denominated debt designated as
non-derivative hedging instruments in certain net investment hedges as discussed in Note 14 in the “Net Investment Hedges” section.
Interest Rates Risk:
The Company may be impacted by interest rate volatility with respect to existing debt and future debt issuances. 3M manages interest rate risk and
expense using a mix of fixed and floating rate debt. In addition, the Company may enter into interest rate swaps that are designated and qualify as
fair value hedges. Under these arrangements, the Company agrees to exchange, at specified intervals, the difference between fixed and floating
interest amounts calculated by reference to an agreed-upon notional principal amount. The dollar equivalent (based on inception date foreign
currency exchange rates) gross notional amount of the Company’s interest rate swaps at December 31, 2020 was $403 million. Additional details
about 3M’s long-term debt can be found in Note 12, including references to information regarding derivatives and/or hedging instruments, further
discussed in Note 14, associated with the Company’s long-term debt.
Commodity Prices Risk:
The Company manages commodity price risks through negotiated supply contracts and price protection agreements. The related mark-to-market
gain or loss on qualifying hedges was included in other comprehensive income to the extent effective, and reclassified into cost of sales in the
period during which the hedged transaction affected earnings.
Value At Risk:
The value at risk analysis is performed annually to assess the Company’s sensitivity to changes in currency rates, interest rates, and commodity
prices. A Monte Carlo simulation technique was used to test the impact on after-tax earnings related to debt instruments, interest rate derivatives
and underlying foreign exchange and commodity exposures outstanding at December 31, 2020. The model (third-party bank dataset) used a 95
percent confidence level over a 12-month time horizon. The exposure to changes in currency rates model used nine currencies, interest rates
related to two currencies, and commodity prices related to five commodities. This model does not purport to represent what actually will be
experienced by the Company. This model does not include foreign currency hedges, because the Company believes their inclusion would not
materially impact the results. The following table summarizes the possible adverse and positive impacts to after-tax earnings related to these
exposures.
Adverse impact on after-tax 	Positive impact on after-tax
earnings 	earnings
(Millions) 	2020 	2019 	2020 	2019
Foreign exchange rates 	$ 	(169) 	$ 	(133) 	$ 	175 	$ 	137
Interest rates 	(1) 	(11) 	2 	10
Commodity prices 	— 	(2) 	— 	1
An analysis of the global exposures related to purchased components and materials is performed at each year-end. A one percent price change
would result in a pre-tax cost or savings of approximately $70 million per year. The global energy exposure is such that a ten
53

-- 65 of 160 --

percent price change would result in a pre-tax cost or savings of approximately $40 million per year. Global energy exposure includes energy costs
used in 3M production and other facilities, primarily electricity and natural gas.
Item 8. Financial Statements and Supplementary Data.
Index to Financial Statements
A complete summary of Form 10-K content, including the index to financial statements, is found at the beginning of this document.
Management’s Responsibility for Financial Reporting
Management is responsible for the integrity and objectivity of the financial information included in this report. The financial statements have been
prepared in accordance with accounting principles generally accepted in the United States of America. Where necessary, the financial statements
reflect estimates based on management’s judgment.
Management has established and maintains a system of internal control over financial reporting for the Company and its subsidiaries. This system
and its established accounting procedures and related controls are designed to provide reasonable assurance that assets are safeguarded, that the
books and records properly reflect all transactions, that policies and procedures are implemented by qualified personnel, and that published
financial statements are properly prepared and fairly presented. The Company’s system of internal control over financial reporting is supported by
widely communicated written policies, including business conduct policies, which are designed to require all employees to maintain high ethical
standards in the conduct of Company affairs. Internal auditors continually review the accounting and control system.
3M Company
Management’s Report on Internal Control Over Financial Reporting
Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting. Management
conducted an assessment of the Company’s internal control over financial reporting based on the framework established by the Committee of
Sponsoring Organizations of the Treadway Commission in Internal Control — Integrated Framework (2013. Based on the assessment,
management concluded that, as of December 31, 2020, the Company’s internal control over financial reporting is effective.
The Company’s internal control over financial reporting as of December 31, 2020 has been audited by PricewaterhouseCoopers LLP, an
independent registered public accounting firm, as stated in their report which is included herein, which expresses an unqualified opinion on the
effectiveness of the Company’s internal control over financial reporting as of December 31, 2020.
3M Company
54

-- 66 of 160 --

Report of Independent Registered Public Accounting Firm
To the Shareholders and Board of Directors of 3M Company
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheet of 3M Company and its subsidiaries (the “Company”) as of December 31, 2020
and 2019, and the related consolidated statements of income, of comprehensive income, of changes in equity and of cash flows for each of the
three years in the period ended December 31, 2020, including the related notes (collectively referred to as the “consolidated financial statements”).
We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal
Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company
as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31,
2020 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained,
in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal
Control - Integrated Framework (2013) issued by the COSO.
Change in Accounting Principle
As discussed in Note 1 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial
reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s
Report on Internal Control Over Financial Reporting. Our responsibility is to express opinions on the Company’s consolidated financial statements
and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and
whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated
financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on
a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated
financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial
reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control
based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We
believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A
company’s internal control over financial reporting includes those policies and procedures that
55

-- 67 of 160 --

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the
company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with
authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was
communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the
consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical
audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating
the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Legal Proceedings Contingencies
As described in Note 16 to the consolidated financial statements, management records liabilities for legal proceedings in those instances where it
can reasonably estimate the amount of the loss and when the liability is probable. Where the reasonable estimate of the probable loss is a range,
management records the most likely estimate of the loss, or the low end of the range if there is no one best estimate. Management either discloses
the amount of a possible loss or range of loss in excess of established accruals if estimable, or states that such an estimate cannot be made.
Management discloses significant legal proceedings even where liability is not probable or the amount of the liability is not estimable, or both, if
management believes there is at least a reasonable possibility that a loss may be incurred.
The principal considerations for our determination that performing procedures relating to legal proceedings contingencies is a critical audit matter
are there was significant judgment by management when assessing the likelihood of a loss being incurred and when estimating the loss or range of
loss for each claim, which in turn led to significant auditor judgment, subjectivity, and effort in performing procedures and evaluating
management’s assessment of the liabilities and disclosures associated with legal proceedings.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the
consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s evaluation of the
liability related to legal proceedings, including controls over determining the likelihood of a loss and whether the amount of loss can be reasonably
estimated, as well as financial statement disclosures. These procedures also included, among others, obtaining and evaluating the letters of audit
inquiry with internal and external legal counsel, evaluating the reasonableness of management’s assessment regarding whether an unfavorable
outcome is reasonably possible or probable and reasonably estimable, and evaluating the sufficiency of the Company’s disclosures related to legal
proceedings.
/s/ PricewaterhouseCoopers LLP
Minneapolis, Minnesota
February 4, 2021
We have served as the Company’s auditor since 1975.
56

-- 68 of 160 --

3M Company and Subsidiaries
Consolidated Statement of Income
Years ended December 31
(Millions, except per share amounts) 	2020 	2019 	2018
Net sales 	$ 	32,184 	$ 	32,136 	$ 	32,765
Operating expenses
Cost of sales 	16,605 	17,136 	16,682
Selling, general and administrative expenses 	6,929 	7,029 	7,602
Research, development and related expenses 	1,878 	1,911 	1,821
Gain on sale of businesses 	(389) 	(114) 	(547)
Total operating expenses 	25,023 	25,962 	25,558
Operating income 	7,161 	6,174 	7,207
Other expense (income), net 	450 	462 	207
Income before income taxes 	6,711 	5,712 	7,000
Provision for income taxes 	1,318 	1,130 	1,637
Income of consolidated group 	$ 	5,393 	$ 	4,582 	$ 	5,363
Income (loss) from unconsolidated subsidiaries, net of taxes 	(5) 	— 	—
Net income including noncontrolling interest 	$ 	5,388 	$ 	4,582 	$ 	5,363
Less: Net income (loss) attributable to noncontrolling interest 	4 	12 	14
Net income attributable to 3M 	$ 	5,384 	$ 	4,570 	$ 	5,349
Weighted average 3M common shares outstanding — basic 	577.6 	577.0 	588.5
Earnings per share attributable to 3M common shareholders — basic 	$ 	9.32 	$ 	7.92 	$ 	9.09
Weighted average 3M common shares outstanding — diluted 	582.2 	585.1 	602.0
Earnings per share attributable to 3M common shareholders — diluted 	$ 	9.25 	$ 	7.81 	$ 	8.89
The accompanying Notes to Consolidated Financial Statements are an integral part of this statement.
57

-- 69 of 160 --

3M Company and Subsidiaries
Consolidated Statement of Comprehensive Income
Years ended December 31
(Millions) 	2020 	2019 	2018
Net income including noncontrolling interest 	$ 	5,388 	$ 	4,582 	$ 	5,363
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment 	447 	211 	(467)
Defined benefit pension and postretirement plans adjustment 	171 	(560) 	444
Cash flow hedging instruments 	(142) 	(72) 	176
Total other comprehensive income (loss), net of tax 	476 	(421) 	153
Comprehensive income (loss) including noncontrolling interest 	5,864 	4,161 	5,516
Comprehensive (income) loss attributable to noncontrolling interest 	(2) 	(11) 	(8)
Comprehensive income (loss) attributable to 3M 	$ 	5,862 	$ 	4,150 	$ 	5,508
The accompanying Notes to Consolidated Financial Statements are an integral part of this statement.
58

-- 70 of 160 --

3M Company and Subsidiaries
Consolidated Balance Sheet
At December 31
(Dollars in millions, except per share amount) 	2020 	2019
Assets
Current assets
Cash and cash equivalents 	$ 	4,634 	$ 	2,353
Marketable securities — current 	404 	98
Accounts receivable — net of allowances of $233 and $161 	4,705 	4,791
Inventories
Finished goods 	2,081 	2,003
Work in process 	1,226 	1,194
Raw materials and supplies 	932 	937
Total inventories 	4,239 	4,134
Prepaids 	675 	704
Other current assets 	325 	891
Total current assets 	14,982 	12,971
Property, plant and equipment 	26,650 	26,124
Less: Accumulated depreciation 	(17,229) 	(16,791)
Property, plant and equipment — net 	9,421 	9,333
Operating lease right of use assets 	864 	858
Goodwill 	13,802 	13,444
Intangible assets — net 	5,835 	6,379
Other assets 	2,440 	1,674
Total assets 	$ 	47,344 	$ 	44,659
Liabilities
Current liabilities
Short-term borrowings and current portion of long-term debt 	$ 	806 	$ 	2,795
Accounts payable 	2,561 	2,228
Accrued payroll 	747 	702
Accrued income taxes 	300 	194
Operating lease liabilities — current 	256 	247
Other current liabilities 	3,278 	3,056
Total current liabilities 	7,948 	9,222
Long-term debt 	17,989 	17,518
Pension and postretirement benefits 	4,405 	3,911
Operating lease liabilities 	609 	607
Other liabilities 	3,462 	3,275
Total liabilities 	$ 	34,413 	$ 	34,533
Commitments and contingencies (Note 16)
Equity
3M Company shareholders’ equity:
Common stock par value, $.01 par value; 944,033,056 shares issued 	$ 	9 	$ 	9
Shares outstanding - December 31, 2020: 577,749,638
Shares outstanding - December 31, 2019: 575,184,835
Additional paid-in capital 	6,162 	5,907
Retained earnings 	43,761 	42,135
Treasury stock, at cost: 	(29,404) 	(29,849)
Accumulated other comprehensive income (loss) 	(7,661) 	(8,139)
Total 3M Company shareholders’ equity 	12,867 	10,063
Noncontrolling interest 	64 	63
Total equity 	$ 	12,931 	$ 	10,126
Total liabilities and equity 	$ 	47,344 	$ 	44,659
The accompanying Notes to Consolidated Financial Statements are an integral part of this statement.
59

-- 71 of 160 --

3M Company and Subsidiaries
Consolidated Statement of Changes in Equity
Years Ended December 31
3M Company Shareholders
Common 	Accumulated
Stock and 	Other
Additional 	Comprehensive 	Non-
Paid-in 	Retained 	Treasury 	Income 	controlling
(Dollars in millions, except per share amounts) 	Total 	Capital 	Earnings 	Stock 	(Loss) 	Interest
Balance at December 31, 2017 	$ 	11,622 	$ 	5,361 	$ 	39,115 	$ (25,887) 	$ 	(7,026) 	$ 	59
Net income 	5,363 	5,349 	14
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment 	(467) 	(461) 	(6)
Defined benefit pension and post-retirement plans adjustment 	444 	444 	—
Cash flow hedging instruments - unrealized gain (loss) 	176 	176 	—
Total other comprehensive income (loss), net of tax 	153
Dividends declared ($5.44 per share, Note 8) 	(3,193) 	(3,193)
Transfer of ownership involving non-wholly owned subsidiaries 	— 	14 	1 	(15)
Stock-based compensation 	291 	291
Reacquired stock 	(4,888) 	(4,888)
Issuances pursuant to stock option and benefit plans 	500 	(649) 	1,149
Balance at December 31, 2018 	$ 	9,848 	$ 	5,652 	$ 	40,636 	$ (29,626) 	$ 	(6,866) 	$ 	52
Impact of adoption of ASU No. 2018-02 	— 	853 	(853)
Impact of adoption of ASU No. 2016-02 	14 	14
Net income 	4,582 	4,570 	12
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment 	211 	212 	(1)
Defined benefit pension and post-retirement plans adjustment 	(560) 	(560) 	—
Cash flow hedging instruments - unrealized gain (loss) 	(72) 	(72) 	—
Total other comprehensive income (loss), net of tax 	(421)
Dividends declared ($5.76 per share, Note 8) 	(3,316) 	(3,316)
Stock-based compensation 	264 	264
Reacquired stock 	(1,381) 	(1,381)
Issuances pursuant to stock option and benefit plans 	536 	(622) 	1,158
Balance at December 31, 2019 	$ 	10,126 	$ 	5,916 	$ 	42,135 	$ (29,849) 	$ 	(8,139) 	$ 	63
Net income 	5,388 	5,384 	4
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment 	447 	449 	(2)
Defined benefit pension and post-retirement plans adjustment 	171 	171 	—
Cash flow hedging instruments - unrealized gain (loss) 	(142) 	(142) 	—
Total other comprehensive income (loss), net of tax 	476
Dividends declared ($5.88 per share, Note 8) 	(3,388) 	(3,388)
Purchase of non-controlling interest 	(1) 	(1)
Stock-based compensation 	255 	255
Reacquired stock 	(358) 	(358)
Issuances pursuant to stock option and benefit plans 	433 	(370) 	803
Balance at December 31, 2020 	$ 	12,931 	$ 	6,171 	$ 	43,761 	$ (29,404) 	$ 	(7,661) 	$ 	64
Supplemental share information 	2020 	2019 	2018
Treasury stock
Beginning balance 	368,848,221 	367,457,888 	349,148,819
Reacquired stock 	2,286,109 	7,575,647 	23,526,293
Issuances pursuant to stock options and benefit plans 	(4,850,912) 	(6,185,314) 	(5,217,224)
Ending balance 	366,283,418 	368,848,221 	367,457,888
The accompanying Notes to Consolidated Financial Statements are an integral part of this statement.
60

-- 72 of 160 --

3M Company and Subsidiaries
Consolidated Statement of Cash Flows
Years ended December 31
(Millions) 	2020 	2019 	2018
Cash Flows from Operating Activities
Net income including noncontrolling interest 	$ 	5,388 	$ 	4,582 	$ 	5,363
Adjustments to reconcile net income including noncontrolling interest to net cash
provided by operating activities
Depreciation and amortization 	1,911 	1,593 	1,488
Company pension and postretirement contributions 	(156) 	(210) 	(370)
Company pension and postretirement expense 	406 	357 	410
Stock-based compensation expense 	262 	278 	302
Gain on sale of businesses 	(389) 	(111) 	(545)
Deferred income taxes 	(165) 	(273) 	(57)
Loss on deconsolidation of Venezuelan subsidiary 	— 	162 	—
Changes in assets and liabilities
Accounts receivable 	165 	345 	(305)
Inventories 	(91) 	370 	(509)
Accounts payable 	252 	(117) 	408
Accrued income taxes (current and long-term) 	132 	205 	134
Other — net 	398 	(111) 	120
Net cash provided by (used in) operating activities 	8,113 	7,070 	6,439
Cash Flows from Investing Activities
Purchases of property, plant and equipment (PP&E) 	(1,501) 	(1,699) 	(1,577)
Proceeds from sale of PP&E and other assets 	128 	123 	262
Acquisitions, net of cash acquired 	(25) 	(4,984) 	13
Purchases of marketable securities and investments 	(1,579) 	(1,635) 	(1,828)
Proceeds from maturities and sale of marketable securities and investments 	1,811 	1,443 	2,497
Proceeds from sale of businesses, net of cash sold 	576 	236 	846
Other — net 	10 	72 	9
Net cash provided by (used in) investing activities 	(580) 	(6,444) 	222
Cash Flows from Financing Activities
Change in short-term debt — net 	(143) 	(316) 	(284)
Repayment of debt (maturities greater than 90 days) 	(3,482) 	(2,716) 	(1,034)
Proceeds from debt (maturities greater than 90 days) 	1,750 	6,281 	2,251
Purchases of treasury stock 	(368) 	(1,407) 	(4,870)
Proceeds from issuance of treasury stock pursuant to stock option and benefit plans 	429 	547 	485
Dividends paid to shareholders 	(3,388) 	(3,316) 	(3,193)
Other — net 	(98) 	(197) 	(56)
Net cash provided by (used in) financing activities 	(5,300) 	(1,124) 	(6,701)
Effect of exchange rate changes on cash and cash equivalents 	48 	(2) 	(160)
Net increase (decrease) in cash and cash equivalents 	2,281 	(500) 	(200)
Cash and cash equivalents at beginning of year 	2,353 	2,853 	3,053
Cash and cash equivalents at end of period 	$ 	4,634 	$ 	2,353 	$ 	2,853
The accompanying Notes to Consolidated Financial Statements are an integral part of this statement.
61

-- 73 of 160 --

Notes to Consolidated Financial Statements
NOTE 1. Significant Accounting Policies
Consolidation: 3M is a diversified global manufacturer, technology innovator and marketer of a wide variety of products. All applicable
subsidiaries are consolidated. All intercompany transactions are eliminated. As used herein, the term “3M” or “Company” refers to 3M Company
and subsidiaries unless the context indicates otherwise.
Basis of presentation: Certain amounts in the prior years’ consolidated financial statements have been reclassified to conform to the current year
presentation.
As described in Note 19, effective in the first quarter of 2020, the Company changed its business segment reporting in its continuing effort to
improve the alignment of businesses around markets and customers. Additionally, the Company consolidated the way it presents geographic area
net sales by providing an aggregate Americas geographic region (combining former United States and Latin America and Canada areas). Also,
effective in the second quarter of 2020, the measure of segment operating performance used by 3M’s chief operating decision maker changed and,
as a result, the Company’s disclosed measure of segment profit/loss has been updated. Information provided herein reflects the impact of these
changes for all periods presented.
Foreign currency translation: Local currencies generally are considered the functional currencies outside the United States with the exception of
3M’s subsidiaries in Argentina, the economy of which was considered highly inflationary beginning in 2018, and accordingly the financial
statements of these subsidiaries are remeasured as if their functional currency is that of their parent. Assets and liabilities for operations in local-
currency environments are translated at month-end exchange rates of the period reported. Income and expense items are translated at average
monthly currency exchange rates in effect during the period. Cumulative translation adjustments are recorded as a component of accumulated
other comprehensive income (loss) in shareholders’ equity.
3M had a consolidating subsidiary in Venezuela, the financial statements of which were remeasured as if its functional currency were that of its
parent because Venezuela’s economic environment is considered highly inflationary. The operating income of this subsidiary was immaterial as a
percent of 3M’s consolidated operating income for the periods presented. In light of circumstances, including the country’s unstable environment
and heightened unrest leading to sustained lack of demand, and expectation that these circumstances will continue for the foreseeable future,
during May 2019, 3M concluded it no longer met the criteria of control in order to continue consolidating its Venezuelan operations. As a result,
as of May 31, 2019, the Company began reflecting its interest in the Venezuelan subsidiary as an equity investment that does not have a readily
determinable fair value. This resulted in a pre-tax charge of $162 million within other expense (income) in the second quarter of 2019. The charge
primarily relates to $144 million of foreign currency translation losses associated with foreign currency movements before Venezuela was
accounted for as a highly inflationary economy and pension elements previously included in accumulated other comprehensive loss along with
write-down of intercompany receivable and investment balances associated with this subsidiary. Beginning May 31, 2019, 3M’s consolidated
balance sheets and statements of operations no longer include the Venezuelan entity’s operations other than an immaterial equity investment and
associated loss or income thereon largely only to the extent, if any, that 3M provides support or materials and receives funding or dividends.
Use of estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at
the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company considered the
coronavirus (COVID-19) related impacts on its estimates, as appropriate, within its consolidated financial statements and there may be changes to
those estimates in future periods. 3M believes that the accounting estimates are appropriate after giving consideration to the increased uncertainties
surrounding the severity and duration of the COVID-19 pandemic. Such estimates and assumptions are subject to inherent uncertainties which may
result in actual amounts differing from these estimates.
Cash and cash equivalents: Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when
acquired.
Marketable securities: Marketable securities include available-for-sale debt securities and are recorded at fair value. Cost of securities sold use the
first in, first out (FIFO) method. The classification of marketable securities as current or non-current is based on the
62

-- 74 of 160 --

availability for use in current operations. 3M reviews impairments associated with its marketable securities in accordance with the measurement
guidance provided by ASC 320, Investments-Debt Securities and ASC 326-30, Available-for-Sale Debt Securities, when determining whether a
decline in fair value below the amortized cost basis has resulted from a credit loss or other factors. An impairment relating to credit losses is
recorded through an allowance for credit losses. The allowance is limited by the amount that the fair value is less than the amortized cost basis. A
change in the allowance for credit losses is recorded into earnings in the period of the change. Any impairment that has not been recorded through
an allowance for credit losses is recorded through accumulated other comprehensive income as a component of shareholders’ equity. The factors
considered in determining whether a credit loss exists can include the extent to which fair value is less than the amortized cost basis, changes in the
credit quality of the underlying loan obligors, credit ratings actions, as well as other factors. When a credit loss exists, the Company compares the
present value of cash flows expected to be collected from the debt security with the amortized cost basis of the security to determine what
allowance amount, if any, should be recorded. Amounts are reclassified out of accumulated other comprehensive income and into earnings upon
sale or a change in the portions of impairment related to credit losses and not related to credit losses.
Investments: All equity securities that do not result in consolidation and are not accounted for under the equity method are measured at fair value
with changes therein reflected in net income. 3M utilizes the measurement alternative for equity investments that do not have readily determinable
fair values and measures these investments at cost less impairment plus or minus observable price changes in orderly transactions. The balance of
these securities is disclosed in Note 7.
Other assets: Other assets include deferred income taxes, product and other insurance receivables, the cash surrender value of life insurance
policies, medical equipment in rental arrangements utilized primarily by hospitals and other medical clinics, prepaid pension and postretirement
and other long-term assets. Investments in life insurance are reported at the amount that could be realized under contract at the balance sheet date,
with any changes in cash surrender value or contract value during the period accounted for as an adjustment of premiums paid. Cash outflows and
inflows associated with life insurance activity are included in “Purchases of marketable securities and investments” and “Proceeds from maturities
and sale of marketable securities and investments,” respectively.
Inventories: Inventories are stated at the lower of cost or net realizable value (NRV), which is defined as estimated selling prices in the ordinary
course of business, less reasonably predictable costs of completion, disposal and transportation. Cost is determined on a first-in, first-out basis.
Property, plant and equipment: Property, plant and equipment, including capitalized interest and internal direct engineering costs, are recorded at
cost. Depreciation of property, plant and equipment generally is computed using the straight-line method based on the estimated useful lives of the
assets. The estimated useful lives of buildings and improvements primarily range from ten to forty years, with the majority in the range of twenty
to forty years. The estimated useful lives of machinery and equipment primarily range from three to fifteen years, with the majority in the range of
five to ten years. Fully depreciated assets other than capitalized internally developed software are retained in property, plant and equipment and
accumulated depreciation accounts until disposal. Upon disposal, assets and related accumulated depreciation are removed from the accounts and
the net amount, less proceeds from disposal, is charged or credited to operations. Property, plant and equipment amounts are reviewed for
impairment whenever events or changes in circumstances indicate that the carrying amount of an asset (asset group) may not be recoverable. An
impairment loss would be recognized when the carrying amount of an asset exceeds the estimated undiscounted future cash flows expected to
result from the use of the asset and its eventual disposition. The amount of the impairment loss recorded is calculated by the excess of the asset’s
carrying value over its fair value. Fair value is generally determined using a discounted cash flow analysis. 3M records capital-related government
grants earned as reductions to the cost of property, plant and equipment; and associated unpaid liabilities and grant proceeds receivable are
considered non-cash changes in such balances for purposes of preparation of statement of cash flows.
Conditional asset retirement obligations: A liability is initially recorded at fair value for an asset retirement obligation associated with the
retirement of tangible long-lived assets in the period in which it is incurred if a reasonable estimate of fair value can be made. Conditional asset
retirement obligations exist for certain long-term assets of the Company. The obligation is initially measured at fair value using expected present
value techniques. Over time the liabilities are accreted for the change in their present value and the initial capitalized costs are depreciated over the
remaining useful lives of the related assets. The asset retirement obligation liability was $145 million and $137 million at December 31, 2020 and
2019, respectively.
Goodwill: Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed in a business
combination. Goodwill is not amortized. Goodwill is tested for impairment annually in the fourth quarter of each year, and is
63

-- 75 of 160 --

tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired.
Impairment testing for goodwill is done at a reporting unit level, with all goodwill assigned to a reporting unit. Reporting units are one level below
the business segment level, but are required to be combined when reporting units within the same segment have similar economic characteristics.
3M did not combine any of its reporting units for impairment testing. The impairment loss is measured as the amount by which the carrying value
of the reporting unit’s net assets exceeds its estimated fair value, not to exceed the carrying value of the reporting unit’s goodwill. The estimated
fair value of a reporting unit is determined using earnings for the reporting unit multiplied by a price/earnings ratio for comparable industry groups
or by using a discounted cash flow analysis. Companies have the option to first assess qualitative factors to determine whether the fair value of a
reporting unit is not “more likely than not” less than its carrying amount, which is commonly referred to as “Step 0”. 3M has chosen not to apply
Step 0 for its annual goodwill assessments.
Intangible assets: Intangible asset types include customer related, patents, other technology-based, tradenames and other intangible assets acquired
from an independent party. Intangible assets with a definite life are amortized over a period ranging from four to twenty years on a systematic and
rational basis (generally straight line) that is representative of the asset’s use. The estimated useful lives vary by category, with customer-related
largely between ten to twenty years, patents largely between seven to twenty years, other technology-based largely between four to twenty years,
definite lived tradenames largely between six and twenty years, and other intangibles largely between five to eight years. Intangible assets are
removed from their respective gross asset and accumulated amortization accounts when they are no longer in use. Refer to Note 4 for additional
details on the gross amount and accumulated amortization of the Company’s intangible assets. Costs related to internally developed intangible
assets, such as patents, are expensed as incurred, within “Research, development and related expenses.”
Intangible assets with a definite life are tested for impairment whenever events or circumstances indicate that the carrying amount of an asset
(asset group) may not be recoverable. An impairment loss is recognized when the carrying amount exceeds the estimated undiscounted cash flows
from the asset’s or asset group’s ongoing use and eventual disposition. If an impairment is identified, the amount of the impairment loss recorded
is calculated by the excess of the asset’s carrying value over its fair value. Fair value is generally determined using a discounted cash flow
analysis.
Intangible assets with an indefinite life, namely certain tradenames, are not amortized. Indefinite-lived intangible assets are tested for impairment
annually, and are tested for impairment between annual tests if an event occurs or circumstances change that would indicate that the carrying
amount may be impaired. An impairment loss would be recognized when the fair value is less than the carrying value of the indefinite-lived
intangible asset.
Restructuring actions: Restructuring actions generally include significant actions involving employee-related severance charges, contract
termination costs, and impairment or accelerated depreciation/amortization of assets associated with such actions. Employee-related severance
charges are largely based upon distributed employment policies and substantive severance plans. These charges are reflected in the quarter when
the actions are probable and the amounts are estimable, which typically is when management approves the associated actions. Severance amounts
for which affected employees in certain circumstances are required to render service in order to receive benefits at their termination dates were
measured at the date such benefits were communicated to the applicable employees and recognized as expense over the employees’ remaining
service periods. Contract termination and other charges primarily reflect costs to terminate a contract before the end of its term (measured at fair
value at the time the Company provided notice to the counterparty) or costs that will continue to be incurred under the contract for its remaining
term without economic benefit to the Company. Asset impairment charges related to intangible assets and property, plant and equipment reflect the
excess of the assets’ carrying values over their fair values.
Revenue (sales recognition: The Company sells a wide range of products to a diversified base of customers around the world and has no material
concentration of credit risk or significant payment terms extended to customers. The vast majority of 3M’s customer arrangements contain a single
performance obligation to transfer manufactured goods as the promise to transfer the individual goods is not separately identifiable from other
promises in the contracts and, therefore, not distinct. However, to a limited extent 3M also enters into customer arrangements that involve
intellectual property out-licensing, multiple performance obligations (such as equipment, installation and service), software with coterminous post-
contract support, services and non-standard terms and conditions.
The Company recognizes revenue in light of the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with
Customers. Revenue is recognized when control of goods has transferred to customers. For the majority of the Company’s customer arrangements,
control transfers to customers at a point-in-time when goods/services have been delivered as that is generally
64

-- 76 of 160 --

when legal title, physical possession and risks and rewards of goods/services transfers to the customer. In limited arrangements, control transfers
over time as the customer simultaneously receives and consumes the benefits as 3M completes the performance obligation(s).
Revenue is recognized at the transaction price which the Company expects to be entitled. When determining the transaction price, 3M estimates
variable consideration applying the portfolio approach practical expedient under ASC 606. The main sources of variable consideration for 3M are
customer rebates, trade promotion funds, and cash discounts. These sales incentives are recorded as a reduction to revenue at the time of the initial
sale using the most-likely amount estimation method. The most-likely amount method is based on the single most likely outcome from a range of
possible consideration outcomes. The range of possible consideration outcomes are primarily derived from the following inputs: sales terms,
historical experience, trend analysis, and projected market conditions in the various markets served. Because 3M serves numerous markets, the
sales incentive programs offered vary across businesses, but the most common incentive relates to amounts paid or credited to customers for
achieving defined volume levels or growth objectives. There are no material instances where variable consideration is constrained and not
recorded at the initial time of sale. Free goods are accounted for as an expense and recorded in cost of sales. Product returns are recorded as a
reduction to revenue based on anticipated sales returns that occur in the normal course of business. 3M primarily has assurance-type warranties
that do not result in separate performance obligations. Sales, use, value-added, and other excise taxes are not recognized in revenue. The Company
has elected to present revenue net of sales taxes and other similar taxes.
For substantially all arrangements recognized over time, the Company applies the “right to invoice” practical expedient. As a result, 3M
recognizes revenue at the invoice amount when the entity has a right to invoice a customer at an amount that corresponds directly with the value to
the customer of the Company’s performance completed to date.
For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using
3M’s best estimate of the standalone selling price of each distinct good or service in the contract.
The Company did not recognize any material revenue in the current reporting period for performance obligations that were fully satisfied in
previous periods.
The Company does not have material unfulfilled performance obligation balances for contracts with an original length greater than one year in any
years presented. Additionally, the Company does not have material costs related to obtaining a contract with amortization periods greater than one
year for any year presented.
3M applies ASC 606 utilizing the following allowable exemptions or practical expedients:
● 	Exemption to not disclose the unfulfilled performance obligation balance for contracts with an original length of one year or less.
● 	Practical expedient relative to costs of obtaining a contract by expensing sales commissions when incurred because the amortization
period would have been one year or less.
● 	Portfolio approach practical expedient relative to estimation of variable consideration.
● 	“Right to invoice” practical expedient based on 3M’s right to invoice the customer at an amount that reasonably represents the value to
the customer of 3M’s performance completed to date.
● 	Election to present revenue net of sales taxes and other similar taxes.
● 	Sales-based royalty exemption permitting future intellectual property out-licensing royalty payments to be excluded from the otherwise
required remaining performance obligations disclosure
The Company recognizes revenue from the rental of durable medical devices in accordance with the guidance of ASC 842, Leases. The Company
recognizes rental revenue based on the length of time a device is used by the patient/organization, (i) at the contracted rental rate for contracted
customers and (ii) generally, retail price for non-contracted customers. The leases are short-term in nature, generally providing for daily or
monthly pricing, and are all classified as operating leases.
Accounts receivable and allowances: Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company
maintains allowances for bad debts, cash discounts, and various other items. The allowances for bad debts and cash discounts are based on the best
estimate of the amount of expected credit losses in existing accounts receivable and anticipated cash discounts. The Company determines the
allowances based on historical write-off experience by industry and regional economic data, current expectations of future credit losses, and
historical cash discounts. The Company reviews the allowances monthly. The
65

-- 77 of 160 --

allowances for bad debts as well as the provision for credit losses, write-off activity and recoveries for the periods presented are not material. The
Company does not have any significant off-balance-sheet credit exposure related to its customers. The Company has long-term customer
receivables that do not have significant credit risk, and the origination dates of which are typically not older than five years. These long-term
receivables are subject to an allowance methodology similar to other receivables.
Advertising and merchandising: These costs are charged to operations in the period incurred, and totaled $278 million in 2020, $348 million in
2019 and $396 million in 2018.
Research, development and related expenses: These costs are charged to operations in the period incurred and are shown on a separate line of the
Consolidated Statement of Income. Research, development and related expenses totaled $1.878 billion in 2020, $1.911 billion in 2019 and $1.821
billion in 2018. Research and development expenses, covering basic scientific research and the application of scientific advances in the
development of new and improved products and their uses, totaled $1.146 billion in 2020, $1.253 billion in 2019 and $1.253 billion in 2018.
Related expenses primarily include technical support; internally developed patent costs, which include costs and fees incurred to prepare, file,
secure and maintain patents; amortization of externally acquired patents and externally acquired in-process research and development; and
gains/losses associated with certain corporate approved investments in R&D-related ventures.
Internal-use software: The Company capitalizes direct costs of services used in the development of, and external software acquired for use as,
internal-use software. Amounts capitalized are amortized over a period of three to seven years, generally on a straight-line basis, unless another
systematic and rational basis is more representative of the software’s use. Amounts are reported as a component of either machinery and
equipment or finance leases within property, plant and equipment. Fully depreciated internal-use software assets are removed from property, plant
and equipment and accumulated depreciation accounts.
Environmental: Environmental expenditures relating to existing conditions caused by past operations that do not contribute to current or future
revenues are expensed. Reserves for liabilities related to anticipated remediation costs are recorded on an undiscounted basis when they are
probable and reasonably estimable, generally no later than the completion of feasibility studies, the Company’s commitment to a plan of action, or
approval by regulatory agencies. Environmental expenditures for capital projects that contribute to current or future operations generally are
capitalized and depreciated over their estimated useful lives.
Income taxes: The provision for income taxes is determined using the asset and liability approach. Under this approach, deferred income taxes
represent the expected future tax consequences of temporary differences between the carrying amounts and tax basis of assets and liabilities. The
Company records a valuation allowance to reduce its deferred tax assets when uncertainty regarding their realizability exists. As of December 31,
2020 and 2019, the Company had valuation allowances of $135 million and $158 million on its deferred tax assets, respectively. The Company
recognizes and measures its uncertain tax positions based on the rules under ASC 740, Income Taxes.
Earnings per share: The difference in the weighted average 3M shares outstanding for calculating basic and diluted earnings per share attributable
to 3M common shareholders is the result of the dilution associated with the Company’s stock-based compensation plans. Certain options
outstanding under these stock-based compensation plans during the years 2020, 2019 and 2018 were not included in the computation of diluted
earnings per share attributable to 3M common shareholders because they would have had an anti-dilutive effect (18.1 million average options for
2020, 8.9 million average options for 2019, and 2.9 million average options for 2018). The computations for basic and diluted earnings per share
for the years ended December 31 follow:
66

-- 78 of 160 --

Earnings Per Share Computations
(Amounts in millions, except per share amounts) 	2020 	2019 	2018
Numerator:
Net income attributable to 3M 	$ 	5,384 	$ 	4,570 	$ 	5,349
Denominator:
Denominator for weighted average 3M common shares outstanding 	– 	basic 	577.6 	577.0 	588.5
Dilution associated with the Company’s stock-based compensation plans 	4.6 	8.1 	13.5
Denominator for weighted average 3M common shares outstanding 	– 	diluted 	582.2 	585.1 	602.0
Earnings per share attributable to 3M common shareholders 	– 	basic 	$ 	9.32 	$ 	7.92 	$ 	9.09
Earnings per share attributable to 3M common shareholders 	– 	diluted 	$ 	9.25 	$ 	7.81 	$ 	8.89
Stock-based compensation: The Company recognizes compensation expense for its stock-based compensation programs, which include stock
options, restricted stock, restricted stock units (RSUs), performance shares, and the General Employees’ Stock Purchase Plan (GESPP). Under
applicable accounting standards, the fair value of share-based compensation is determined at the grant date and the recognition of the related
expense is recorded over the period in which the share-based compensation vests. However, with respect to income taxes, the related deduction
from taxes payable is based on the award’s intrinsic value at the time of exercise (for an option) or on the fair value upon vesting of the award (for
RSUs), which can be either greater (creating an excess tax benefit) or less (creating a tax deficiency) than the deferred tax benefit recognized as
compensation cost is recognized in the financial statements. These excess tax benefits/deficiencies are recognized as income tax benefit/expense in
the statement of income and, within the statement of cash flows, are classified in operating activities in the same manner as other cash flows
related to income taxes. The extent of excess tax benefits/deficiencies is subject to variation in 3M stock price and timing/extent of RSU vestings
and employee stock option exercises.
Comprehensive income: Total comprehensive income and the components of accumulated other comprehensive income (loss) are presented in the
Consolidated Statement of Comprehensive Income and the Consolidated Statement of Changes in Equity. Accumulated other comprehensive
income (loss) is composed of foreign currency translation effects (including hedges of net investments in international companies), defined benefit
pension and postretirement plan adjustments, unrealized gains and losses on available-for-sale debt securities, and unrealized gains and losses on
cash flow hedging instruments. The Company uses the portfolio approach for releasing income tax effects from accumulated other comprehensive
income.
Derivatives and hedging activities: All derivative instruments within the scope of ASC 815, Derivatives and Hedging, are recorded on the balance
sheet at fair value. The Company uses interest rate swaps, currency swaps, and foreign currency forward and option contracts to manage risks
generally associated with foreign exchange rate, interest rate and commodity market volatility. All hedging instruments that qualify for hedge
accounting are designated and effective as hedges, in accordance with U.S. generally accepted accounting principles. If the underlying hedged
transaction ceases to exist, all changes in fair value of the related derivatives that have not been settled are recognized in current earnings.
Instruments that do not qualify for hedge accounting are marked to market with changes recognized in current earnings. Cash flows from
derivative instruments are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated
hedge or undesignated (economic) hedge relationships. The Company does not hold or issue derivative financial instruments for trading purposes
and is not a party to leveraged derivatives.
Credit risk: The Company is exposed to credit loss in the event of nonperformance by counterparties in interest rate swaps, currency swaps, and
forward and option contracts. However, the Company’s risk is limited to the fair value of the instruments. The Company actively monitors its
exposure to credit risk through the use of credit approvals and credit limits, and by selecting major international banks and financial institutions as
counterparties. 3M enters into master netting arrangements with counterparties when possible to mitigate credit risk in derivative transactions. A
master netting arrangement may allow each counterparty to net settle amounts owed between a 3M entity and the counterparty as a result of
multiple, separate derivative transactions. The Company does not anticipate nonperformance by any of these counterparties. 3M has elected to
present the fair value of derivative assets and liabilities within the Company’s consolidated balance sheet on a gross basis even when derivative
transactions are subject to master netting arrangements and may otherwise qualify for net presentation.
Fair value measurements: 3M follows ASC 820, Fair Value Measurements and Disclosures, with respect to assets and liabilities that are measured
at fair value on a recurring basis and nonrecurring basis. Under the standard, fair value is defined as the exit price, or the
67

-- 79 of 160 --

amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the
measurement date. The standard also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs
and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs
market participants would use in valuing the asset or liability developed based on market data obtained from sources independent of the Company.
Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or
liability developed based upon the best information available in the circumstances. The hierarchy is broken down into three levels. Level 1 inputs
are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs include quoted prices for similar assets or
liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted
prices) that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability.
Categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Acquisitions: The Company accounts for business acquisitions in accordance with ASC 805, Business Combinations. This standard requires the
acquiring entity in a business combination to recognize all (and only) the assets acquired and liabilities assumed in the transaction and establishes
the acquisition-date fair value as the measurement objective for all assets acquired and liabilities assumed in a business combination. Certain
provisions of this standard prescribe, among other things, the determination of acquisition-date fair value of consideration paid in a business
combination (including contingent consideration) and the exclusion of transaction and acquisition-related restructuring costs from acquisition
accounting. In addition to business combinations, 3M periodically acquires certain tangible and/or intangible assets and purchases interests in
certain enterprises that do not otherwise qualify for accounting as business combinations. These transactions are largely reflected as additional
asset purchase and investment activity.
Leases: 3M determines if an arrangement is a lease upon inception. A contract is or contains a lease if the contract conveys the right to control the
use of an identified asset for a period of time in exchange for consideration. The right to control the use of an asset includes the right to obtain
substantially all of the economic benefits of the underlying asset and the right to direct how and for what purpose the asset is used. 3M determines
certain service agreements that contain the right to use an underlying asset are not leases because 3M does not control how and for what purpose
the identified asset is used. Examples of such agreements include master supply agreements, product processing agreements, warehouse and
distribution services agreements, power purchase agreements, and transportation purchase agreements.
After adoption of ASU 2016-02 and related standards in 2019, operating lease right-of-use assets and liabilities are recognized at commencement
date based on the present value of lease payments over the lease term. The discount rate used to calculate present value is 3M’s incremental
borrowing rate or, if available, the rate implicit in the lease. 3M determines the incremental borrowing rate for leases using a portfolio approach
based primarily on the lease term and the economic environment of the applicable country or region.
As a lessee, the Company leases distribution centers, office space, land, and equipment. Certain 3M lease agreements include rental payments
adjusted annually based on changes in an inflation index. 3M’s leases do not contain material residual value guarantees or material restrictive
covenants. Lease expense is recognized on a straight-line basis over the lease term.
Certain leases include one or more options to renew, with terms that can extend the lease term up to five years. 3M includes options to renew the
lease as part of the right of use lease asset and liability when it is reasonably certain the Company will exercise the option. In addition, certain
leases contain fair value purchase and termination options with an associated penalty. In general, 3M is not reasonably certain to exercise such
options.
For the measurement and classification of its lease agreements, 3M groups lease and non-lease components into a single lease component for all
underlying asset classes. Variable lease payments primarily include payments for non-lease components, such as maintenance costs, payments for
leased assets used beyond their noncancelable lease term as adjusted for contractual options to terminate or renew, and payments for non-
components such as sales tax. Certain 3M leases contain immaterial variable lease payments based on number of units produced.
68

-- 80 of 160 --

New Accounting Pronouncements
In June 2016, the FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments, which revised guidance for the
accounting for credit losses on financial instruments within its scope, and through March 2020 issued ASUs that amended the standard (ASU No.
2018-19, ASU No. 2019-04, ASU No. 2019-05, ASU No. 2019-11, and ASU No. 2020-03). The new standard introduced an approach, based on
expected losses, to estimate credit losses on certain types of financial instruments and modified the impairment model for available-for-sale debt
securities. The new approach to estimating credit losses (referred to as the current expected credit losses model) applies to most financial assets
measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net
investments in leases and off-balance-sheet credit exposures. With respect to available-for-sale (AFS) debt securities, the ASU amended the
current other-than-temporary impairment model. For such securities with unrealized losses, entities still consider if a portion of any impairment is
related only to credit losses and therefore recognized as a reduction in income. However, rather than also reflecting that credit loss amount as a
permanent reduction in cost (amortized cost) basis of that AFS debt security, the ASU requires that credit losses be reflected as an allowance. As a
result, under certain circumstances, a recovery in value could result in previous allowances, or portions thereof, reversing back into income. For
3M, this ASU was effective January 1, 2020. Adoption of this ASU did not have a material impact due to the nature and extent of 3M’s financial
instruments in scope for this ASU (primarily accounts receivable) and the historical, current and expected credit quality of its customers as of the
date of adoption.
In August 2018, the FASB issued ASU No. 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing
Arrangement That Is a Service Contract, which aligned the accounting for implementation costs incurred in a cloud computing arrangement that is
a service arrangement (i.e. hosting arrangement) with the guidance on capitalizing costs in ASC 350-40, Internal-Use Software. The ASU
permitted either a prospective or retrospective transition approach. For 3M, the ASU was effective as of January 1, 2020, with the Company
adopting on a prospective basis. Relevant capitalizable costs are included in prepaid expenses or other non-current assets, as applicable,
prospectively beginning in 2020. Implementation costs incurred as part of 3M’s cloud-computing service arrangements were not material in 2020.
In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (Topic 740. This ASU simplifies the
accounting for income taxes by, among other things, eliminating certain existing exceptions related to the general approach in ASC 740 relating to
franchise taxes, reducing complexity in the interim-period accounting for year-to-date loss limitations and changes in tax laws, and clarifying the
accounting for transactions outside of business combination that result in a step-up in the tax basis of goodwill. The transition requirements are
primarily prospective and the effective date for 3M is January 1, 2021, with early adoption permitted. As 3M does not have material activity
associated with items such as franchise taxes or the types of transactions described above, does not typically have entities subject to relevant loss
limitations and is not currently addressing enacted tax law changes for which this ASU applies, 3M does not expect this ASU to have a material
impact on its consolidated results of operations and financial condition.
In January 2020, the FASB issued ASU No. 2020-01, Clarifying the Interactions between Topic 321, Investments—Equity Securities, Topic 323,
Investments—Equity Method and Joint Ventures, and Topic 815, Derivatives and Hedging. This ASU clarifies that when accounting for certain
equity securities, a company should consider observable transactions before applying or upon discontinuing the equity method of accounting for
the purposes of applying the measurement alternative. Further, this ASU notes when determining the accounting for certain derivatives, a company
should not consider if the underlying securities would be accounted for under the equity method or fair value option. The transition requirements
are prospective and the effective date for 3M is January 1, 2021, with early adoption permitted. As 3M does not currently have a material amount
of equity securities and equity method investments or relevant derivatives, 3M does not expect this ASU to have a material impact on its
consolidated results of operations and financial condition, but will apply such guidance, where applicable, to future circumstances.
In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848: Facilitation of the Effects of Reference Rate Reform on
Financial Reporting and in January 2021 issued ASU No. 2021-01, Reference Rate Reform (Topic 848: Scope. These ASUs provides temporary
optional expedients and exceptions to existing guidance on contract modifications and hedge accounting to facilitate the market transition from
existing reference rates, such as LIBOR which is being phased out beginning at the end of 2021, to alternate reference rates, such as SOFR. These
standards were effective upon issuance and allowed application to contract changes as early as January 1, 2020. These provisions may impact the
Company as contract modifications and other changes occur during the LIBOR transition period. The Company continues to evaluate the optional
relief guidance provided within these ASUs, has reviewed
69

-- 81 of 160 --

its debt securities, bank facilities, and derivative instruments and continues to evaluate commercial contracts that may utilize LIBOR as the
reference rate. 3M will continue its assessment and monitor regulatory developments during the LIBOR transition period.
NOTE 2. Revenue
Contract Balances:
Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Refer to Note 7 for deferred
revenue balances at December 31, 2019 and 2020. Approximately $410 million of the December 31, 2019 balance was recognized as revenue
during the year ended December 31, 2020, while approximately $600 million of the December 31, 2018 balance was recognized as revenue during
the year ended December 31, 2019.
Operating Lease Revenue:
Net sales includes rental revenue from durable medical devices as part of operating lease arrangements (reported within the Medical Solutions
Division), which was $586 million for the year ended December 31, 2020. Applicable rental revenue for the years ended December 31, 2019 and
2018 was not material.
Disaggregated revenue information:
The Company views the following disaggregated disclosures as useful to understanding the composition of revenue recognized during the
respective reporting periods:
Year ended
December 31,
Net Sales (Millions) 	2020 	2019 	2018
Abrasives 	$ 	1,180 	$ 	1,387 	$ 	1,512
Automotive Aftermarket 	1,102 	1,229 	1,356
Closure and Masking Systems 	993 	1,111 	1,224
Communication Markets 	— 	— 	175
Electrical Markets 	1,121 	1,200 	1,244
Industrial Adhesives and Tapes 	2,562 	2,689 	2,841
Personal Safety 	4,433 	3,504 	3,601
Roofing Granules 	390 	366 	353
Other Safety and Industrial 	(14) 	28 	108
Total Safety and Industrial Business Segment 	$ 	11,767 	$ 	11,514 	$ 	12,414
Advanced Materials 	$ 	1,036 	$ 	1,245 	$ 	1,236
Automotive and Aerospace 	1,612 	1,913 	2,074
Commercial Solutions 	1,529 	1,785 	1,863
Electronics 	3,767 	3,711 	3,971
Transportation Safety 	890 	943 	951
Other Transportation and Electronics 	(7) 	(6) 	9
Total Transportation and Electronics Business Segment 	$ 	8,827 	$ 	9,591 	$ 	10,104
Drug Delivery 	$ 	146 	$ 	372 	$ 	407
Food Safety 	342 	341 	328
Health Information Systems 	1,140 	1,177 	837
Medical Solutions 	4,787 	3,439 	3,073
Oral Care 	1,076 	1,321 	1,353
Separation and Purification Sciences 	853 	791 	817
Other Health Care 	1 	(10) 	6
Total Health Care Business Group 	$ 	8,345 	$ 	7,431 	$ 	6,821
Consumer Health Care 	$ 	366 	$ 	379 	$ 	389
Home Care 	1,066 	991 	1,013
Home Improvement 	2,527 	2,297 	2,216
Stationery and Office 	1,223 	1,378 	1,399
Other Consumer 	154 	106 	110
Total Consumer Business Group 	$ 	5,336 	$ 	5,151 	$ 	5,127
Corporate and Unallocated 	$ 	(1) 	$ 	110 	$ 	50
Elimination of Dual Credit 	(2,090) 	(1,661) 	(1,751)
Total Company 	$ 	32,184 	$ 	32,136 	$ 	32,765
70

-- 82 of 160 --

Year ended December 31, 2020
Net Sales (Millions) 	Americas 	Asia Pacific
Europe,
Middle
East and
Africa
Other
Unallocated 	Worldwide
Safety and Industrial 	$ 	6,177 	$ 	2,805 	$ 	2,791 	$ 	(6) 	$ 	11,767
Transportation and Electronics 	2,455 	5,097 	1,282 	(7) 	8,827
Health Care 	5,062 	1,478 	1,809 	(4) 	8,345
Consumer 	3,832 	939 	567 	(2) 	5,336
Corporate and Unallocated 	(1) 	— 	— 	— 	(1)
Elimination of Dual Credit 	(1,000) 	(750) 	(340) 	— 	(2,090)
Total Company 	$ 	16,525 	$ 	9,569 	$ 	6,109 	$ 	(19) 	$ 	32,184
Year ended December 31, 2019
Net Sales (Millions) 	Americas
Asia
Pacific
Europe,
Middle
East and
Africa
Other
Unallocated 	Worldwide
Safety and Industrial 	$ 	6,008 	$ 	2,844 	$ 	2,666 	$ 	(4) 	$ 	11,514
Transportation and Electronics 	2,901 	5,221 	1,472 	(3) 	9,591
Health Care 	4,200 	1,490 	1,743 	(2) 	7,431
Consumer 	3,641 	952 	559 	(1) 	5,151
Corporate and Unallocated 	109 	— 	1 	— 	110
Elimination of Dual Credit 	(735) 	(711) 	(215) 	— 	(1,661)
Total Company 	$ 	16,124 	$ 	9,796 	$ 	6,226 	$ 	(10) 	$ 	32,136
Year ended December 31, 2018
Net Sales (Millions) 	Americas
Asia
Pacific
Europe,
Middle
East and
Africa
Other
Unallocated 	Worldwide
Safety and Industrial 	$ 	6,345 	$ 	3,076 	$ 	2,996 	$ 	(3) 	$ 	12,414
Transportation and Electronics 	3,015 	5,513 	1,577 	(1) 	10,104
Health Care 	3,636 	1,453 	1,733 	(1) 	6,821
Consumer 	3,562 	980 	586 	(1) 	5,127
Corporate and Unallocated 	51 	— 	— 	(1) 	50
Elimination of Dual Credit 	(745) 	(768) 	(238) 	— 	(1,751)
Total Company 	$ 	15,864 	$ 10,254 	$ 	6,654 	$ 	(7) 	$ 	32,765
Americas included United States net sales to customers of $13.9 billion, $13.2 billion and $12.8 billion in 2020, 2019 and 2018, respectively. Asia
Pacific included China/Hong Kong net sales to customers of $3.5 billion, $3.3 billion and $3.6 billion in 2020, 2019, and 2018, respectively.
NOTE 3. Acquisitions and Divestitures
Acquisitions:
3M makes acquisitions of certain businesses from time to time that are aligned with its strategic intent with respect to, among other factors, growth
markets and adjacent product lines or technologies. Goodwill resulting from business combinations is largely attributable to the existing workforce
of the acquired businesses and synergies expected to arise after 3M’s acquisition of these businesses.
71

-- 83 of 160 --

2020 acquisitions:
There were no acquisitions that closed during the year ended December 31, 2020.
2019 acquisitions:
In February 2019, 3M completed the acquisition of the technology business of M*Modal for $0.7 billion of cash, net of cash acquired, and
assumption of $0.3 billion of M*Modal’s debt. Based in Pittsburgh, Pennsylvania, M*Modal is a leading healthcare technology provider of cloud-
based, conversational artificial intelligence-powered systems that help physicians efficiently capture and improve the patient narrative. The
allocation of purchase consideration related to M*Modal was completed in the fourth quarter of 2019. Net sales and operating loss (inclusive of
transaction and integration costs) of this business included in 3M’s consolidated results of operations in 2019 were approximately $300 million
and $25 million, respectively. M*Modal is reported within the Company’s Health Care business.
In October 2019, the Company completed the acquisition of all of the ownership interests of Acelity Inc. and its KCI subsidiaries. Acelity is a
leading global medical technology company focused on advanced wound care and specialty surgical applications marketed under the KCI brand.
In the first quarter of 2020, the Company paid certain considerations previously accrued under the terms of related agreements. Adjustments in
2020 to the purchase price allocation were approximately $34 million and related to identification and valuation of certain acquired assets and
liabilities. The change to provisional amounts did not result in material impacts to results of operations in 2020 or any portion related to earlier
quarters in the measurement period. The allocation of purchase consideration related to Acelity was completed in the third quarter of 2020. Net
sales and operating loss (inclusive of transaction and integration costs) of this business included in 3M’s consolidated results of operations in the
fourth quarter of 2019 were approximately $350 million and $45 million, respectively. Acelity is reported within the Company’s Health Care
business.
Proforma information related to these acquisitions has not been included as the impact on the Company’s consolidated results of operations was
not considered material. The following table shows the impact on the consolidated balance sheet of the purchase price allocations related to the
2019 acquisitions and assigned finite-lived asset weighted average lives.
2019 Acquisition Activity
Finite-Lived
Intangible-Asset
(Millions) 	Weighted-Average
Asset (Liability) 	M*Modal 	Acelity 	Total 	Lives (Years)
Accounts receivable 	$ 	75 	$ 	295 	$ 	370
Inventory 	— 	186 	186
Other current assets 	2 	65 	67
Property, plant, and equipment 	8 	147 	155
Purchased finite-lived intangible assets:
Customer related intangible assets 	275 	1,760 	2,035 	18
Other technology-based intangible assets 	160 	1,390 	1,550 	10
Definite-lived tradenames 	11 	485 	496 	16
Purchased goodwill 	517 	2,952 	3,469
Other assets 	58 	73 	131
Accounts payable and other liabilities 	(127) 	(438) 	(565)
Interest bearing debt 	(251) 	(2,322) 	(2,573)
Deferred tax asset/(liability) and accrued income taxes 	(24) 	(288) 	(312)
Net assets acquired 	$ 	704 	$ 	4,305 	$ 	5,009
Supplemental information:
Cash paid 	$ 	708 	$ 	4,486 	$ 	5,194
Less: Cash acquired 	4 	206 	210
Cash paid, net of cash acquired 	$ 	704 	$ 	4,280 	$ 	4,984
Consideration payable 	— 	25 	25
$ 	704 	$ 	4,305 	$ 	5,009
72

-- 84 of 160 --

Purchased identifiable finite-lived intangible assets related to acquisitions which closed in 2019 totaled $4.081 billion. The associated finite-lived
intangible assets acquired will be amortized on a systematic and rational basis (generally straight line) over a weighted-average life of 14 years
(lives ranging from 6 to 19 years).
2018 acquisition:
There were no acquisitions that closed during 2018.
Divestitures:
3M may divest certain businesses from time to time based upon review of the Company’s portfolio considering, among other items, factors
relative to the extent of strategic and technological alignment and optimization of capital deployment, in addition to considering if selling the
businesses results in the greatest value creation for the Company and for shareholders. As discussed in Note 19 (Business Segments), gains/losses
on sale of businesses are reflected in Corporate and Unallocated.
2020 divestitures:
In January 2020, 3M completed the sale of its advanced ballistic-protection business, formerly part of the Transportation and Electronics business,
to Avon Rubber p.l.c for $86 million in cash and recognized certain contingent consideration from the outcome of pending tenders. Further
contingent consideration of less than $25 million may be recognized depending on outcomes in the future. The business, with annual sales of
approximately $85 million, consists of ballistic helmets, body armor, flat armor and related helmet-attachment products serving government and
law enforcement. 3M reflected immaterial impacts in the third quarter of 2019 as a result of measuring this disposal group at the lower of its
carrying amount or fair value less cost to sell and in the first quarter 2020 related to completion of the divestiture and recognition of contingent
consideration.
In May 2020, 3M completed the sale of substantially all of its drug delivery business, formerly part of the Health Care business, to an affiliate of
Altaris Capital Partners, LLC for $617 million in consideration including $487 million of cash, approximately $70 million in the form of an
interest-bearing security, and approximately $60 million in the form of a 17 percent noncontrolling interest in the new company, Kindeva Drug
Delivery (Kindeva). Non-cash consideration was valued at time of initial recognition on an income-based approach using relevant estimated future
cash flows and applicable market interest rates while considering impacts of restrictions related to transferability. The divested business had
annual sales of approximately $380 million. 3M retained its transdermal drug delivery components business. 3M reflected a pre-tax gain of $387
million as a result of the divestiture. The Company reflects its ownership interest in Kindeva using the equity method of accounting incorporating
the recording of 3M’s share of earnings/losses on a lag-basis based on availability of Kindeva financial statements. As a result, income/loss from
this unconsolidated subsidiary began to be reflected in 3M’s financial statements in the third quarter of 2020. Kindeva and 3M entered into certain
limited-term agreements related to post-divestiture transition and supply services.
In the third quarter of 2020, 3M completed the sale of a small dermatology products business, formerly part of the Health Care business, for
immaterial proceeds that approximated the business’s book value.
2019 divestitures:
During the first quarter of 2019, the Company sold certain oral care technology comprising a business and reflected an earnout on a previous
divestiture resulting in an aggregate immaterial gain.
In August 2019, 3M closed on the sale of its gas and flame detection business, a leader in fixed and portable gas and flame detection, to Teledyne
Technologies Incorporated. 3M’s gas and flame business was part of the overall October 2017 acquisition of underlying legal entities and
associated assets of Scott Safety. This business has annual sales of approximately $120 million. The transaction resulted in a pre-tax gain of $112
million that was reported within the Company’s Safety and Industrial business.
2018 divestitures:
In February 2018, 3M closed on the sale of certain personal safety product offerings primarily focused on noise, environmental, and heat stress
monitoring to TSI, Inc. This business has annual sales of approximately $15 million. The transaction resulted in a pre-tax
73

-- 85 of 160 --

gain of less than $20 million. In addition, during the first quarter of 2018, 3M divested a polymer additives compounding business, formerly part
of the Company’s Health Care business, and reflected a gain on final closing adjustments from a prior divestiture which, in aggregate, were not
material. In May 2018, 3M divested an abrasives glass products business, formerly part of the Company’s Safety and Industrial business, with
annual sales of approximately $10 million. The transaction resulted in a pre-tax gain of less than $15 million.
In June 2018, 3M completed the sale of substantially all of its Communication Markets Division to Corning Incorporated. This business, with
annual sales of approximately $400 million, consists of optical fiber and copper passive connectivity solutions for the telecommunications industry
including 3M’s xDSL, FTTx, and structured cabling solutions and, in certain countries, telecommunications system integration services. 3M
received cash proceeds of $772 million and reflected a pre-tax gain of $494 million as a result of this divestiture. In December 2018, the Company
completed the sale of the remaining telecommunications system integration services portion of the business based in Germany, resulting in a pre-
tax gain of $15 million.
Operating income and held for sale amounts
The aggregate operating income of these businesses was approximately $40 million, $40 million, and $85 million in 2020, 2019, and 2018,
respectively. The approximate amounts of major assets and liabilities associated with disposal groups classified as held-for-sale as of December
31, 2019 included the following:
December 31,
(Millions) 	2019
Inventory 	$ 	70
Property, plant and equipment 	150
Intangible assets 	35
In addition, approximately $30 million of goodwill was estimated to be attributable to disposal groups classified as held-for-sale as of December
31, 2019, based upon relative fair value. The amounts above have not been segregated and are classified within the existing corresponding line
items on the Company’s consolidated balance sheet.
NOTE 4. Goodwill and Intangible Assets
Goodwill
There was no goodwill recorded from acquisitions during 2020. Goodwill from acquisitions total $3.5 billion in 2019, none of which was
deductible for tax purposes. The acquisition activity in the following table also includes the net impact of adjustments to the preliminary allocation
of purchase price within the one year measurement-period following prior acquisitions, which decreased goodwill by $34 million during 2020. The
amounts in the “Translation and other” column in the following table primarily relate to changes in foreign currency exchange rates. The goodwill
balance by business segment follows:
(Millions)
Safety and
Industrial
Transportation
and Electronics 	Health Care 	Consumer 	Total Company
Balance as of December 31, 2018 	$ 	4,716 	$ 	1,857 	$ 	3,248 	$ 	230 	$ 	10,051
Acquisition activity 	— 	— 	3,469 	— 	3,469
Divestiture activity 	(49) 	— 	— 	— 	(49)
Translation and other 	(46) 	(27) 	22 	24 	(27)
Balance as of December 31, 2019 	$ 	4,621 	$ 	1,830 	$ 	6,739 	$ 	254 	$ 	13,444
Acquisition activity 	— 	— 	(34) 	— 	(34)
Divestiture activity 	— 	(10) 	(19) 	— 	(29)
Translation and other 	66 	38 	306 	11 	421
Balance as of December 31, 2020 	$ 	4,687 	$ 	1,858 	$ 	6,992 	$ 	265 	$ 	13,802
Accounting standards require that goodwill be tested for impairment annually and between annual tests in certain circumstances such as a change
in reporting units or the testing of recoverability of a significant asset group within a reporting unit. At 3M, reporting units correspond to a
division.
As described in Note 19, effective in the first quarter of 2020, the Company changed its business segment reporting. For any product changes that
resulted in reporting unit changes, the Company applied the relative fair value method to determine the impact on
74

-- 86 of 160 --

goodwill of the associated reporting units, the results of which were immaterial. In conjunction with the change in segment reporting, 3M
completed an assessment indicating no goodwill impairment existed as a result of this new segment structure. Goodwill balances reported above
reflect these business segment reporting changes in the earliest period presented. The Company also completed its annual goodwill impairment test
in the fourth quarter of 2020 for all reporting units and determined that no impairment existed. In addition, the Company had no impairments of
goodwill in 2019 or 2018.
Acquired Intangible Assets
The carrying amount and accumulated amortization of acquired finite-lived intangible assets, in addition to the balance of non-amortizable
intangible assets, as of December 31, follow:
December 31, 	December 31,
(Millions) 	2020 	2019
Customer related intangible assets 	$ 	4,280 	$ 	4,316
Patents 	537 	538
Other technology-based intangible assets 	2,114 	2,124
Definite-lived tradenames 	1,178 	1,158
Other amortizable intangible assets 	104 	125
Total gross carrying amount 	$ 	8,213 	$ 	8,261
Accumulated amortization — customer related 	(1,422) 	(1,180)
Accumulated amortization — patents 	(512) 	(499)
Accumulated amortization — other technology-based 	(638) 	(435)
Accumulated amortization — definite-lived tradenames 	(385) 	(316)
Accumulated amortization — other 	(79) 	(90)
Total accumulated amortization 	$ 	(3,036) 	$ 	(2,520)
Total finite-lived intangible assets — net 	$ 	5,177 	$ 	5,741
Non-amortizable intangible assets (primarily tradenames) 	658 	638
Total intangible assets — net 	$ 	5,835 	$ 	6,379
Certain tradenames acquired by 3M are not amortized because they have been in existence for over 60 years, have a history of leading-market
share positions, have been and are intended to be continuously renewed, and the associated products of which are expected to generate cash flows
for 3M for an indefinite period of time. As discussed in Note 15, 3M reflected an immaterial charge related to impairment of certain indefinite-
lived assets in the first quarter of 2020.
Amortization expense for the years ended December 31 follows:
(Millions) 	2020 	2019 	2018
Amortization expense 	$ 	537 	$ 	341 	$ 	249
Expected amortization expense for acquired amortizable intangible assets recorded as of December 31, 2020 follows:
After
(Millions) 	2021 	2022 	2023 	2024 	2025 	2025
Amortization expense 	$ 	528 	$ 	515 	$ 	488 	$ 	459 	$ 	428 	$ 	2,759
The preceding expected amortization expense is an estimate. Actual amounts of amortization expense may differ from estimated amounts due to
additional intangible asset acquisitions, changes in foreign currency exchange rates, impairment of intangible assets, accelerated amortization of
intangible assets and other events. 3M expenses the costs incurred to renew or extend the term of intangible assets.
75

-- 87 of 160 --

NOTE 5. Restructuring Actions
2020 Restructuring Actions:
Operational/Marketing Capability Restructuring:
In late 2020, 3M announced it would undertake certain actions to further enhance its operations and marketing capabilities to take advantage of
certain global market trends while de-prioritizing investments in slower-growth end markets. During the fourth quarter of 2020, management
approved and committed to undertake associated restructuring actions impacting approximately 2,100 positions resulting in a pre-tax charge of
$137 million. 3M is planning further actions under this initiative primarily in the second half of 2021. This aggregate initiative, spanning 2020 and
2021, is expected to impact approximately 2,900 positions worldwide with an expected pre-tax charge of $250 to $300 million. The related 2020
restructuring charges were recorded in the income statement as follows:
(Millions) 	Fourth Quarter 2020
Cost of sales 	$ 	51
Selling, general and administrative expenses 	79
Research, development and related expenses 	7
Total operating income impact 	$ 	137
The business segment operating income impact of these restructuring charges is summarized as follows:
Fourth Quarter 2020
(Millions) 	Employee-Related
Asset-Related and
Other 	Total
Safety and Industrial 	$ 	36 	$ 	7 	$ 	43
Transportation and Electronics 	16 	12 	28
Health Care 	23 	3 	26
Consumer 	10 	1 	11
Corporate and Unallocated 	16 	13 	29
Total Operating Expense 	$ 	101 	$ 	36 	$ 	137
Restructuring actions, including cash and non-cash impacts, follow:
(Millions) 	Employee-Related
Asset-Related and
Other 	Total
Expense incurred in the fourth quarter of 2020 	$ 	101 	$ 	36 	$ 	137
Non-cash changes 	— 	(36) 	(36)
Accrued restructuring action balances as of December 31, 2020 	$ 	101 	$ 	— 	$ 	101
Remaining activities related to this restructuring actions approved and committed under this initiative in the 2020 are expected to be largely
completed through 2021.
Divestiture-Related Restructuring
During the second quarter of 2020, following the divestiture of substantially all of the drug delivery business (see Note 3) management approved
and committed to undertake certain restructuring actions addressing corporate functional costs and manufacturing footprint across 3M in relation
to the magnitude of amounts previously allocated/burdened to the divested business.
76

-- 88 of 160 --

These actions affected approximately 1,300 positions worldwide and resulted in a second quarter 2020 pre-tax charge of $55 million, within
Corporate and Unallocated. The divestiture-related restructuring actions were recorded in the income statement as follows:
(Millions) 	Second Quarter 2020
Cost of sales 	$ 	42
Selling, general and administrative expenses 	12
Research, development and related expenses 	1
Total operating income impact 	$ 	55
Divestiture-related restructuring actions, including cash and non-cash impacts, follow:
(Millions) 	Employee-Related
Asset-Related and
Other 	Total
Expense incurred in the second quarter of 2020 	$ 	32 	$ 	23 	$ 	55
Non-cash changes 	— 	(14) 	(14)
Cash payments 	(14) 	— 	(14)
Adjustments 	(3) 	— 	(3)
Accrued divestiture-related restructuring action balances as of December 31, 2020 	$ 	15 	$ 	9 	$ 	24
Remaining activities related to this divestiture-related restructuring are expected to be largely completed through the second quarter of 2021.
Other Restructuring
Additionally, in the second quarter of 2020, management approved and committed to undertake certain restructuring actions addressing structural
enterprise costs and operations in certain end markets as a result of the COVID-19 pandemic and related economic impacts. These actions affected
approximately 400 positions worldwide and resulted in a second quarter 2020 pre-tax charge of $58 million. The restructuring charges were
recorded in the income statement as follows:
(Millions) 	Second Quarter 2020
Cost of sales 	$ 	13
Selling, general and administrative expenses 	37
Research, development and related expenses 	8
Total operating income impact 	$ 	58
The business segment operating income impact of these restructuring charges is summarized as follows:
Second Quarter 2020
(Millions) 	Employee-Related
Asset-Related and
Other 	Total
Safety and Industrial 	$ 	7 	$ 	— 	$ 	7
Transportation and Electronics 	11 	— 	11
Health Care 	12 	— 	12
Consumer 	5 	— 	5
Corporate and Unallocated 	— 	23 	23
Total Operating Expense 	$ 	35 	$ 	23 	$ 	58
77

-- 89 of 160 --

Restructuring actions, including cash and non-cash impacts, follow:
(Millions) 	Employee-Related 	Asset-Related 	Total
Expense incurred in the second quarter of 2020 	$ 	35 	$ 	23 	$ 	58
Non-cash changes 	— 	(23) 	(23)
Cash payments 	(2) 	— 	(2)
Adjustments 	(9) 	— 	(9)
Accrued restructuring action balances as of December 31, 2020 	$ 	24 	$ 	— 	$ 	24
Remaining activities related to this restructuring are expected to be largely completed through the second quarter of 2021.
2019 Restructuring Actions:
During the second quarter of 2019, in light of slower than expected 2019 sales, management approved and committed to undertake certain
restructuring actions. These actions impacted approximately 2,000 positions worldwide, including attrition. The Company recorded second quarter
2019 pre-tax charges of $148 million. Additionally, during the fourth quarter of 2019, to realign 3M’s organizational structure and operating
model to improve growth and operational efficiency, management approved and committed to undertake certain restructuring actions. These
actions impacted approximately 1,500 positions worldwide. The Company recorded fourth quarter 2019 pre-tax charges of $134 million. These
restructuring charges were recorded in the income statement as follows:
(Millions)
Second and Fourth Quarter
2019
Cost of sales 	$ 	72
Selling, general and administrative expenses 	137
Research, development and related expenses 	37
Total operating income impact 	246
Other expense (income), net 	36
Total income before income taxes impact 	$ 	282
The second quarter 2019 actions included a voluntary early retirement incentive initial charge (further discussed in Note 13), the charge for which
is included in other expense (income), net above.
The operating income impact of these restructuring charges are summarized by business segment as follows:
Second and Fourth Quarter 2019
(Millions) 	Employee-Related 	Asset-Related 	Total
Safety and Industrial 	$ 	50 	$ 	— 	$ 	50
Transportation and Electronics 	31 	— 	31
Health Care 	17 	— 	17
Consumer 	8 	— 	8
Corporate and Unallocated 	100 	40 	140
Total Operating Expense 	$ 	206 	$ 	40 	$ 	246
Restructuring actions, including cash and non-cash impacts, follow:
78

-- 90 of 160 --

(Millions) 	Employee-Related 	Asset-Related 	Total
Expense incurred in the second quarter and fourth quarter of 2019 	$ 	242 	$ 	40 	$ 	282
Non-cash changes 	(36) 	(40) 	(76)
Cash payments 	(52) 	— 	(52)
Adjustments 	(14) 	— 	(14)
Accrued restructuring action balances as of December 31, 2019 	$ 	140 	$ 	— 	$ 	140
Cash Payments 	(51) 	— 	(51)
Adjustments 	(59) 	— 	(59)
Accrued restructuring action balances as of December 31, 2020 	$ 	30 	$ 	— 	$ 	30
Adjustments in the table above reflect changes in estimates from factors such as additional natural attrition and redeployment as COVID-19
delayed the start of plan execution and update of costs associated with the mix of impacted roles. Remaining activities related to this restructuring
are expected to be completed largely through early 2021.
79

-- 91 of 160 --

2018 Restructuring Actions:
Divestiture-Related Restructuring
During the second quarter and fourth quarter of 2018, management approved and committed to undertake certain restructuring actions related to
addressing corporate functional costs following the Communication Markets Division divestiture. These actions affected approximately 1,200
positions worldwide and resulted in a second quarter 2018 pre-tax charge of $105 million and a fourth quarter pre-tax charge of $22 million, net of
adjustments for reductions in cost estimates of $10 million, essentially all within Corporate and Unallocated. The restructuring charges were
recorded in the income statement as follows:
(Millions) 	Second and Fourth Quarter 2018
Cost of sales 	$ 	27
Selling, general and administrative expenses 	105
Research, development and related expenses 	5
Total 	$ 	137
Restructuring actions, including cash and non-cash impacts, follow:
(Millions) 	Employee-Related 	Asset-Related 	Total
Expense incurred in the second quarter and fourth quarter of 2018 	$ 	125 	$ 	12 	$ 	137
Non-cash changes 	— 	(12) 	(12)
Cash payments 	(24) 	— 	(24)
Adjustments 	(17) 	— 	(17)
Accrued restructuring action balances as of December 31, 2018 	$ 	84 	$ 	— 	$ 	84
Cash payments 	(76) 	— 	(76)
Adjustments 	(5) 	— 	(5)
Accrued restructuring action balances as of December 31, 2019 	$ 	3 	$ 	— 	$ 	3
Remaining activities related to this restructuring were substantially completed in 2019.
NOTE 6. Supplemental Income Statement Information
Other expense (income), net consists of the following:
(Millions) 	2020 	2019 	2018
Interest expense 	$ 	529 	$ 	448 	$ 	350
Interest income 	(29) 	(80) 	(70)
Pension and postretirement net periodic benefit cost (benefit) 	(50) 	(68) 	(73)
Loss on deconsolidation of Venezuelan subsidiary 	— 	162 	—
Total 	$ 	450 	$ 	462 	$ 	207
Interest expense includes an early debt extinguishment pre-tax charge of approximately $10 million in the fourth quarter of 2020.
Pension and postretirement net periodic benefit costs described in the table above include all components of defined benefit plan net periodic
benefit costs except service cost, which is reported in various operating expense lines. Pension and postretirement net periodic benefit costs for
2019 included a second quarter charge related to the voluntary early retirement incentive program announced in May 2019 in addition to U.S. non-
qualified pension plan settlement charges of $32 million recognized in the fourth quarter of 2019. Refer to Note 13 for additional details on the
voluntary early retirement incentive program in addition to the components of pension and postretirement net periodic benefit costs.
In the second quarter of 2019, the Company incurred a charge of $162 million related to the deconsolidation of its Venezuelan subsidiary. Refer to
Note 1 for additional details.
80

-- 92 of 160 --

NOTE 7. Supplemental Balance Sheet Information
Additional supplemental balance sheet information is provided in the table that follows.
(Millions) 	2020 	2019
Other current assets
Derivative assets-current 	$ 	34 	$ 	75
Held-to-maturity debt security held in trust 	— 	470
Insurance related (receivables, prepaid expenses and other) 	125 	172
Other 	166 	174
Total other current assets 	$ 	325 	$ 	891
Property, plant and equipment - at cost
Land 	$ 	338 	$ 	351
Buildings and leasehold improvements 	8,021 	7,877
Machinery and equipment 	16,866 	16,586
Construction in progress 	1,425 	1,310
Gross property, plant and equipment 	26,650 	26,124
Accumulated depreciation 	(17,229) 	(16,791)
Property, plant and equipment - net 	$ 	9,421 	$ 	9,333
Other assets
Deferred income taxes 	$ 	871 	$ 	521
Prepaid pension and post retirement 	630 	230
Insurance related receivables and other 	49 	67
Cash surrender value of life insurance policies 	258 	254
Equity method investments 	134 	70
Equity and other investments 	80 	126
Other 	418 	406
Total other assets 	$ 	2,440 	$ 	1,674
Other current liabilities
Accrued rebates 	$ 	639 	$ 	594
Deferred revenue 	498 	430
Derivative liabilities 	81 	17
Employee benefits and withholdings 	192 	229
Contingent liability claims and other 	556 	566
Property, sales-related and other taxes 	308 	247
Pension and postretirement benefits 	71 	67
Other 	933 	906
Total other current liabilities 	$ 	3,278 	$ 	3,056
Other liabilities
Long term income taxes payable 	$ 	1,511 	$ 	1,507
Employee benefits 	410 	312
Contingent liability claims and other 	815 	787
Finance lease obligations 	93 	111
Deferred income taxes 	333 	301
Other 	300 	257
Total other liabilities 	$ 	3,462 	$ 	3,275
81

-- 93 of 160 --

NOTE 8. Supplemental Equity and Comprehensive Income Information
Common stock ($.01 par value per share) of 3.0 billion shares is authorized, with 944,033,056 shares issued as of December 31, 2020, 2019 and
2018. Preferred stock, without par value, of 10 million shares is authorized but unissued.
Cash dividends declared and paid totaled $1.47, $1.44, and $1.36 per share for each quarter in 2020, 2019 and 2018, respectively, which resulted
in total year declared and paid dividends of $5.88, $5.76, and $5.44 per share, respectively.
In connection with 3M’s January 1, 2019 adoption of ASU No. 2018-02, Reclassification of Certain Tax Effects from Accumulated Other
Comprehensive Income, and ASU No. 2016-02, Leases, the Company recorded an increase in retained earnings of approximately $0.9 billion
(with offsetting increase to accumulated other comprehensive loss for the same amount) and $14 million, respectively.
Transfer of Ownership Interest Involving Non-Wholly Owned Subsidiaries
During 2018, a wholly owned subsidiary in India was sold to 3M India Limited, which is 75 percent owned by the Company. Because the
Company retained its controlling interest in the subsidiary involved, the sale resulted in a deemed dividend to 3M, resulting in an increase in 3M
Company shareholders’ equity and a decrease in noncontrolling interest. Refer to the Consolidated Statement of Changes in Equity for further
details.
Changes in Accumulated Other Comprehensive Income (Loss) Attributable to 3M by Component
Defined Benefit 	Cash Flow 	Total
Pension and 	Hedging 	Accumulated
Cumulative 	Postretirement 	Instruments, 	Other
Translation 	Plans 	Unrealized 	Comprehensive
(Millions) 	Adjustment 	Adjustment 	Gain (Loss) 	Income (Loss)
Balance at December 31, 2017, net of tax: 	$ 	(1,638) 	$ 	(5,276) 	$ 	(112) 	$ 	(7,026)
Other comprehensive income (loss), before tax:
Amounts before reclassifications 	(414) 	55 	133 	(226)
Amounts reclassified out 	— 	606 	96 	702
Total other comprehensive income (loss), before tax 	(414) 	661 	229 	476
Tax effect 	(47) 	(217) 	(53) 	(317)
Total other comprehensive income (loss), net of tax 	(461) 	444 	176 	159
Impact from purchase of subsidiary shares 	1 	— 	— 	1
Balance at December 31, 2018, net of tax: 	$ 	(2,098) 	$ 	(4,832) 	$ 	64 	$ 	(6,866)
Impact of adoption of ASU No. 2018-02 	(13) 	(817) 	(23) 	(853)
Other comprehensive income (loss), before tax:
Amounts before reclassifications 	102 	(1,227) 	(26) 	(1,151)
Amounts reclassified out 	142 	459 	(70) 	531
Total other comprehensive income (loss), before tax 	244 	(768) 	(96) 	(620)
Tax effect 	(32) 	208 	24 	200
Total other comprehensive income (loss), net of tax 	212 	(560) 	(72) 	(420)
Balance at December 31, 2019, net of tax: 	$ 	(1,899) 	$ 	(6,209) 	$ 	(31) 	$ 	(8,139)
Other comprehensive income (loss), before tax:
Amounts before reclassifications 	387 	(555) 	(113) 	(281)
Amounts reclassified out 	— 	676 	(71) 	605
Total other comprehensive income (loss), before tax 	387 	121 	(184) 	324
Tax effect 	62 	50 	42 	154
Total other comprehensive income (loss), net of tax 	449 	171 	(142) 	478
Balance at December 31, 2020, net of tax: 	$ 	(1,450) 	$ 	(6,038) 	$ 	(173) 	$ 	(7,661)
Income taxes are not provided for foreign translation relating to permanent investments in international subsidiaries, but tax effects within
cumulative translation does include impacts from items such as net investment hedge transactions. Reclassification adjustments are made to avoid
double counting in comprehensive income items that are subsequently recorded as part of net income.
82

-- 94 of 160 --

Reclassifications out of Accumulated Other Comprehensive Income Attributable to 3M
Amounts Reclassified from
Details about Accumulated Other 	Accumulated Other Comprehensive Income
Comprehensive Income Components 	Year ended December 31, 	Location on Income
(Millions) 	2020 	2019 	2018 	Statement
Cumulative translation adjustment
Deconsolidation of Venezuelan subsidiary 	$ 	— 	$ 	(142) 	$ 	— 	Other (expense) income, net
Total before tax 	— 	(142) 	—
Tax effect 	— 	— 	— 	Provision for income taxes
Net of tax 	$ 	— 	$ 	(142) 	$ 	—
Defined benefit pension and postretirement plans adjustments
Gains (losses) associated with defined benefit pension and postretirement
plans amortization
Transition asset 	$ 	(2) 	$ 	— 	$ 	— 	See Note 13
Prior service benefit 	62 	69 	76 	See Note 13
Net actuarial loss 	(716) 	(478) 	(678) 	See Note 13
Curtailments/Settlements 	(20) 	(48) 	(4) 	See Note 13
Deconsolidation of Venezuelan subsidiary 	— 	(2) 	— 	Other (expense) income, net
Total before tax 	(676) 	(459) 	(606)
Tax effect 	161 	110 	145 	Provision for income taxes
Net of tax 	$ 	(515) 	$ 	(349) 	$ 	(461)
Cash flow hedging instruments gains (losses)
Foreign currency forward/option contracts 	$ 	80 	$ 	74 	$ 	(95) 	Cost of sales
Interest rate contracts 	(9) 	(4) 	(1) 	Interest expense
Total before tax 	71 	70 	(96)
Tax effect 	(17) 	(17) 	19 	Provision for income taxes
Net of tax 	$ 	54 	$ 	53 	$ 	(77)
Total reclassifications for the period, net of tax 	$ 	(461) 	$ 	(438) 	$ 	(538)
NOTE 9. Supplemental Cash Flow Information
(Millions) 	2020 	2019 	2018
Cash income tax payments, net of refunds 	$ 	1,351 	$ 	1,198 	$ 	1,560
Cash interest payments 	524 	370 	314
Cash interest payments include interest paid on debt and finance lease balances. Cash interest payments exclude the cash paid for early debt
extinguishment costs. Additional details are described in Note 12.
Individual amounts in the Consolidated Statement of Cash Flows exclude the impacts of acquisitions, divestitures and exchange rate impacts,
which are presented separately.
NOTE 10. Income Taxes
Income Before Income Taxes
(Millions) 	2020 	2019 	2018
United States 	$ 	3,720 	$ 	3,008 	$ 	3,487
International 	2,991 	2,704 	3,513
Total 	$ 	6,711 	$ 	5,712 	$ 	7,000
83

-- 95 of 160 --

Provision for Income Taxes
(Millions) 	2020 	2019 	2018
Currently payable
Federal 	$ 	720 	$ 	534 	$ 	698
State 	123 	59 	109
International 	633 	673 	763
Tax Cuts and Jobs Act (TCJA) non-current transition tax provision 	— 	— 	176
Deferred
Federal 	(59) 	(32) 	(38)
State 	(20) 	(26) 	(17)
International 	(79) 	(78) 	(54)
Total 	$ 	1,318 	$ 	1,130 	$ 	1,637
Components of Deferred Tax Assets and Liabilities
(Millions) 	2020 	2019
Deferred tax assets:
Accruals not currently deductible
Employee benefit costs 	$ 	232 	$ 	169
Product and other claims 	338 	280
Miscellaneous accruals 	153 	119
Pension costs 	849 	824
Stock-based compensation 	231 	218
Net operating/capital loss/tax credit carryforwards 	148 	150
Foreign tax credits 	100 	66
Currency translation 	90 	—
Inventory 	54 	70
Other 	112 	113
Gross deferred tax assets 	2,307 	2,009
Valuation allowance 	(135) 	(158)
Total deferred tax assets 	$ 	2,172 	$ 	1,851
Deferred tax liabilities:
Product and other insurance receivables 	$ 	(4) 	$ 	—
Accelerated depreciation 	(607) 	(580)
Intangible amortization 	(1,023) 	(1,021)
Currency translation 	— 	(30)
Other 	— 	—
Total deferred tax liabilities 	$ 	(1,634) 	$ 	(1,631)
Net deferred tax assets 	$ 	538 	$ 	220
The net deferred tax assets are included as components of Other Assets and Other Liabilities within the Consolidated Balance Sheet. See Note 7
“Supplemental Balance Sheet Information” for further details.
As of December 31, 2020, the Company had tax effected operating losses, capital losses, and tax credit carryovers for federal (approximately $108
million), state (approximately $84 million), and international (approximately $58 million), with all amounts before limitation impacts and
valuation allowances. Federal tax attribute carryovers will expire after one to 10 years, the state after one to 11 years, and the international after
one year to an indefinite carryover period. As of December 31, 2020, the Company has provided $135 million of valuation allowance against
certain of these deferred tax assets based on management’s determination that it is more-likely-than-not that the tax benefits related to these assets
will not be realized.
84

-- 96 of 160 --

Reconciliation of Effective Income Tax Rate
2020 	2019 	2018
Statutory U.S. tax rate 	21.0 % 	21.0 % 	21.0 %
State income taxes - net of federal benefit 	1.2 	0.5 	1.0
International income taxes - net 	(1.2) 	0.2 	0.2
Global Intangible Low Taxed Income (GILTI) 	0.8 	1.8 	1.1
Foreign Derived Intangible Income (FDII) 	(1.8) 	(2.9) 	(1.3)
U.S. TCJA enactment - net impacts 	— 	— 	2.5
U.S. research and development credit 	(1.0) 	(1.7) 	(1.5)
Reserves for tax contingencies 	0.5 	2.3 	1.2
Employee share-based payments 	(0.5) 	(1.3) 	(1.4)
All other - net 	0.6 	(0.1) 	0.6
Effective worldwide tax rate 	19.6 % 	19.8 % 	23.4 %
The effective tax rate for 2020 was 19.6 percent, compared to 19.8 percent in 2019, a decrease of 0.2 percentage points, impacted by several
factors. Primary factors that decreased the effective tax rate for 2020 included geographical income mix and adjustments to uncertain tax positions.
These decreases were partially offset by decreased benefit from stock options.
The effective tax rate for 2019 was 19.8 percent, compared to 23.4 percent in 2018, a decrease of 3.6 percentage points, impacted by several
factors. Primary factors that decreased the effective tax rate for 2020 included prior year measurement period adjustments related to 2017 Tax Cuts
and Jobs Act (TCJA), prior year resolution of the NRD lawsuit (as described in Note 16), and geographical income mix. These decreases were
partially offset by the deconsolidation of the Venezuelan subsidiary, adjustments to uncertain tax positions, and significant litigation-related
charges.
The TCJA was enacted in December 2017, after which the SEC staff issued Staff Accounting Bulletin (SAB) 118, which provided a measurement
period of up to one year from the TCJA’s enactment date for companies to complete their accounting under ASC 740. In connection with the
enactment of the TCJA, the Company recorded net charges of $176 million as measurement period adjustments in 2018, which are comprised of
both a transition tax in addition to a remeasurement of deferred tax assets/liabilities and other impacts.
The TCJA’s transition tax is payable over eight years beginning in 2018. As of December 31, 2020 and December 31, 2019, 3M reflected $584
million and $653 million, respectively, in long term income taxes payable. As of December 31, 2020 and December 31, 2019, 3M reflected $69
million and $33 million, respectively, payable within one year associated with the transition tax.
The IRS has completed its field examination of the Company’s U.S. federal income tax returns for 2005 through 2016, but the years have not
closed as the Company is in the process of resolving issues identified during those examinations. The Company is under examination or in appeals
for 2017 through 2018. In addition to the U.S. federal examination, there is also audit activity in several U.S. state and foreign jurisdictions where
the Company is subject to ongoing tax examinations and governmental assessments, which could be impacted by evolving political environments
in those jurisdictions. As of December 31, 2020, no taxing authority proposed significant adjustments to the Company’s tax positions for which the
Company is not adequately reserved.
It is reasonably possible that the amount of unrecognized tax benefits could significantly change within the next 12 months. The Company has
ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by
local tax authorities and not fully sustained. These uncertain tax positions are reviewed on an ongoing basis and adjusted in light of facts and
circumstances including progression of tax audits, developments in case law and closing of statutes of limitation. At this time, the Company is not
able to estimate the range by which these potential events could impact 3M’s unrecognized tax benefits within the next 12 months.
85

-- 97 of 160 --

The Company recognizes the amount of tax benefit that has a greater than 50 percent likelihood of being ultimately realized upon settlement. A
reconciliation of the beginning and ending amount of gross unrecognized tax benefits (UTB) is as follows:
Federal, State and Foreign Tax
(Millions) 	2020 	2019 	2018
Gross UTB Balance at January 1 	$ 	1,167 	$ 	647 	$ 	530
Additions based on tax positions related to the current year 	74 	76 	129
Additions for tax positions of prior years 	106 	132 	146
Additions related to recent acquisitions 	— 	396 	—
Reductions for tax positions of prior years 	(173) 	(56) 	(123)
Settlements 	(8) 	(4) 	(17)
Reductions due to lapse of applicable statute of limitations 	(53) 	(24) 	(18)
Gross UTB Balance at December 31 	$ 	1,113 	$ 	1,167 	$ 	647
Net UTB that would impact the effective tax rate at December 31 	$ 	1,145 	$ 	1,178 	$ 	655
The total amount of UTB, if recognized, would affect the effective tax rate by $1,145 million as of December 31, 2020, $1,178 million as of
December 31, 2019, and $655 million as of December 31, 2018. The ending net UTB results from adjusting the gross balance for deferred items,
interest and penalties, and deductible taxes. The net UTB is included as components of Other Assets, Accrued Income Taxes, and Other Liabilities
within the Consolidated Balance Sheet.
The Company recognizes interest and penalties accrued related to unrecognized tax benefits in tax expense. The Company recognized in the
consolidated statement of income on a gross basis approximately $21 million of expense, $33 million of expense, and $12 million of expense in
2020, 2019, and 2018, respectively. The amount of interest and penalties recognized may be an expense or benefit due to new or remeasured
unrecognized tax benefit accruals. At December 31, 2020, and December 31, 2019, accrued interest and penalties in the consolidated balance sheet
on a gross basis were $126 million and $102 million, respectively. Included in these interest and penalty amounts are interest and penalties related
to tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.
As a result of certain employment commitments and capital investments made by 3M, income from certain manufacturing activities in the
following countries is subject to reduced tax rates or, in some cases, is exempt from tax for years through the following: China (2022), Switzerland
(2023), Singapore (2025), and Brazil (2029). The income tax benefits attributable to the tax status of these subsidiaries are estimated to be $163
million (28 cents per diluted share) in 2020, $127 million (22 cents per diluted share) in 2019, and $227 million (38 cents per diluted share) in
2018.
As of December 31, 2020, the Company has approximately $15 billion of undistributed earnings in its foreign subsidiaries. During the third
quarter of 2020, 3M determined that approximately $5 billion of these earnings are no longer considered permanently reinvested. The incremental
tax cost to repatriate these earnings to the US is immaterial. The Company has not provided deferred taxes on approximately $10 billion of
undistributed earnings from non-U.S. subsidiaries as of December 31, 2020 which are indefinitely reinvested in operations. Because of the
multiple avenues by which to repatriate the earnings to minimize tax cost, and because a large portion of these earnings are not liquid, it is not
practical to determine the income tax liability that would be payable if such earnings were not reinvested indefinitely.
In March 2020, in response to the impact of the COVID-19 pandemic in the U.S. and across the globe, the United States Congress passed the
Coronavirus Aid, Relief and Economic Security (CARES) Act. In December 2020, Congress passed a second relief package, Consolidated
Appropriations Act, 2021. The enactment period impacts to 3M were immaterial to income tax expense.
86

-- 98 of 160 --

NOTE 11. Marketable Securities and Held-to-Maturity Debt Securities
Marketable Securities
The Company invests in asset-backed securities, certificates of deposit/time deposits, commercial paper, and other securities. The following is a
summary of amounts recorded on the Consolidated Balance Sheet for marketable securities (current and non-current).
(Millions) 	December 31, 2020 	December 31, 2019
Corporate debt securities 	$ 	7 	$ 	—
Commercial paper 	237 	85
Certificates of deposit/time deposits 	31 	10
U.S. treasury securities 	125 	—
U.S. municipal securities 	4 	3
Current marketable securities 	$ 	404 	$ 	98
U.S. municipal securities 	$ 	30 	$ 	43
Non-current marketable securities 	$ 	30 	$ 	43
Total marketable securities 	$ 	434 	$ 	141
At December 31, 2020 and 2019, gross unrealized, gross realized, and net realized gains and/or losses (pre-tax) were not material.
The balance at December 31, 2020, for marketable securities by contractual maturity are shown below. Actual maturities may differ from
contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.
(Millions) 	December 31, 2020
Due in one year or less 	$ 	404
Due after one year through five years 	15
Due after five years through ten years 	15
Total marketable securities 	$ 	434
Held-to-Maturity Debt Securities
In connection with the in-substance debt defeasance of the Third Lien Notes described in Note 12, the Company purchased a $0.5 billion U.S.
Treasury security in the fourth quarter of 2019 and transferred it to a trust with irrevocable instructions to use the proceeds from its maturity to
satisfy the redemption of the Third Lien Notes that occurred in May 2020. At December 31, 2019, this debt security was considered held-to-
maturity due to the restrictions in satisfying and discharging the Third Lien Notes, was carried at amortized cost, and was reflected in other current
assets on the Company’s consolidated balance sheet. At December 31, 2019, the difference between the amortized cost of the U.S. Treasury
security and its fair value was not material. Upon the maturity of the debt security in May 2020, the Company has no held-to-maturity debt
securities.
87

-- 99 of 160 --

NOTE 12. Long-Term Debt and Short-Term Borrowings
The following debt tables reflect effective interest rates, which include the impact of interest rate swaps, as of December 31, 2020. If the debt was
issued on a combined basis, the debt has been separated to show the impact of the fixed versus floating effective interest rates. Carrying value
includes the impact of debt issuance costs and fair value hedging activity. For notes subject to in-substance defeasance, the final maturity reflected
below is that associated with the redemption date included in the irrevocable instructions given to the trust. Long-term debt and short-term
borrowings as of December 31 consisted of the following:
Long-Term Debt
(Millions) 	Currency/ 	Effective 	Final 	Carrying Value
Description / 2020 Principal Amount 	Fixed vs. Floating 	Interest Rate 	Maturity Date 	2020 	2019
Third lien senior secured notes subject to in-substance
defeasance (repaid in 2020) 	USD Fixed 	— % 	2020 	$ 	— $ 	463
Medium-term note (repaid in 2020) 	EUR Floating 	— % 	2020 	— 	726
Medium-term note (repaid in 2020) 	USD Floating 	— % 	2020 	— 	299
Medium-term note (repaid in 2020) 	USD Floating 	— % 	2020 	— 	200
Medium-term note (repaid in 2020) 	USD Fixed 	— % 	2020 	— 	599
Medium-term note (repaid in 2020) 	USD Fixed 	— % 	2020 	— 	199
Medium-term note (repaid in 2020) 	USD Floating 	— % 	2020 	— 	204
Eurobond (300 million euros) 	EUR Floating 	(0.28)% 	2021 	374 	346
Eurobond (300 million euros) 	EUR Fixed 	1.97 % 	2021 	367 	334
Medium-term note (500 million euros) 	EUR Fixed 	0.45 % 	2022 	612 	557
Medium-term note ($600 million) 	USD Fixed 	2.17 % 	2022 	598 	597
Medium-term note ($450 million) 	USD Fixed 	2.76 % 	2022 	449 	449
Medium-term note (600 million euros) 	EUR Fixed 	1.14 % 	2023 	731 	665
Medium-term note ($650 million) 	USD Fixed 	2.26 % 	2023 	649 	648
Registered note ($500 million) 	USD Fixed 	1.86 % 	2023 	498 	497
Medium-term note ($300 million) 	USD Floating 	0.52 % 	2024 	299 	299
Medium-term note ($300 million) 	USD Fixed 	3.30 % 	2024 	299 	299
Medium-term note ($500 million) 	USD Fixed 	2.98 % 	2024 	502 	503
Medium-term note ($550 million) 	USD Fixed 	3.04 % 	2025 	548 	547
Registered note ($750 million) 	USD Fixed 	2.12 % 	2025 	744 	743
Registered note ($500 million) 	USD Fixed 	2.67 % 	2025 	498 	—
Medium-term note (750 million euros) 	EUR Fixed 	1.66 % 	2026 	908 	826
Medium-term note ($650 million) 	USD Fixed 	2.37 % 	2026 	644 	643
Medium-term note ($850 million) 	USD Fixed 	2.95 % 	2027 	843 	842
30-year debenture ($220 million) 	USD Fixed 	6.44 % 	2028 	225 	226
Medium-term note ($600 million) 	USD Fixed 	3.62 % 	2028 	598 	597
Medium-term note ($800 million) 	USD Fixed 	3.38 % 	2029 	796 	796
Registered note ($1 billion) 	USD Fixed 	2.50 % 	2029 	986 	984
Medium-term note (500 million euros) 	EUR Fixed 	1.90 % 	2030 	604 	549
Registered note ($600 million) 	USD Fixed 	3.09 % 	2030 	595 	—
Medium-term note (500 million euros) 	EUR Fixed 	1.54 % 	2031 	608 	554
30-year bond ($555 million) 	USD Fixed 	5.73 % 	2037 	551 	551
Floating rate note ($96 million) 	USD Floating 	— % 	2041 	96 	96
Medium-term note ($325 million) 	USD Fixed 	4.05 % 	2044 	315 	314
Floating rate note ($55 million) 	USD Floating 	— % 	2044 	53 	53
Medium-term note ($500 million) 	USD Fixed 	3.37 % 	2046 	476 	475
Medium-term note ($500 million) 	USD Fixed 	3.68 % 	2047 	492 	492
Medium-term note ($650 million) 	USD Fixed 	4.07 % 	2048 	637 	637
Medium-term note ($500 million) 	USD Fixed 	3.78 % 	2048 	505 	506
Registered note ($1 billion) 	USD Fixed 	3.37 % 	2049 	969 	968
Registered note ($650 million) 	USD Fixed 	3.72 % 	2050 	642 	—
Other borrowings 	Various 	0.01 % 	2021-2040 	72 	76
Total long-term debt 	$ 	18,783 	$ 	19,359
Less: current portion of long-term debt 	794 	1,841
Long-term debt (excluding current portion) 	$ 	17,989 	$ 	17,518
88

-- 100 of 160 --

Post-Swap Borrowing (Long-Term Debt, Including Current Portion)
2020 	2019
Carrying 	Effective 	Carrying 	Effective
(Millions) 	Value 	Interest Rate 	Value 	Interest Rate
Fixed-rate debt 	$ 	17,889 	2.80 % 	$ 	17,061 	3.01 %
Floating-rate debt 	894 	0.06 % 	2,298 	1.06 %
Total long-term debt, including current portion 	$ 	18,783 	$ 	19,359
Short-Term Borrowings and Current Portion of Long-Term Debt
Effective 	Carrying Value
(Millions) 	Interest Rate 	2020 	2019
Current portion of long-term debt 	0.78 % 	$ 	794 	$ 	1,841
U.S. dollar commercial paper 	—% 	— 	150
Japan subsidiary credit facility 	—% 	— 	632
German subsidiary credit facility 	—% 	— 	168
Other borrowings 	4.83 % 	12 	4
Total short-term borrowings and current portion of long-term debt 	$ 	806 	$ 	2,795
Other short-term borrowings primarily consisted of bank borrowings by international subsidiaries.
Future Maturities of Long-term Debt
Maturities of long-term debt in the table below reflect the impact of put provisions associated with certain debt instruments and are net of the
unaccreted debt issue costs such that total maturities equal the carrying value of long-term debt as of December 31, 2020. The maturities of long-
term debt for the periods subsequent to December 31, 2020 are as follows (in millions):
After
2021 	2022 	2023 	2024 	2025 	2025 	Total
$ 	794 	$ 	1,659 	$ 	1,878 	$ 	1,100 	$ 	1,790 	$ 	11,562 	$ 	18,783
As a result of put provisions associated with certain debt instruments, long-term debt payments due in 2021 include floating rate notes totaling $53
million (classified as current portion of long-term debt).
Credit Facilities
In November 2019, 3M amended and restated its existing $3.75 billion five-year revolving credit facility expiring in March 2021 to a $3.0 billion
five-year revolving credit facility expiring in November 2024. The revolving credit agreement includes a provision under which 3M may request
an increase of up to $1.0 billion (at lender’s discretion), bringing the total facility up to $4.0 billion. In addition, 3M entered into a $1.25 billion
364-day credit facility, which was renewed in November 2020 with an expiration date of November 2021. The 364-day credit agreement includes
a provision under which 3M may convert any advances outstanding on the maturity date into term loans having a maturity date one year later.
These credit facilities were undrawn at December 31, 2020. Under both the $3.0 billion and $1.25 billion credit agreements, the Company is
required to maintain its EBITDA to Interest Ratio as of the end of each fiscal quarter at not less than 3.0 to 1. This is calculated (as defined in the
agreement) as the ratio of consolidated total EBITDA for the four consecutive quarters then ended to total interest expense on all funded debt for
the same period. At December 31, 2020, this ratio was approximately 17 to 1. Debt covenants do not restrict the payment of dividends.
Other Credit Facilities
Apart from the committed credit facilities described above, in September 2019, 3M entered into a credit facility initially expiring in July 2020 that
was further extended to August 2021 in the amount of 80 billion Japanese yen. In November 2019, 3M entered into a credit facility expiring in
November 2020 in the amount of 150 million euros. During the third quarter of 2020, the Company paid the outstanding balances and closed these
credit facilities.
89

-- 101 of 160 --

The Company also had an additional $273 million in stand-alone letters of credit and bank guarantees issued and outstanding at December 31,
2020. These instruments are utilized in connection with normal business activities.
Long-Term Debt Issuances
The principal amounts, interest rates and maturity dates of individual long-term debt issuances can be found in the long-term debt table found at
the beginning of this note.
In March 2020, 3M issued $1.75 billion aggregate principal amount of fixed rate registered notes. These were comprised of $500 million of 5-year
notes due 2025 with a coupon rate of 2.65%, $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year
notes due 2050 with a coupon rate of 3.70%.
In February 2019, 3M issued $2.25 billion aggregate principal amount of fixed rate medium-term notes. These were comprised of $450 million of
3-year notes due 2022 with a coupon rate of 2.75%, $500 million of remaining 5-year notes due 2024 with a coupon rate of 3.25%, $800 million of
10-year notes due 2029 with a coupon rate of 3.375%, and $500 million of remaining 29.5-year notes due 2048 with a coupon rate of 4.00%.
Issuances of the 5-year and 29.5-year notes were pursuant to a reopening of existing securities issued in September 2018.
In August 2019, 3M issued $3.25 billion aggregate principal amount of fixed rate registered notes. These were comprised of $500 million of 3.5-
year notes due 2023 with a coupon rate of 1.75%, $750 million of 5.5-year notes due 2025 with a coupon rate of 2.00%, $1.0 billion of 10-year
notes due 2029 with a coupon rate of 2.375%, and $1.0 billion of 30-year notes due 2049 with a coupon rate of 3.25%.
In September 2018, 3M issued $2.25 billion aggregate principal amount of medium-term notes. These were comprised of $400 million of 3-year
fixed rate notes due 2021 with a coupon rate of 3.00%, $300 million of 5.5-year fixed rate notes due 2024 with a coupon rate of 3.25%, $300
million of 5.5-year floating rate notes due 2024 with a rate based on a floating three-month LIBOR index, $600 million aggregate principal amount
of 10-year fixed rate medium-term notes due 2028 with a coupon rate of 3.625%, and $650 million of 30-year fixed rate notes due 2048 with a
coupon rate of 4.00%. Upon debt issuance, the Company entered into a fixed-to-floating interest rate swap on $200 million aggregate principal
amount of the 3-year fixed rate notes issued with an interest rate based on a three-month LIBOR index.
Long-Term Debt Maturities and Extinguishments
In December 2020, 3M, via make-whole-call offers, repaid $1 billion aggregate principal amount of its outstanding notes. This included $400
million aggregate principal amount of 3.00% notes and $600 million aggregate principal amount of 1.625% notes, both of which were due to
mature in 2021. The Company recorded an early debt extinguishment pre-tax charge of approximately $10 million within interest expense. This
charge reflected the differential between the carrying value and the amount paid to reacquire the notes and related expenses.
In May 2020, 3M repaid the aggregate $445 million principal amount of Third Lien notes subject to the in-substance defeasance noted below and
repaid 650 million euros aggregate principal amount of floating-rate medium-term notes that matured. In August 2020, 3M repaid $500 million
aggregate principal amount of floating rate medium-term notes that matured.
In June 2019, 3M repaid $625 million aggregate principal amount of fixed-rate medium-term notes that matured.
In 2019, 3M also assumed approximately $2.6 billion of debt in connection with the acquisitions of Acelity and M*Modal (See Note 3) of which
$2.1 billion was immediately redeemed or paid at close.
In November and August 2018, respectively, 3M repaid 500 million euros and $450 million aggregate principal amount of floating rate medium-
term notes that matured.
90

-- 102 of 160 --

In-Substance Defeasance
In conjunction with the October 2019 acquisition of Acelity (see Note 3), 3M assumed outstanding debt of the business, of which $445 million in
principal amount of third lien senior secured notes (Third Lien Notes) maturing in 2021 with a coupon rate of 12.5% was not immediately
redeemed at closing. Instead, at closing, 3M satisfied and discharged the Third Lien Notes via an in-substance defeasance, whereby 3M transferred
cash equivalents and marketable securities to a trust with irrevocable instructions to redeem the Third Lien Notes on May 1, 2020. The trust assets
were restricted from use in 3M’s operations and were only used for the redemption of the Third Lien Notes that occurred in May 2020. These
actions, however, did not represent a legal defeasance. Therefore, this debt was included in current portion of long-term debt and the related trust
assets were included in current assets on the Company’s consolidated balance sheet as of December 31, 2019.
Floating Rate Notes
At various times, 3M has issued floating rate notes containing put provisions. 3M would be required to repurchase these securities at various prices
ranging from 99 percent to 100 percent of par value according to the reduction schedules for each security. In December 2004, 3M issued a forty-
year $60 million floating rate note, with a rate based on a floating LIBOR index. Under the terms of this floating rate note due in 2044, holders
have an annual put feature at 100 percent of par value from 2014 and every anniversary thereafter until final maturity. Under the terms of the
floating rate notes due in 2027, 2040 and 2041, holders have put options that commence ten years from the date of issuance and each third
anniversary thereafter until final maturity at prices ranging from 99 percent to 100 percent of par value. For the periods presented, 3M was
required to repurchase an immaterial amount of principal on the aforementioned floating rate notes.
NOTE 13. Pension and Postretirement Benefit Plans
3M has company-sponsored retirement plans covering substantially all U.S. employees and many employees outside the United States. In total,
3M has over 75 defined benefit plans in 28 countries. Pension benefits associated with these plans generally are based on each participant’s years
of service, compensation, and age at retirement or termination. The primary U.S. defined-benefit pension plan was closed to new participants
effective January 1, 2009. The Company also provides certain postretirement health care and life insurance benefits for its U.S. employees who
reach retirement age while employed by the Company and were employed by the Company prior to January 1, 2016. Most international employees
and retirees are covered by government health care programs. The cost of company-provided postretirement health care plans for international
employees is not material and is combined with U.S. amounts in the tables that follow.
The Company has made deposits for its defined benefit plans with independent trustees. Trust funds and deposits with insurance companies are
maintained to provide pension benefits to plan participants and their beneficiaries. There are no plan assets in the non-qualified plan due to its
nature. For its U.S. postretirement health care and life insurance benefit plans, the Company has set aside amounts at least equal to annual benefit
payments with an independent trustee.
The Company also sponsors employee savings plans under Section 401(k) of the Internal Revenue Code. These plans are offered to substantially
all regular U.S. employees. For eligible employees hired prior to January 1, 2009, employee 401(k) contributions of up to 5% of eligible
compensation matched in cash at rates of 45% or 60%, depending on the plan in which the employee participates. Employees hired on or after
January 1, 2009, receive a cash match of 100% for employee 401(k) contributions of up to 5% of eligible compensation and receive an employer
retirement income account cash contribution of 3% of the participant’s total eligible compensation. All contributions are invested in a number of
investment funds pursuant to the employees’ elections. Employer contributions to the U.S. defined contribution plans were $201 million, $186
million and $173 million for 2020, 2019 and 2018, respectively. 3M subsidiaries in various international countries also participate in defined
contribution plans. Employer contributions to the international defined contribution plans were $103 million, $96 million and $99 million for
2020, 2019 and 2018, respectively.
In May 2019 (as part of the 2019 restructuring actions discussed in Note 5), the Company began offering a voluntary early retirement incentive
program to certain eligible participants of its U.S. pension plans who meet age and years of pension service requirements. The eligible participants
who accepted the offer and retired by July 1, 2019 received an enhanced pension benefit. Pension benefits were enhanced by adding one additional
year of pension service and one additional year of age for certain benefit calculations. Approximately 800 participants accepted the offer and
retired before July 1, 2019. As a result, the Company incurred a $35 million charge related to these special termination benefits in the second
quarter of 2019.
91

-- 103 of 160 --

In the fourth quarter of 2019, the Company recognized a non-operating $32 million settlement expense in its U.S. non-qualified pension plan. The
charge is related to lump sum payments made to employees at retirement. The settlement expense is an accelerated recognition of past actuarial
losses.
In May 2019, 3M modified the 3M Retiree Life Insurance Plan postretirement benefit to close it to new participants effective August 1, 2019
(which results in employees who retire on or after August 1, 2019 not being eligible to participate in the plan) and reducing the maximum life
insurance and death benefit to $8,000 for deaths on or after August 1, 2019. Due to these changes, the plan was re-measured in the second quarter
of 2019, resulting in a decrease to the accumulated projected benefit obligation liability of approximately $150 million and a related increase to
shareholders’ equity, specifically accumulated other comprehensive income in addition to an immaterial income statement benefit prospectively.
In the second quarter of 2020, as a result of the divestiture of the drug delivery business, the Company recognized a curtailment in its United
Kingdom Pension Plan. The resulting re-measurement of the pension plan funded status reduced long-term prepaid pension and post retirement
assets (located within “other assets” of the Company’s balance sheet) by approximately $80 million, which was offset within accumulated other
comprehensive income (located within the equity section of the Company’s balance sheet). The expense impact of this re-measurement was
immaterial for the second quarter of 2020 and subsequent periods.
The following tables include a reconciliation of the beginning and ending balances of the benefit obligation and the fair value of plan assets as well
as a summary of the related amounts recognized in the Company’s consolidated balance sheet as of December 31 of the respective years. 3M also
has certain non-qualified unfunded pension and postretirement benefit plans, inclusive of plans related to supplement/excess benefits for
employees impacted by particular relocations and other matters, that individually and in the aggregate are not significant and which are not
included in the tables that follow. The obligations for these plans are included within other liabilities in the Company’s consolidated balance sheet
and aggregated less than $40 million as of December 31, 2020 and 2019.
Qualified and Non-qualified
Pension Benefits 	Postretirement
United States 	International 	Benefits
(Millions) 	2020 	2019 	2020 	2019 	2020 	2019
Change in benefit obligation
Benefit obligation at beginning of year 	$ 	17,935 	$ 	15,948 	$ 	7,931 	$ 	6,965 	$ 	2,242 	$ 	2,175
Acquisitions/Transfers 	— 	— 	1 	9 	— 	—
Service cost 	261 	251 	152 	131 	43 	43
Interest cost 	499 	620 	117 	156 	62 	82
Participant contributions 	— 	— 	9 	7 	— 	—
Foreign exchange rate changes 	— 	— 	427 	55 	(14) 	—
Plan amendments 	— 	— 	— 	3 	— 	(171)
Actuarial (gain) loss 	1,785 	2,209 	464 	906 	176 	225
Benefit payments 	(1,104) 	(1,128) 	(274) 	(302) 	(107) 	(112)
Settlements, curtailments, special termination benefits and
other 	— 	35 	(57) 	1 	(5) 	—
Benefit obligation at end of year 	$ 	19,376 	$ 	17,935 	$ 	8,770 	$ 	7,931 	$ 	2,397 	$ 	2,242
Change in plan assets
Fair value of plan assets at beginning of year 	$ 	16,099 	$ 	14,803 	$ 	6,923 	$ 	6,170 	$ 	1,338 	$ 	1,260
Acquisitions/Transfers 	— 	— 	— 	4 	— 	—
Actual return on plan assets 	2,071 	2,323 	1,102 	858 	147 	187
Company contributions 	61 	101 	92 	106 	3 	3
Participant contributions 	— 	— 	9 	7 	— 	—
Foreign exchange rate changes 	— 	— 	376 	80 	— 	—
Benefit payments 	(1,104) 	(1,128) 	(274) 	(302) 	(107) 	(112)
Settlements, curtailments, special termination benefits and
other 	— 	— 	(34) 	— 	(5) 	—
Fair value of plan assets at end of year 	$ 	17,127 	$ 	16,099 	$ 	8,194 	$ 	6,923 	$ 	1,376 	$ 	1,338
Funded status at end of year 	$ 	(2,249) 	$ 	(1,836) 	$ 	(576) 	$ 	(1,008) 	$ 	(1,021) 	$ 	(904)
92

-- 104 of 160 --

Qualified and Non-qualified
Pension Benefits 	Postretirement
United States 	International 	Benefits
(Millions) 	2020 	2019 	2020 	2019 	2020 	2019
Amounts recognized in the Consolidated Balance Sheet as of
Dec. 31,
Non-current assets 	$ 	— 	$ 	— 	$ 	630 	$ 	230 	$ 	— 	$ 	—
Accrued benefit cost
Current liabilities 	(52) 	(48) 	(15) 	(15) 	(4) 	(4)
Non-current liabilities 	(2,197) 	(1,788) 	(1,191) 	(1,223) 	(1,017) 	(900)
Ending balance 	$ 	(2,249) 	$ 	(1,836) 	$ 	(576) 	$ 	(1,008) 	$ 	(1,021) 	$ 	(904)
Qualified and Non-qualified
Pension Benefits 	Postretirement
United States 	International 	Benefits
(Millions) 	2020 	2019 	2020 	2019 	2020 	2019
Amounts recognized in accumulated other comprehensive
income as of Dec. 31,
Net transition obligation (asset) 	$ 	— 	$ 	— 	$ 	9 	$ 	10 	$ 	— 	$ 	—
Net actuarial loss (gain) 	6,080 	5,899 	1,557 	1,967 	713 	663
Prior service cost (credit) 	(104) 	(128) 	(2) 	(5) 	(230) 	(262)
Ending balance 	$ 	5,976 	$ 	5,771 	$ 	1,564 	$ 	1,972 	$ 	483 	$ 	401
The balance of amounts recognized for international plans in accumulated other comprehensive income as of December 31 in the preceding table
are presented based on the foreign currency exchange rate on that date.
The pension accumulated benefit obligation represents the actuarial present value of benefits based on employee service and compensation as of
the measurement date and does not include an assumption about future compensation levels. The accumulated benefit obligation of the U.S.
pension plans was $18.441 billion and $17.125 billion at December 31, 2020 and 2019, respectively. The accumulated benefit obligation of the
international pension plans was $8.181 billion and $7.355 billion at December 31, 2020 and 2018, respectively.
The following amounts relate to pension plans with accumulated benefit obligations in excess of plan assets as of December 31:
Qualified and Non-qualified Pension Plans
United States 	International
(Millions) 	2020 	2019 	2020 	2019
Projected benefit obligation 	$ 	19,376 	$ 	17,935 	$ 	3,385 	$ 	2,986
Accumulated benefit obligation 	18,441 	17,125 	3,119 	2,752
Fair value of plan assets 	17,127 	16,099 	2,199 	1,778
93

-- 105 of 160 --

Components of net periodic cost and other amounts recognized in other comprehensive income
The service cost component of defined benefit net periodic benefit cost is recorded in cost of sales, selling, general and administrative expenses,
and research, development and related expenses. As discussed in Note 6, the other components of net periodic benefit cost are reflected in other
expense (income), net. Components of net periodic benefit cost and other supplemental information for the years ended December 31 follow:
Qualified and Non-qualified
Pension Benefits 	Postretirement
United States 	International 	Benefits
(Millions) 	2020 	2019 	2018 	2020 	2019 	2018 	2020 	2019 	2018
Net periodic benefit cost (benefit)
Operating expense
Service cost 	$ 	261 	$ 	251 	$ 	288 	$ 	152 	$ 	131 	$ 	143 	$ 	43 	$ 	43 	$ 	52
Non-operating expense
Interest cost 	499 	620 	563 	117 	156 	157 	62 	82 	79
Expected return on plan assets 	(1,019) 	(1,040) 	(1,087) 	(306) 	(299) 	(307) 	(79) 	(81) 	(84)
Amortization of transition asset 	— 	— 	— 	2 	— 	— 	— 	— 	—
Amortization of prior service benefit 	(24) 	(24) 	(23) 	(5) 	(12) 	(13) 	(33) 	(33) 	(40)
Amortization of net actuarial loss 	536 	366 	503 	131 	78 	114 	49 	34 	61
Settlements, curtailments, special termination benefits and
other 	16 	70 	— 	1 	10 	4 	3 	5 	—
Total non-operating expense (benefit) 	8 	(8) 	(44) 	(60) 	(67) 	(45) 	2 	7 	16
Total net periodic benefit cost (benefit) 	$ 	269 	$ 	243 	$ 	244 	$ 	92 	$ 	64 	$ 	98 	$ 	45 	$ 	50 	$ 	68
Other changes in plan assets and benefit obligations
recognized in other comprehensive (income) loss
Amortization of transition asset 	$ 	— 	$ 	— 	$ 	— 	$ 	(2) 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	—
Prior service cost (benefit) 	— 	— 	— 	— 	3 	7 	— 	(171) 	—
Amortization of prior service benefit 	24 	24 	23 	5 	12 	13 	33 	33 	40
Net actuarial (gain) loss 	733 	926 	(44) 	(358) 	344 	194 	108 	119 	(127)
Amortization of net actuarial loss 	(536) 	(366) 	(503) 	(131) 	(78) 	(114) 	(49) 	(34) 	(61)
Foreign currency 	— 	— 	— 	79 	7 	(83) 	(7) 	(1) 	(2)
Settlements, curtailments, special termination benefits and
other 	(16) 	(35) 	— 	(1) 	(8) 	(4) 	(3) 	(5) 	—
Total recognized in other comprehensive (income) loss 	$ 	205 	$ 	549 	$ 	(524) 	$ (408) 	$ 	280 	$ 	13 	$ 	82 	$ 	(59) 	$ (150)
Total recognized in net periodic benefit cost (benefit) and
other comprehensive (income) loss 	$ 	474 	$ 	792 	$ 	(280) 	$ (316) 	$ 	344 	$ 	111 	$ 127 	$ 	(9) 	$ 	(82)
Weighted-average assumptions used to determine benefit obligations as of December 31
Qualified and Non-qualified Pension Benefits 	Postretirement
United States 	International 	Benefits
2020 	2019 	2018 	2020 	2019 	2018 	2020 	2019 	2018
Discount rate 	2.55 % 	3.25 % 	4.36 % 	1.38 % 	1.81 % 	2.50 % 	2.50 % 	3.27 % 	4.41 %
Compensation rate increase 	3.21 % 	3.21 % 	4.10 % 	2.88 % 	2.88 % 	2.89 % 	N/A 	N/A 	N/A
Weighted-average assumptions used to determine net cost for years ended December 31
Qualified and Non-qualified Pension Benefits 	Postretirement
United States 	International 	Benefits
2020 	2019 	2018 	2020 	2019 	2018 	2020 	2019 	2018
Discount rate - service cost 	3.41 % 	4.44 % 	3.78 % 	1.61 % 	2.39 % 	2.27 % 	3.45 % 	4.53 % 	3.86 %
Discount rate - interest cost 	2.87 % 	4.02 % 	3.35 % 	1.61 % 	2.26 % 	2.14 % 	3.00 % 	4.15 % 	3.52 %
Expected return on assets 	6.75 % 	7.00 % 	7.25 % 	4.70 % 	4.90 % 	5.02 % 	6.32 % 	6.43 % 	6.53 %
Compensation rate increase 	3.21 % 	4.10 % 	4.10 % 	2.88 % 	2.89 % 	2.89 % 	N/A 	N/A 	N/A
94

-- 106 of 160 --

The Company provides eligible retirees in the U.S. postretirement health care benefit plans to a savings account benefits-based plan. The
contributions provided by the Company to the health savings accounts increase 3 percent per year for employees who retired prior to January 1,
2016 and increase 1.5 percent for employees who retire on or after January 1, 2016. Therefore, the Company no longer has material exposure to
health care cost inflation.
The Company determines the discount rate used to measure plan liabilities as of the December 31 measurement date for the pension and
postretirement benefit plans, which is also the date used for the related annual measurement assumptions. The discount rate reflects the current rate
at which the associated liabilities could be effectively settled at the end of the year. The Company sets its rate to reflect the yield of a portfolio of
high quality, fixed-income debt instruments that would produce cash flows sufficient in timing and amount to settle projected future benefits.
Using this methodology, the Company determined a discount rate of 2.55% for the U.S. pension plans and 2.50% for the postretirement benefit
plans as of December 31, 2020, which is a decrease of 0.70 percentage points and 0.77 percentage points, respectively, from the rates used as of
December 31, 2019. A decrease in the discount rate increases the Projected Benefit Obligation (PBO), the significant decrease in the discount rate
as of December 31, 2020 resulted in an approximately $1.8 billion higher benefit obligation for the U.S. pension and postretirement plans.
The Company measures service cost and interest cost separately using the spot yield curve approach applied to each corresponding obligation.
Service costs are determined based on duration-specific spot rates applied to the service cost cash flows. The interest cost calculation is determined
by applying duration-specific spot rates to the year-by-year projected benefit payments. The spot yield curve approach does not affect the
measurement of the total benefit obligations as the change in service and interest costs offset in the actuarial gains and losses recorded in other
comprehensive income.
For the primary U.S. qualified pension plan, the Company’s assumption for the expected return on plan assets was 6.75% in 2020. Projected
returns are based primarily on broad, publicly traded equity and fixed-income indices and forward-looking estimates of active portfolio and
investment management. As of December 31, 2020, the Company’s 2021 expected long-term rate of return on U.S. plan assets is 6.50%. The
expected return assumption is based on the strategic asset allocation of the plan, long term capital market return expectations and expected
performance from active investment management. The 2020 expected long-term rate of return is based on an asset allocation assumption of 22%
global equities, 12% private equities, 49% fixed-income securities, and 17% absolute return investments independent of traditional performance
benchmarks, along with positive returns from active investment management. The actual net rate of return on plan assets in 2020 was 13.6%. In
2019 the plan earned a rate of return of 16.3% and in 2018 earned a return of -0.5%. The average annual actual return on the plan assets over the
past 10 and 25 years has been 8.8% and 9.0%, respectively. Return on assets assumptions for international pension and other post-retirement
benefit plans are calculated on a plan-by-plan basis using plan asset allocations and expected long-term rate of return assumptions.
As of December 31, 2019, the Company converted to the “Pri-2012 Aggregate Mortality Table”. In 2020, the Company updated the mortality
improvement scales to the Society of Actuaries Scale MP-2020. The December 31, 2020 update resulted in an immaterial decrease to the U.S.
pension PBO and U.S. accumulated postretirement benefit obligations.
During 2020, the Company contributed $153 million to its U.S. and international pension plans and $3 million to its postretirement plans. During
2019, the Company contributed $207 million to its U.S. and international pension plans and $3 million to its postretirement plans. In 2021, the
Company expects to contribute an amount in the range of $100 million to $200 million of cash to its U.S. and international retirement plans. The
Company does not have a required minimum cash pension contribution obligation for its U.S. plans in 2021. Future contributions will depend on
market conditions, interest rates and other factors.
95

-- 107 of 160 --

Future Pension and Postretirement Benefit Payments
The following table provides the estimated pension and postretirement benefit payments that are payable from the plans to participants.
Qualified and Non-qualified
Pension Benefits 	Postretirement
(Millions) 	United States 	International 	Benefits
2021 Benefit Payments 	$ 	1,127 	$ 	263 	$ 	127
2022 Benefit Payments 	1,134 	276 	133
2023 Benefit Payments 	1,135 	292 	140
2024 Benefit Payments 	1,134 	311 	145
2025 Benefit Payments 	1,139 	319 	152
Next five years 	5,619 	1,752 	792
Plan Asset Management
3M’s investment strategy for its pension and postretirement plans is to manage the funds on a going-concern basis. The primary goal of the trust
funds is to meet the obligations as required. The secondary goal is to earn the highest rate of return possible, without jeopardizing its primary goal,
and without subjecting the Company to an undue amount of contribution risk. Fund returns are used to help finance present and future obligations
to the extent possible within actuarially determined funding limits and tax-determined asset limits, thus reducing the potential need for additional
contributions from 3M. The investment strategy has used long duration cash bonds and derivative instruments to offset a significant portion of the
interest rate sensitivity of U.S. pension liabilities.
Normally, 3M does not buy or sell any of its own securities as a direct investment for its pension and other postretirement benefit funds. However,
due to external investment management of the funds, the plans may indirectly buy, sell or hold 3M securities. The aggregate amount of 3M
securities are not considered to be material relative to the aggregate fund percentages.
The discussion that follows references the fair value measurements of certain assets in terms of levels 1, 2 and 3. See Note 15 for descriptions of
these levels. While the company believes the valuation methods are appropriate and consistent with other market participants, the use of different
methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the
reporting date.
U.S. Pension Plans and Postretirement Benefit Plan Assets
In order to achieve the investment objectives in the U.S. pension plans and U.S. postretirement benefit plans, the investment policies include a
target strategic asset allocation. The investment policies allow some tolerance around the target in recognition that market fluctuations and
illiquidity of some investments may cause the allocation to a specific asset class to vary from the target allocation, potentially for long periods of
time. Acceptable ranges have been designed to allow for deviation from strategic targets and to allow for the opportunity for tactical over- and
under-weights. The portfolios will normally be rebalanced when the quarter-end asset allocation deviates from acceptable ranges. The allocation is
reviewed regularly by the named fiduciary of the plans. Approximately 50% of the postretirement benefit plan assets are in a 401(h) account. The
401(h) account assets are in the same trust as the primary U.S. pension plan and invested with the same investment objectives as the primary U.S.
pension plan.
96

-- 108 of 160 --

The fair values of the assets held by the U.S. pension plans by asset class are as follows:
Fair Value Measurements Using Inputs Considered as 	Fair Value at
(Millions) 	Level 1 	Level 2 	Level 3 	Dec. 31,
Asset Class 	2020 	2019 	2020 	2019 	2020 	2019 	2020 	2019
Equities
U.S. equities 	$ 2,082 	$ 1,575 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	2,082 	$ 	1,575
Non-U.S. equities 	2,041 	1,585 	— 	— 	— 	— 	2,041 	1,585
Index and long/short equity funds* 	433 	417
Total Equities 	$ 4,123 	$ 3,160 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	4,556 	$ 	3,577
Fixed Income
U.S. government securities 	$ 1,301 	$ 2,346 	$ 	978 	$ 	916 	$ 	— 	$ 	— 	$ 	2,279 	$ 	3,262
Non-U.S. government securities 	— 	— 	71 	61 	— 	— 	71 	61
Preferred and convertible securities 	— 	— 	55 	52 	— 	— 	55 	52
U.S. corporate bonds 	10 	10 	4,501 	3,566 	— 	— 	4,511 	3,576
Non-U.S. corporate bonds 	— 	— 	820 	759 	— 	— 	820 	759
Derivative instruments 	(4) 	(5) 	7 	109 	— 	— 	3 	104
Other* 	71 	—
Total Fixed Income 	$ 1,307 	$ 2,351 	$ 6,432 	$ 5,463 	$ 	— 	$ 	— 	$ 	7,810 	$ 	7,814
Private Equity
Growth equity 	$ 	70 	$ 	80 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	70 	$ 	80
Partnership investments* 	1,801 	1,865
Total Private Equity 	$ 	70 	$ 	80 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	1,871 	$ 	1,945
Absolute Return
Fixed income and other 	$ 	— 	$ 	1 	$ 	134 	$ 	117 	$ 	— 	$ 	— 	$ 	134 	$ 	118
Hedge fund/fund of funds* 	2,046 	2,010
Partnership investments* 	567 	589
Total Absolute Return 	$ 	— 	$ 	1 	$ 	134 	$ 	117 	$ 	— 	$ 	— 	$ 	2,747 	$ 	2,717
Cash and Cash Equivalents
Cash and cash equivalents 	$ 	25 	$ 	20 	$ 	12 	$ 	5 	$ 	— 	$ 	— 	$ 	37 	$ 	25
Repurchase agreements and derivative margin activity 	— 	— 	(6) 	(1) 	— 	— 	(6) 	(1)
Cash and cash equivalents, valued at net asset value* 	475 	480
Total Cash and Cash Equivalents 	$ 	25 	$ 	20 	$ 	6 	$ 	4 	$ 	— 	$ 	— 	$ 	506 	$ 	504
Total 	$ 5,525 	$ 5,612 	$ 6,572 	$ 5,584 	$ 	— 	$ 	— 	$ 	17,490 	$ 16,557
Other items to reconcile to fair value of plan assets 	$ 	(363) 	$ 	(458)
Fair value of plan assets 	$ 	17,127 	$ 16,099
* In accordance with ASC 820-10, certain investments that are measured at fair value using the net asset value (NAV) per share (or its equivalent)
as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the fair value of the underlying assets owned by
the fund, minus its liabilities then divided by the number of units outstanding and is determined by the investment manager or custodian of the
fund. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the
fair value of plan assets.
97

-- 109 of 160 --

The fair values of the assets held by the postretirement benefit plans by asset class are as follows:
Fair Value Measurements Using Inputs Considered as 	Fair Value at
(Millions) 	Level 1 	Level 2 	Level 3 	Dec. 31,
Asset Class 	2020 	2019 	2020 	2019 	2020 	2019 	2020 	2019
Equities
U.S. equities 	$ 	347 	$ 	337 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	347 	$ 	337
Non-U.S. equities 	103 	77 	— 	— 	— 	— 	103 	77
Index and long/short equity funds* 	31 	33
Total Equities 	$ 	450 	$ 	414 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	481 	$ 	447
Fixed Income
U.S. government securities 	$ 	95 	$ 	136 	$ 	214 	$ 	242 	$ 	— 	$ 	— 	$ 	309 	$ 	378
Non-U.S. government securities 	— 	— 	6 	6 	— 	— 	6 	6
U.S. corporate bonds 	1 	— 	267 	203 	— 	— 	268 	203
Non-U.S. corporate bonds 	— 	— 	52 	46 	— 	— 	52 	46
Derivative instruments 	— 	— 	— 	5 	— 	— 	— 	5
Other* 	3 	—
Total Fixed Income 	$ 	96 	$ 	136 	$ 	539 	$ 	502 	$ 	— 	$ 	— 	$ 	638 	$ 	638
Private Equity
Growth equity 	$ 	3 	$ 	4 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	3 	$ 	4
Partnership investments* 	95 	92
Total Private Equity 	$ 	3 	$ 	4 	$ 	— 	$ 	— 	$ 	— 	$ 	— 	$ 	98 	$ 	96
Absolute Return
Fixed income and other 	$ 	— 	$ 	— 	$ 	7 	$ 	5 	$ 	— 	$ 	— 	$ 	7 	$ 	5
Hedge fund/fund of funds* 	100 	92
Partnership investments* 	28 	27
Total Absolute Return 	$ 	— 	$ 	— 	$ 	7 	$ 	5 	$ 	— 	$ 	— 	$ 	135 	$ 	124
Cash and Cash Equivalents
Cash and cash equivalents 	$ 	25 	$ 	33 	$ 	1 	$ 	1 	$ 	— 	$ 	— 	$ 	26 	$ 	34
Cash and cash equivalents, valued at net asset value* 	23 	22
Total Cash and Cash Equivalents 	$ 	25 	$ 	33 	$ 	1 	$ 	1 	$ 	— 	$ 	— 	$ 	49 	$ 	56
Total 	$ 	574 	$ 	587 	$ 	547 	$ 	508 	$ 	— 	$ 	— 	$ 1,401 	$ 1,361
Other items to reconcile to fair value of plan assets 	$ 	(25) 	$ 	(23)
Fair value of plan assets 	$ 1,376 	$ 1,338
*In accordance with ASC 820-10, certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical
expedient have not been classified in the fair value hierarchy. The NAV is based on the fair value of the underlying assets owned by the fund,
minus its liabilities then divided by the number of units outstanding and is determined by the investment manager or custodian of the fund. The
fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the fair value
of plan assets.
Publicly traded equities are valued at the closing price reported in the active market in which the individual securities are traded.
Fixed income includes derivative instruments such as credit default swaps, interest rate swaps and futures contracts. Corporate debt includes bonds
and notes, asset backed securities, collateralized mortgage obligations and private placements. Swaps and derivative instruments are valued by the
custodian using closing market swap curves and market derived inputs. U.S. government and government agency bonds and notes are valued at the
closing price reported in the active market in which the individual security is traded. Corporate bonds and notes, asset backed securities and
collateralized mortgage obligations are valued at either the yields currently available on comparable securities of issuers with similar credit ratings
or valued under a discounted cash flow approach that utilizes observable inputs, such as current yields of similar instruments, but includes
adjustments for certain risks that may not be observable such as credit and liquidity risks. Private placements are valued by the custodian using
recognized pricing services and sources.
The private equity portfolio is a diversified mix of derivative instruments, growth equity and partnership interests. Growth equity investments are
valued at the closing price reported in the active market in which the individual securities are traded.
Absolute return consists primarily of partnership interests in hedge funds, hedge fund of funds or other private fund vehicles. Corporate debt
instruments are valued at either the yields currently available on comparable securities of issuers with similar credit ratings or valued under a
discounted cash flow approach that utilizes observable inputs, such as current yields of similar instruments, but includes adjustments for certain
risks that may not be observable such as credit and liquidity risk ratings.
98

-- 110 of 160 --

Other items to reconcile to fair value of plan assets include, interest receivables, amounts due for securities sold, amounts payable for securities
purchased and interest payable.
The balances of and changes in the fair values of the U.S. pension plans’ and postretirement plans’ level 3 assets for the periods ended
December 31, 2020 and 2019 were not material.
International Pension Plans Assets
Outside the U.S., pension plan assets are typically managed by decentralized fiduciary committees. The disclosure below of asset categories is
presented in aggregate for over 70 defined benefit plans in 25 countries; however, there is significant variation in asset allocation policy from
country to country. Local regulations, local funding rules, and local financial and tax considerations are part of the funding and investment
allocation process in each country. The Company provides standard funding and investment guidance to all international plans with more focused
guidance to the larger plans.
Each plan has its own strategic asset allocation. The asset allocations are reviewed periodically and rebalanced when necessary.
The fair values of the assets held by the international pension plans by asset class are as follows:
Fair Value Measurements Using Inputs Considered as 	Fair Value at
(Millions) 	Level 1 	Level 2 	Level 3 	Dec. 31,
Asset Class 	2020 	2019 	2020 	2019 	2020 	2019 	2020 	2019
Equities
Growth equities 	$ 	547 	$ 	638 	$ 	209 	$ 	796 	$ 	— 	$ 	— 	$ 	756 	$ 	1,434
Value equities 	659 	696 	396 	10 	— 	— 	1,055 	706
Core equities 	46 	61 	99 	88 	4 	5 	149 	154
Equities, valued at net asset value* 	74 	18
Total Equities 	$ 	1,252 	$ 	1,395 	$ 	704 	$ 	894 	$ 	4 	$ 	5 	$ 	2,034 	$ 	2,312
Fixed Income
Domestic government 	$ 	71 	$ 	353 	$ 	1,045 	$ 	433 	$ 	5 	$ 	4 	$ 	1,121 	$ 	790
Foreign government 	33 	22 	476 	603 	— 	— 	509 	625
Corporate debt securities 	34 	3 	2,470 	1,599 	11 	9 	2,515 	1,611
Fixed income securities, valued at net asset value* 	563 	449
Total Fixed Income 	$ 	138 	$ 	378 	$ 	3,991 	$ 	2,635 	$ 	16 	$ 	13 	$ 	4,708 	$ 	3,475
Private Equity
Real estate 	$ 	128 	$ 	6 	$ 	86 	$ 	207 	$ 	5 	$ 	4 	$ 	219 	$ 	217
Real estate, valued at net asset value* 	92 	36
Partnership investments* 	116 	85
Total Private Equity 	$ 	128 	$ 	6 	$ 	86 	$ 	207 	$ 	5 	$ 	4 	$ 	427 	$ 	338
Absolute Return
Derivatives 	$ 	— 	$ 	— 	$ 	1 	$ 	3 	$ 	— 	$ 	— 	$ 	1 	$ 	3
Insurance 	— 	— 	— 	— 	555 	513 	555 	513
Other 	8 	— 	— 	— 	6 	5 	14 	5
Other, valued at net asset value* 	1 	1
Hedge funds* 	410 	195
Total Absolute Return 	$ 	8 	$ 	— 	$ 	1 	$ 	3 	$ 	561 	$ 	518 	$ 	981 	$ 	717
Cash and Cash Equivalents
Cash and cash equivalents 	$ 	149 	$ 	94 	$ 	51 	$ 	39 	$ 	— 	$ 	— 	$ 	200 	$ 	133
Cash and cash equivalents, valued at net asset value* 	1 	1
Total Cash and Cash Equivalents 	$ 	149 	$ 	94 	$ 	51 	$ 	39 	$ 	— 	$ 	— 	$ 	201 	$ 	134
Total 	$ 	1,675 	$ 	1,873 	$ 	4,833 	$ 	3,778 	$ 	586 	$ 	540 	$ 	8,351 	$ 	6,976
Other items to reconcile to fair value of plan assets 	$ 	(157) 	$ 	(53)
Fair value of plan assets 	$ 	8,194 	$ 	6,923
*In accordance with ASC 820-10, certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical
expedient have not been classified in the fair value hierarchy. The NAV is based on the fair value of the underlying assets owned by the fund,
minus its liabilities then divided by the number of units outstanding and is determined by the investment manager or custodian of the fund. The
fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the fair value
of plan assets.
99

-- 111 of 160 --

Equities consist primarily of mandates in public equity securities managed to various public equity indices. Publicly traded equities are valued at
the closing price reported in the active market in which the individual securities are traded.
Fixed Income investments include domestic and foreign government, and corporate, (including mortgage backed and other debt) securities.
Governments, corporate bonds and notes and mortgage backed securities are valued at the closing price reported if traded on an active market or at
yields currently available on comparable securities of issuers with similar credit ratings or valued under a discounted cash flow approach that
utilizes observable inputs, such as current yields of similar instruments, but includes adjustments for certain risks that may not be observable such
as credit and liquidity risks.
Private equity funds consist of partnership interests in a variety of funds. Real estate consists of property funds and REITS (Real Estate Investment
Trusts). REITS are valued at the closing price reported in the active market in which it is traded.
Absolute return consists of private partnership interests in hedge funds, insurance contracts, derivative instruments, hedge fund of funds, and other
alternative investments. Insurance consists of insurance contracts, which are valued using cash surrender values which is the amount the plan
would receive if the contract was cashed out at year end. Derivative instruments consist of various swaps and bond futures that are used to help
manage risks.
Other items to reconcile to fair value of plan assets include the net of interest receivables, amounts due for securities sold, amounts payable for
securities purchased and interest payable.
The balances of and changes in the fair values of the international pension plans’ level 3 assets consist primarily of insurance contracts under the
absolute return asset class. In 2020 the aggregate of net purchases and net unrealized gains and losses decreased this balance by $0.5 million and
the change in currency exchange rates increased balance by $43.5 million for a net increase of $43 million. In 2019 the aggregate net purchases
and net unrealized gains increased this balance by $24 million and the change in currency exchange rates decreased the balance by $7 million for a
net increase to this balance of $17 million.
NOTE 14. Derivatives
The Company uses interest rate swaps, currency swaps, and forward and option contracts to manage risks generally associated with foreign
exchange rate, interest rate and commodity price fluctuations. The information that follows explains the various types of derivatives and financial
instruments used by 3M, how and why 3M uses such instruments, how such instruments are accounted for, and how such instruments impact 3M’s
financial position and performance.
3M adopted ASU No. 2017-12, 	Targeted Improvements to Accounting for Hedging Activities 	as of January 1, 2019. The disclosures contained
within this note have been updated to reflect the new guidance, except for prior period amounts presented, as the disclosure changes were adopted
prospectively. For derivative instruments that are designated in a cash flow or fair value hedging relationship, the impact of this accounting
standard was to remove the requirement to test for ineffectiveness. Prior to the adoption of this ASU, any gain or loss related to hedge
ineffectiveness was recognized in current earnings. For any net investment hedges entered into on or after January 1, 2019, amounts excluded from
the assessment of hedge effectiveness, including the time value of the forward contract at the inception of the hedge, are recognized in earnings
using an amortization approach over the life of the hedging instrument on a straight-line basis. Any difference between the change in the fair value
of the excluded component and the amount amortized into earnings during the period is recorded in cumulative translation within other
comprehensive income.
Additional information with respect to derivatives is included elsewhere as follows:
● 	Impact on other comprehensive income of nonderivative hedging and derivative instruments is included in Note 8.
● 	Fair value of derivative instruments is included in Note 15.
● 	Derivatives and/or hedging instruments associated with the Company’s long-term debt are also described in Note 12.
Types of Derivatives/Hedging Instruments and Inclusion in Income/Other Comprehensive Income:
Cash Flow Hedges:
For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of
other comprehensive income and reclassified into earnings in the same period during which the hedged transaction
100

-- 112 of 160 --

affects earnings. Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized
in current earnings.
Cash Flow Hedging - Foreign Currency Forward and Option Contracts: The Company enters into foreign exchange forward and option contracts
to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies. These transactions are designated as
cash flow hedges. The settlement or extension of these derivatives will result in reclassifications (from accumulated other comprehensive income)
to earnings in the period during which the hedged transactions affect earnings. 3M may dedesignate these cash flow hedge relationships in advance
of the occurrence of the forecasted transaction. The portion of gains or losses on the derivative instrument previously included in accumulated
other comprehensive income for dedesignated hedges remains in accumulated other comprehensive income until the forecasted transaction occurs
or becomes probable of not occurring. Changes in the value of derivative instruments after dedesignation are recorded in earnings and are included
in the Derivatives Not Designated as Hedging Instruments section below. The maximum length of time over which 3M hedges its exposure to the
variability in future cash flows of the forecasted transactions is 36 months.
Cash Flow Hedging — Interest Rate Contracts: The Company may use forward starting interest rate contracts and treasury rate lock contracts to
hedge exposure to variability in cash flows from interest payments on forecasted debt issuances.
During 2018, the Company entered into forward starting interest rate swaps with a notional amount of $1.2 billion as hedges
against interest rate volatility associated with forecasted issuances of fixed rate debt. Concurrent with the issuance of the medium-term notes in
September 2018, 3M terminated $500 million of these interest rate swaps. The termination resulted in an immaterial gain within accumulated other
comprehensive income that will be amortized over the respective lives of the debt. As of December 31, 2018, the Company had $700 million of
notional amount in outstanding forward starting interest rate swaps as hedges against interest rate volatility with forecasted issuances of fixed rate
debt.
During 2019, the Company entered into additional forward starting interest rate swaps with a notional amount of $743 million. Concurrent with
the issuance of the medium-term notes in February 2019 and the additional issuance of registered notes in August 2019, 3M terminated all
outstanding interest rate swaps related to forecasted issuances of debt. These terminations resulted in a net loss of $143 million within accumulated
other comprehensive income that will be amortized over the respective lives of the debt.
In March 2020, the Company entered into treasury rate lock contracts with a notional amount of $500 million that were terminated concurrently
with the March 2020 issuance of registered notes as discussed in Note 12. The termination resulted in an immaterial net loss within accumulated
other comprehensive income that will be amortized for the respective lives of the debt.
The amortization of gains and losses on forward starting interest rate swaps is included in the tables below as part of the gain/(loss) reclassified
from accumulated other comprehensive income into income.
As of December 31, 2020, the Company had a balance of $173 million associated with the after-tax net unrealized loss associated with cash flow
hedging instruments recorded in accumulated other comprehensive income. This includes a remaining balance of $107 million (after-tax loss)
related to the forward starting interest rate swap and treasury rate lock contacts, which will be amortized over the respective lives of the notes.
Based on exchange rates as of December 31, 2020, 3M expects to reclassify approximately $51 million, $23 million, and $99 million of the after-
tax net unrealized foreign exchange cash flow hedging losses to earnings in 2021, 2022, and after 2022, respectively, (with the impact offset by
earnings/losses from underlying hedged items).
101

-- 113 of 160 --

The location in the consolidated statements of income and comprehensive income and amounts of gains and losses related to derivative
instruments designated as cash flow hedges are provided in the following table. Reclassifications of amounts from accumulated other
comprehensive income into income include accumulated gains (losses) on dedesignated hedges at the time earnings are impacted by the forecasted
transaction.
Pretax Gain (Loss)
Recognized in Other 	Pretax Gain (Loss) Reclassified
Comprehensive 	from Accumulated Other
Income on Derivative 	Comprehensive Income into Income
Year ended December 31, 2020 (Millions) 	Amount 	Location 	Amount
Foreign currency forward/option contracts 	$ 	(111) 	Cost of sales 	$ 	80
Interest rate contracts 	(2) 	Interest expense 	(9)
Total 	$ 	(113) 	$ 	71
Year ended December 31, 2019 (Millions) 	Amount 	Location 	Amount
Foreign currency forward/option contracts 	$ 	96 	Cost of sales 	$ 	74
Interest rate contracts 	(122) 	Interest expense 	(4)
Total 	$ 	(26) 	$ 	70
Pretax Gain (Loss) Recognized in
Pretax Gain (Loss) 	Income on Effective Portion of 	Ineffective Portion of Gain
Recognized in Other 	Derivative as a Result of 	(Loss) on Derivative and
Comprehensive 	Reclassification from 	Amount Excluded from
Income on Effective 	Accumulated Other 	Effectiveness Testing
Portion of Derivative 	Comprehensive Income 	Recognized in Income
Year ended December 31, 2018 (Millions) 	Amount 	Location 	Amount 	Location 	Amount
Foreign currency forward/option contracts 	$ 	151 	Cost of sales 	$ 	(95) 	Cost of sales 	$ 	—
Interest rate swap contracts 	(18) 	Interest expense 	(1) 	Interest expense 	—
Total 	$ 	133 	$ 	(96) 	$ 	—
Fair Value Hedges:
For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivatives as well as the offsetting loss or
gain on the hedged item attributable to the hedged risk are recognized in current earnings.
Fair Value Hedging - Interest Rate Swaps: The Company manages interest expense using a mix of fixed and floating rate debt. To help manage
borrowing costs, the Company may enter into interest rate swaps. Under these arrangements, the Company agrees to exchange, at specified
intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. The
mark-to-market of these fair value hedges is recorded as gains or losses in interest expense and is offset by the gain or loss of the underlying debt
instrument, which also is recorded in interest expense.
In November 2013, 3M issued a Eurobond due in 2021 for a face amount of 600 million euros. Upon debt issuance, 3M completed a fixed-to-
floating interest rate swap on a notional amount of 300 million euros as a fair value hedge of a portion of the fixed interest rate Eurobond
obligation.
In June 2014, 3M issued $950 million aggregate principal amount of medium-term notes. Upon debt issuance, the Company entered into an
interest rate swap to convert $600 million of a $625 million note that was due in 2019, included in this issuance, to an interest rate based on a
floating three-month LIBOR index as a fair value hedge of a portion of the fixed interest rate medium-term note obligation. This interest rate swap
matured in conjunction with the repayment of the $625 million aggregate principal amount of fixed-rate medium notes that matured in June 2019.
In August 2015, 3M issued $1.5 billion aggregate principal amount of medium-term notes. Upon debt issuance, the Company entered into two
interest rate swaps as fair value hedges of a portion of the fixed interest rate medium-term note obligation. The first converted a $450 million
three-year fixed rate note that matured in August 2018 at which time the associated interest rate swap also matured, and
102

-- 114 of 160 --

the second converted $300 million of a five-year fixed rate note that matured in August 2020 at which time the associated interest rate swap also
matured.
In the fourth quarter of 2017, the Company entered into an interest rate swap as a fair value hedge with a notional amount of $200 million that
converted the company’s fixed-rate medium-term note that matured in August 2020 at which time the associated interest rate swap also matured.
In September 2018, the Company entered into an interest rate swap with a notional amount of $200 million that converted a portion of the
Company’s $400 million aggregate principal amount of fixed rate medium-term notes due 2021 into a floating rate note with an interest rate based
on a three-month LIBOR index as a hedge of its exposure to changes in fair value that are attributable to interest rate risk. The Company
terminated this interest rate swap in conjunction with the early debt repayment in December 2020 of $400 million aggregate principal amount of
fixed-rate medium notes further described in Note 12.
Refer to the section below titled 	Statement of Income Location and Impact of Cash Flow and Fair Value Derivative Instruments 	for details on the
location within the consolidated statements of income for amounts of gains and losses related to derivative instruments designated as fair value
hedges and similar information relative to the hedged items for the year ended December 31, 2020 and 2019.
The location in the consolidated statements of income and amounts of gains and losses related to derivative instruments designated as fair value
hedges and similar information relative to the hedged items are as follows for periods prior to 2019:
Gain (Loss) on Derivative 	Gain (Loss) on Hedged Item
Recognized in Income 	Recognized in Income
Year ended December 31, 2018 (Millions) 	Location 	Amount 	Location 	Amount
Interest rate swap contracts 	Interest expense 	$ 	(5) 	Interest expense 	$ 	5
Total 	$ 	(5) 	$ 	5
The following amounts were recorded on the consolidated balance sheet related to cumulative basis adjustments for fair value hedges:
Cumulative Amount of Fair Value Hedging
Carrying Value of the 	Adjustment Included in the Carrying Value
Hedged Liabilities (in millions) 	of the Hedged Liabilities (in millions)
Location on the Consolidated Balance Sheet 	December 31, 2020 	December 31, 2019 	December 31, 2020 	December 31, 2019
Short-term borrowings and current portion of long-term
debt 	$ 	373 	$ 	499 	$ 	5 	$ 	—
Long-term debt 	225 	775 	6 	22
Total 	$ 	598 	$ 	1,274 	$ 	11 	$ 	22
Net Investment Hedges:
The Company may use non-derivative (foreign currency denominated debt) and derivative (foreign exchange forward contracts) instruments to
hedge portions of the Company’s investment in foreign subsidiaries and manage foreign exchange risk. For instruments that are designated and
qualify as hedges of net investments in foreign operations and that meet the effectiveness requirements, the net gains or losses attributable to
changes in spot exchange rates are recorded in cumulative translation within other comprehensive income. The remainder of the change in value of
such instruments is recorded in earnings. Recognition in earnings of amounts previously recorded in cumulative translation is limited to
circumstances such as complete or substantially complete liquidation of the net investment in the hedged foreign operation. To the extent foreign
currency denominated debt is not designated in or is dedesignated from a net investment hedge relationship, changes in value of that portion of
foreign currency denominated debt due to exchange rate changes are recorded in earnings through their maturity date.
3M’s use of foreign exchange forward contracts designated in hedges of the Company’s net investment in foreign subsidiaries can vary by time
period depending on when foreign currency denominated debt balances designated in such relationships are dedesignated, matured, or are newly
issued and designated. Additionally, variation can occur in connection with the extent of the Company’s desired foreign exchange risk coverage.
During the first quarter of 2018, the Company dedesignated 300 million euros of foreign currency denominated debt from a former net investment
hedge relationship.
103

-- 115 of 160 --

At December 31, 2020, the total notional amount of foreign exchange forward contracts designated in net investment hedges was approximately 50
million euros, along with a principal amount of long-term debt instruments designated in net investment hedges totaling 3.5 billion euros. The
maturity dates of these derivative and nonderivative instruments designated in net investment hedges range from 2021 to 2031.
The location in the consolidated statements of income and comprehensive income and amounts of gains and losses related to derivative and
nonderivative instruments designated as net investment hedges are as follows. There were no reclassifications of the effective portion of net
investment hedges out of accumulated other comprehensive income into income for the periods presented in the table below.
Pretax Gain (Loss)
Recognized as
Cumulative Translation 	Amount of Gain (Loss) Excluded
within Other 	from Effectiveness Testing
Comprehensive Income 	Recognized in Income
Year ended December 31, 2020 (Millions) 	Amount 	Location 	Amount
Foreign currency denominated debt 	$ 	(351) 	Cost of sales 	$ 	—
Foreign currency forward contracts 	(1) 	Cost of sales 	5
Total 	$ 	(352) 	$ 	5
Year ended December 31, 2019 (Millions) 	Amount 	Location 	Amount
Foreign currency denominated debt 	$ 	108 	Cost of sales 	$ 	—
Foreign currency forward contracts 	32 	Cost of sales 	20
Total 	$ 	140 	$ 	20
Pretax Gain (Loss)
Recognized as
Cumulative Translation
within Other 	Ineffective Portion of Gain (Loss) on
Comprehensive Income 	Instrument and Amount Excluded
on Effective Portion of 	from Effectiveness Testing
Instrument 	Recognized in Income
Year ended December 31, 2018 (Millions) 	Amount 	Location 	Amount
Foreign currency denominated debt 	$ 	222 	Cost of sales 	$ 	(2)
Foreign currency forward contracts 	18 	Cost of sales 	4
Total 	$ 	240 	$ 	2
Derivatives Not Designated as Hedging Instruments:
Derivatives not designated as hedging instruments include dedesignated foreign currency forward and option contracts that formerly were
designated in cash flow hedging relationships (as referenced in the Cash Flow Hedges section above). In addition, 3M enters into foreign currency
contracts that are not designated in hedging relationships to offset, in part, the impacts of changes in value of various non-functional currency
denominated items including certain intercompany financing balances. These derivative instruments are not designated in hedging relationships;
therefore, fair value gains and losses on these contracts are recorded in earnings. The Company does not hold or issue derivative financial
instruments for trading purposes.
The location in the consolidated statements of income and amounts of gains and losses related to derivative instruments not designated as hedging
instruments are as follows:
Gain (Loss) on Derivative Recognized in Income
Year ended December 31,
2020 	2019 	2018
(Millions) 	Location 	Amount 	Amount 	Amount
Foreign currency forward/option contracts 	Cost of sales 	$ 	2 	$ 	2 	$ 	13
Foreign currency forward contracts 	Interest expense 	43 	(13) 	(109)
Total 	$ 	45 	$ 	(11) 	$ 	(96)
104

-- 116 of 160 --

Statement of Income Location and Impact of Cash Flow and Fair Value Derivative Instruments
The location in the consolidated statement of income and pre-tax amounts recognized in income related to derivative instruments designated in a
cash flow or fair value hedging relationship are as follows:
Location and Amount of Gain (Loss) Recognized in
Income
Year ended December 31, 2020
(Millions) 	Cost of sales
Other expense
(income), net
Total amounts of income and expense line items presented in the consolidated statement of income in which
the effects of cash flow or fair value hedges are recorded 	$ 	16,605 	$ 	450
The effects of cash flow and fair value hedging:
Gain or (loss) on cash flow hedging relationships:
Foreign currency forward/option contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into income 	$ 	80 	$ 	—
Interest rate contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into income 	— 	(9)
Gain or (loss) on fair value hedging relationships:
Interest rate contracts:
Hedged items 	$ 	— 	$ 	4
Derivatives designated as hedging instruments 	— 	(4)
Location and Amount of Gain (Loss) Recognized in
Income
Year ended December 31, 2019
(Millions) 	Cost of sales
Other expense
(income), net
Total amounts of income and expense line items presented in the consolidated statement of income in which
the effects of cash flow or fair value hedges are recorded 	$ 	17,136 	$ 	462
The effects of cash flow and fair value hedging:
Gain or (loss) on cash flow hedging relationships:
Foreign currency forward/option contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into income 	$ 	74 	$ 	—
Interest rate contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into income 	— 	(4)
Gain or (loss) on fair value hedging relationships:
Interest rate contracts:
Hedged items 	$ 	— 	$ 	(8)
Derivatives designated as hedging instruments 	— 	8
105

-- 117 of 160 --

Location and Fair Value Amount of Derivative Instruments:
The following tables summarize the fair value of 3M’s derivative instruments, excluding nonderivative instruments used as hedging instruments,
and their location in the consolidated balance sheet. Notional amounts below are presented at period end foreign exchange rates, except for certain
interest rate swaps, which are presented using the inception date’s foreign exchange rate. Additional information with respect to the fair value of
derivative instruments is included in Note 15.
Gross 	Assets 	Liabilities
Notional 	Fair 	Fair
December 31, 2020 (Millions) 	Amount 	Location 	Value Amount 	Location 	Value Amount
Derivatives designated as
hedging instruments
Foreign currency forward/option contracts 	$ 	1,630 	Other current assets 	$ 	14 	Other current liabilities 	$ 	67
Foreign currency forward/option contracts 	669 	Other assets 	10 	Other liabilities 	25
Interest rate contracts 	403 	Other current assets 	7 	Other current liabilities 	—
Total derivatives designated as hedging
instruments 	$ 	31 	$ 	92
Derivatives not designated as
hedging instruments
Foreign currency forward/option contracts 	$ 	3,166 	Other current assets 	$ 	13 	Other current liabilities 	$ 	14
Total derivatives not designated as
hedging instruments 	$ 	13 	$ 	14
Total derivative instruments 	$ 	44 	$ 	106
Gross 	Assets 	Liabilities
Notional 	Fair 	Fair
December 31, 2019 (Millions) 	Amount 	Location 	Value Amount 	Location 	Value Amount
Derivatives designated as
hedging instruments
Foreign currency forward/option contracts 	$ 	1,995 	Other current assets 	$ 	64 	Other current liabilities 	$ 	9
Foreign currency forward/option contracts 	1,041 	Other assets 	50 	Other liabilities 	3
Interest rate contracts 	500 	Other current assets 	— 	Other current liabilities 	—
Interest rate contracts 	603 	Other assets 	17 	Other liabilities 	—
Total derivatives designated as hedging
instruments 	$ 	131 	$ 	12
Derivatives not designated as
hedging instruments
Foreign currency forward/option contracts 	$ 	2,684 	Other current assets 	$ 	11 	Other current liabilities 	$ 	8
Total derivatives not designated as
hedging instruments 	$ 	11 	$ 	8
Total derivative instruments 	$ 	142 	$ 	20
Credit Risk and Offsetting of Assets and Liabilities of Derivative Instruments:
The Company is exposed to credit loss in the event of nonperformance by counterparties in interest rate swaps, currency swaps, and forward and
option contracts. However, the Company’s risk is limited to the fair value of the instruments. The Company actively monitors its exposure to
credit risk through the use of credit approvals and credit limits, and by selecting major international banks and financial institutions as
counterparties. 3M enters into master netting arrangements with counterparties when possible to mitigate credit risk in derivative transactions. A
master netting arrangement may allow each counterparty to net settle amounts owed between a 3M entity and the counterparty as a result of
multiple, separate derivative transactions. As of December 31, 2020, 3M has International Swaps and Derivatives Association (ISDA) agreements
with 17 applicable banks and financial institutions which contain netting provisions. In addition to a master agreement with 3M supported by a
primary counterparty’s parent guarantee, 3M also has associated credit support agreements in place with 16 of its primary derivative counterparties
which, among other things, provide the
106

-- 118 of 160 --

circumstances under which either party is required to post eligible collateral (when the market value of transactions covered by these agreements
exceeds specified thresholds or if a counterparty’s credit rating has been downgraded to a predetermined rating). The Company does not anticipate
nonperformance by any of these counterparties.
3M has elected to present the fair value of derivative assets and liabilities within the Company’s consolidated balance sheet on a gross basis even
when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. However, the following
tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance
with various criteria in the event of default or termination as stipulated by the terms of netting arrangements with each of the counterparties. For
each counterparty, if netted, the Company would offset the asset and liability balances of all derivatives at the end of the reporting period based on
the 3M entity that is a party to the transactions. Derivatives not subject to master netting agreements are not eligible for net presentation. As of the
applicable dates presented below, no cash collateral had been received or pledged related to these derivative instruments.
Offsetting of Financial Assets under Master Netting Agreements with Derivative Counterparties
Gross Amounts not Offset in the
Consolidated Balance Sheet that are Subject
Gross Amount of 	to Master Netting Agreements
Derivative Assets 	Gross Amount of
Presented in the 	Eligible Offsetting 	Cash
Consolidated 	Recognized 	Collateral 	Net Amount of
December 31, 2020 (Millions) 	Balance Sheet 	Derivative Liabilities 	Received 	Derivative Assets
Derivatives subject to master netting
agreements 	$ 	44 	$ 	11 	$ 	— 	$ 	33
Derivatives not subject to master netting
agreements 	— 	—
Total 	$ 	44 	$ 	33
December 31, 2019 (Millions)
Derivatives subject to master netting agreements 	$ 	142 	$ 	14 	$ 	— 	$ 	128
Derivatives not subject to master netting agreements 	— 	—
Total 	$ 	142 	$ 	128
Offsetting of Financial Liabilities under Master Netting Agreements with Derivative Counterparties
Gross Amounts not Offset in the
Consolidated Balance Sheet that are Subject
Gross Amount of 	to Master Netting Agreements
Derivative Liabilities 	Gross Amount of
Presented in the 	Eligible Offsetting 	Cash 	Net Amount of
Consolidated 	Recognized 	Collateral 	Derivative
December 31, 2020 (Millions) 	Balance Sheet 	Derivative Assets 	Pledged 	Liabilities
Derivatives subject to master netting
agreements 	$ 	106 	$ 	11 	$ 	— 	$ 	95
Derivatives not subject to master netting
agreements 	— 	—
Total 	$ 	106 	$ 	95
December 31, 2019 (Millions)
Derivatives subject to master netting agreements 	$ 	20 	$ 	14 	$ 	— 	$ 	6
Derivatives not subject to master netting agreements 	— 	—
Total 	$ 	20 	$ 	6
Foreign Currency Effects
3M estimates that year-on-year foreign currency transaction effects, including hedging impacts, decreased pre-tax income by approximately $21
million in 2020 and increased pre-tax income by approximately $201 million in 2019. These estimates include transaction gains and losses,
including derivative instruments designed to reduce foreign currency exchange rate risks.
107

-- 119 of 160 --

NOTE 15. Fair Value Measurements
3M follows ASC 820, Fair Value Measurements and Disclosures, with respect to assets and liabilities that are measured at fair value on a
recurring basis and nonrecurring basis. The Company adopted ASU No. 2018-13, Changes to the Disclosure Requirements for Fair Value
Measurements, as of January 1, 2020. This ASU primarily amended the disclosures around Level 3 investments, of which the Company had an
immaterial amount for all periods presented.
Assets and Liabilities that are Measured at Fair Value on a Recurring Basis:
For 3M, assets and liabilities that are measured at fair value on a recurring basis primarily relate to available-for-sale marketable securities and
certain derivative instruments. Derivatives include cash flow hedges, interest rate swaps and net investment hedges. The information in the
following paragraphs and tables primarily addresses matters relative to these financial assets and liabilities. Separately, there were no material fair
value measurements with respect to nonfinancial assets or liabilities that are recognized or disclosed at fair value in the Company’s financial
statements on a recurring basis for 2020 and 2019.
3M uses various valuation techniques, which are primarily based upon the market and income approaches, with respect to financial assets and
liabilities. Following is a description of the valuation methodologies used for the respective financial assets and liabilities measured at fair value.
Available-for-sale marketable securities — except certain U.S. municipal securities:
Marketable securities, except certain U.S. municipal securities, are valued utilizing multiple sources. A weighted average price is used for these
securities. Market prices are obtained for these securities from a variety of industry standard data providers, security master files from large
financial institutions, and other third-party sources. These multiple prices are used as inputs into a distribution-curve-based algorithm to determine
the daily fair value to be used. 3M classifies U.S. treasury securities as level 1, while all other marketable securities (excluding certain U.S.
municipal securities) are classified as level 2. Marketable securities are discussed further in Note 11.
Available-for-sale marketable securities —certain U.S. municipal securities only:
3M holds municipal securities with certain cities in the United States as of December 31, 2020. Due to the nature of these securities, the valuation
method utilized includes referencing the carrying value of the corresponding finance lease obligation as adjusted for additional issuances when 3M
sells its assets to the municipality and decreases in the form of bond amortization payments, and as such will be classified as level 3 securities
separately.
Investments:
Investments include equity securities that are traded in an active market. Closing stock prices are readily available from active markets and are
representative of fair value. 3M classifies these securities as Level 1. Investments are included within other assets on the Company’s consolidated
balance sheet.
Derivative instruments:
The Company’s derivative assets and liabilities within the scope of ASC 815, Derivatives and Hedging, are required to be recorded at fair value.
The Company’s derivatives that are recorded at fair value include foreign currency forward and option contracts, interest rate swaps, and net
investment hedges where the hedging instrument is recorded at fair value. Net investment hedges that use foreign currency denominated debt to
hedge 3M’s net investment are not impacted by the fair value measurement standard under ASC 820, as the debt used as the hedging instrument is
marked to a value with respect to changes in spot foreign currency exchange rates and not with respect to other factors that may impact fair value.
3M has determined that foreign currency forwards, currency swaps, foreign currency options, interest rate swaps and cross-currency swaps will be
considered level 2 measurements. 3M uses inputs other than quoted prices that are observable for the asset. These inputs include foreign currency
exchange rates, volatilities, and interest rates. Derivative positions are primarily valued using standard calculations/models that use as their basis
readily observable market parameters. Industry standard data providers are 3M’s primary
108

-- 120 of 160 --

source for forward and spot rate information for both interest rates and currency rates, with resulting valuations periodically validated through
third-party or counterparty quotes and a net present value stream of cash flows model.
The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis.
Fair Value Measurements
Description 	Fair Value at 	Using Inputs Considered as
(Millions) 	December 31, 2020 	Level 1 	Level 2 	Level 3
Assets:
Available-for-sale:
Marketable securities:
Corporate debt securities 	$ 	7 	$ 	— 	$ 	7 	$ 	—
Commercial paper 	237 	— 	237 	—
Certificates of deposit/time deposits 	31 	— 	31 	—
U.S. treasury securities 	125 	125 	— 	—
U.S. municipal securities 	34 	— 	— 	34
Derivative instruments — assets:
Foreign currency forward/option contracts 	37 	— 	37 	—
Interest rate contracts 	7 	— 	7 	—
Liabilities:
Derivative instruments — liabilities:
Foreign currency forward/option contracts 	106 	— 	106 	—
Fair Value Measurements
Description 	Fair Value at 	Using Inputs Considered as
(Millions) 	December 31, 2019 	Level 1 	Level 2 	Level 3
Assets:
Available-for-sale:
Marketable securities:
Commercial paper 	$ 	85 	$ 	— 	$ 	85 	$ 	—
Certificates of deposit/time deposits 	10 	— 	10 	—
U.S. municipal securities 	46 	— 	— 	46
Investments 	25 	25 	— 	—
Derivative instruments — assets:
Foreign currency forward/option contracts 	125 	— 	125 	—
Interest rate contracts 	17 	— 	17 	—
Liabilities:
Derivative instruments — liabilities:
Foreign currency forward/option contracts 	20 	— 	20 	—
109

-- 121 of 160 --

The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the table
above that used significant unobservable inputs (level 3).
Marketable securities — certain U.S. municipal securities only
(Millions) 	2020 	2019 	2018
Beginning balance 	$ 	46 	$ 	40 	$ 	30
Total gains or losses:
Included in earnings 	— 	— 	—
Included in other comprehensive income 	— 	— 	—
Purchases and issuances 	10 	9 	13
Sales and settlements 	(22) 	(3) 	(3)
Transfers in and/or out of level 3 	— 	— 	—
Ending balance 	34 	46 	40
Change in unrealized gains or losses for the period included in earnings for
securities held at the end of the reporting period 	— 	— 	—
In addition, the plan assets of 3M’s pension and postretirement benefit plans are measured at fair value on a recurring basis (at least annually).
Refer to Note 13.
Assets and Liabilities that are Measured at Fair Value on a Nonrecurring Basis:
Disclosures are required for certain assets and liabilities that are measured at fair value, but are recognized and disclosed at fair value on a
nonrecurring basis in periods subsequent to initial recognition. For 3M, such measurements of fair value primarily to indefinite-lived and long-
lived asset impairments, goodwill impairments, and adjustment in carrying value of equity securities for which the measurement alternative of cost
less impairment plus or minus observable price changes is used. There were no material long-lived asset impairments for 2018 and 2019. There
were no material adjustments to equity securities using the measurement alternative for 2019. 3M reflected an immaterial charge related to
impairment of certain indefinite-lived assets and a net charge of $22 million related to adjustment to the carrying value of equity securities using
the measurement alternative during the first quarter of 2020.
Fair Value of Financial Instruments:
The Company’s financial instruments include cash and cash equivalents, marketable securities, held-to-maturity debt securities, accounts
receivable, certain investments, accounts payable, borrowings, and derivative contracts. The fair values of cash equivalents, accounts receivable,
held-to-maturity debt securities, accounts payable, and short-term borrowings and current portion of long-term debt approximated carrying values
because of the short-term nature of these instruments. Available-for-sale marketable securities, in addition to certain derivative instruments, are
recorded at fair values as indicated in the preceding disclosures. To estimate fair values (classified as level 2) for its long-term debt, the Company
utilized third-party quotes, which are derived all or in part from model prices, external sources, market prices, or the third-party’s internal records.
Information with respect to the carrying amounts and estimated fair values of these financial instruments follow:
December 31, 2020 	December 31, 2019
Carrying 	Fair 	Carrying 	Fair
(Millions) 	Value 	Value 	Value 	Value
Long-term debt, excluding current portion 	$ 	17,989 	$ 	20,496 	$ 	17,518 	$ 	18,475
The fair values reflected above consider the terms of the related debt absent the impacts of derivative/hedging activity. The carrying amount of
long-term debt referenced above is impacted by certain fixed-to-floating interest rate swaps that are designated as fair value hedges and by the
designation of certain fixed rate Eurobond securities issued by the Company as hedging instruments of the Company’s net investment in its
European subsidiaries. A number of 3M’s fixed-rate bonds were trading at a premium at December 31, 2020 and 2019 due to the lower interest
rates and tighter credit spreads compared to issuance levels.
110

-- 122 of 160 --

NOTE 16. Commitments and Contingencies
Unconditional Purchase Obligations:
Unconditional purchase obligations are defined as an agreement to purchase goods or services that is enforceable and legally binding (non-
cancelable, or cancelable only in certain circumstances). The Company estimates its total unconditional purchase obligation commitment (for
those contracts with terms in excess of one year) as of December 31, 2020, at $985 million. Payments by year are estimated as follows: 2021 ($294
million), 2022 ($328 million), 2023 ($216 million), 2024 ($95 million), 2025 ($46 million) and after 2026 ($6 million). Many of these
commitments relate to take or pay contracts, in which 3M guarantees payment to ensure availability of products or services that are sold to
customers. The Company expects to receive consideration (products or services) for these unconditional purchase obligations. The purchase
obligation amounts do not represent the entire anticipated purchases in the future, but represent only those items for which the Company is
contractually obligated. The majority of 3M’s products and services are purchased as needed, with no unconditional commitment. For this reason,
these amounts will not provide an indication of the Company’s expected future cash outflows related to purchases.
Warranties/Guarantees:
3M’s accrued product warranty liabilities, recorded on the Consolidated Balance Sheet as part of current and long-term liabilities, are estimated at
approximately $46 million at December 31, 2020, and $51 million at December 31, 2019. Further information on product warranties are not
disclosed, as the Company considers the balance immaterial to its consolidated results of operations and financial condition. The fair value of 3M
guarantees of loans with third parties and other guarantee arrangements are not material.
Related Party Activity:
3M does not have any material related party activity.
Legal Proceedings:
The Company and some of its subsidiaries are involved in numerous claims and lawsuits, principally in the United States, and regulatory
proceedings worldwide. These claims, lawsuits and proceedings include, but are not limited to, products liability (involving products that the
Company now or formerly manufactured and sold), intellectual property, commercial, antitrust, federal False Claims Act, securities, and state and
federal environmental laws. Unless otherwise stated, the Company is vigorously defending all such litigation and proceedings. From time to time,
the Company also receives subpoenas or requests for information from various government agencies. The Company generally responds to such
subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in
considerable costs being incurred by the Company. Such subpoenas and requests can also lead to the assertion of claims or the commencement of
administrative, civil or criminal legal proceedings against the Company and others, as well as to settlements. The outcomes of legal proceedings
and regulatory matters are often difficult to predict. Any determination that the Company’s operations or activities are not, or were not, in
compliance with applicable laws or regulations could result in the imposition of fines, civil or criminal penalties, and equitable remedies, including
disgorgement, suspension or debarment or injunctive relief.
Process for Disclosure and Recording of Liabilities Related to Legal Proceedings
Many lawsuits and claims involve highly complex issues relating to causation, scientific evidence, and alleged actual damages, all of which are
otherwise subject to substantial uncertainties. Assessments of lawsuits and claims can involve a series of complex judgments about future events
and can rely heavily on estimates and assumptions. When making determinations about recording liabilities related to legal proceedings, the
Company complies with the requirements of ASC 450, Contingencies, and related guidance, and records liabilities in those instances where it can
reasonably estimate the amount of the loss and when liability is probable. Where the reasonable estimate of the probable loss is a range, the
Company records as an accrual in its financial statements the most likely estimate of the loss, or the low end of the range if there is no one best
estimate. The Company either discloses the amount of a possible loss or range of loss in excess of established accruals if estimable, or states that
such an estimate cannot be made. The Company discloses significant legal proceedings even where liability is not probable or the amount of the
liability is not estimable, or both, if the Company believes there is at least a reasonable possibility that a loss may be incurred.
111

-- 123 of 160 --

Because litigation is subject to inherent uncertainties, and unfavorable rulings or developments could occur, there can be no certainty that the
Company may not ultimately incur charges in excess of presently recorded liabilities. Many of the matters described are at preliminary stages or
seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. A future adverse ruling, settlement,
unfavorable development, or increase in accruals for one or more of these matters could result in future charges that could have a material adverse
effect on the Company’s results of operations or cash flows in the period in which they are recorded. Although the Company cannot estimate its
exposure to all legal proceedings, the Company currently believes that the ultimate outcome of legal proceedings or future charges, if any, would
not have a material adverse effect on the consolidated financial position of the Company. Based on experience and developments, the Company
reexamines its estimates of probable liabilities and associated expenses and receivables each period, and whether it is able to estimate a liability
previously determined to be not estimable and/or not probable. Where appropriate, the Company makes additions to or adjustments of its estimated
liabilities. As a result, the current estimates of the potential impact on the Company’s consolidated financial position, results of operations and
cash flows for the legal proceedings and claims pending against the Company could change in the future.
Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings
The Company estimates insurance receivables based on an analysis of the terms of its numerous policies, including their exclusions, pertinent case
law interpreting comparable policies, its experience with similar claims, and assessment of the nature of the claim and remaining coverage, and
records an amount it has concluded is likely to be recovered. For those insured legal proceedings where the Company has recorded an accrued
liability in its financial statements, the Company also records receivables for the amount of insurance that it expects to recover under the
Company’s insurance program. For those insured matters where the Company has not recorded an accrued liability because the liability is not
probable or the amount of the liability is not estimable, or both, but where the Company has incurred an expense in defending itself, the Company
records receivables for the amount of insurance that it expects to recover for the expense incurred.
The following sections first describe the significant legal proceedings in which the Company is involved, and then describe the liabilities and
associated insurance receivables the Company has accrued relating to its significant legal proceedings.
Respirator Mask/Asbestos Litigation
As of December 31, 2020, the Company is a named defendant, with multiple co-defendants, in numerous lawsuits in various courts that purport to
represent approximately 2,075 individual claimants, compared to approximately 1,727 individual claimants with actions pending on December 31,
2019.
The vast majority of the lawsuits and claims resolved by and currently pending against the Company allege use of some of the Company’s mask
and respirator products and seek damages from the Company and other defendants for alleged personal injury from workplace exposures to
asbestos, silica, coal mine dust or other occupational dusts found in products manufactured by other defendants or generally in the workplace. As
of year-end 2020, there has been an increase in the number of cases filed alleging injuries from exposures to coal mine dust. A minority of the
lawsuits and claims resolved by and currently pending against the Company generally allege personal injury from occupational exposure to
asbestos from products previously manufactured by the Company, which are often unspecified, as well as products manufactured by other
defendants, or occasionally at Company premises.
The Company’s current volume of new and pending matters is substantially lower than it experienced at the peak of filings in 2003. The Company
expects that filing of claims by unimpaired claimants in the future will continue to be at much lower levels than in the past. Accordingly, the
number of claims alleging more serious injuries, including mesothelioma, other malignancies, and black lung disease, will represent a greater
percentage of total claims than in the past. Over the past twenty plus years, the Company has prevailed in fifteen of the sixteen cases tried to a jury
(including the lawsuits in 2018 described below). In 2018, 3M received a jury verdict in its favor in two lawsuits – one in California state court in
February and the other in Massachusetts state court in December – both involving allegations that 3M respirators were defective and failed to
protect the plaintiffs against asbestos fibers. In April 2018, a jury in state court in Kentucky found 3M’s 8710 respirators failed to protect two coal
miners from coal mine dust and awarded compensatory damages of approximately $2 million and punitive damages totaling $63 million. In
August 2018, the trial court entered judgment and the Company appealed. During March and April 2019, the Company agreed in principle to settle
a substantial majority of the coal mine dust lawsuits in Kentucky and West Virginia for $340 million, including the jury verdict in April 2018 in
the Kentucky case mentioned above. That settlement was completed in 2019, and the appeal has been dismissed. In October 2020, 3M defended a
respirator case before a jury in King County, Washington, involving a former shipyard worker who alleged 3M’s 8710
112

-- 124 of 160 --

respirator was defective and that 3M acted negligently in failing to protect him against asbestos fibers. The jury delivered a complete defense
verdict in favor of 3M, concluding that the 8710 respirator was not defective in design or warnings and any conduct by 3M was not a cause of
plaintiff’s mesothelioma. The plaintiff has filed a notice of appeal.
The Company has demonstrated in these past trial proceedings that its respiratory protection products are effective as claimed when used in the
intended manner and in the intended circumstances. Consequently, the Company believes that claimants are unable to establish that their medical
conditions, even if significant, are attributable to the Company’s respiratory protection products. Nonetheless, the Company’s litigation experience
indicates that claims of persons alleging more serious injuries, including mesothelioma, other malignancies, and black lung disease, are costlier to
resolve than the claims of unimpaired persons, and it therefore believes the average cost of resolving pending and future claims on a per-claim
basis will continue to be higher than it experienced in prior periods when the vast majority of claims were asserted by medically unimpaired
claimants.
As previously reported, the State of West Virginia, through its Attorney General, filed a complaint in 2003 against the Company and two other
manufacturers of respiratory protection products in the Circuit Court of Lincoln County, West Virginia, and amended its complaint in 2005. The
amended complaint seeks substantial, but unspecified, compensatory damages primarily for reimbursement of the costs allegedly incurred by the
State for worker’s compensation and healthcare benefits provided to all workers with occupational pneumoconiosis and unspecified punitive
damages. In October 2019, the court granted the State’s motion to sever its unfair trade practices claim. In January 2020, the manufacturers filed a
petition with the West Virginia Supreme Court, challenging the trial court’s rulings; that petition was denied in November 2020. No liability has
been recorded for this matter because the Company believes that liability is not probable and estimable at this time. In addition, the Company is
not able to estimate a possible loss or range of loss given the lack of any meaningful discovery responses by the State of West Virginia, the
otherwise minimal activity in this case, and the assertions of claims against two other manufacturers where a defendant’s share of liability may
turn on the law of joint and several liability and by the amount of fault, if any, a jury may allocate to each defendant if the case were ultimately
tried.
Respirator Mask/Asbestos Liabilities and Insurance Receivables
The Company regularly conducts a comprehensive legal review of its respirator mask/asbestos liabilities. The Company reviews recent and
historical claims data, including without limitation, (i) the number of pending claims filed against the Company, (ii) the nature and mix of those
claims (i.e., the proportion of claims asserting usage of the Company’s mask or respirator products and alleging exposure to each of asbestos,
silica, coal or other occupational dusts, and claims pleading use of asbestos-containing products allegedly manufactured by the Company), (iii) the
costs to defend and resolve pending claims, and (iv) trends in filing rates and in costs to defend and resolve claims, (collectively, the “Claims
Data”). As part of its comprehensive legal review, the Company regularly provides the Claims Data to a third party with expertise in determining
the impact of Claims Data on future filing trends and costs. The third party assists the Company in estimating the costs to defend and resolve
pending and future claims. The Company uses these estimates to develop its best estimate of probable liability.
Developments may occur that could affect the Company’s estimate of its liabilities. These developments include, but are not limited to, significant
changes in (i) the key assumptions underlying the Company’s accrual, including, the number of future claims, the nature and mix of those claims,
the average cost of defending and resolving claims, and in maintaining trial readiness (ii) trial and appellate outcomes, (iii) the law and procedure
applicable to these claims, and (iv) the financial viability of other co-defendants and insurers.
As a result of its review of its respirator mask/asbestos liabilities, of pending and expected lawsuits and of the cost of resolving claims of persons
who claim more serious injuries, including mesothelioma, other malignancies, and black lung disease, the Company increased its accruals in 2020
for respirator mask/asbestos liabilities by a total of $120 million. In 2020, the Company made payments for legal defense costs and settlements of
$66 million related to the respirator mask/asbestos litigation. During the first quarter of 2019, the Company recorded a pre-tax charge of $313
million in conjunction with an increase in the accrual as a result of the March and April 2019 settlements-in-principle of the coal mine dust
lawsuits mentioned above and the Company’s assessment of other current and expected coal mine dust lawsuits (including the costs to resolve all
current and expected coal mine dust lawsuits in Kentucky and West Virginia). As of December 31, 2020, the Company had an accrual for
respirator mask/asbestos liabilities (excluding Aearo accruals) of $662 million. This accrual represents the Company’s best estimate of probable
loss and reflects an estimation period for future claims that may be filed against the Company approaching the year 2050. The Company cannot
estimate the amount or upper end of the range of amounts by which the liability may exceed the accrual the Company has established because of
the (i) inherent difficulty in projecting the number of claims that have not yet been asserted or the time period in which future claims may be
asserted, (ii) the complaints nearly always assert claims against multiple defendants where the damages alleged are
113

-- 125 of 160 --

typically not attributed to individual defendants so that a defendant’s share of liability may turn on the law of joint and several liability, which can
vary by state, (iii) the multiple factors described above that the Company considers in estimating its liabilities, and (iv) the several possible
developments described above that may occur that could affect the Company’s estimate of liabilities.
As of December 31, 2020, the Company’s receivable for insurance recoveries related to the respirator mask/asbestos litigation was $4 million. The
Company continues to seek coverage under the policies of certain insolvent and other insurers. Once those claims for coverage are resolved, the
Company will have collected substantially all of its remaining insurance coverage for respirator mask/asbestos claims.
Respirator Mask/Asbestos Litigation — Aearo Technologies
On April 1, 2008, a subsidiary of the Company acquired the stock of Aearo Holding Corp., the parent of Aearo Technologies (“Aearo”). Aearo
manufactured and sold various products, including personal protection equipment, such as eye, ear, head, face, fall and certain respiratory
protection products.
As of December 31, 2020, Aearo and/or other companies that previously owned and operated Aearo’s respirator business (American Optical
Corporation, Warner-Lambert LLC, AO Corp. and Cabot Corporation (“Cabot”)) are named defendants, with multiple co-defendants, including
the Company, in numerous lawsuits in various courts in which plaintiffs allege use of mask and respirator products and seek damages from Aearo
and other defendants for alleged personal injury from workplace exposures to asbestos, silica-related, coal mine dust, or other occupational dusts
found in products manufactured by other defendants or generally in the workplace.
As of December 31, 2020, the Company, through its Aearo subsidiary, had accruals of $28 million for product liabilities and defense costs related
to current and future Aearo-related asbestos, silica-related and coal mine dust claims. This accrual represents the Company’s best estimate of
Aearo’s probable loss and reflects an estimation period for future claims that may be filed against Aearo approaching the year 2050. The accrual
was reduced by $37 million during the second quarter of 2020 after paying Aearo’s share of certain settlements under the informal arrangement
described below. The accrual reflects the Company’s assessment of pending and expected lawsuits, its review of its respirator mask/asbestos
liabilities, and the cost of resolving claims of persons who claim more serious injuries. Responsibility for legal costs, as well as for settlements and
judgments, is currently shared in an informal arrangement among Aearo, Cabot, American Optical Corporation and a subsidiary of Warner
Lambert and their respective insurers (the “Payor Group”). Liability is allocated among the parties based on the number of years each company
sold respiratory products under the “AO Safety” brand and/or owned the AO Safety Division of American Optical Corporation and the alleged
years of exposure of the individual plaintiff.
Aearo’s share of the contingent liability is further limited by an agreement entered into between Aearo and Cabot on July 11, 1995. This
agreement provides that, so long as Aearo pays to Cabot a quarterly fee of $100,000, Cabot will retain responsibility and liability for, and
indemnify Aearo against, any product liability claims involving exposure to asbestos, silica, or silica products for respirators sold prior to July 11,
1995. Because of the difficulty in determining how long a particular respirator remains in the stream of commerce after being sold, Aearo and
Cabot have applied the agreement to claims arising out of the alleged use of respirators involving exposure to asbestos, silica or silica products
prior to January 1, 1997. With these arrangements in place, Aearo’s potential liability is limited to exposures alleged to have arisen from the use of
respirators involving exposure to asbestos, silica, or silica products on or after January 1, 1997. To date, Aearo has elected to pay the quarterly fee.
Aearo could potentially be exposed to additional claims for some part of the pre-July 11, 1995 period covered by its agreement with Cabot if
Aearo elects to discontinue its participation in this arrangement, or if Cabot is no longer able to meet its obligations in these matters.
Developments may occur that could affect the estimate of Aearo’s liabilities. These developments include, but are not limited to: (i) significant
changes in the number of future claims, (ii) significant changes in the average cost of resolving claims, (iii) significant changes in the legal costs of
defending these claims, (iv) significant changes in the mix and nature of claims received, (v) trial and appellate outcomes, (vi) significant changes
in the law and procedure applicable to these claims, (vii) significant changes in the liability allocation among the co-defendants, (viii) the financial
viability of members of the Payor Group including exhaustion of available insurance coverage limits, and/or (ix) a determination that the
interpretation of the contractual obligations on which Aearo has estimated its share of liability is inaccurate. The Company cannot determine the
impact of these potential developments on its current estimate of Aearo’s share of liability for these existing and future claims. If any of the
developments described above were to occur, the actual amount of these liabilities for existing and future claims could be significantly larger than
the amount accrued.
114

-- 126 of 160 --

Because of the inherent difficulty in projecting the number of claims that have not yet been asserted, the complexity of allocating responsibility for
future claims among the Payor Group, and the several possible developments that may occur that could affect the estimate of Aearo’s liabilities,
the Company cannot estimate the amount or range of amounts by which Aearo’s liability may exceed the accrual the Company has established.
Environmental Matters and Litigation
The Company’s operations are subject to environmental laws and regulations including those pertaining to air emissions, wastewater discharges,
toxic substances, and the handling and disposal of solid and hazardous wastes enforceable by national, state, and local authorities around the
world, and private parties in the United States and abroad. These laws and regulations provide, under certain circumstances, a basis for the
remediation of contamination, for capital investment in pollution control equipment, for restoration of or compensation for damages to natural
resources, and for personal injury and property damage claims. The Company has incurred, and will continue to incur, costs and capital
expenditures in complying with these laws and regulations, defending personal injury and property damage claims, and modifying its business
operations in light of its environmental responsibilities. In its effort to satisfy its environmental responsibilities and comply with environmental
laws and regulations, the Company has established, and periodically updates, policies relating to environmental standards of performance for its
operations worldwide.
Under certain environmental laws, including the United States Comprehensive Environmental Response, Compensation and Liability Act of 1980
(CERCLA) and similar state laws, the Company may be jointly and severally liable, typically with other companies, for the costs of remediation of
environmental contamination at current or former facilities and at off-site locations. The Company has identified numerous locations, most of
which are in the United States, at which it may have some liability. Please refer to the section entitled “Environmental Liabilities and Insurance
Receivables” that follows for information on the amount of the accrual for such liabilities.
Environmental Matters
As previously reported, the Company has been voluntarily cooperating with ongoing reviews by local, state, federal (primarily the U.S.
Environmental Protection Agency (EPA)), and international agencies of possible environmental and health effects of various perfluorinated
compounds, including perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), or other per- and
polyfluoroalkyl substances (collectively PFAS). As a result of its phase-out decision in May 2000, the Company no longer manufactures certain
PFAS compounds including PFOA, PFOS, PFHxS, and their pre-cursor compounds. The Company ceased manufacturing and using the vast
majority of these compounds within approximately two years of the phase-out announcement and ceased all manufacturing and the last significant
use of this chemistry by the end of 2008. The Company continues to manufacture a variety of shorter chain length PFAS compounds, including,
but not limited to, pre-cursor compounds to perfluorobutane sulfonate (PFBS). These compounds are used as input materials to a variety of
products, including engineered fluorinated fluids, fluoropolymers and fluorelastomers, as well as surfactants, additives, and coatings. Through its
ongoing life cycle management and its raw material composition identification processes associated with the Company’s policies covering the use
of all persistent and bio-accumulative materials, the Company continues to review, control or eliminate the presence of certain PFAS in purchased
materials or as byproducts in some of 3M’s current fluorochemical manufacturing processes, products, and waste streams.
Regulatory activities concerning PFAS continue in the United States, Europe and elsewhere, and before certain international bodies. These
activities include gathering of exposure and use information, risk assessment, and consideration of regulatory approaches. In the European Union,
where 3M has manufacturing facilities in countries such as Germany and Belgium, recent regulatory activities have included preliminary work on
various restrictions under the Regulation concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), including
the restriction of PFAS in certain usages and a broader restriction of PFAS as a class. As of December 2020, PFOA is subject to certain restrictions
under EU’s Persistent Organic Pollutants (POPs) Recast Regulation.
In the United States, as the database of studies of both PFOA and PFOS has expanded, the EPA has developed human health effects documents
summarizing the available data from these studies. In February 2014, the EPA initiated external peer review of its draft human health effects
documents for PFOA and PFOS. The peer review panel met in August 2014. In May 2016, the EPA announced lifetime health advisory levels for
PFOA and PFOS at 70 parts per trillion (ppt) (superseding the provisional levels established by the EPA in 2009 of 400 ppt for PFOA and 200 ppt
for PFOS). Where PFOA and PFOS are found together, EPA recommends that the concentrations be added together, and the lifetime health
advisory for PFOA and PFOS combined is also 70 ppt. Lifetime health advisories, which are non-enforceable and non-regulatory, provide
information about concentrations of drinking water contaminants at
115

-- 127 of 160 --

which adverse health effects are not expected to occur over the specified exposure duration. To collect exposure information under the Safe
Drinking Water Act, the EPA published on May 2, 2012 a list of unregulated substances, including six PFAS chemicals, required to be monitored
during the period 2013-2015 by public water system suppliers to determine the extent of their occurrence. Through January 2017, the EPA
reported results for 4,920 public water supplies nationwide. Based on the 2016 lifetime health advisory, 13 public water supplies exceed the level
for PFOA and 46 exceed the level for PFOS (unchanged from the July 2016 EPA summary). A technical advisory issued by EPA in September
2016 on laboratory analysis of drinking water samples stated that 65 public water supplies had exceeded the combined level for PFOA and PFOS.
These results are based on one or more samples collected during the period 2012-2015 and do not necessarily reflect current conditions of these
public water supplies. EPA reporting does not identify the sources of the PFOA and PFOS in the public water supplies.
The Company is continuing to make progress in its work, under the supervision of state regulators, to remediate historic disposal of PFAS-
containing waste associated with manufacturing operations at its Decatur, Alabama; Cottage Grove, Minnesota; and Cordova, Illinois plants. As
previously reported, the Company entered into a voluntary remedial action agreement with the Alabama Department of Environmental
Management (ADEM) to remediate the presence of PFAS in the soil and groundwater at the Company’s manufacturing facility in Decatur,
Alabama associated with the historic (1978-1998) incorporation of wastewater treatment plant sludge. With ADEM’s agreement, 3M substantially
completed installation of a multilayer cap on the former sludge incorporation areas. Further remediation activities, including certain on-site and
off-site investigations and studies, will be conducted in accordance with the July 2020 Interim Consent Order described below in the “Other
PFAS-related Matters” section.
The Company continues to work with the Minnesota Pollution Control Agency (MPCA) pursuant to the terms of the previously disclosed
May 2007 Settlement Agreement and Consent Order to address the presence of certain PFAS in the soil and groundwater at former disposal sites
in Washington County, Minnesota (Oakdale and Woodbury) and at the Company’s manufacturing facility at Cottage Grove, Minnesota. Under this
agreement, the Company’s principal obligations include (i) evaluating releases of certain PFAS from these sites and proposing response actions;
(ii) providing treatment or alternative drinking water upon identifying any level exceeding a Health Based Value (HBV) or Health Risk Limit
(HRL) (i.e., the amount of a chemical in drinking water determined by the Minnesota Department of Health (MDH) to be safe for human
consumption over a lifetime) for certain PFAS for which a HBV and/or HRL exists as a result of contamination from these sites; (iii) remediating
identified sources of other PFAS at these sites that are not controlled by actions to remediate PFOA and PFOS; and (iv) sharing information with
the MPCA about certain perfluorinated compounds. During 2008, the MPCA issued formal decisions adopting remedial options for the former
disposal sites in Washington County, Minnesota (Oakdale and Woodbury). In August 2009, the MPCA issued a formal decision adopting remedial
options for the Company’s Cottage Grove manufacturing facility. During the spring and summer of 2010, 3M began implementing the agreed
upon remedial options at the Cottage Grove and Woodbury sites. 3M commenced the remedial option at the Oakdale site in late 2010. At each
location the remedial options were recommended by the Company and approved by the MPCA. Remediation work has been completed at the
Oakdale and Woodbury sites, and they are in an operational maintenance mode. Remediation work has been substantially completed at the Cottage
Grove site, with operational and maintenance activities ongoing.
In August 2014, the Illinois EPA approved a request by the Company to establish a groundwater management zone at its manufacturing facility in
Cordova, Illinois, which includes ongoing pumping of impacted site groundwater, groundwater monitoring and routine reporting of results.
In May 2017, the MDH issued new HBVs for PFOA and PFOS. The new HBVs are 35 ppt for PFOA and 27 ppt for PFOS. In connection with its
announcement the MDH stated that “Drinking water with PFOA and PFOS, even at the levels above the updated values, does not represent an
immediate health risk. These values are designed to reduce long-term health risks across the population and are based on multiple safety factors to
protect the most vulnerable citizens, which makes them overprotective for most of the residents in our state.” In December 2017, the MDH issued
a new HBV for perfluorobutane sulfonate (PFBS) of 2 parts per billion (ppb). In February 2018, the MDH published reports finding no unusual
rates of certain cancers or adverse birth outcomes (low birth rates or premature births) among residents of Washington and Dakota Counties in
Minnesota. In April 2019, the MDH issued a new HBV for PFOS of 15 ppt and a new HBV for PFHxS of 47 ppt.
In May 2018, the EPA announced a four-step PFAS action plan, which includes evaluating the need to set Safe Drinking Water Act maximum
contaminant levels (MCLs) for PFOA and PFOS and beginning the steps necessary to designate PFOA and PFOS as “hazardous substances” under
CERCLA. In November 2018, the EPA asked for public comment on draft toxicity assessments for two PFAS compounds, including PFBS. In
February 2019, the EPA issued a PFAS Action Plan that outlines short- and long-term actions the EPA is taking to address PFAS – actions that
include developing a national drinking water determination for PFOA and PFOS,
116

-- 128 of 160 --

strengthening enforcement authorities and evaluating cleanup approaches, nationwide drinking water monitoring for PFAS, expanding scientific
knowledge for understanding and managing risk from PFAS, and developing consistent risk communication tools for communicating with other
agencies and the public. With respect to groundwater contaminated with PFOA and PFOS, the EPA issued interim recommendations in December
2019, providing guidance for screening levels and preliminary remediation goals for groundwater that is a current or potential drinking water
source, to inform final clean-up levels of contaminated sites. In February 2020, the EPA provided notice and requested public comment on certain
preliminary determinations to regulate PFOA and PFOS under the Safe Drinking Water Act (SDWA). In June 2020, 3M submitted comments on
EPA’s preliminary determinations to regulate PFOA and PFOS under the SDWA.
EPA announced in its Spring 2020 Regulatory Agenda, released in June 2020, that it intended to publish a notice of proposed rulemaking to
designate PFOA and PFOS as hazardous substances under CERCLA in August 2020. In November 2020, EPA announced it was developing of a
new analytical method to test for PFAS in wastewater and other environmental media. In December 2020, EPA released two new guidance
documents related to PFAS. First, it issued a Draft Compliance Guide for Imported Articles Containing Surface Coatings Subject to the Long-
Chain Perfluoroalkyl Carboxylate and Perfluoroalkyl Sulfonate Chemical Substances Significant New Use Rule. Second, EPA released for public
comment interim guidance on destroying and disposing of certain PFAS and PFAS-containing materials.
In January 2021, EPA announced its intention to initiate a process to develop a national primary drinking water regulation for PFOA and PFOS;
the process will include further analyses, scientific review and opportunities for public comment. EPA also announced in January 2021 that it will
issue an advance notice of proposed rulemaking (ANPR) to solicit public comment on whether the agency should take additional regulatory steps
to address PFAS contamination, including designating PFOA and PFOS and other PFAS as hazardous substances under the Comprehensive
Environmental Response, Compensation, and Liability Act (CERCLA) and seeking comment on whether PFOA and PFOS and other PFAS should
be subject to regulation as hazardous waste under the Resource Conservation and Recovery Act (RCRA). EPA indicated it will also issue an
ANPR to collect information regarding manufacturers of PFAS and the presence and treatment of PFAS in discharges from these facilities.
The U.S. Agency for Toxic Substances and Disease Registry (ATSDR) within the Department of Health and Human Services released a draft
Toxicological Profile for PFAS for public review and comment in June 2018. In the draft report, ATSDR proposed draft minimal risk levels
(MRLs) for PFOS, PFOA and several other PFAS. An MRL is an estimate of the daily human exposure to a hazardous substance that is likely to
be without appreciable risk of adverse non-cancer health effects over a specified duration of exposure. MRLs are not intended to define cleanup or
action levels for ATSDR or other agencies. In August 2018, 3M submitted comments on the ATSDR proposal, noting that there are major
shortcomings with the current draft, especially with the MRLs, and that the ATSDR’s profile must reflect the best science and full weight of
evidence known about these chemicals.
Several state legislatures and state agencies have been evaluating or have taken actions related to cleanup standards, groundwater values or
drinking water values for PFOS, PFOA, and other PFAS, and 3M has submitted various responsive comments. In September 2019, 3M and several
other parties filed a lawsuit in New Hampshire state court to enjoin PFAS regulations in New Hampshire. In November 2019, the court issued a
preliminary injunction preventing the regulations from being enforced. In April 2020, the New Hampshire Supreme Court agreed to review several
issues related to the preliminary injunctive order. In July 2020, the governor signed a bill passed by the New Hampshire legislature setting the
same drinking water standards that had been enjoined by the court.
Vermont finalized drinking water standards for a combination of PFOA, PFOS and three other PFAS in March 2020. New Jersey finalized
drinking water standards and designated PFOA and PFOS as hazardous substances in June 2020. New York established drinking water standards
for PFOA and PFOS in July 2020. Michigan implemented final drinking water standards for certain PFAS, including PFOS and PFOA, in August
2020. Massachusetts published final regulations establishing a drinking water standard relating to six combined PFAS in October 2020. Some
other states have also been evaluating or have taken actions relating to PFOA, PFOS and other PFAS in products such as food packaging, carpets
and other products.
In October 2020, 3M and several other parties filed notices of appeal in the appellate division of the Superior Court of New Jersey to challenge the
validity of the New Jersey PFOS and PFOA regulations. In January 2021, the appellate division of the court denied the group’s motion to stay the
regulations, and the parties are proceeding to litigation on the merits.
117

-- 129 of 160 --

The Company cannot predict what additional regulatory actions in the United States, Europe and elsewhere arising from the foregoing or other
proceedings and activities, if any, may be taken regarding such compounds or the consequences of any such actions to the Company.
Litigation Related to Historical PFAS Manufacturing Operations in Alabama
As previously reported, a former employee filed a putative class action lawsuit against 3M, BFI Waste Management Systems of Alabama, and
others in the Circuit Court of Morgan County, Alabama (the “St. John” case), seeking property damage from exposure to certain
perfluorochemicals at or near the Company’s Decatur, Alabama, manufacturing facility. The parties have agreed to continue to stay the St. John
case through February 2021, pending ongoing mediation between the parties involved in this case and another case discussed below. Two
additional putative class actions filed in the same court by certain residents in the vicinity of the Decatur plant seeking relief on similar grounds
(the Chandler case and the Stover case, respectively) are stayed pending the resolution of class certification issues in the St. John case.
In October 2015, West Morgan-East Lawrence Water & Sewer Authority (Water Authority) filed an individual complaint against 3M Company,
Dyneon, L.L.C, and Daikin America, Inc., in the U.S. District Court for the Northern District of Alabama. The complaint also includes
representative plaintiffs who brought the complaint on behalf of themselves, and a class of all owners and possessors of property who use water
provided by the Water Authority and five local water works to which the Water Authority supplies water (collectively, the “Water Utilities”). The
complaint seeks compensatory and punitive damages and injunctive relief based on allegations that the defendants’ chemicals, including PFOA
and PFOS from their manufacturing processes in Decatur, have contaminated the water in the Tennessee River at the water intake, and that the
chemicals cannot be removed by the water treatment processes utilized by the Water Authority. In April 2019, 3M and the Water Authority settled
the lawsuit for $35 million, which will fund a new water filtration system, with 3M indemnifying the Water Authority from liability resulting from
the resolution of the currently pending and future lawsuits against the Water Authority alleging liability or damages related to 3M PFAS. The
putative class claims brought by the representative plaintiffs who were supplied drinking water by the Water Authority (the “Lindsey” case)
remain. The parties are in active discussions regarding a negotiated resolution, and the case is currently stayed.
In June 2016, the Tennessee Riverkeeper, Inc. (Riverkeeper), a non-profit corporation, filed a lawsuit in the U.S. District Court for the Northern
District of Alabama against 3M; BFI Waste Systems of Alabama; the City of Decatur, Alabama; and the Municipal Utilities Board of Decatur,
Morgan County, Alabama. The complaint alleges that the defendants violated the Resource Conservation and Recovery Act in connection with the
disposal of certain PFAS through their ownership and operation of their respective sites. The complaint further alleges such practices may present
an imminent and substantial endangerment to health and/or the environment and that Riverkeeper has suffered and will continue to suffer
irreparable harm caused by defendants’ failure to abate the endangerment unless the court grants the requested relief, including declaratory and
injunctive relief. This case has been stayed through February 2021, pending ongoing mediation between the parties in conjunction with the St.
John case.
In August 2016, a group of over 200 plaintiffs filed a putative class action against West Morgan-East Lawrence Water and Sewer Authority
(Water Authority), 3M, Dyneon, Daikin, BFI, and the City of Decatur in state court in Lawrence County, Alabama (the “Billings” case). Plaintiffs
are residents of Lawrence, Morgan and other counties who are or have been customers of the Water Authority. They contend defendants have
released PFAS that contaminate the Tennessee River and, in turn, their drinking water, causing damage to their health and properties. In January
2017, the court in the St. John case, discussed above, stayed this litigation pending resolution of the St. John case. Plaintiffs in the Billings case
amended their complaint in November 2020 and added 557 additional plaintiffs, and in January 2021 amended again to add 331 additional
plaintiffs.
In January 2017, several hundred plaintiffs sued 3M, Dyneon and Daikin America in Lawrence and Morgan Counties, Alabama (the “Owens”
case). The plaintiffs are owners of property, residents, and holders of property interests who receive their water from the West Morgan-East
Lawrence Water and Sewer Authority (Water Authority). They assert common law claims for negligence, nuisance, trespass, wantonness and
battery, and they seek injunctive relief and punitive damages. The plaintiffs contend that the defendants own and operate manufacturing and
disposal facilities in Decatur that have released and continue to release PFOA, PFOS and related chemicals into the groundwater and surface water
of their sites, resulting in discharges into the Tennessee River. The plaintiffs contend that, as a result of the alleged discharges, the water supplied
by the Water Authority to the plaintiffs was, and is, contaminated with PFOA, PFOS and related chemicals at a level dangerous to humans. The
court denied a motion by co-defendant Daikin to stay this case pending resolution of the St. John case, and the case is progressing through
discovery.
118

-- 130 of 160 --

In November 2017, a putative class action (the “King” case) was filed against 3M, Dyneon, Daikin America and the West Morgan-East Lawrence
Water and Sewer Authority (Water Authority) in the U.S. District Court for the Northern District of Alabama. The plaintiffs are residents of
Lawrence and Morgan County, Alabama who receive their water from the Water Authority and seek injunctive relief, attorneys’ fees,
compensatory and punitive damages for their alleged personal injuries. The plaintiffs contend that the defendants own and operate manufacturing
and disposal facilities in Decatur, Alabama that have released and continue to release PFOA, PFOS and related chemicals into the groundwater
and surface water of their sites, resulting in discharges into the Tennessee River. The plaintiffs contend that, as a result of the alleged discharges,
the water supplied by the Water Authority to the plaintiffs was, and is, contaminated with PFOA, PFOS and related chemicals at a level dangerous
to humans. In November 2019, the King plaintiffs amended their complaint to withdraw all class allegations. Since then, the plaintiffs have added
37 new individual plaintiffs and voluntarily dismissed five plaintiffs (for a total of 55 plaintiffs). The case is scheduled for trial in June 2022.
Discovery in this case is proceeding.
In July 2019, 3M announced that it had initiated an investigation into the possible presence of PFAS in three closed municipal landfills in Decatur
that accepted waste from 3M’s Decatur plant and other companies in the 1960s through the 1980s. 3M is working with local and state entities as it
conducts its investigation and will report the results and recommended remedial action, if any, to those entities and the public. 3M is also
defending or has received notice of potential lawsuits in state and federal court brought by individual property owners who claim damages related
to historical PFAS disposal at former area landfills near their properties. 3M has resolved for an immaterial amount some of the claims brought by
property owners.
In September 2020, the City of Guin Water Works and Sewer Board (Guin WWSB) brought a lawsuit against 3M in Alabama state court, alleging
that PFAS contamination in the Guin water system stems from manufacturing operations at 3M’s Guin facility and disposal activity at a nearby
landfill. In this same month, Guin WWSB dismissed its lawsuit without prejudice and is working with 3M to further investigate the presence of
chemicals in the area.
Litigation Related to Historical PFAS Manufacturing Operations in Minnesota
In July 2016, the City of Lake Elmo filed a lawsuit in the U.S. District Court for the District of Minnesota against 3M alleging that the City
suffered damages from drinking water supplies contaminated with PFAS, including costs to construct alternative sources of drinking water. In
April 2019, 3M and the City of Lake Elmo agreed to settle the lawsuit for less than $5 million.
State Attorneys General Litigation related to PFAS
Minnesota. In December 2010, the State of Minnesota, by its Attorney General, filed a lawsuit in Hennepin County District Court against 3M
seeking damages and injunctive relief with respect to the presence of PFAS in the groundwater, surface water, fish or other aquatic life, and
sediments in the state of Minnesota (the “NRD Lawsuit”). In February 2018, 3M and the State of Minnesota reached a resolution of the NRD
Lawsuit. Under the terms of the settlement, 3M agreed to provide an $850 million grant to the State for a special “3M Water Quality and
Sustainability Fund.” This Fund, which is administered by the State, will enable projects that support water sustainability in the Twin Cities East
Metro region, such as continued delivery of water to residents and enhancing groundwater recharge to support sustainable growth. Other purposes
of the grant include habitat and recreation improvements, such as fishing piers, trails, and open space preservation. 3M recorded a pre-tax charge
of $897 million, inclusive of legal fees and other related obligations, in the first quarter of 2018 associated with the resolution of this matter.
In connection with the above referenced settlement, the Minnesota Pollution Control Agency and the Department of Natural Resources, as co-
trustees of the Fund, released in September 2020 a conceptual drinking water supply plan for the communities in the East Metro area, seeking
public comment on three recommended options for utilizing the Fund. In December 2020, 3M submitted preliminary comments on the co-trustees’
draft conceptual drinking water supply plan to address legal and technical aspects of the draft plan.
New York. The State of New York, by its Attorney General, has filed four lawsuits (in June 2018, February 2019, July 2019, and November 2019)
against 3M and other defendants seeking to recover the costs incurred in responding to PFAS contamination allegedly caused by Aqueous Film
Forming Foam (AFFF) manufactured by 3M and others. Each of the four suits was filed in Albany County Supreme Court before being removed
to federal court, and each has been transferred to the multi-district litigation (MDL) proceeding for AFFF cases, which is discussed further below.
The state is seeking compensatory and punitive damages, and injunctive
119

-- 131 of 160 --

and equitable relief in the form of a monetary fund for the State’s reasonably expected future damages, and/or requiring defendants to perform
investigative and remedial work.
Ohio. In December 2018, the State of Ohio, by its Attorney General, filed a lawsuit in the Common Pleas Court of Lucas County, Ohio against
3M, Tyco Fire Products LP, Chemguard, Inc., Buckeye Fire Equipment Co., National Foam, Inc., and Angus Fire Armour Corp., seeking
injunctive relief and compensatory and punitive damages for remediation costs and alleged injury to Ohio natural resources from AFFF
manufacturers. This case was removed to federal court and transferred to the MDL.
New Jersey. In March 2019, the New Jersey Attorney General filed two actions against 3M, DuPont, and Chemours on behalf of the New Jersey
Department of Environmental Protection (NJDEP), the NJDEP’s commissioner, and the New Jersey Spill Compensation Fund regarding alleged
discharges at two DuPont facilities in Pennsville, New Jersey (Salem County) and Parlin, New Jersey (Middlesex County). 3M is included as a
defendant in both cases because it allegedly supplied PFOA to DuPont for use at the facilities at issue. Both cases expressly seek to have the
defendants pay all costs necessary to investigate, remediate, assess, and restore the affected natural resources of New Jersey. DuPont removed
these cases to federal court. In August 2019, the court stayed all proceedings in these actions pending a ruling on NJDEP’s motions to remand the
cases to state court. In April 2020, the federal court denied the state’s motion to remand. In June 2020, the court entered a consent order lifting the
stay and consolidating the two actions, along with two others brought by the NJDEP relating to the DuPont facilities, for case management and
pretrial purposes. The case is in early stages of litigation.
In May 2019, the New Jersey Attorney General and NJDEP filed a lawsuit against 3M, DuPont, and six other companies, alleging natural resource
damages from AFFF products and seeking damages, including punitive damages, and associated fees. This case was removed to federal court and
transferred to the AFFF MDL.
New Hampshire. In May 2019, the New Hampshire Attorney General filed two lawsuits alleging contamination of the state’s drinking water
supplies and other natural resources by PFAS chemicals. The first lawsuit was filed against 3M and seven co-defendants, alleging PFAS
contamination resulting from the use of AFFF products at several sites around the state. This case was removed to federal court and transferred to
the AFFF MDL. The second suit asserts PFAS contamination from non-AFFF sources and names 3M, DuPont, and Chemours as defendants. In its
June 2020 ruling on defendants’ motions to dismiss, the court dismissed the state’s trespass claim, but allowed several claims to proceed. In
October 2020, the state amended its complaint to add a state commission as plaintiff and make a claim related to the state’s drinking water and
groundwater trust fund statute. Defendants have filed motions to dismiss related to these amendments, and the case remains in early stages of
litigation.
Vermont. In June 2019, the Vermont Attorney General filed two lawsuits alleging contamination of the state’s drinking water supplies and other
natural resources by PFAS chemicals. The first lawsuit was filed against 3M and ten co-defendants, alleging PFAS contamination resulting from
the use of AFFF products at several sites around the state. This case was removed to federal court and transferred to the AFFF MDL. The second
suit asserts PFAS contamination from non-AFFF sources and names 3M and several entities related to DuPont and Chemours as defendants. This
suit is proceeding in state court. In May 2020, the court denied the defendants’ motion to dismiss, but dismissed the state’s trespass claim as to
property the state does not own. The parties are now engaged in discovery.
Michigan. In January 2020, the Michigan Attorney General filed a lawsuit in state court against 3M, Dyneon, DuPont, Chemours and others
seeking injunctive and equitable relief and damages for alleged injury to Michigan public natural resources and its residents related to PFAS,
excluding AFFF. The defendants filed motions to dismiss, and 3M’s motion was denied in August 2020. Discovery has started in this case. In
addition, in August 2020, the Michigan Attorney General filed two lawsuits against numerous AFFF manufacturers and distributors, and suppliers
of PFAS to AFFF manufacturers. 3M is named a defendant in one of the lawsuits, filed in federal court, and the case has been transferred to the
AFFF MDL, where it remains in early stages of litigation.
Guam. In September 2019, the Attorney General of Guam filed a lawsuit against 3M and other defendants relating to contamination of the
territory’s drinking water supplies and other natural resources by PFAS, allegedly resulting from the use of AFFF products at several sites around
the island. This lawsuit has been removed to federal court and transferred to the AFFF MDL.
Commonwealth of Northern Mariana Islands. In December 2019, the Attorney General of the Commonwealth of Northern Mariana Islands, a U.S.
territory, filed a lawsuit against 3M and other defendants relating to contamination of the territory’s drinking water
120

-- 132 of 160 --

supplies and other natural resources by PFAS, allegedly resulting from the use of AFFF products. This lawsuit has been removed to federal court
and transferred to the AFFF MDL.
Mississippi. In December 2020, the Mississippi Attorney General filed an AFFF-related PFAS lawsuit against 3M and other defendants directly
with the AFFF MDL court in South Carolina. The lawsuit alleges injuries to the State’s property and natural resources purportedly caused by
PFAS contamination from AFFF use and seeks both compensatory and punitive damages.
In addition to the above state attorneys general actions, the Company is in discussions with several state attorneys general and agencies,
responding to information and other requests relating to PFAS matters and exploring potential resolution of some of the matters raised.
Aqueous Film Forming Foam (AFFF Environmental Litigation
3M manufactured and marketed AFFF for use in firefighting at airports and military bases from approximately 1963 to 2002. As of December 31,
2020, 943 lawsuits (including 26 putative class actions) alleging injuries by AFFF use have been filed against 3M (along with other defendants) in
various state and federal courts. As previously noted, some of these cases have been brought by state or territory attorneys general. In most of
these cases, plaintiffs typically allege that certain PFAS used in AFFF contaminated the soil and groundwater where AFFF was used and seek
damages for alleged injuries such as loss of use and enjoyment of properties, diminished property values, investigation costs, remediation costs,
personal injury and/or funds for medical monitoring. 414 cases filed since October 2019 have been brought by current or former firefighters who
claim to have suffered personal injury as a result of exposure to AFFF while using the product. The United States, the U.S. Department of Defense
and several companies have been sued along with 3M, including but not limited to Ansul Co. (acquired by Tyco, Inc.), Angus Fire, Buckeye Fire
Protection Co., Chemguard, Chemours, DuPont, National Foam, Inc., and United Technologies Corp.
In December 2018, the U.S. Judicial Panel on Multidistrict Litigation (JPML) granted motions to transfer and consolidate all AFFF cases pending
in federal courts to the U.S. District Court for the District of South Carolina to be managed in an MDL proceeding to centralize pre-trial
proceedings. Additional AFFF cases continue to be transferred into the MDL as they are filed or removed to federal court. As of December 31,
2020, there were 947 cases in the MDL, 933 of which name 3M as a defendant. The parties in the MDL are currently in the process of conducting
discovery.
In June 2019, several subsidiaries of Valero Energy Corporation, an independent petroleum refiner, filed eight AFFF cases against 3M and other
defendants, including DuPont/Chemours, National Foam, Buckeye Fire Equipment, and Kidde-Fenwal, in various state courts. Plaintiffs seek
damages that allegedly have been or will be incurred in investigating and remediating PFAS contamination at their properties and replacing or
disposing of AFFF products containing long-chain PFAS. Two of these cases have been removed to federal court and transferred to the AFFF
MDL. Five cases remain pending in state courts where they are in early stages of litigation, after Valero dismissed its Ohio state court action
without prejudice in October 2019. The parties in the state court cases have agreed to stay all five cases until March 2021.
Two subsidiaries of Husky Energy filed suit in April 2020 against 3M and other AFFF manufacturers in Wisconsin state court relating to alleged
PFAS contamination from AFFF use at Husky facilities in Superior, Wisconsin and Lima, Ohio. The parties have entered into a tolling agreement
deferring further action on the plaintiffs’ claims. The plaintiffs filed a notice of dismissal without prejudice in September 2020.
As of December 31, 2020, the Company is a defendant in two AFFF-related lawsuits originally filed in state courts (in California and Missouri)
that had been removed to federal court. Plaintiffs in these cases have filed motions seeking remand to state court and opposing transfer to the
AFFF MDL. In addition, the Company is in discussions with several parties that have raised claims related to the use and disposal of AFFF and is
exploring a negotiated resolution with some of them.
.
Other PFAS-related Product and Environmental Litigation
3M manufactured and sold products containing various PFOA and PFOS, including Scotchgard, for several decades. Starting in 2017, 3M has
been served with individual and putative class action complaints in various state and federal courts alleging, among other things, that 3M’s
customers’ improper disposal of PFOA and PFOS resulted in the contamination of groundwater or surface water. The plaintiffs in these cases
generally allege that 3M failed to warn its customers about the hazards of improper disposal of the
121

-- 133 of 160 --

product. They also generally allege that contaminated groundwater has caused various injuries, including personal injury, loss of use and
enjoyment of their properties, diminished property values, investigation costs, and remediation costs. Several companies have been sued along
with 3M, including Saint-Gobain Performance Plastics Corp., Honeywell International Inc. f/k/a Allied-Signal Inc. and/or AlliedSignal Laminate
Systems, Inc., Wolverine World Wide Inc., Georgia-Pacific LLC, E.I. DuPont De Nemours and Co., Chemours Co., and various carpet
manufacturers.
In New York, 3M is defending 41 individual cases and one putative class action filed in the U.S. District Court for the Northern District of New
York and four additional cases filed in New York state court against 3M, Saint-Gobain Performance Plastics Corp. (Saint-Gobain), Honeywell
International Inc. and E.I. DuPont De Nemours and Co. (DuPont). The plaintiffs allege that 3M manufactured and sold PFOA that was used for
manufacturing purposes at Saint-Gobain’s and Honeywell’s facilities located in the Village of Hoosick Falls and the Town of Hoosick. The
plaintiffs claim that the drinking water around Hoosick Falls became contaminated with unsafe levels of PFOA due to the activities of the
defendants and allege that they suffered bodily injury due to the ingestion and inhalation of PFOA. The four state court cases also include Tonaga,
Inc. (Taconic) as a defendant and make similar allegations related to Taconic’s facility in neighboring Petersburg. The plaintiffs seek unstated
compensatory, consequential, and punitive damages, as well as attorneys’ fees and costs. 3M has answered the complaints in these cases, which
are now proceeding through discovery. The plaintiffs in the putative class action have moved for class certification. 3M is also defending 11
individual cases in New York filed by Nassau County drinking water providers in the U.S. District Court for the Eastern District of New York.
The plaintiffs in these cases allege that 3M, DuPont, and additional unnamed defendants are responsible for the contamination of plaintiffs’ water
supply sources with various PFAS compounds. DuPont’s motion to transfer these cases to the AFFF MDL was denied in March 2020. 3M has
filed answers in the eight cases in which it has been served. Preliminary discovery is ongoing.
In Michigan, one consolidated putative class action is pending in the U.S. District Court for the Western District of Michigan against 3M and
Wolverine World Wide (Wolverine). The action arises from Wolverine’s allegedly improper disposal of materials and wastes, including 3M
Scotchgard, related to Wolverine’s shoe manufacturing operations. Plaintiffs allege Wolverine used 3M Scotchgard in its manufacturing process
and that chemicals from 3M’s product contaminated the environment and drinking water sources after disposal. In January 2021, 3M moved to
dismiss certain claims in the complaint, and the case remains in early stages of litigation. In addition to the consolidated federal court putative
class action, as of December 31, 2020, 3M is a defendant in approximately 274 private individual actions in Michigan state court based on similar
allegations. These cases are coordinated for pre-trial purposes. Five of these cases were selected over time for bellwether trials. In January 2020,
the court issued the first round of dispositive motion rulings related to the first two bellwether cases, including dismissing the second bellwether
case entirely and dismissing certain plaintiffs’ medical monitoring and risk of future disease claims, and granting summary judgment to the
defendants on one plaintiff’s cholesterol injury claims. The parties settled the first bellwether case in early 2020. In June 2020, the court denied the
plaintiffs’ motion to reconsider the dismissal of the second bellwether case, and the plaintiffs have appealed the decision to the state appellate
court. In January 2021, the court granted summary judgment in favor of the defendants in one of three remaining bellwether cases. The remaining
two bellwether trials are tentatively scheduled for October 2021, subject to COVID-19 developments. The parties have engaged in mediation
efforts in both the putative class action and the state court mass action cases.
Wolverine also filed a third-party complaint against 3M in a suit by the State of Michigan and intervenor townships that seeks to compel
Wolverine to investigate and address contamination associated with its historic disposal activity. 3M filed an answer and counterclaims to
Wolverine’s third-party complaint in June 2019. In September and October 2019, the parties (including 3M as third-party defendant) engaged in
mediation. In December 2019, the State of Michigan, the intervening townships, and Wolverine announced that they had tentatively resolved the
State and townships’ claims against Wolverine in exchange for a $70 million payment and certain future remediation measures by Wolverine. In
February 2020, the court approved a Consent Decree that memorializes Wolverine’s ongoing remediation obligations and the State’s and
intervening townships’ covenants not to bring further lawsuits as to the remediated area. 3M has been formally designated as a “Contributing
Party,” and as such, the State’s and townships’ covenants will also apply to 3M. In February 2020, 3M and Wolverine executed an agreement to
resolve the legal claims between the two companies. Pursuant to the agreement, 3M made a one-time financial contribution of $55 million in
March 2020 to support Wolverine’s past and ongoing efforts to address PFAS remediation under Wolverine’s Consent Decree with the State and
the townships. This amount was part of 3M’s charge taken in the fourth quarter of 2019 as discussed below in the “Environmental Liabilities and
Insurance Receivables” section.
3M is also a defendant, together with Georgia-Pacific as co-defendant, in a putative class action in federal court in Michigan brought by residents
of Parchment, who allege that the municipal drinking water is contaminated from waste generated by a paper mill owned by Georgia-Pacific’s
corporate predecessor. The defendants moved to dismiss certain claims in the complaint, and that motion was
122

-- 134 of 160 --

denied in January 2021. The parties continue to engage in discovery. As a result of discussions among Georgia-Pacific, 3M and municipalities near
Parchment, Georgia-Pacific and 3M have contributed to a fund of approximately $5 million to provide expanded municipal water service in the
area. The municipalities have released 3M from claims relating to or arising out of the extension of municipal water or the alleged PFAS
contamination in the area of that extension. The putative class action claims are not included in this resolution.
In Alabama and Georgia, 3M, together with multiple co-defendants, is defending four state court cases, including three brought by municipal water
utilities, relating to 3M’s sale of PFAS-containing products to carpet manufacturers in Georgia. The plaintiffs in these cases allege that the carpet
manufacturers improperly discharged PFAS into the surface water and groundwater, contaminating drinking water supplies of cities located
downstream along the Coosa River, including Rome, Georgia and Centre and Gadsden, Alabama. The three water utility cases remain in the early
stages of litigation. One state court case was brought by individuals asserting PFAS contamination by the Georgia carpet manufacturers and
seeking economic damages and injunctive relief on behalf of a putative class of Rome and Floyd County water subscribers. This case has been
removed to federal court, where 3M has filed a motion to dismiss a series of amended complaints.
In California, 3M and other defendants are defending an action brought in federal court by Golden State Water Company, alleging PFAS
contamination of certain wells located in its water systems. 3M filed a motion to dismiss in November 2020 and in January 2021, the court granted
defendants’ motion to dismiss the case for lack of personal jurisdiction. In December 2020, the Orange County Water District and ten additional
local water providers sued 3M, Decra Roofing and certain DuPont-related entities in California state court, alleging PFAS contamination of the
plaintiffs’ water sources and also referring to 3M's industrial minerals facility in Corona, California as a potential source of contamination.
In Delaware, 3M, together with several co-defendants, is defending one putative class action brought by individuals alleging PFAS contamination
of their water supply resulting from the operations of local metal plating facilities. Plaintiffs allege that 3M supplied PFAS to the metal plating
facilities. DuPont, Chemours, and the metal platers have also been named as defendants. This case has been removed from state court to federal
court, and plaintiffs have withdrawn its motion to remand to state court and filed an amended complaint. 3M has filed a motion to dismiss the
amended complaint.
In New Jersey, 3M is a defendant in an action brought in federal court by Middlesex Water Company, alleging PFAS contamination of its water
wells. 3M’s motion to transfer the case to the AFFF MDL was denied. 3M has moved to dismiss the complaint, and the case is currently in
discovery. In addition, 3M, together with several co-defendants, is defending two federal court cases by multiple individuals with private drinking
water wells near DuPont and Solvay facilities that were allegedly supplied with PFAS by 3M. Plaintiffs seek medical monitoring and damages.
3M has filed a motion to dismiss in the first of those actions and the second is in early stages of litigation. 3M and other defendants are also
defending three federal court cases brought by individuals who live near the DuPont and Solvay facilities, alleging personal injury caused by
PFAS exposure. Those cases are in early stages of litigation. In September 2020, a federal court case was filed against 3M on behalf of the
Borough of Hopatcong, alleging general PFAS contamination of its public water supply. In December 2020, 3M filed a motion to dismiss the
Hopatcong matter.
In October 2018, 3M and other defendants, including DuPont and Chemours, were named in a putative class action in the U.S. District Court for
the Southern District of Ohio brought by the named plaintiff, a firefighter allegedly exposed to PFAS chemicals through his use of firefighting
foam, purporting to represent a putative class of all U.S. individuals with detectable levels of PFAS in their blood. The plaintiff brings claims for
negligence, battery, and conspiracy and seeks injunctive relief, including an order “establishing an independent panel of scientists” to evaluate
PFAS. 3M and other entities jointly filed a motion to dismiss in February 2019. In September 2019, the court denied the defendants’ motion to
dismiss. In February 2020, the court denied 3M’s motion to transfer the case to the AFFF MDL. In December 2020, the defendants filed their joint
opposition to the class certification motion filed earlier by the plaintiff.
In West Virginia, 3M and other defendants are defending a state court action brought by Weirton Area Water Board that alleges PFAS
contamination of local water supplies. This case has been removed to federal court. The defendants filed various motions to dismiss the complaint
based on pleading deficiencies and lack of personal jurisdiction. In November 2020, the court granted some of the personal jurisdiction motions,
denied other personal jurisdiction motions (including 3M’s) and ordered the remaining parties to engage in discovery on jurisdiction. In December
2020, the court denied the defendants’ non-jurisdictional motion to dismiss. The case remains in early stages of litigation.
123

-- 135 of 160 --

Other PFAS-related Matters
In July 2019, the Company received a written request from the Subcommittee on Environment of the Committee on Oversight and Reform, U.S.
House of Representatives, seeking certain documents and information relating to the Company’s manufacturing and distribution of PFAS
products. In September 2019, a 3M representative testified before and responded to questions from the Subcommittee on Environment with respect
to PFAS and the Company’s environmental stewardship initiatives. The Company continues to cooperate with the Subcommittee.
The Company operates under a 2009 consent order issued under the federal Toxic Substances Control Act (TSCA) (the “2009 TSCA consent
order”) for the manufacture and use of two perfluorinated materials (FBSA and FBSEE) at its Decatur, Alabama site that does not permit release
of these materials into “the waters of the United States.” In March 2019, the Company halted the manufacture, processing, and use of these
materials at the site upon learning that these materials may have been released from certain specified processes at the Decatur site into the
Tennessee River. In April 2019, the Company voluntarily disclosed the releases to the U.S. Environmental Protection Agency (EPA) and the
Alabama Department of Environmental Management (ADEM). During June and July 2019, the Company took steps to fully control the
aforementioned processes by capturing all wastewater produced by the processes and by treating all air emissions. These processes have been back
on-line and in operation since July 2019. The Company continues to cooperate with the EPA and ADEM in their investigations and will work with
the regulatory authorities to demonstrate compliance with the release restrictions.
The Company is authorized to discharge wastewater from its Decatur plant pursuant to the terms of a Clean Water Act National Pollutant
Discharge Elimination System (NPDES) permit issued by ADEM. The NPDES permit requires the Company to report on a monthly and quarterly
basis the quality and quantity of pollutants discharged to the Tennessee River. In June 2019, the Company voluntarily disclosed to the EPA and
ADEM that it had included incorrect values in certain of its monthly and quarterly reports. The Company has submitted the corrected values to
both the EPA and ADEM.
As part of ongoing work with the EPA and ADEM to address compliance matters at the Decatur facility, the Company discovered it had not fully
characterized its PFAS discharge in its NPDES permit. In September 2019, the Company disclosed the matter to the EPA and ADEM and
announced that it had elected to temporarily idle certain other manufacturing processes at 3M Decatur. The Company is reviewing its operations at
the plant, has installed wastewater treatment controls and has restarted idled processes.
As a result of the Company’s discussions with ADEM to address these and other related matters in the state of Alabama, 3M and ADEM have
agreed to the terms of an interim Consent Order in July 2020 to cover all PFAS-related wastewater discharges and air emissions from the
Company’s Decatur facility. Under the interim Consent Order, the Company’s principal obligations include commitments related to (i) future
ongoing site operations such as (a) providing certain notices or reports and performing various analytical and characterization studies and (b)
future capital improvements; and (ii) remediation activities, including certain on-site and off-site investigations and studies. Obligations related to
ongoing future site operations under the Consent Order will involve additional operating costs and capital expenditures over multiple years. The
Company does not expect them to have a material impact on its consolidated results of operations or financial position. With respect to
remediation activities, financial obligations related to certain activities under the Consent Order are probable and estimable, and are included in the
Company’s accruals for “other environmental liabilities” as described in the “Environmental Liabilities and Insurance Receivables” section below.
As offsite investigation activities continue, additional remediation amounts may become probable and estimable in the future.
In December 2019, the Company received a grand jury subpoena from the U.S. Attorney’s Office for the Northern District of Alabama for
documents related to, among other matters, the Company’s compliance with the 2009 TSCA consent order and unpermitted discharges to the
Tennessee River. The Company is cooperating with this inquiry and is producing documents in response to the subpoena.
In addition, as part of its ongoing evaluation of regulatory compliance at its Cordova, Illinois facility, the Company discovered it had not fully
characterized its PFAS discharge in its NPDES permit for the Cordova facility. In November 2019, the Company disclosed this matter to the EPA,
and in January 2020 disclosed this matter to the Illinois Environmental Protection Agency (IEPA). The Company continues to work with the EPA
and IEPA to address these issues from the Cordova facility. In December 2020, the EPA requested certain documents and information related to
TSCA compliance at the facility. The Company is cooperating and producing documents and information in response to the request.
124

-- 136 of 160 --

The Company is also reviewing operations at its other plants with similar manufacturing processes, such as the plant in Cottage Grove, Minnesota,
to ensure those operations are in compliance with applicable environmental regulatory requirements and Company policies and procedures. As a
result of these reviews, the Company discovered it had not fully characterized its PFAS discharge in its NPDES permit for the Cottage Grove
facility. In March 2020, the Company disclosed this matter to the Minnesota Pollution Control Agency (MPCA) and the EPA. In July 2020, the
Company received an information request from MPCA for documents and information related to, among other matters, the Company’s compliance
with the Clean Water Act at its Cottage Grove facility. The Company is cooperating with this inquiry and is producing documents and information
in response to the request for information. The Company continues to work with the MPCA and EPA to address the discharges from the Cottage
Grove facility.
Separately, in June 2020, the Company reported to EPA and MPCA that it had not fully complied with elements of the inspection, characterization
and waste stream profile verification process of the Waste and Feedstream Analysis Plan (WAP/FAP) of its Resource Conservation and Recovery
Act (RCRA) permit for its Cottage Grove incinerator. In July 2020, the Company received an information request from MPCA related to the June
2020 disclosure, to which the Company responded in September 2020. The Company continues to work with the MPCA to address WAP/FAP
implementation issues disclosed in June 2020. In January 2021, the Company received a notice of violation (NOV) from MPCA related to, among
other matters, the above-described Clean Water Act and RCRA issues. The Company is cooperating with MPCA to address the issues that are the
subject of the NOV.
In February 2020, the Company received an information request from EPA for documents and information related to, among other matters, the
Company’s compliance with the Clean Water Act at its facilities that manufacture, process and use PFAS, including the Decatur, Cordova and
Cottage Grove facilities. The Company is cooperating with this inquiry and is producing documents and information in response to the request for
information.
The Company will continue to work with relevant federal and state agencies (including EPA, the U.S. Department of Justice, state environmental
agencies and state attorneys general) as it conducts these reviews. The Company cannot predict at this time the outcomes of resolving these
compliance matters or what potential actions may be taken by the regulatory agencies.
Other Environmental Litigation
In July 2018, the Company, along with more than 120 other companies, was served with a complaint seeking cost recovery and contribution
towards the cleaning up of approximately eight miles of the Lower Passaic River in New Jersey. The plaintiff, Occidental Chemical Corporation,
alleges that it agreed to design and pay the estimated $165 million cost to remove and cap sediment containing eight chemicals of concern,
including PCBs and dioxins. The complaint seeks to spread those costs among the defendants, including the Company. The Company’s
involvement in the case relates to its past use of two commercial drum conditioning facilities in New Jersey. Whether, and to what extent, the
Company may be required to contribute to the costs at issue in the case remains to be determined.
For environmental matters and litigation described above, unless otherwise stated, no liability has been recorded as the Company believes liability
in those matters is not probable and estimable and the Company is not able to estimate a possible loss or range of loss at this time. The Company’s
environmental liabilities and insurance receivables are described below.
Environmental Liabilities and Insurance Receivables
The Company periodically examines whether the contingent liabilities related to the environmental matters and litigation described above are
probable and estimable based on experience and developments in those matters. During 2020, the Company increased its accrual for PFAS-related
other environmental liabilities by $96 million and made related payments of $125 million. During the first quarter of 2019, the EPA issued its
PFAS Action Plan and the Company settled the litigation with the Water Authority (both matters are described in more detail above). The
Company completed a comprehensive review with the assistance of environmental consultants and other experts regarding environmental matters
and litigation related to historical PFAS manufacturing operations in Minnesota; Alabama; Gendorf, Germany; and at four former landfills in
Alabama. As a result of these developments and of that review, the Company increased its accrual for “other environmental liabilities” by $235
million pre-tax (including the settlement with the Water Authority) in the first quarter of 2019. During the fourth quarter of 2019, 3M updated its
evaluation of certain customer-related litigation based on continued, productive settlement discussions with multiple parties. As previously
disclosed, 3M has been engaged in mediation and resolution negotiations in multiple cases. In addition, during the fourth quarter of 2019, the
Company updated its assessment of environmental matters and litigation related to its historical PFAS manufacturing operations and expanded
125

-- 137 of 160 --

its evaluation of other 3M sites that may have used certain PFAS-containing materials and locations at which they were disposed. As a result of
these actions during the fourth quarter the Company recorded a pre-tax charge of $214 million. As of December 31, 2020, the Company had
recorded liabilities of $416 million for “other environmental liabilities.” The accruals represent the Company’s best estimate of the probable loss.
The Company is not able to estimate a possible loss or range of loss in excess of the established accruals at this time.
As of December 31, 2020, the Company had recorded liabilities of $23 million for estimated non-PFAS related “environmental remediation” costs
to clean up, treat, or remove hazardous substances at current or former 3M manufacturing or third-party sites. The Company evaluates available
facts with respect to each individual site each quarter and records liabilities for remediation costs on an undiscounted basis when they are probable
and reasonably estimable, generally no later than the completion of feasibility studies or the Company’s commitment to a plan of action. Liabilities
for estimated costs of environmental remediation, depending on the site, are based primarily upon internal or third-party environmental studies,
and estimates as to the number, participation level and financial viability of any other potentially responsible parties, the extent of the
contamination and the nature of required remedial actions. The Company adjusts recorded liabilities as further information develops or
circumstances change. The Company expects that it will pay the amounts recorded over the periods of remediation for the applicable sites,
currently ranging up to 20 years.
It is difficult to estimate the cost of environmental compliance and remediation given the uncertainties regarding the interpretation and
enforcement of applicable environmental laws and regulations, the extent of environmental contamination and the existence of alternative cleanup
methods. Developments may occur that could affect the Company’s current assessment, including, but not limited to: (i) changes in the
information available regarding the environmental impact of the Company’s operations and products; (ii) changes in environmental regulations,
changes in permissible levels of specific compounds in drinking water sources, or changes in enforcement theories and policies, including efforts
to recover natural resource damages; (iii) new and evolving analytical and remediation techniques; (iv) success in allocating liability to other
potentially responsible parties; and (v) the financial viability of other potentially responsible parties and third-party indemnitors. For sites included
in both “environmental remediation liabilities” and “other environmental liabilities,” at which remediation activity is largely complete and
remaining activity relates primarily to operation and maintenance of the remedy, including required post-remediation monitoring, the Company
believes the exposure to loss in excess of the amount accrued would not be material to the Company’s consolidated results of operations or
financial condition. However, for locations at which remediation activity is largely ongoing, the Company cannot estimate a possible loss or range
of loss in excess of the associated established accruals for the reasons described above.
The Company has both pre-1986 general and product liability occurrence coverage and post-1985 occurrence reported product liability and other
environmental coverage for environmental matters and litigation. As of December 31, 2020, the Company’s receivable for insurance recoveries
related to the environmental matters and litigation was $8 million. Various factors could affect the timing and amount of recovery of this and
future expected increases in the receivable, including (i) delays in or avoidance of payment by insurers; (ii) the extent to which insurers may
become insolvent in the future, (iii) the outcome of negotiations with insurers, and (iv) the scope of the insurers’ purported defenses and exclusions
to avoid coverage.
Product Liability Litigation
Aearo Technologies sold Dual-Ended Combat Arms – Version 2 earplugs starting in about 2003. 3M acquired Aearo Technologies in 2008 and
sold these earplugs from 2008 through 2015, when the product was discontinued. In December 2018, a military veteran filed an individual lawsuit
against 3M in the San Bernardino Superior Court in California alleging that he sustained personal injuries while serving in the military caused by
3M’s Dual-Ended Combat Arms earplugs – Version 2. The plaintiff asserts claims of product liability and fraudulent misrepresentation and
concealment. The plaintiff seeks various damages, including medical and related expenses, loss of income, and punitive damages.
As of December 31, 2020, the Company is a named defendant in approximately 3,130 lawsuits (including 14 putative class actions) in various
state and federal courts that purport to represent approximately 12,400 individual claimants making similar allegations. In April 2019, the U.S.
Judicial Panel on Multidistrict Litigation granted motions to transfer and consolidate all cases pending in federal courts to the U.S. District Court
for the Northern District of Florida to be managed in a multi-district litigation (MDL) proceeding to centralize pre-trial proceedings. Discovery is
underway. The plaintiffs and 3M filed preliminary summary judgment motions on the government contractor defense. In July 2020, based on the
then current record, the court granted the plaintiffs’ summary judgment motion and denied the defendants’ summary judgment motion, ruling that
plaintiffs’ claims are not barred by the government contractor defense. The court denied the Company’s request to immediately certify the
summary judgment ruling for appeal to the
126

-- 138 of 160 --

U.S. Court of Appeals for the Eleventh Circuit. In December 2020, the MDL court granted the plaintiffs’ motion to consolidate three plaintiffs for
the first bellwether trial scheduled to begin in March 2021. Individual trials for the next two bellwether plaintiffs are scheduled to proceed in May
and June of 2021.
3M is also defending 24 lawsuits brought by non-military plaintiffs in state court in Hennepin County, Minnesota. 3M removed these actions to
federal court and the federal court remanded them to state court in March 2020. The Company has appealed the remand orders to the U.S. Court of
Appeals for the Eighth Circuit. The state court actions will be subject to a bellwether selection process. The first trial in Hennepin County was
scheduled for March 2021 but has been delayed.
No liability has been recorded for these matters because the Company believes that any such liability is not probable and estimable at this time.
As of December 31, 2020, the Company was a named defendant in 23 lawsuits in the United States involving 26 plaintiffs and one Canadian
putative class action with a single named plaintiff, alleging that the Bair Hugger™ patient warming system caused a surgical site infection.
As previously disclosed, 3M had been a named defendant in lawsuits in federal courts involving over 5,000 plaintiffs. The plaintiffs claim they
underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections due to the use of the Bair
Hugger™ patient warming system. The plaintiffs seek damages and other relief based on theories of strict liability, negligence, breach of express
and implied warranties, failure to warn, design and manufacturing defect, fraudulent and/or negligent misrepresentation/concealment, unjust
enrichment, and violations of various state consumer fraud, deceptive or unlawful trade practices and/or false advertising acts.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all cases pending in federal courts to the U.S. District Court for the
District of Minnesota to be managed in a multi-district litigation (MDL) proceeding. In July 2019, the court excluded several of the plaintiffs’
causation experts, and granted summary judgment for 3M in all cases pending at that time in the MDL. Plaintiffs have appealed that decision to the
U.S. Court of Appeals for the Eighth Circuit. Plaintiffs have also appealed a 2018 jury verdict in favor of 3M in the first bellwether trial in the
MDL and appealed the dismissal of another bellwether case.
Among the 23 remaining lawsuits in the United States, 20 are in the MDL court and three are in state court. The MDL court declined to remand
one case to Oklahoma state court and has stayed all 20 remaining lawsuits pending the appeal of the summary judgment decision. In February
2020, the MDL court remanded two cases to state court in Jackson County, Missouri that combined Bair Hugger product liability claims with
medical malpractice claims. There is also one case in Hidalgo County, Texas that combines Bair Hugger product liability claims with medical
malpractice claims. In August 2019, the MDL court enjoined the individual plaintiff from pursuing his claims in Texas state court because he had
previously filed and dismissed a claim in the MDL. That plaintiff has appealed the order to the U.S. Court of Appeals for the Eighth Circuit. The
Texas state court has stayed the entire case while the appeal is pending.
As previously disclosed, 3M had been named a defendant in 61 cases in Minnesota state court. In January 2018, the Minnesota state court
excluded plaintiffs’ experts and granted 3M’s motion for summary judgment on general causation. The Minnesota Court of Appeals affirmed the
state court orders in their entirety and the Minnesota Supreme Court denied plaintiffs’ petition for review and entered the finial dismissal in 2019,
effectively ending the Minnesota state court cases.
In June 2016, the Company was served with a putative class action filed in the Ontario Superior Court of Justice for all Canadian residents who
underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections that the representative plaintiff
claims was due to the use of the Bair Hugger™ patient warming system. The representative plaintiff seeks relief (including punitive damages)
under Canadian law based on theories similar to those asserted in the MDL.
No liability has been recorded for the Bair Hugger™ litigation because the Company believes that any such liability is not probable and estimable
at this time.
For product liability litigation matters described in this section for which a liability has been recorded, the amount recorded is not material to the
Company’s consolidated results of operations or financial condition. In addition, the Company is not able to estimate a possible loss or range of
loss in excess of the established accruals at this time.
127

-- 139 of 160 --

Securities Litigation
In July 2019, Heavy & General Laborers’ Locals 472 & 172 Welfare Fund filed a putative securities class action against 3M Company, its former
Chairman and CEO, current Chairman and CEO, and former CFO in the U.S. District Court for the District of New Jersey. In August 2019, an
individual plaintiff filed a similar putative securities class action in the same district. Plaintiffs allege that defendants made false and misleading
statements regarding 3M's exposure to liability associated with PFAS, and bring claims for damages under Section 10(b) of the Securities
Exchange Act of 1934 and SEC Rule 10b-5 against all defendants, and under Section 20(a) of the Securities and Exchange Act of 1934 against the
individual defendants. In October 2019, the court consolidated the securities class actions and appointed a group of lead plaintiffs. In January
2020, the defendants filed a motion to transfer venue to the U.S. District Court for the District of Minnesota. In August 2020, the court denied the
motion to transfer venue, and in September 2020, the defendants filed a petition for writ of mandamus to the U.S. Court of Appeals for the Third
Circuit. In November 2020, the federal Court of Appeals granted 3M’s petition for a writ of mandamus and directed the New Jersey federal court
to transfer the action to the Minnesota federal court. The defendants filed a motion to dismiss the action in January 2021. The suit is in the early
stages of litigation.
In October 2019, a follow-on derivative lawsuit was filed in the U.S. District Court for the District of New Jersey against 3M and several of its
current and former executives and directors. In November and December 2019, two additional derivative lawsuits were filed in a Minnesota state
court. The derivative lawsuits rely on similar factual allegations as the putative securities class action discussed above. The plaintiffs have agreed
to stay these cases pending a ruling on a motion to dismiss the securities class action. In October 2020, the derivative action pending in the U.S.
District Court for the District of New Jersey was dismissed, without prejudice, for failure to serve the complaint within the required time period.
In August 2020, an individual shareholder who had previously submitted a books and records demand filed an additional follow-on derivative
lawsuit in the U.S. District Court for the District of New Jersey against 3M and several of its current and former executives and directors. This
derivative lawsuit also relies on similar factual allegations as the putative securities class action discussed above.
Federal False Claims Act / Qui Tam Litigation
In October 2019, 3M acquired Acelity, Inc. and its KCI subsidiaries, including Kinetic Concepts, Inc. and KCI USA, Inc. As previously disclosed
in the SEC filings by the KCI entities, in 2009, Kinetic Concepts, Inc. received a subpoena from the U.S. Department of Health and Human
Services Office of Inspector General. In 2011, following the completion of the government’s review and its decision declining to intervene in two
qui tam actions described further below, the qui tam relator-plaintiffs’ pleadings were unsealed.
The government inquiry followed two qui tam actions filed in 2008 by two former employees against Kinetic Concepts, Inc. and KCI USA, Inc.
(collectively, the “KCI defendants”) under seal in the U.S. District Court for the Central District of California. The complaints contain allegations
that the KCI Defendants violated the federal False Claims Act by submitting false or fraudulent claims to federal healthcare programs by billing
for V.A.C.® Therapy in a manner that was not consistent with the Local Coverage Determinations issued by the Durable Medical Equipment
Medicare Administrative Contractors and seek monetary damages. One complaint (the “Godecke case”) also contains allegations that the KCI
Defendants retaliated against the relator-plaintiff for alleged whistle-blowing behavior.
In October 2016, the KCI Defendants filed counterclaims in the Godecke case, asserting breach of contract and conversion. In August 2017, the
relator-plaintiff’s fraud claim in the Godecke case was dismissed in favor of the KCI defendants. In January 2018, the district court stayed the
retaliation claim and the KCI Defendants' counterclaims pending the relator-plaintiff’s appeal. In September 2019, the U.S. Court of Appeals for
the Ninth Circuit reversed and remanded the case to the district court for further proceedings. The district court has ordered a stay of the
proceedings pending a further status conference in March 2021. Separately, in June 2019, following discovery, the district court in the second case
(the “Hartpence case”) entered summary judgment in the KCI Defendants’ favor on all of the relator-plaintiff’s claims. The relator-plaintiff then
filed an appeal in the U.S. Court of Appeals for the Ninth Circuit. Oral argument in the Hartpence case was held in July 2020. The appellate
court’s opinion remains pending.
For the matters described in this section for which a liability has been recorded, the amount recorded is not material to the Company’s consolidated
results of operations or financial condition.
128

-- 140 of 160 --

Compliance Matter
The Company, through its internal processes, discovered certain travel activities and related funding and record keeping issues raising concerns,
arising from marketing efforts by certain business groups based in China. The Company initiated an internal investigation to determine whether
the expenditures may have violated the U.S. Foreign Corrupt Practices Act (FCPA) or other potentially applicable anti-corruption laws. 	The
Company has retained outside counsel and a forensic accounting firm to assist with the investigation. In July 2019, the Company voluntarily
disclosed this investigation to both the Department of Justice and Securities and Exchange Commission and is cooperating with both agencies. The
Company cannot predict at this time the outcome of its investigation or what potential actions may be taken by the Department of Justice or
Securities and Exchange Commission.
NOTE 17. Leases
The components of lease expense are as follows:
Year ended December 31,
(Millions) 	2020 	2019
Operating lease cost 	$ 	348 	$ 	308
Finance lease cost:
Amortization of assets 	21 	20
Interest on lease liabilities 	1 	2
Variable lease cost 	101 	93
Total net lease cost 	$ 	471 	$ 	423
Short-term lease cost and income related to sub-lease activity is immaterial for the Company.
Supplemental balance sheet information related to leases is as follows:
Location on Face of 	As of December 31,
(Millions unless noted) 	Balance Sheet 	2020 	2019
Operating leases:
Operating lease right of use assets 	Operating lease right of use assets 	$ 	864 	$ 	858
Current operating lease liabilities 	Operating lease liabilities - current 	$ 	256 	$ 	247
Noncurrent operating lease liabilities 	Operating lease liabilities 	609 	607
Total operating lease liabilities 	$ 	865 	$ 	854
Finance leases:
Property and equipment, at cost 	Property, plant and equipment 	$ 	225 	$ 	239
Accumulated amortization
Property, plant and equipment
(accumulated depreciation) 	(106) 	(102)
Property and equipment, net 	$ 	119 	$ 	137
Current obligations of finance leases 	Other current liabilities 	$ 	22 	$ 	21
Finance leases, net of current obligations 	Other liabilities 	93 	111
Total finance lease liabilities 	$ 	115 	$ 	132
Weighted average remaining lease term (in years):
Operating leases 	5.6 	5.7
Finance leases 	7.6 	9.0
Weighted average discount rate:
Operating leases 	2.4 % 	3.2 %
Finance leases 	3.5 % 	3.8 %
129

-- 141 of 160 --

Supplemental cash flow and other information related to leases is as follows:
Year Ended December 31,
(Millions) 	2020 	2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases 	$ 	326 	$ 	309
Operating cash flows from finance leases 	1 	2
Financing cash flows from finance leases 	58 	18
Right of use assets obtained in exchange for lease liabilities:
Operating leases 	250 	326
Finance leases 	18 	61
In the first quarter of 2020, 3M sold and leased-back certain recently constructed machinery and equipment in return for municipal securities,
which in aggregate, were recorded as a finance lease asset and obligation of approximately $10 million. In the first quarter of 2019, 3M sold and
leased-back certain recently constructed machinery and equipment in return for municipal securities, which in aggregate, were recorded as a
finance lease asset and obligation of approximately $9 million. During 2019, the Company sold and leased-back an office location and a
manufacturing site resulting in a combined gain of $82 million.
Maturities of lease liabilities were as follows:
December 31, 2020
(Millions) 	Finance Leases 	Operating Leases
2021 	$ 	20 	$ 	273
2022 	18 	201
2023 	18 	141
2024 	16 	93
2025 	10 	60
After 2025 	41 	162
Total 	$ 	123 	$ 	930
Less: Amounts representing interest 	8 	65
Present value of future minimum lease payments 	115 	865
Less: Current obligations 	22 	256
Long-term obligations 	$ 	93 	$ 	609
As of December 31, 2020, the Company has additional operating lease commitments that have not yet commenced of approximately $18 million.
These commitments pertain to 3M’s right of use of certain buildings.
Disclosures related to periods prior to 2019 adoption of new lease standard:
Capital and Operating Leases:
Rental expense under operating leases was $393 million in 2018.
NOTE 18. Stock-Based Compensation
The 3M 2016 Long-Term Incentive Plan provides for the issuance or delivery of up to 123,965,000 shares of 3M common stock pursuant to
awards granted under the plan. Awards may be issued in the form of incentive stock options, nonqualified stock options, stock appreciation rights,
restricted stock, restricted stock units, other stock awards, and performance units and performance shares. As of December 31, 2020, the remaining
shares available for grant under the LTIP Program are 16 million and there were approximately 8,000 participants with outstanding options,
restricted stock, or restricted stock units.
The Company’s annual stock option and restricted stock unit grant is made in February to provide a strong and immediate link between the
performance of individuals during the preceding year and the size of their annual stock compensation grants. The grant to eligible employees uses
the closing stock price on the grant date. Accounting rules require recognition of expense under a non-
130

-- 142 of 160 --

substantive vesting period approach, requiring compensation expense recognition when an employee is eligible to retire. Employees are considered
eligible to retire at age 55 and after having completed ten years of service. This retiree-eligible population represents 35 percent of the annual
grant’s stock-based compensation expense; therefore, higher stock-based compensation expense is recognized in the first quarter.
In addition to the annual grants, the Company makes other minor grants of stock options, restricted stock units and other stock-based grants. The
Company issues cash settled restricted stock units and stock appreciation rights in certain countries. These grants do not result in the issuance of
common stock and are considered immaterial by the Company.
Amounts recognized in the financial statements with respect to stock-based compensation programs, which include stock options, restricted stock,
restricted stock units, performance shares and the General Employees’ Stock Purchase Plan (GESPP), are provided in the following table.
Capitalized stock-based compensation amounts were not material.
Stock-Based Compensation Expense
Years ended December 31
(Millions) 	2020 	2019 	2018
Cost of sales 	$ 	50 	$ 	47 	$ 	48
Selling, general and administrative expenses 	169 	185 	207
Research, development and related expenses 	43 	46 	47
Stock-based compensation expenses 	$ 	262 	$ 	278 	$ 	302
Income tax benefits 	(82) 	(141) 	(154)
Stock-based compensation expenses (benefits), net of tax 	$ 	180 	$ 	137 	$ 	148
Stock Option Program
The following table summarizes stock option activity for the years ended December 31:
2020 	2019 	2018
Weighted 	Weighted 	Weighted
Number of 	Average 	Number of 	Average 	Number of 	Average
(Options in thousands) 	Options 	Exercise Price 	Options 	Exercise Price 	Options 	Exercise Price
Under option —
January 1 	33,675 	$ 	151.15 	34,569 	$ 	138.98 	34,965 	$ 	125.73
Granted 	4,777 	157.25 	3,434 	200.80 	3,211 	233.19
Exercised 	(2,759) 	93.23 	(4,193) 	89.89 	(3,482) 	91.01
Forfeited 	(292) 	181.33 	(135) 	201.27 	(125) 	188.00
December 31 	35,401 	$ 	156.23 	33,675 	$ 	151.15 	34,569 	$ 	138.98
Options exercisable
December 31 	27,537 	$ 	149.67 	26,487 	$ 	136.75 	26,117 	$ 	121.98
Stock options generally vest over a period from one to three years with the expiration date at 10 years from date of grant. As of December 31,
2020, there was $56 million of compensation expense that has yet to be recognized related to non-vested stock option based awards. This expense
is expected to be recognized over the remaining weighted-average vesting period of 20 months. For options outstanding at December 31, 2020, the
weighted-average remaining contractual life was 63 months and the aggregate intrinsic value was $929 million. For options exercisable at
December 31, 2020, the weighted-average remaining contractual life was 51 months and the aggregate intrinsic value was $847 million.
The total intrinsic values of stock options exercised during 2020, 2019 and 2018 was $206 million, $433 million and $469 million, respectively.
Cash received from options exercised during 2020, 2019 and 2018 was $256 million, $375 million and $316 million, respectively. The Company’s
actual tax benefits realized for the tax deductions related to the exercise of employee stock options for 2020, 2019 and 2018 was $44 million, $91
million and $99 million, respectively.
For the primary annual stock option grant, the weighted average fair value at the date of grant was calculated using the Black-Scholes option-
pricing model and the assumptions that follow.
131

-- 143 of 160 --

Stock Option Assumptions
Annual
2020 	2019 	2018
Exercise price 	$ 	157.24 	$ 	201.12 	$ 	233.63
Risk-free interest rate 	1.5 % 	2.6 % 	2.7 %
Dividend yield 	2.7 % 	2.5 % 	2.4 %
Expected volatility 	19.7 % 	20.4 % 	21.0 %
Expected life (months) 	78 	79 	78
Black-Scholes fair value 	$ 	21.58 	$ 	34.19 	$ 	41.59
Expected volatility is a statistical measure of the amount by which a stock price is expected to fluctuate during a period. For the 2020 annual grant
date, the Company estimated the expected volatility based upon the following three volatilities of 3M stock: the median of the term of the expected
life rolling volatility; the median of the most recent term of the expected life volatility; and the implied volatility on the grant date. The expected
term assumption is based on the weighted average of historical grants.
Restricted Stock and Restricted Stock Units
The following table summarizes restricted stock and restricted stock unit activity for the years ended December 31:
2020 	2019 	2018
Weighted 	Weighted 	Weighted
Average 	Average 	Average
Number of 	Grant Date 	Number of 	Grant Date 	Number of 	Grant Date
(Shares in thousands) 	Shares 	Fair Value 	Shares 	Fair Value 	Shares 	Fair Value
Nonvested balance —
As of January 1 	1,573 	$ 	201.11 	1,789 	$ 	180.02 	1,994 	$ 	162.60
Granted
Annual 	733 	157.29 	564 	200.41 	467 	233.61
Other 	45 	159.49 	15 	180.08 	8 	207.76
Vested 	(570) 	176.20 	(732) 	149.33 	(640) 	164.83
Forfeited 	(59) 	196.31 	(63) 	192.52 	(40) 	186.48
As of December 31 	1,722 	$ 	189.78 	1,573 	$ 	201.11 	1,789 	$ 	180.02
As of December 31, 2020, there was $79 million of compensation expense that has yet to be recognized related to non-vested restricted stock and
restricted stock units. This expense is expected to be recognized over the remaining weighted-average vesting period of 23 months. The total fair
value of restricted stock and restricted stock units that vested during December 31, 2020, 2019 and 2018 was $91 million, $144 million and $155
million, respectively. The Company’s actual tax benefits realized for the tax deductions related to the vesting of restricted stock and restricted
stock units for 2020, 2019 and 2018 was $26 million, $28 million and $29 million, respectively.
Restricted stock units granted generally vest three years following the grant date assuming continued employment. Dividend equivalents equal to
the dividends payable on the same number of shares of 3M common stock accrue on these restricted stock units during the vesting period, although
no dividend equivalents are paid on any of these restricted stock units that are forfeited prior to the vesting date. Dividends are paid out in cash at
the vest date on restricted stock units. Since the rights to dividends are forfeitable, there is no impact on basic earnings per share calculations.
Weighted average restricted stock unit shares outstanding are included in the computation of diluted earnings per share.
Performance Shares
Instead of restricted stock units, the Company makes annual grants of performance shares to members of its executive management. The 2020
performance criteria for these performance shares (organic volume growth, return on invested capital, free cash flow conversion, and earnings per
share growth) were selected because the Company believes that they are important drivers of long-term stockholder value. The number of shares
of 3M common stock that could actually be delivered at the end of the three-year
132

-- 144 of 160 --

performance period may be anywhere from 0% to 200% of each performance share granted, depending on the performance of the Company during
such performance period. When granted, these performance shares are awarded at 100% of the estimated number of shares at the end of the three-
year performance period and are reflected under “Granted” in the table below. Non-substantive vesting requires that expense for the performance
shares be recognized over one or three years depending on when each individual became a 3M executive. The performance share grants accrue
dividends; therefore, the grant date fair value is equal to the closing stock price on the date of grant. Since the rights to dividends are forfeitable,
there is no impact on basic earnings per share calculations. Weighted average performance shares whose performance period is complete are
included in computation of diluted earnings per share.
The following table summarizes performance share activity for the years ended December 31:
2020 	2019 	2018
Weighted 	Weighted 	Weighted
Average 	Average 	Average
Number of 	Grant Date 	Number of 	Grant Date 	Number of 	Grant Date
(Shares in thousands) 	Shares 	Fair Value 	Shares 	Fair Value 	Shares 	Fair Value
Undistributed balance —
As of January 1 	444 	$ 205.58 	562 	$ 	188.96 	686 	$ 	171.90
Granted 	203 	153.16 	166 	207.49 	166 	229.13
Distributed 	(206) 	190.84 	(210) 	162.16 	(206) 	159.82
Performance change 	25 	166.49 	(48) 	204.73 	(56) 	198.39
Forfeited 	(43) 	172.92 	(26) 	209.96 	(28) 	204.09
As of December 31 	423 	$ 188.61 	444 	$ 	205.58 	562 	$ 	188.96
As of December 31, 2020, there was $17 million of compensation expense that has yet to be recognized related to performance shares. This
expense is expected to be recognized over the remaining weighted-average earnings period of 20 months. The total fair value of performance
shares that were distributed were $35 million, $45 million, and $48 million for 2020, 2019 and 2018, respectively. The Company’s actual tax
benefits realized for the tax deductions related to the distribution of performance shares were $7 million, $9 million, and $11 million per year for
2020, 2019, and 2018, respectively.
General Employees’ Stock Purchase Plan (GESPP:
As of December 31, 2020, shareholders have approved 60 million shares for issuance under the Company’s GESPP. Substantially all employees
are eligible to participate in the plan. Participants are granted options at 85% of market value at the date of grant. There are no GESPP shares
under option at the beginning or end of each year because options are granted on the first business day and exercised on the last business day of the
same month.
The weighted-average fair value per option granted during 2020, 2019 and 2018 was $23.47, $27.14 and $31.91, respectively. The fair value of
GESPP options was based on the 15% purchase price discount. The Company recognized compensation expense for GESSP options of $31 million
in 2020, $30 million in 2019, and $30 million in 2018.
NOTE 19. Business Segments and Geographic Information
3M’s businesses are organized, managed and internally grouped into segments based on differences in markets, products, technologies and
services. 3M manages its operations in four business segments: Safety and Industrial; Transportation and Electronics; Health Care; and Consumer.
3M’s four business segments bring together common or related 3M technologies, enhancing the development of innovative products and services
and providing for efficient sharing of business resources. Transactions among reportable segments are recorded at cost. 3M is an integrated
enterprise characterized by substantial intersegment cooperation, cost allocations and inventory transfers. Therefore, management does not
represent that these segments, if operated independently, would report the operating income information shown.
Effective in the second quarter of 2020, the measure of segment operating performance used by 3M’s chief operating decision maker (CODM)
changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment operating income) has been updated for all periods
presented. The change to business segment operating income aligns with the update to how the CODM assesses performance and allocates
resources for the Company’s business segments.
133

-- 145 of 160 --

3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating income and income
before taxes. Business segment operating income includes dual credit for certain related operating income (as described below in “Elimination of
Dual Credit”). Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described
below in “Corporate and Unallocated”). Additionally, the following special items are excluded from business segment operating income and,
instead, are included within Corporate and Unallocated: significant litigation-related charges/benefits, gain/loss on sale of businesses (see Note 3),
and divestiture-related restructuring actions (see Note 5).
In addition, effective in the first quarter of 2020, in a continuing effort to improve the alignment of its businesses around customers and markets,
the Company made the following changes:
Continued alignment of customer account activity
● 	As part of 3M’s regular customer-focus initiatives, the Company realigned certain customer account activity (“sales district”) to correlate
with the primary divisional product offerings in various countries and reduce complexity for customers when interacting with multiple
3M businesses. This largely impacted the amount of dual credit certain business segments receive as a result of sales district attribution.
3M business segment reporting measures include dual credit to business segments for certain sales and operating income. This dual credit
is based on which business segment provides customer account activity with respect to a particular product sold in a specific country. As
a result of this change, previously reported aggregate business segment net sales and operating income for the total year 2019 decreased
$42 million and $10 million, respectively, offset by corresponding decreases in the “Elimination of Dual Credit” net sales and operating
income amounts.
Additional actions impacting product line alignments
● 	The remaining retail auto care product lines formerly in the Automotive Aftermarket Division (within the Safety and Industrial business
segment), were realigned to the Construction and Home Improvement Division (within the Consumer business segment). This change
resulted in a decrease of previously reported net sales and operating income for total year 2019 of $35 million and $11 million,
respectively, in the Safety and Industrial business segment, offset by a corresponding increase in net sales and operating income within
the Consumer business segment.
● 	In addition, certain product lines were realigned within business segments. The transdermal drug delivery components business, formerly
included in the Drug Delivery Systems Division, was realigned to the Medical Solutions Division (both of which are within the Health
Care business segment) and the paint protection film business, formerly included in the Automotive and Aerospace Division, was
realigned to the Commercial Solutions Division (both of which are within the Transportation and Electronics business segment).
The financial information presented herein reflects the impact of the preceding business segment reporting changes for all periods presented.
134

-- 146 of 160 --

Business Segment Products
Business Segment 	Representative revenue-generating activities, products or services
Safety and Industrial 	o 	Industrial abrasives and finishing for metalworking applications
o 	Autobody repair solutions
o 	Closure systems for personal hygiene products, masking, and packaging materials
o 	Electrical products and materials for construction and maintenance, power distribution and electrical OEMs
o 	Structural adhesives and tapes
o 	Respiratory, hearing, eye and fall protection solutions
o 	Natural and color-coated mineral granules for shingles
Transportation and Electronics 	o 	Advanced ceramic solutions
o 	Attachment tapes, films, sound and temperature management for transportation vehicles
o 	Premium large format graphic films for advertising and fleet signage
o 	Light management films and electronics assembly solutions
o 	Packaging and interconnection solutions
o 	Reflective signage for highway, and vehicle safety
Health Care 	o 	Food safety indicator solutions
o 	Health care procedure coding and reimbursement software
o 	Skin, wound care, and infection prevention products and solutions
o 	Dentistry and orthodontia solutions
o 	Filtration and purification systems
Consumer 	o 	Consumer bandages, braces, supports and consumer respirators
o 	Cleaning products for the home
o 	Retail abrasives, paint accessories, car care DIY products, picture hanging and consumer air quality
solutions
o 	Stationery products
135

-- 147 of 160 --

Business Segment Information
Year ended December 31,
Net Sales (Millions) 	2020 	2019 	2018
Safety and Industrial 	$ 	11,767 	$ 	11,514 	$ 	12,414
Transportation and Electronics 	8,827 	9,591 	10,104
Health Care 	8,345 	7,431 	6,821
Consumer 	5,336 	5,151 	5,127
Corporate and Unallocated 	(1) 	110 	50
Elimination of Dual Credit 	(2,090) 	(1,661) 	(1,751)
Total Company 	$ 	32,184 	$ 	32,136 	$ 	32,765
Operating Performance (Millions)
Safety and Industrial 	$ 	3,054 	$ 	2,510 	$ 	2,860
Transportation and Electronics 	1,927 	2,221 	2,643
Health Care 	1,828 	1,858 	1,918
Consumer 	1,249 	1,124 	1,084
Elimination of Dual Credit 	(534) 	(409) 	(436)
Total business segment operating income 	$ 	7,524 	$ 	7,304 	$ 	8,069
Corporate and Unallocated
Special items:
Significant litigation-related (charges)/benefits 	$ 	(17) 	$ 	(762) 	$ 	(897)
Gain/(loss) on sale of businesses 	389 	114 	547
Divestiture-related restructuring actions 	(55) 	— 	(127)
Other corporate expense - net 	(680) 	(482) 	(385)
Total Corporate and Unallocated 	(363) 	(1,130) 	(862)
Total Company operating income 	$ 	7,161 	$ 	6,174 	$ 	7,207
Other expense/(income), net 	450 	462 	207
Income before income taxes 	$ 	6,711 	$ 	5,712 	$ 	7,000
Business Segment Information
Assets 	Depreciation & Amortization 	Capital Expenditures
(Millions) 	2020 	2019 	2020 	2019 	2018 	2020 	2019 	2018
Safety and Industrial 	$ 	11,711 	$ 	11,682 	$ 	562 	$ 	509 	$ 	493 	$ 	451 	$ 	391 	$ 	375
Transportation and Electronics 	6,997 	6,871 	429 	401 	390 	454 	390 	339
Health Care 	14,531 	14,790 	626 	392 	262 	251 	264 	245
Consumer 	2,567 	2,428 	140 	134 	126 	120 	130 	115
Corporate and Unallocated 	11,538 	8,888 	154 	157 	217 	225 	524 	503
Total Company 	$ 	47,344 	$ 	44,659 	$ 	1,911 	$ 	1,593 	$ 	1,488 	$ 	1,501 	$ 	1,699 	$ 	1,577
Assets subject to attribution to business segments largely include accounts receivable; inventories; property, plant and equipment; goodwill;
intangible assets; and certain limited other assets. All other items are reflected in Corporate and Unallocated. Accounts receivable and inventory
are attributed based on underlying sales or activity. Property, plant and equipment are attributed to a particular business segment based on that
item’s primary user while certain items such as corporate-shared headquarters/administrative centers, laboratories, distribution centers and
enterprise software systems are reflected in Corporate and Unallocated. Intangible assets and goodwill are largely directly associated with a
particular reporting unit and attributed on that basis. Business segment depreciation reflected above is based on the underlying usage of assets
(while the particular asset itself may be entirely reflected within a different business segment’s asset balance as its primary user). This depreciation
also includes allocated depreciation associated with a number of the assets reflected in Corporate and Unallocated as described above.
During 2020, information relative to business segment depreciation and assets reviewed by 3M’s CODM changed. The change did not impact each
segment’s operating income, but did change the separate summarization of depreciation by segment in CODM information. Depreciation
previously was summarized based generally on depreciation of a particular asset being associated entirely
136

-- 148 of 160 --

with a single reporting unit, as opposed to an estimate of underlying asset usage. New CODM reporting of depreciation is as described above.
With respect to assets in CODM reporting, previously certain assets used by multiple segments were “split” in terms of determining the balances
associated with each business segment (new reporting aligns the entire asset to a single primary user), certain shared manufacturing assets were
retained in Corporate and Unallocated, and a number of other assets were allocated to the business segments. The impact of these changes has
been reflected in the above table for all periods presented.
Corporate and Unallocated
Corporate and unallocated operating income includes a variety of miscellaneous items, such as corporate investment gains and losses, certain
derivative gains and losses, certain insurance-related gains and losses, certain litigation and environmental expenses, corporate restructuring
charges and certain under- or over-absorbed costs (e.g. pension, stock-based compensation) that the Company may choose not to allocate directly
to its business segments and is disclosed as ‘other corporate expense-net”. Additionally, Corporate and Unallocated includes special items such as
significant litigation-related charges/benefits, gain/loss on sale of businesses (see Note 3), and divestiture-related restructuring costs (see Note 5).
Corporate and Unallocated also includes sales, costs, and income from contract manufacturing, transition services and other arrangements with the
acquirer of all of the Communication Markets Division following its 2018 divestiture through 2019 and the acquirer of the former drug delivery
business following its 2020 divestiture. Because this category includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly
and annual basis.
Elimination of Dual Credit
3M business segment reporting measures include dual credit to business segments for certain sales and related operating income. Management
evaluates each of its four business segments based on net sales and operating income performance, including dual credit reporting to further
incentivize sales growth. As a result, 3M reflects additional (“dual”) credit to another business segment when the customer account activity (“sales
district”) with respect to the particular product sold to the external customer is provided by a different business segment. This additional dual
credit is largely reflected at the division level. For example, privacy screen protection products are primarily sold by the Display Materials and
Systems Division within the Transportation and Electronics business segment; however, certain sales districts within the Consumer business
segment provide the customer account activity for sales of the product to particular customers. In this example, the non-primary selling segment
(Consumer) would also receive credit for the associated net sales initiated through its sales district and the related approximate operating income.
The assigned operating income related to dual credit activity may differ from operating income that would result from actual costs associated with
such sales. The offset to the dual credit business segment reporting is reflected as a reconciling item entitled “Elimination of Dual Credit,” such
that sales and operating income in total are unchanged.
Geographic Information
Geographic area information is used by the Company as a secondary performance measure to manage its businesses. Export sales and certain
income and expense items are generally reported within the geographic area where the final sales to 3M customers are made. Refer to Note 2 for
geographic net sales.
Property, Plant and
Equipment - net
(Millions) 	2020 	2019
Americas 	$ 	5,752 	$ 	5,873
Asia Pacific 	1,662 	1,637
Europe, Middle East and Africa 	2,007 	1,823
Total Company 	$ 	9,421 	$ 	9,333
United States net property, plant and equipment (PP&E) was $5,358 and $5,442 million at December 31, 2020 and 2019, respectively. China/Hong
Kong net property, plant and equipment (PP&E) was $583 million and $553 million at December 31, 2020 and 2019, respectively.
137

-- 149 of 160 --

NOTE 20. Quarterly Data (Unaudited)
(Millions, except per-share amounts) 	First 	Second 	Third 	Fourth 	Year
2020 	Quarter 	Quarter 	Quarter 	Quarter 	2020
Net sales 	$ 	8,075 	$ 	7,176 	$ 	8,350 	$ 	8,583 	$ 	32,184
Cost of sales 	4,109 	3,805 	4,303 	4,388 	16,605
Net income including noncontrolling interest 	1,294 	1,287 	1,417 	1,390 	5,388
Net income attributable to 3M 	1,292 	1,290 	1,413 	1,389 	5,384
Earnings per share attributable to 3M common shareholders - basic 	2.24 	2.24 	2.45 	2.40 	9.32
Earnings per share attributable to 3M common shareholders - diluted 	2.22 	2.22 	2.43 	2.38 	9.25
(Millions, except per-share amounts) 	First 	Second 	Third 	Fourth 	Year
2019 	Quarter 	Quarter 	Quarter 	Quarter 	2019
Net sales 	$ 	7,863 	$ 	8,171 	$ 	7,991 	$ 	8,111 	$ 	32,136
Cost of sales 	4,310 	4,313 	4,188 	4,325 	17,136
Net income including noncontrolling interest 	893 	1,131 	1,588 	970 	4,582
Net income attributable to 3M 	891 	1,127 	1,583 	969 	4,570
Earnings per share attributable to 3M common shareholders - basic 	1.54 	1.95 	2.75 	1.68 	7.92
Earnings per share attributable to 3M common shareholders - diluted 	1.51 	1.92 	2.72 	1.66 	7.81
Gross profit is calculated as net sales minus cost of sales.
In the first quarter of 2020, 3M recorded a net pre-tax charge of $17 million ($13 million after tax) related to PFAS (certain perfluorinated
compounds) matters. The charge was more than offset by a reduction in tax expense of $52 million related to resolution of tax treatment with
authorities regarding the previously disclosed 2018 agreement reached with the State of Minnesota that resolved the Natural Resources Damages
(NRD) lawsuit. These items, in aggregate, resulted in a $39 million after tax benefit, or $0.07 per diluted share. Also, in the second quarter of
2020, the Company recorded an aggregate after tax gain on sale of businesses of $303 million, or $0.52 per diluted share in addition to divestiture-
related restructuring charges of $46 million, or $0.08 per diluted share.
In 2019, the Company recorded significant litigation-related charges related to PFAS matters and coal mine dust respirator mask lawsuits as
further described in Note 16, which reduced net income by $590 million, or $1.01 per diluted share, of which $424 million, or $0.72 per diluted
share occurred in the first quarter and $166 million, or $0.29 per diluted share occurred in the fourth quarter. Additionally, in 2019, the Company
recorded an aggregate after tax gain on sale of businesses of $129 million, or $0.22 per diluted share. In the second quarter of 2019, the Company
recorded a non-operating charge related to the deconsolidation of its Venezuelan subsidiary, which reduced net income by $162 million, or $0.28
per diluted share.
138

-- 150 of 160 --

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.
None.
Item 9A. Controls and Procedures.
a. The Company carried out an evaluation, under the supervision and with the participation of its management, including the Chief Executive
Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as
defined in the Exchange Act Rule 13a-15(e)) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive
Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.
b. The Company’s management is responsible for establishing and maintaining an adequate system of internal control over financial reporting, as
defined in the Exchange Act Rule 13a-15(f). Management conducted an assessment of the Company’s internal control over financial reporting
based on the framework established by the Committee of Sponsoring Organizations of the Treadway Commission in 	Internal Control —
Integrated Framework (2013). 	Based on the assessment, management concluded that, as of December 31, 2020, the Company’s internal control
over financial reporting is effective. The Company’s internal control over financial reporting as of December 31, 2020 has been audited by
PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which is included herein, which expresses
an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2020.
c. There was no change in the Company’s internal control over financial reporting that occurred during the Company’s most recently completed
fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
The Company is implementing an enterprise resource planning (“ERP”) system on a worldwide basis, which is expected to improve the efficiency
of certain financial and related transaction processes. The gradual implementation is expected to occur in phases over the next several years. The
implementation of a worldwide ERP system will likely affect the processes that constitute our internal control over financial reporting and will
require testing for effectiveness.
The Company completed implementation with respect to various processes/sub-processes in certain subsidiaries/locations, including aspects
relative to the United States, and will continue to roll out the ERP system over the next several years. As with any new information technology
application we implement, this application, along with the internal controls over financial reporting included in this process, was appropriately
considered within the testing for effectiveness with respect to the implementation in these instances. We concluded, as part of its evaluation
described in the above paragraphs, that the implementation of the ERP system in these circumstances has not materially affected our internal
control over financial reporting.
Item 9B. Other Information.
Disclosure Under Iran Threat Reduction and Syria Human Rights Act of 2012
The Company is making the following disclosure under Section 13(r) of the Exchange Act:
Protection of Intellectual Property Rights in Iran Pursuant to Specific License
As part of its intellectual property (“IP”) protection efforts, 3M has obtained and maintains patents and trademarks in Iran. Periodically, 3M pays
renewal fees, through IP service providers/counsel located in Germany, Dubai and Iran, to the Iran Intellectual Property Office (“IIPO”) for these
patents and trademarks and has sought to prosecute and defend such trademarks. On January 15, 2020, OFAC granted 3M a specific license to
make payments to IIPO at its account in Bank Melli, which was designated on November 5, 2018 by OFAC under its counter terrorism authority
pursuant to Executive Order 13224. As authorized by OFAC’s specific license, in the quarter ended December 31, 2020, 3M paid $522 to IIPO as
part of its intellectual property protection efforts in Iran. 3M plans to continue these activities, as authorized under the specific license.
139

-- 151 of 160 --

PART III
Documents Incorporated by Reference
In response to Part III, Items 10, 11, 12, 13 and 14, parts of the Company’s definitive proxy statement (to be filed pursuant to Regulation 14A
within 120 days after Registrant’s fiscal year-end of December 31, 2020) for its annual meeting to be held on May 11, 2021, are incorporated by
reference in this Form 10-K.
Item 10. Directors, Executive Officers and Corporate Governance.
The information relating to directors and nominees of 3M is set forth under the caption “Proposal No. 1” in 3M’s proxy statement for its annual
meeting of stockholders to be held on May 11, 2021 (“3M Proxy Statement”) and is incorporated by reference herein. Information about executive
officers is included in Item 1 of this Annual Report on Form 10-K. The information required by Items 405, 407(c)(3), (d)(4) and (d)(5) of
Regulation S-K is contained under the captions “Corporate Governance At 3M — Board Membership Criteria — Identification, Evaluation, and
Selection of Nominees,” “—Shareholder Nominations,” “—Shareholder Nominations – Advance Notice Bylaw”, and “—Proxy Access
Nominations” and “Corporate Governance At 3M -- Board Committees – Audit Committee” of the 3M Proxy Statement and such information is
incorporated by reference herein.
Code of Ethics. All of our employees, including our Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer and
Controller, are required to abide by 3M’s long-standing business conduct policies to ensure that our business is conducted in a consistently legal
and ethical manner. 3M has posted the text of such code of ethics on its website (https://www.3M.com/3M/en_US/ethics-compliance). At the same
website, any future amendments to the code of ethics will also be posted. Any person may request a copy of the code of ethics, at no cost, by
writing to us at the following address:
3M Company
3M Center, Building 220-11W-09
St. Paul, MN 55144-1000
Attention: Vice President, 3M Ethics & Compliance
Item 11. Executive Compensation.
The information required by Item 402 of Regulation S-K is contained under the captions “Executive Compensation” (excluding the information
under the caption “— Compensation Committee Report”) and “Director Compensation” and “Stock Retention Requirement” of the 3M Proxy
Statement. Such information is incorporated by reference.
The information required by Items 407(e)(4) and (e)(5) of Regulation S-K is contained in the “Executive Compensation” section under the
captions “Compensation Committee Report” and “Compensation Committee Interlocks and Insider Participation” of the 3M Proxy Statement.
Such information (other than the Compensation Committee Report, which shall not be deemed to be “filed”) is incorporated by reference.
140

-- 152 of 160 --

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The information relating to security ownership of certain beneficial owners and management is set forth under the designation “Security
Ownership of Management” and “Security Ownership of Certain Beneficial Owners” in the 3M Proxy Statement and such information is
incorporated by reference herein.
Equity compensation plans information as of December 31, 2020 follows:
Equity Compensation Plans Information (1)
A 	B 	C
Number of 	Weighted- 	Number of securities
securities to be 	average exercise 	remaining available for
issued upon 	price of 	future issuance under
exercise of 	outstanding 	equity compensation
outstanding 	options, 	plans (excluding
options, warrants 	warrants and 	securities reflected in
Plan Category (options and shares in thousands) 	and rights 	rights 	column (A))
Equity compensation plans approved by security holders
Stock options 	35,401 	$ 	156.23 	—
Restricted stock units 	1,722 	—
Performance shares 	423 	—
Non-employee director deferred stock units 	244 	—
Total 	37,790 	16,044
Employee stock purchase plan 	— 	22,887
Subtotal 	37,790 	38,931
Total 	37,790 	38,931
(1) 	In column B, the weighted-average exercise price is only applicable to stock options. In column C, the number of securities remaining
available for future issuance for stock options, restricted stock units, and stock awards for non-employee directors is approved in total and not
individually with respect to these items.
Item 13. Certain Relationships and Related Transactions, and Director Independence.
With respect to certain relationships and related transactions as set forth in Item 404 of Regulation S-K, no matters require disclosure with respect
to transactions with related persons. The information required by Item 404(b) and Item 407(a) of Regulation S-K is contained under the section
“Corporate Governance at 3M” under the captions “Director Independence” and “Related Person Transaction Policy and Procedures” of the 3M
Proxy Statement and such information is incorporated by reference herein.
Item 14. Principal Accounting Fees and Services.
The information relating to principal accounting fees and services is set forth in the section entitled “Audit Committee Matters” under the
designation “Audit Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services of the Independent Accounting Firm” and
“Fees of the Independent Accounting Firm” in the 3M Proxy Statement and such information is incorporated by reference herein.
141

-- 153 of 160 --

PART IV
Item 15. Exhibits, Financial Statement Schedules.
(a) (1) Financial Statements. The consolidated financial statements filed as part of this report are listed in the index to financial statements at the
beginning of this document.
(a) (2) Financial Statement Schedules. Financial statement schedules are omitted because of the absence of the conditions under which they are
required or because the required information is included in the Consolidated Financial Statements or the notes thereto. The financial statements of
unconsolidated subsidiaries are omitted because, considered in the aggregate, they would not constitute a significant subsidiary.
(a) (3) Exhibits. The exhibits are either filed with this report or incorporated by reference into this report. See (b) Exhibits, which follow.
(b) Exhibits.
(3) 	Articles of Incorporation and bylaws
(3.1)
(3.2)
Certificate of incorporation, as amended as of December 4, 2017, is incorporated by reference from our Form 8-K dated
December 7, 2017.
Amended and Restated Bylaws, as adopted as of February 2, 2021, are incorporated by reference from our Form 8-K dated
February 3, 2021.
(4) 	Instruments defining the rights of security holders, including indentures:
(4.1)
(4.2)
Indenture, dated as of November 17, 2000, between 3M and The Bank of New York Mellon Trust Company, N.A., as successor
trustee, with respect to 3M’s senior debt securities, is incorporated by reference from our Form 8-K dated December 7, 2000.
First Supplemental Indenture, dated as of July 29, 2011, to Indenture dated as of November 17, 2000, between 3M and The Bank
(4.3)
of New York Mellon Trust Company, N.A., as successor trustee, with respect to 3M’s senior debt securities, is incorporated by
reference from our Form 10-Q for the quarter ended June 30, 2011.
Description of Securities is incorporated by reference from our Form 10-K for the year ended December 31, 2019.
(10) 	Material contracts and management compensation plans and arrangements:
(10.1)* 	3M Company 2016 Long-Term Incentive Plan is incorporated by reference from our Form 8-K dated May 12, 2016.
(10.2)* 	Form of Stock Option Award Agreement under the 3M Company 2016 Long-Term Incentive Plan is incorporated by reference
from our Form 8-K dated May 12, 2016.
(10.3)* 	Form of Stock Appreciation Right Award Agreement under the 3M Company 2016 Long-Term Incentive Plan is incorporated by
reference from our Form 8-K dated May 12, 2016.
(10.4)* 	Form of Restricted Stock Unit Award Agreement under the 3M Company 2016 Long-Term Incentive Plan is incorporated by
reference from our Form 8-K dated May 12, 2016.
(10.5)* 	Form of Performance Share Award Agreement for performance share awards granted under the 3M Company 2016 Long-Term
Incentive Plan on or after February 5, 2018 is incorporated by reference from our Form 10-K for the year ended December 31,
2017.
(10.6)* 	Form of Performance Share Award Agreement for performance share awards granted under the 3M Company 2016 Long-Term
Incentive Plan on or after February 1, 2021 is filed herewith.
(10.7)* 	Form of Stock Issuance Award Agreement for stock issuances on or after January 1, 2019 to Non-Employee Directors under the
3M Company 2016 Long-Term Incentive Plan is incorporated by reference from our Form 10-K for the year ended December 31,
2018.
(10.8)* 	Form of Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to Non-Employee
Directors under the 3M Company 2016 Long-Term Incentive Plan is incorporated by reference from our Form 10-K for the year
ended December 31, 2018.
(10.9)* 	3M 2008 Long-Term Incentive Plan (including amendments through February 2, 2016) is incorporated by reference from our Form
10-K for the year ended December 31, 2015.
142

-- 154 of 160 --

(10.10)* 	Form of Agreement for Stock Option Grants to Executive Officers under 3M 2008 Long-Term Incentive Plan is incorporated by
reference from our Form 8-K dated May 13, 2008.
(10.11)* 	Form of Stock Option Agreement for options granted to Executive Officers under the 3M 2008 Long-Term Incentive Plan,
commencing February 9, 2010, is incorporated by reference from our Form 10-K for the year ended December 31, 2009.
(10.12)* 	Form of Stock Option Agreement for U.S. Employees under 3M 2008 Long-Term Incentive Plan is incorporated by reference from
our Form 10-K for the year ended December 31, 2008.
(10.13)* 	Amended and Restated 3M VIP Excess Plan is incorporated by reference from our Form 10-K for the year ended December 31,
2016.
(10.14)* 	Amended and Restated 3M VIP (Voluntary Investment Plan) Plus Plan is incorporated by reference from our Form 10-K for the
year ended December 31, 2016.
(10.15)* 	3M Deferred Compensation Excess Plan is incorporated by reference from our Form 10-K for the year ended December 31, 2009.
(10.16)* 	3M Performance Awards Deferred Compensation Plan is incorporated by reference from our Form 10-K for the year ended
December 31, 2009.
(10.17)* 	3M Annual Incentive Plan (including amendments through February 3, 2020) incorporated by reference from our Form 10-K for
the year ended December 31, 2019.
(10.18)* 	3M Executive Severance Plan is incorporated by reference from our Form 10-K for the year ended December 31, 2019.
(10.19)* 	3M Compensation Plan for Non-Employee Directors, as amended, through November 8, 2004, is incorporated by reference from
our Form 10-K for the year ended December 31, 2004.
(10.20)* 	Amendment of 3M Compensation Plan for Non-Employee Directors is incorporated by reference from our Form 8-K dated
November 14, 2008.
(10.21)* 	Amendment of 3M Compensation Plan for Non-Employee Directors as of August 12, 2013, is incorporated by reference from our
Form 10-Q for the quarter ended September 30, 2013.
(10.22)* 	Amendment and Restatement of 3M Compensation Plan for Non-Employee Directors as of January 1, 2019, is incorporated by
reference from our Form 10-K for the year ended December 31, 2018.
(10.23)* 	3M Executive Life Insurance Plan, as amended, is incorporated by reference from our Form 10-K for the year ended December 31,
2017.
(10.24)* 	Policy on Reimbursement of Incentive Payments is incorporated by reference from our Form 10-Q for the quarter ended June 30,
2018.
(10.25)* 	Amended and Restated 3M Nonqualified Pension Plan I is incorporated by reference from our Form 10-K for the year ended
December 31, 2016.
(10.26)* 	Amended and Restated 3M Nonqualified Pension Plan II is incorporated by reference from our Form 10-K for the year ended
December 31, 2016.
(10.27)* 	Amended and Restated 3M Nonqualified Pension Plan III is incorporated by reference from our Form 10-K for the year ended
December 31, 2016.
(10.28)* 	Offer letter of Employment of Monish Patolawala, dated May 19, 2020 is incorporated by reference from our Form 8-K dated June
3, 2020.
(10.29) 	Amended and restated five-year credit agreement as of November 15, 2019, is incorporated by reference from our Form 8-K dated
November 19, 2019.
(10.30) 	364-day credit agreement as of November 13, 2020, is incorporated by reference from our Form 8-K dated November 17, 2020.
(10.31) 	Registration Rights Agreement as of August 4, 2009, between 3M Company and State Street Bank and Trust Company as
Independent Fiduciary of the 3M Employee Retirement Income Plan, is incorporated by reference from our Form 8-K dated
August 5, 2009.
143

-- 155 of 160 --

Filed herewith, in addition to items, if any, specifically identified above:
(21) Subsidiaries of the Registrant.
(23) Consent of independent registered public accounting firm.
(24) Power of attorney.
(31.1)
(31.2)
(32.1)
(32.2)
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.
Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.
Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.
(95) Mine Safety Disclosures.
(101.INS) 	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are
embedded within the Inline XBRL document)
(101.SCH) 	Inline XBRL Taxonomy Extension Schema Document
(101.CAL) 	Inline XBRL Taxonomy Extension Calculation Linkbase Document
(101.DEF) 	Inline XBRL Taxonomy Extension Definition Linkbase Document
(101.LAB) 	Inline XBRL Taxonomy Extension Label Linkbase Document
(101.PRE)
(104)
Inline XBRL Taxonomy Extension Presentation Linkbase Document
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
________________________
* Management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to Item 15 of Form 10-K.
Item 16. Form 10-K Summary.
A Form 10-K summary is provided at the beginning of this document, with hyperlinked cross-references. This allows users to easily locate the
corresponding items in Form 10-K, where the disclosure is fully presented. The summary does not include certain Part III information that is
incorporated by reference from a future proxy statement filing.
144

-- 156 of 160 --

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
3M COMPANY
By /s/ Monish Patolawala
Monish Patolawala,
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
February 4, 2021
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
Registrant and in the capacities indicated on February 4, 2021.
Signature 	Title
Michael F. Roman 	Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer and Director)
Theresa E. Reinseth 	Vice President, Corporate Controller and Chief Accounting Officer
(Principal Accounting Officer)
Thomas K. Brown 	Director
Pamela J. Craig 	Director
David B. Dillon 	Director
Michael L. Eskew 	Director
Herbert L. Henkel 	Director
Amy E. Hood
Muhtar Kent
Director
Director
Dambisa F. Moyo 	Director
Gregory R. Page 	Director
Patricia A. Woertz 	Director
Monish Patolawala, by signing his name hereto, does hereby sign this document pursuant to powers of attorney duly executed by the other persons
named, filed with the Securities and Exchange Commission on behalf of such other persons, all in the capacities and on the date stated, such
persons constituting a majority of the directors of the Company.
By 	/s/ Monish Patolawala
Monish Patolawala, 	Attorney-in-Fact
145

-- 157 of 160 --

This page is left intentionally blank.
146

-- 158 of 160 --

Account Information
Registered 3M shareholders can access account
information and get answers to frequently asked
questions in several ways:
Internet: 	www.shareowneronline.com
Telephone: 	(651) 450-4064 or 1-800-401-1952
E-mail: 	Go to www.shareowneronline.com
and select Contact Us.
Mail: 	EQ Shareowner Services
P.O. Box 64854
St. Paul, MN 55164-0854
Dividends
Quarterly dividends on 3M common stock typically are
paid on or about the 12th of March, June, September and
December. 3M has paid dividends since 1916. Shareholders
can reinvest dividends and make additional cash contributions
through the Automatic Dividend Reinvestment Plan or have
dividend payments automatically deposited into checking
or savings accounts through the Electronic Dividend
Deposit Service.
Stock Listings
3M’s common stock trades on the New York and Chicago
stock exchanges, and is also traded on the SWX Swiss
Exchange. Our symbol is MMM. 3M is one of 30 companies in
the Dow Jones Industrial Average and is also a component of
the Standard & Poor’s 500 Index.
3M Stock Performance (With Dividend Reinvestment)
The graph above compares the five-year cumulative total
shareholder return for 3M common stock with that of the
Standard & Poor’s 500 Stock Index (S&P 500) and the
Dow Jones Industrial Average (DJIA). The comparison
assumes that $100 was invested in 3M stock and the two
indexes on Dec. 31, 2015, and that all quarterly dividends
were reinvested.
2020 Annual Report
Shareholder information
2020
220.0
200.0
180.0
160.0
140.0
120.0
100.0
2016	2015 	2017 	2019	2018
3M
DJIA
S&P
500
www.3M.com
Visit us on the Web
10-K for a discussion of these risks and uncertainties.
“Risk Factors” in Item 1A of the Annual Report on Form
Factors That May Affect Future Results” in Item 1 and
refer to the section titled “Cautionary Note Concerning
results to differ materially from those projected. Please
that involve risks and uncertainties that could cause
This Annual Report contains forward-looking statements
Forward-Looking Statements
Telephone: 1-800-3M HELPS (1-800-364-3577)
Internet: www.3M.com/product
Information about 3M products and services is available at:
Product Information
investors.3M.com
and Forms 10-K and 10-Q are available online at:
Corporate news releases, 3M’s Annual Report,
Corporate News and Reports
Phone: (651) 737-8503
St. Paul, MN 55144-1000
3M Center, Building 224-1W-02
3M Investor Relations
representatives of financial institutions should contact:
Securities analysts, portfolio managers and
Investor Inquiries
determine your voting options.
If a broker holds your shares, please contact the broker to
www.proxyvote.com, by calling 1-800-690-6903, or by mail.
Shareholders of record may vote proxies via the Internet at
Tuesday, May 11, 2021, at 8:30 a.m. (Central Daylight Time).
3M’s annual meeting of shareholders will be held virtually on
Annual Shareholders’ Meeting

-- 159 of 160 --

On the cover:
NIOSH approved 3M™ Aura™ Health Care Particulate Respirator and
Surgical Mask 1870+. NIOSH approved 3M N95 respirators play a
crucial role in helping to protect health care workers, first responders
and other essential workers on the front lines of the pandemic. N95s
and similar respirators are intended to seal tightly to the face, covering
the mouth and nose and can filter at least 95% of airborne particles
that the wearer might breathe in — including those that may contain
viruses and bacteria.
Corporate Headquarters
3M Center
St. Paul, MN 55144-1000
USA
(651) 733-1110
www.3M.com
Please recycle
© 3M 2021. All rights reserved.
This publication was printed by a
Certified Green Printer (according
to the Sustainable Green Printing
partnership) on a paper containing
10% recycled content.

-- 160 of 160 --